Kuinka elää kuolematta – Löydä ruoat, jotka tutkitusti ehkäisevät sairauksia ja edesauttavat toipumista

Michael Greger & Gene Stone

Lähdeluettelo

Alkulause

1. Monte T. ja Pritikin I. Pritikin: The Man Who Healed America’s Heart. Emmaus, PA: Rodale Press; 1988.

2. Gould K.L., Ornish D., Scherwitz L. ym. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 1995; 274: 894–901.

3. Ornish D., Scherwitz L., Billings J. ym. Intensive lifestyle changes for reversal of coronary heart disease. Five-year follow-up of the Lifestyle Heart Trial. JAMA. 1998; 280: 2001–7.

4. Ornish D.M., Scherwitz L.W., Doody R.S. ym. Effects of stress management training and dietary changes in treating ischemic heart disease. JAMA. 1983; 249: 54–9.

5. Ornish D. Intensive lifestyle changes and health reform. Lancet Oncol. 2009; 10(7): 638–9.

6. Adams K.M., Kohlmeier M. ja Zeisel S.H. Nutrition education in U.S. medical schools: latest update of a national survey. Acad Med. 2010; 85(9): 1537–42.

7. Jamal A., Dube S.R., Malarcher A.M., Shaw L. ja Engstrom M.C. Tobacco use screening and counseling during physician office visits among adults. National Ambulatory Medical Care Survey and National Health Interview Survey, United States, 2005–2009. MMWR Morb Mortal Wkly Rep. 2012; 61 Suppl: 38–45.

Johdanto

1. Berzlanovich A.M., Keil W., Waldhoer T., Sim E., Fasching P. ja Fazeny-Dorner B. Do centenarians die healthy? An autopsy study. J Gerontol A Biol Sci Med Sci. 2005; 60(7): 862–5.

2. Kohn R.R. Cause of death in very old people. JAMA. 1982; 247(20): 2793–7.

3. Katso viite 1.

4. Lenders C., Gorman K., Milch H. ym. A novel nutrition medicine education model: the Boston University experience. Adv Nutr. 2013; 4(1): 1–7.

5. Murray C.J., Atkinson C., Bhalla K. ym. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013; 310(6): 591–608.

6. Kris-Etherton P.M., Akabas S.R., Bales C.W. ym. The need to advance nutrition education in the training of health care professionals and recommended research to evaluate implementation and effectiveness. Am J Clin Nutr. 2014; 99(5 Suppl): 1153S–66S.

7. Swift C.S. Nutrition trends: implications for diabetes health care professionals. Diabetes Spectr.2009; 29(1): 23–5.

8. Vetter M.L., Herring S.J., Sood M., Shah N.R. ja Kalet A.L. What do resident physicians know about nutrition? An evaluation of attitudes, self-perceived proficiency and knowledge. J Am Coll Nutr.2008; 27(2): 287–98.

9. Lazarus K., Weinsier R.L. ja Boker J.R. Nutrition knowledge and practices of physicians in a family- practice residency program: the effect of an education program provided by a physician nutrition specialist. Am J Clin Nutr. 1993; 58(3): 319–25.

10. Senate Committee on Business, Professions and Economic Development. Bill Analysis on SB 380. http://www.leginfo.ca.gov/pub/11-12/bill/sen/sb_0351-0400/sb_380_cfa_20110421_125358_sen_comm.html. Kuulemistilaisuus järjestetty 25.4.2011. Haettu 31.3.2015.

11. The Medical Board of California. Continuing Medical Education. http://www.mbc.ca.gov/Licensees/Continuing_Education/Nd. Haettu 31.3.2015.

12. Wizard Edison says doctors of future will give no medicine. Newark Advocate. January 2, 1903.

13. Stange K.C., Zyzanski S.J., Jaen C.R., ym. Illuminating the ”black box.” A description of 4454 patient visits to 138 family physicians. J Fam Pract. 1998; 46(5): 377–89.

14. Aitken M., Johns Hopkins Bloomberg School of Public Health. The trillion dollar market for medicines: characteristics, dynamics and outlook. http://www.jhsph.edu/research/centers–and-institutes/center-for-drug-safety-and-effectiveness/academic-training/seminar–series/MUrray%20Aikten.pdf. 24.2.2014. Haettu 29.3.2015.

15. Willett W.C. Balancing life-style and genomics research for disease prevention. Science.2002; 296(5568): 695–8.

16. Sama.

17. Robertson T.L., Kato H., Rhoads G.G. ym. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol. 1977; 39(2): 239–43.

18. Mayo Clinic News Network. Nearly 7 in 10 Americans take prescription drugs, Mayo Clinic, Olmsted Medical Center Find. http://newsnetwork.mayoclinic.org/discussion/nearly-7-in–10-americans-take-prescription-drugs-mayo-clinic-olmsted-medical-center-find/. 19.6.2013. Haettu 31.3.2015.

19. Murray C.J., Atkinson C., Bhalla K. ym. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013; 310(6): 591–608.

20. Crimmins E.M. ja Beltran-Sanchez H. Mortality and morbidity trends: is there compression of morbidity? J Gerontol B Psychol Sci Soc Sci. 2011; 66(1): 75–86.

21. Sama.

22. Olshansky S.J., Passaro D.J., Hershow R.C. ym. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005; 352(11): 1138–45.

23. Offord D.R. Selection of levels of prevention. Addict Behav. 2000; 25(6): 833–42.

24. Gofrit O.N., Shemer J., Leibovici D., Modan B. ja Shapira S.C. Quaternary prevention: a new look at an old challenge. Isr Med Assoc J. 2000; 2(7): 498–500.

25. Strasser T. Reflections on cardiovascular diseases. Interdiscip Sci Rev. 1978; 3(3): 225–30.

26. Lloyd-Jones D.M., Hong Y., Labarthe D. ym. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010; 121(4): 586–613.

27. Yancy C.W. Is ideal cardiovascular health attainable? Circulation. 2011; 123(8): 835–7.

28. Katso viite 26.

29. Yusuf S., Hawken S., Ounpuu S. ym. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364(9438): 937–52.

30. Katso viite 26.

31. Shay C.M., Ning H., Allen N.B. ym. Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003–2008. Circulation. 2012; 125(1): 45–56.

32. Sama.

33. Omran A.R. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971; 49(4): 509–38.

34. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Leading causes of death, 1900–1998. http://www.cdc.gov/nchs/data/dvs/lead1900 98.pdf. Haettu 29.4.2015.

35. Kochanek K.D., Murphy S.L., Xu J. ja Arias E. Mortality in the United States, 2013. NCHS Data Brief 2014; 178.

36. Lim S.S., Vos T., Flaxman A.D. ym. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224–60.

37. Popkin B.M. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr. 2006; 84(2): 289–98.

38. Zhai F., Wang H., Du S. ym. Prospective study on nutrition transition in China. Nutr Rev.2009; 67 Suppl 1: S56–61.

39. Singh P.N., Arthur K.N., Orlich M.J. ym. Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians. Am J Clin Nutr. 2014; 100 Suppl 1: 359S–64S.

40. Sama.

41. McCarty M.F. Proposal for a dietary ”phytochemical index.” Med Hypotheses. 2004; 63(5): 813–7.

42. Mirmiran P., Bahadoran Z., Golzarand M., Shiva N. ja Azizi F. Association between dietary phytochemical index and 3-year changes in weight, waist circumference and body adiposity index in adults: Tehran Lipid and Glucose study. Nutr Metab (Lond). 2012; 9(1): 108.

43. Sama.

44. Golzarand M., Bahadoran Z., Mirmiran P., Sadeghian-Sharif S. ja Azizi F. Dietary phytochemical index is inversely associated with the occurrence of hypertension in adults: a 3-year follow-up (the Tehran Lipid and Glucose Study). Eur J Clin Nutr. 2015; 69(3): 392–8.

45. Golzarand M., Mirmiran P., Bahadoran Z., Alamdari S. ja Azizi F. Dietary phytochemical index and subsequent changes of lipid profile: a 3-year follow-up in Tehran Lipid and Glucose Study in Iran. ARYA Atheroscler. 2014; 10(4): 203–10.

46. Bahadoran Z., Karimi Z., Houshiar-Rad A., Mirzayi H.R. ja Rashidkhani B. Dietary phytochemical index and the risk of breast cancer: a case control study in a population of Iranian women. Asian Pac J Cancer Prev. 2013; 14(5): 2747–51.

47. Yhdysvaltojen maatalousministeriö (USDA), Economic Research Service. Loss-adjusted food availability. http://www.ers.usda.gov/datafiles/Food_Availabily_Per_Capita_Data_System/LossAdjusted_Food_Availability/calories.xls. 30.9.2014. Haettu 29.4.2015.

48. Wansink B., Kniffin K.M. ja Shimizu M. Death row nutrition. Curious conclusions of last meals. Appetite. 2012; 59(3): 837–43.

49. Bambs C., Kip K.E., Dinga A., Mulukutla S.R., Aiyer A.N. ja Reis S.E. Low prevalence of ”ideal cardiovascular health” in a community-based population: the heart strategies concentrating on risk evaluation (Heart SCORE) study. Circulation. 2011; 123(8): 850–7.

50. Yancy C.W. Is ideal cardiovascular health attainable? Circulation. 2011; 123(8): 835–7.

51. Ford E.S., Bergmann M.M., Krord J., Schienkiewitz A., Weikert C. ja Boeing H. Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition- Potsdam study. Arch Intern Med. 2009; 169(15): 1355–62.

52. Platz E.A., Willett W.C., Colditz G.A., Rimm E.B., Spiegelman D. ja Giovannucci E. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control. 2000; 11(7): 579–88.

53. Wahls T.L. The seventy percent solution. J Gen Intern Med. 2011; 26(10): 1215–6.

54. Ford E.S., Bergmann M.M., Boeing H., Li C. ja Capewell S. Healthy lifestyle behaviors and all-cause mortality among adults in the United States. Prev Med. 2012; 55(1): 23–7.

55. Khaw K.T., Wareham N., Bingham S., Welch A., Luben R. ja Day N. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med. 2008; 5(1): e12.

56. Jiang H., Ju Z. ja Rudolph K.L. Telomere shortening and ageing. Z Gerontol Geriatr. 2007; 40(5): 314–24.

57. Mather K.A., Jorm A.F., Parslow R.A. ja Christensen H. Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci. 2011; 66(2): 202–13.

58. Tsuji A., Ishiko A., Takasaki T. ja Ikeda N. Estimating age of humans based on telomere shortening. Forensic Sci Int. 2002; 126(3): 197–9.

59. Shammas M.A. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011; 14(1): 28–34.

60. Huzen J., Wong L.S., van Veldhuisen D.J. ym. Telomere length loss due to smoking and metabolic traits. J Intern Med. 2014; 275(2): 155–63.

61. Hou L., Savage S.A., Blaser M.J. ym. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev. 2009; 18(11): 3103–9.

62. Gu Y., Honig L.S., Schupf N. ym. Mediterranean diet and leukocyte telomere length in a multiethnic elderly population. Age (Dordr). 2015; 37(2): 9758.

63. García-Calzón S., Moleres A., Martínez-González M.A. ym. Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population. Clin Nutr. 2014; S0261–5614(14): 00191–5.

64. Sama.

65. Leung C.W., Laraia B.A., Needham B.L. ym. Soda and cell aging: associations between sugarsweetened beverage consumption and leukocyte telomere length in healthy adults from the National Health and Nutrition Examination Surveys. Am J Public Health. 2014; 104(12): 2425–31.

66. Nettleton J.A., Diez-Roux A., Jenny N.S., Fitzpatrick A.L. ja Jacobs D.R. Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2008; 88(5): 1405–12.

67. Gu Y., Honig L.S., Schupf N. ym. Mediterranean diet and leukocyte telomere length in a multiethnic elderly population. Age (Dordr). 2015; 37(2): 9758.

68. Flanary B.E. ja Kletetschka G. Analysis of telomere length and telomerase activity in tree species of various life-spans, and with age in the bristlecone pine Pinus longaeva. Biogerontology. 2005; 6(2): 101–11.

69. Ornish D., Lin J., Daubenmier J. ym. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008; 9(11): 1048–57.

70. Skordalakes E. Telomerase and the benefits of healthy living. Lancet Oncol. 2008; 9(11): 1023–4.

71. Ornish D., Lin J., Chan J.M. ym. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013; 14(11): 1112–20.

72. Mason C., Risques R.A., Xiao L. ym. Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women. Obesity (Silver Spring). 2013; 21(12): E549–54.

73. Katso viite 69.

74. Katso viite 71.

75. Artandi S.E. ja Depinho R.A. Telomeres and telomerase in cancer. Carcinogenesis. 2010; 31(1): 9–18.

76. Mozaffarian D., Benjamin E.J., Go A.S. ym. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015; 131(4): e29–322.

77. American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015.

78. NHLBI Fact Book, Fiscal Year 2012. National Heart, Lung, and Blood Institute, NIH. http://www.nhlbi.nih.gov/files/docs/factbook/FactBook2012.pdf. 2.2013. Haettu 31.3.2015.

79. Katso viite 76.

80. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016; 64(2).

81. Katso viite 77.

82. Katso viite 80.

83. Sama.

84. Mozaffarian D., Benjamin E.J., Go A.S. ym. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015; 131(4): e29–322.

85. Katso viite 80.

86. Katso viite 77.

87. Katso viite 80.

88. Sama.

89. Sama.

90. Sama.

91. Sama.

92. Tuso P.J., Ismail M.H., Ha B.P. ja Bartolotto C. Nutritional update for physicians: plant-based diets. Perm J. 2013; 17(2): 61–6.

93. Egger G.J., Binns A.F. ja Rossner S.R. The emergence of ”lifestyle medicine” as a structured approach for management of chronic disease. Med J Aust. 2009; 190(3): 143–5.

94. Hyman M.A., Ornish D. ja Roizen M. Lifestyle medicine: treating the causes of disease. Altern Ther Health Med. 2009; 15(6): 12–4.

95. Willett W.C. Balancing life-style and genomics research for disease prevention. Science. 2002; 296(5568): 695–8.

96. Katso viite 94.

97. Allen J., Anderson D.R., Baun B. ym. Reflections on developments in health promotion in the past quarter century from founding members of the American Journal of Health Promotion Editorial Board. Am J Health Promot. 2011; 25(4): ei– eviii.

98. Katso viite 92.

99. Sama.

100. Sama.

101. Kono S. Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur J Cancer Prev. 2004; 13(2): 127–32.

102. Katso viite 95.

103. Katso viite 101.

104. Kulshreshtha A., Goyal A., Veledar E. ym. Association between ideal cardiovascular health and carotid intima-media thickness: a twin study. J Am Heart Assoc. 2014; 3(1): e000282.

105. Corona M., Velarde R.A., Remolina S. ym. Vitellogenin, juvenile hormone, insulin signaling, and queen honey bee longevity. Proc Natl Acad Sci USA. 2007; 104(17): 7128–33.

106. Kucharski R., Maleszka J., Foret S. ja Maleszka R. Nutritional control of reproductive status in honeybees via DNA methylation. Science. 2008; 319(5871): 1827–30.

107. Gnyszka A., Jastrzebski Z. ja Flis S. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer Res. 2013; 33(8): 2989–96.

108. Joven J., Micol V., Segura-Carretero A., Alonso-Villaverde C. ja Menéndez J.A. Polyphenols and the modulation of gene expression pathways: can we eat our way out of the danger of chronic disease? Crit Rev Food Sci Nutr. 2014; 54(8): 985–1001.

109. Fang M.Z., Wang Y., Ai N. ym. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003; 63(22): 7563–70.

110. Myzak M.C., Tong P., Dashwood W.M., Dashwood R.H. ja Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood). 2007; 232(2): 227–34.

111. Dashwood R.H. ja Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol. 2007; 17(5): 363–9.

112. Gryder B.E., Sodji Q.H. ja Oyelere A.K. Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Future Med Chem. 2012; 4(4): 505–24.

113. Ornish D., Magbanua M.J., Weidner G. ym. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA. 2008; 105(24): 8369–74.

Osa 1

1. Kuinka elää kuolematta sydäntautiin

1. Myerburg R.J. ja Junttila M.J. 2012. Sudden cardiac death caused by coronary heart disease. Circulation. 28; 125(8): 1043–52.
2. Campbell T.C., Parpia B. ja Chen J. Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China study. Am J Cardiol. 1998; 82(10B): 18T-21T.
3. Shaper A.G. ja Jones K.W. Serum-cholesterol, diet, and coronary heart- disease in Africans and Asians in Uganda: 1959. Int J Epidemiol. 2012; 41(5): 1221–5.
4. Thomas W.A., Davies J.N., O’Neal R.M. ja Dimakulangan A.A. Incidence of myocardial infarction correlated with venous and pulmonary thrombosis and embolism. A geographic study based on autopsies in Uganda, East Africa and St. Louis, U.S.A. Am J Cardiol. 1960; 5: 41–7.
5. Benfante R. Studies of cardiovascular disease and cause-specific mortality trends in Japanese-American men living in Hawaii and risk factor comparisons with other Japanese populations in the Pacific region: a review. Hum Biol. 1992; 64(6): 791–805.
6. Chen J., Campbell T.C., Li J. ja Peto R. Diet, life-style and mortality in China: A study of the characteristics of 65 Chinese counties. New York: Oxford University Press; 1990.
7. Katso viite 3.
8. De Biase S.G., Fernandes S.F., Gianini R.J. ja Duarte J.L. Vegetarian diet and cholesterol and triglycerides levels. Arq Bras Cardiol. 2007; 88(1): 35–9.
9. Stoy P.J. Dental disease and civilization. Ulster Med J. 1951; 20(2): 144–58.
10. Kris-Etherton P.M., Harris W.S. ja Appel L.J. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003; 23(2): e20–30.
11. Shepherd C.J. ja Jackson A.J. Global fishmeal and fish-oil supply: inputs, outputs and markets. J Fish Biol. 2013; 83(4): 1046–66.
12. Rizos E.C., Ntzani E.E., Bika E., Kostapanos M.S. ja Elisaf M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012; 308(10): 1024–33.
13. Kwak S.M., Myung S.K., Lee Y.J. ja Seo H.G. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012; 172(9): 686–94.
14. Fodor J.G., Helis E., Yazdekhasti N. ja Vohnout B. ”Fishing” for the origins of the ”Eskimos and heart disease” story: facts or wishful thinking? Can J Cardiol. 2014; 30(8): 864–8.
15. Burr M.L., Fehily A.M., Gilbert J.F. ym. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989; 2(8666): 757–61.
16. Burr M.L. Secondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel. Proc Nutr Soc. 2007; 66(1): 9–15.
17. Burr M.L., Ashfield-Watt P.A.L., Dunstan F.D.J. ym. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003; 57(2): 193–200.
18. Katso viite 12.
19. Smith D.A. ACP Journal Club. Review: omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults. Ann Intern Med. 2012; 157(12): JC6–5.
20. Enos W.F., Holmes R.H. ja Beyer J. Coronary disease among United States soldiers killed in action in Korea; preliminary report. JAMA. 1953; 152(12): 1090–3.
21. Strong J.P. Landmark perspective: Coronary atherosclerosis in soldiers. A clue to the natural history of atherosclerosis in the young. JAMA. 1986; 256(20): 2863–6.
22. Voller R.D. ja Strong W.B. Pediatric aspects of atherosclerosis. Am Heart J. 1981; 101(6): 815–36.
23. Napoli C., D’Armiento F.P., Mancini F.P. y,. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997; 100(11): 2680–90.
24. Benjamin M.M. ja Roberts W.C. Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent). 2013; 26(2): 124–36.
25. McMahan C.A., Gidding S.S., Malcom G.T. ym. Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis. Pediatrics. 2006; 118(4): 1447–55.
26. Trumbo P.R. ja Shimakawa T. Tolerable upper intake levels for trans fat, saturated fat, and cholesterol. Nutr Rev. 2011; 69(5): 270–8.
27. Roberts W.C. It’s the cholesterol, stupid! Am J Cardiol. 2010; 106(9): 1364–6.
28. O’Keefe J.H., Cordain L., Harris W.H., Moe R.M. ja Vogel R. Optimal low- density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol. 2004; 43(11): 2142–6.
29. Esselstyn C.B. In cholesterol lowering, moderation kills. Cleve Clin J Med. 2000; 67(8): 560–4.
30. Roberts W.C. The cause of atherosclerosis. Nutr Clin Pract. 2008; 23(5): 464–7.
31. Sama.
32. King S. The best selling drugs since 1996 – why AbbVie’s Humira is set to eclipse Pfizer’s Lipitor. http://www.forbes.com/sites/simonking/2013/07/15/the-best-selling-drugs-since-1996–why-abbvies-humira-is-set-to-eclipse-pfizers-lipitor/. 15.7.2013. Haettu 1.5.2015.
33. Ginter E., Kajaba I. ja Sauša M. Addition of statins into the public water supply? Risks of side effects and low cholesterol levels. Cas Lek Cesk. 2012; 151(5): 243–7.
34. Ferenczi E.A., Asaria P., Hughes A.D., Chaturvedi N. ja Francis D.P. Can a statin neutralize the cardiovascular risk of unhealthy dietary choices? Am J Cardiol. 2010; 106(4): 587–92.
35. Draeger A., Monastyrskaya K., Mohaupt M. ym. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J Pathol. 2006; 210(1): 94–102.
36. Scott D., Blizzard L., Fell J. ja Jones G. Statin therapy, muscle function and falls risk in communitydwelling older adults. Q JM. 2009; 102(9): 625–33.
37. Jefferson E. FDA announces safety changes in labeling for some cholesterol-lowering drugs. Yhdysvaltojen elintarvike- ja lääkeviraston verkkojulkaisu. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm293623.htm. 28.2.2012. Haettu 14.2.2015.
38. McDougall J.A., Malone K.E., Daling J.R., Cushing-Haugen K.L., Porter P.L. ja Li C.I. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev. 2013; 22(9): 1529–37.
39. Jenkins D.J., Kendall C.W., Marchie A. ym. The Garden of Eden—plant based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century. Comp Biochem Physiol, Part A Mol Integr Physiol. 2003; 136(1): 141–51.
40. Esselstyn C.B. Is the present therapy for coronary artery disease the radical mastectomy of the twenty-first century? Am J Cardiol. 2010; 106(6): 902–4.
41. Kadoch M.A. The power of nutrition as medicine. Prev Med. 2012; 55(1): 80.
42. Wakai K., Marugame T., Kuriyama S. ym. Decrease in risk of lung cancer death in Japanese men after smoking cessation by age at quitting: pooled analysis of three large-scale cohort studies. Cancer Sci. 2007; 98(4): 584–9.
43. Vogel R.A., Corretti M.C. ja Plotnick G.D. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol. 1997; 79(3): 350–4.
44. Erridge C. The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4. Br J Nutr. 2011; 105(1): 15–23.
45. Ornish D., Scherwitz L.W., Billings J.H. ym. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998; 280(23): 2001–7.
46. Ornish D., Scherwitz L.W., Doody R.S. ym. Effects of stress management training and dietary changes in treating ischemic heart disease. JAMA. 1983; 249(1): 54–9.
47. Katso viite 45.
48. Ellis F.R. ja Sanders T.A. Angina and vegan diet. Am Heart J. 1977; 93(6): 803–5.
49. Sweeney M. Effects of very low-fat diets on anginal symptoms. Med Hypotheses. 2004; 63(3): 553.
50. Savarese G., Rosano G., D’amore C. ym. Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis. Int J Cardiol. 2013; 169(4): 262–70.
51. Colpo E., Vilanova C.D., Brenner Reetz L.G. ym. A single consumption of high amounts of the Brazil nuts improves lipid profile of healthy volunteers. J Nutr Metab. 2013; 2013: 1–7.
52. Stern R.H., Yang B.B., Hounslow N.J. ym. Pharmacodynamics and pharmacokineticpharmacodynamic relationships of atorvastatin, an HMG-CoA reductase Inhibitor. J Clin Pharmacol. 2000; 40(6): 616–3.
53. Hegsted M. Dietary Guidelines. Food Politicsin verkkojulkaisu. www.foodpolitics.com/wp-content/uploads/Hegsted.pdf. nd. Haettu 14.2.2015.
54. Campbell T.C. The Low-Carb Fraud. Dallas, TX: BenBella Books, Inc.; 2014.
55. Herman J. Saving U.S. dietary advice from conflicts of interest. Food and Drug Law Journal 2010; 65(20): 285–316.
56. Sama.
57. Goodwin J.S. ja Goodwin J.M. The tomato effect. Rejection of highly efficacious therapies. JAMA. 1984; 251(18): 2387–90.
58. Adams K.M., Kohlmeier M. ja Zeisel S.H. Nutrition education in U.S. medical schools: latest update of a national survey. Acad Med. 2010; 85(9): 1537–42.
59. Kalifornian senaatin lakialoitteen nro 380 kuulemistilaisuus. Vimeo verkkojulkaisu. http://vimeo.com/23744792. 25.4.2011. Haettu 14.2.2015.
60. Murray J.L. Coke and the AAFP—the real thing or a dangerous liaison? Fam Med. 2010; 42(1): 57–8.
61. Blum A. AAFP-Coke editorial was music to [our] ears. J Fam Pract. 2010; 59(2): 74.
62. Brownell K.D. ja Warner K.E. The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? Milbank Q. 2009; 87(1): 259–94.
63. Sama.
64. Simon M. AND now a word from our sponsors. Eat Drinks Politicsin verkkojulkaisu. http://www.eatdrinkpolitics.com/wp-content/uploads/AND_Corporate_Sponsorship_Report.pdf. 22.1.2013. Haettu 14.2.2015.
65. Bruckert E., Pouchain D., Auboiron S. ja Mulet C. Cross-analysis of dietary prescriptions and adherence in 356 hypercholesterolaemic patients. Arch Cardiovasc Dis. 2012; 105(11): 557–65.
66. Barnard N.D. The physician’s role in nutrition-related disorders: from bystander to leader. Virtual Mentor. 2013; 15(4): 367–72.

2. Kuinka elää kuolematta keuhkosairauksiin
1. American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015.
2. Howlader N., Noone A.M., Krapcho M. ym. (toim.) SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. http://seer.cancer.gov/csr/1975_2011/. 4.2014. Haettu 27.2.2015.
3. American Lung Association. Lung Cancer Fact Sheet. http://www.lung.org/lung-disease/lung-cancer/resources/facts-figures/lung-cancer-fact-sheet.html. 2015. Haettu 14.2.2015.
4. Moodie R., Stuckler D., Monteiro C. ym. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet. 2013; 381 (9867): 670–9.
5. American Cancer Society. When smokers quit— what are the benefits over time? http://www.cancer.org/healthy/stayawayfromtobacco/guidetoquittingsmoking/guide-to-quitting–smoking-benefits. 6.2.2015. Haettu 26.2.2015.
6. Yhdysvaltojen terveys- ja sosiaalipalveluministeriö. A Report of the Surgeon General. How Tobacco Smoke Causes Disease: What It Means to You. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010.
7. Riso P., Martini D., Møller P. ym. DNA damage and repair activity after broccoli intake in young healthy smokers. Mutagenesis. 2010; 25(6): 595–602.
8. Gupta G.P. ja Massagué J. Cancer metastasis: building a framework. Cell. 2006; 127(4): 679–95.
9. Wu X., Zhu Y., Yan H. ym. Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer. 2010; 10: 269.
10. Kim S.Y., Yoon S., Kwon S.M., Park K.S. ja Lee-Kim Y.C. Kale juice improves coronary artery disease risk factors in hypercholesterolemic men. Biomed Environ Sci. 2008; 21(2): 91–7.
11. Dressendorfer R.H., Wade C.E., Hornick C. ja Timmis G.C. High-density lipoprotein-cholesterol in marathon runners during a 20-day road race. JAMA. 1982; 247(12): 1715–7.
12. Park W., Amin A.R., Chen Z.G. ja Shin D.M. New perspectives of curcumin in cancer prevention. Cancer Prev Res (Phila). 2013; 6(5): 387–400.
13. Sama.
14. Nagabhushan M., Amonkar A.J. ja Bhide S.V. In vitro antimutagenicity of curcumin against environmental mutagens. Food Chem Toxicol. 1987; 25(7): 545–7.
15. Polasa K., Raghuram T.C., Krishna T.P. ja Krishnaswamy K. Effect of turmeric on urinary mutagens in smokers. Mutagenesis. 1992; 7(2): 107–9.
16. Ravindran J., Prasad S. ja Aggarwal B.B. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 2009; 11(3): 495–510.
17. Wu S.H., Hang L.W., Yang J.S. ym. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways. Anticancer Res. 2010; 30(6): 2125–33.
18. Su C.C., Lin J.G., Li T.M. ym. Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3. Anticancer Res. 2006; 26(6B): 4379–89.
19. Katso viite 16.
20. Sama.
21. Pallis A.G. ja Syrigos K.N. Lung cancer in never smokers: disease characteristics and risk factors. Crit Rev Oncol Hematol. 2013; 88(3): 494–503.
22. Chiang T.A., Wu P.F., Wang L.F., Lee H., Lee C.H. ja Ko Y.C. Mutagenicity and polycyclic aromatic hydrocarbon content of fumes from heated cooking oils produced in Taiwan. Mutat Res. 1997; 381(2): 157–61.
23. Katragadda H.R., Fullana A., Sidhu S. ja Carbonell-Barrachina A.A. Emissions of volatile aldehydes from heated cooking oils. Food Chem. 2010; 120(1): 59–65.
24. Jin Z.Y., Wu M., Han R.Q. ym. Household ventilation may reduce effects of indoor air pollutants for prevention of lung cancer: a case-control study in a Chinese population. PLoS ONE. 2014; 9(7): e102685.
25. Seow A., Poh W.T., Teh M. ym. Fumes from meat cooking and lung cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev. 2000; 9(11): 1215–21.
26. Jedrychowski W., Perera F.P., Tang D. ym. Impact of barbecued meat consumed in pregnancy on birth outcomes accounting for personal prenatal exposure to airborne polycyclic aromatic hydrocarbons: birth cohort study in Poland. Nutrition. 2012; 28(4): 372–7.
27. Perera F.P., Li Z., Whyatt R. ym. Prenatal airborne polycyclic aromatic hydrocarbon exposure and child IQ at age 5 years. Pediatrics. 2009; 124(2): e195–202.
28. Chen J.W., Wang S.L., Hsieh D.P., Yang H.H. ja Lee H.L. Carcinogenic potencies of polycyclic aromatic hydrocarbons for back-door neighbors of restaurants with cooking emissions. Sci Total Environ. 2012; 417–418: 68–75.
29. Yang S.C., Jenq S.N., Kang Z.C. ja Lee H. Identification of benzo[a]pyrene 7,8-diol 9,10-epoxide N2-deoxyguanosine in human lung adenocarcinoma cells exposed to cooking oil fumes from frying fish under domestic conditions. Chem Res Toxicol. 2000; 13(10): 1046–50.
30. Katso viite 28.
31. Lijinsky W. N-Nitroso compounds in the diet. Mutat Res. 1999 Jul 15; 443(1–2): 129–38.
32. Thiébaud H.P., Knize M.G., Kuzmicky P.A., Hsieh D.P. ja Felton J.S. Airborne mutagens produced by frying beef, pork and a soy-based food. Food Chem Toxicol. 1995; 33(10): 821–8.
33. Sama.
34. Mitsakou C., Housiadas C., Eleftheriadis K., Vratolis S., Helmis C. ja Asimakopoulos D. Lung deposition of fine and ultrafine particles outdoors and indoors during a cooking event and a no activity period. Indoor Air. 2007; 17(2): 143–52.
35. Keuhkoahtaumataudin tilastot Yhdysvalloissa. COPD Foundationin verkkojulkaisu. http://www.copdfoundation.org/What-is-COPD/COPD-Facts/Statistics.aspx. 2015. Haettu 14.2.2015.
36. Tabak C., Smit H.A., Räsänen L. ym. Dietary factors and pulmonary function: a cross sectional study in middle aged men from three European countries. Thorax. 1999; 54(11): 1021–6.
37. Walda I.C., Tabak C., Smit H.A. ym. Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countries. Eur J Clin Nutr. 2002; 56(7): 638–43.
38. Varraso R., Jiang R., Barr R.G., Willett W.C., Camargo C.A, Jr. Prospective study of cured meats consumption and risk of chronic obstructive pulmonary disease in men. Am J Epidemiol. 2007 Dec 15; 166(12): 1438–45.
39. Jiang R., Paik D.C., Hankinson J.L. ja Barr R.G. Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults. Am J Respir Crit Care Med. 2007 Apr 15; 175(8): 798–804.
40. Jiang R., Camargo C.A., Varraso R., Paik D.C., Willett W.C. ja Barr R.G. Consumption of cured meats and prospective risk of chronic obstructive pulmonary disease in women. Am J Clin Nutr. 2008; 87(4): 1002–8.
41. Keranis E., Makris D., Rodopoulou P. ym. Impact of dietary shift to higher-antioxidant foods in COPD: a randomised trial. Eur Respir J. 2010; 36(4): 774–80.
42. Warner J.O. Worldwide variations in the prevalence of atopic symptoms: what does it all mean? Thorax. 1999; 54 Suppl 2: S46–51.
43. What Is Asthma? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/asthma/. 4.8.2014. Haettu 14.2.2015.
44. Katso viite 42.
45. Aït-Khaled N., Pearce N., Anderson H.R. ym. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009; 64(1): 123–48.
46. Asher M.I., Stewart A.W., Mallol J. ym. Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One. Respir Res. 2010; 11: 8.
47. Ellwood P., Asher M.I., Bjorkstén B., Burr M., Pearce N. ja Robertson C.F. Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J. 2001; 17(3): 436–43.
48. Protudjer J.L., Sevenhuysen G.P., Ramsey C.D., Kozyrskyj A.L. ja Becker A.B. Low vegetable intake is associated with allergic asthma and moderate-to-severe airway hyperresponsiveness. Pediatr Pulmonol. 2012; 47(12): 1159–69.
49. Bime C., Wei C.Y., Holbrook J., Smith L.J. ja Wise R.A. Association of dietary soy genistein intake with lung function and asthma control: a post-hoc analysis of patients enrolled in a prospective multicentre clinical trial. Prim Care Respir J. 2012; 21(4): 398–404.
50. Agrawal S., Pearce N. ja Ebrahim S. Prevalence and risk factors for self-reported asthma in an adult Indian population: a cross-sectional survey. Int J Tuberc Lung Dis. 2013 17(2): 275–82.
51. Tsai H.J. ja Tsai A.C. The association of diet with respiratory symptoms and asthma in schoolchildren in Taipei, Taiwan. J Asthma. 2007; 44(8): 599–603.
52. Yusoff N.A., Hampton S.M., Dickerson J.W. ja Morgan J.B. The effects of exclusion of dietary egg and milk in the management of asthmatic children: a pilot study. J R Soc Promot Health. 2004; 124(2): 74–80.
53. Wood L.G., Garg M.L., Blake R.J., Garcia-Caraballo S. ja Gibson P.G. Airway and circulating levels of carotenoids in asthma and healthy controls. J Am Coll Nutr. 2005; 24(6): 448–55.
54. Miller E.R., Appel L.J. ja Risby T.H. Effect of dietary patterns on measures of lipid peroxidation: results from a randomized clinical trial. Circulation. 1998; 98(22): 2390–5.
55. Wood L.G., Garg M.L., Smart J.M., Scott H.A., Barker D. ja Gibson P.G. Manipulating antioxidant intake in asthma: a randomized controlled trial. Am J Clin Nutr. 2012; 96(3): 534–43.
56. Sama.
57. Patel S., Murray C.S., Woodcock A., Simpson A. ja Custovic A. Dietary antioxidant intake, allergic sensitization and allergic diseases in young children. Allergy. 2009; 64(12): 1766–72.
58. Troisi R.J., Willett W.C., Weiss S.T., Trichopoulos D., Rosner B. ja Speizer F.E. A prospective study of diet and adult-onset asthma. Am J Respir Crit Care Med. 1995; 151(5): 1401–8.
59. Katso viite 55.
60. Lindahl O., Lindwall L., Spångberg A., Stenram A. ja Ockerman P.A. Vegan regimen with reduced medication in the treatment of bronchial asthma. J Asthma. 1985; 22(1): 45–55.
61. Sama.
62. Sama.

3. Kuinka elää kuolematta aivosairauksiin
1. Mozaffarian D., Benjamin E.J., Go A.S. ym. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015; 131(4): e29–322.
2. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016; 64(2).
3.Katso viite 1.
4. Grau-Olivares M. ja Arboix A. Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? Expert Rev Neurother. 2009; 9(8): 1201–17.
5. Aune D., Chan D.S., Lau R. ym. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2011; 343: d6617.
6. Aune D., Chan D.S., Greenwood D.C. ym. Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies. Ann Oncol. 2012; 23(6): 1394–402.
7. Yao B., Fang H., Xu W. ym. Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies. Eur J Epidemiol. 2014; 29(2): 79–88.
8. Threapleton D.E., Greenwood D.C., Evans C.E. ym. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2013; 347: f6879.
9. Maskarinec G., Takata Y., Pagano I. ym. Trends and dietary determinants of overweight and obesity in a multiethnic population. Obesity (Silver Spring). 2006; 14(4): 717–26.
10. Kim Y. ja Je Y. Dietary fiber intake and total mortality: a meta-analysis of prospective cohort studies. Am J Epidemiol. 2014; 180(6): 565–73.
11. Threapleton D.E., Greenwood D.C., Evans C.E. ym. Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis. Stroke. 2013; 44(5): 1360–8.
12. Clemens R., Kranz S., Mobley A.R. ym. Filling America’s fiber intake gap: summary of a roundtable to probe realistic solutions with a focus on grain-based foods. J Nutr. 2012; 142(7): 1390S–401S.
13. Katso viite 11.
14. Whitehead A., Beck E.J., Tosh S. ja Wolever T.M. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014; 100(6): 1413–21.
15. Silva F.M., Kramer C.K., De Almeida J.C., Steemburgo T., Gross J.L. ja Azevedo MJ. Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Nutr Rev. 2013; 71(12): 790–801.
16. Streppel M.T., Arends L.R., van ’t Veer P., Grobbee D.E. ja Geleijnse J.M. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med. 2005; 165(2): 150–6.
17. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016; 64(2).
18. van de Laar R.J., Stehouwer C.D.A., van Bussel B.C.T. ym. Lower lifetime dietary fiber intake is associated with carotid artery stiffness: the Amsterdam Growth and Health Longitudinal Study. Am J Clin Nutr. 2012; 96(1): 14–23.
19. Sama.
20. Casiglia E., Tikhonoff V., Caffi S. ym. High dietary fiber intake prevents stroke at a population level. Clin Nutr. 2013; 32(5): 811–8.
21. Tikhonoff V., Palatini P. ja Casiglia E. Tikhonoffin et al. kirje koskien artikkelia ”Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis”, Stroke. 2013; 44(9): e109.
22. Threapleton D.E., Greenwood D.C. ja Burley V.J. Threapletonin et al. vastaus kirjeeseen koskien artikkelia ”Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis”, Stroke. 2013; 44(9): e110.
23. Eaton S.B. ja Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med. 1985; 312(5): 283–9.
24. Cogswell M.E., Zhang Z., Carriquiry A.L. ym. Sodium and potassium intakes among US adults: NHANES 2003–2008. Am J Clin Nutr. 2012; 96(3): 647–57.
25. Sama.
26. D’Elia L., Barba G., Cappuccio F.P. ym. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. J Am Coll Cardiol. 2011; 57(10): 1210–9.
27. Yhdysvaltojen maatalousministeriö (USDA). USDA National Nutrient Database for Standard Reference. http://ndb.nal.usda.gov/ndb/nutrients/index?fg=&nutrient1=306&nutrient2=&nutrient3=&subset=0&sort=c&totCount=0&offset=0&measureby=g. 2011. Haettu 1.4.2015.
28. Yhdysvaltojen maatalousministeriö (USDA). Dietary Guidelines for Americans 2005. Appendix B-1. Food sources of potassium. http://www.health.gov/dietaryguidelines/dga2005/document/html/appendixb.htm. 9.7.2008. Haettu 1.5.2015.
29. Hu D., Huang J., Wang Y., Zhang D. ja Qu Y. Fruits and vegetables consumption and risk of stroke: a meta-analysis of prospective cohort studies. Stroke. 2014; 45(6): 1613–9.
30. Morand C., Dubray C., Milenkovic D. ym. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr. 2011; 93(1): 73–80.
31. Takumi H., Nakamura H., Simizu T. ym. Bioavailability of orally administered water-dispersible hesperetin and its effect on peripheral vasodilatation in human subjects: implication of endothelial functions of plasma conjugated metabolites. Food Funct. 2012; 3(4): 389–98.
32. Patyar S. ja Patyar R.R. Correlation between sleep duration and risk of stroke. J Stroke Cerebrovasc Dis. 2015; 24(5): 905–11.
33. Ikehara S., Iso H., Date C. ym. JACC Study Group. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep. 2009; 32(3): 295–301.
34. Fang J., Wheaton A.G. ja Ayala C. Sleep duration and history of stroke among adults from the USA. J Sleep Res. 2014; 23(5): 531–7.
35. von Ruesten A., Weikert C., Fietze I. ym. Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS ONE. 2012; 7(1): e30972.
36. Pan A., De Silva D.A., Yuan J.M. ym. Sleep duration and risk of stroke mortality among Chinese adults: Singapore Chinese health study. Stroke. 2014; 45(6): 1620–5.
37. Leng Y., Cappuccio F.P., Wainwright N.W. ym. Sleep duration and risk of fatal and nonfatal stroke: a prospective study and meta-analysis. Neurology. 2015; 84(11): 1072–9.
38. Sansevero T.B. The Profit Machine. Madrid: Cultiva Libros. 2009; 59.
39. Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc. 1972; 20(4): 145–7.
40. Chance B., Sies H. ja Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979; 59(3): 527–605.
41. Emerit I. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Radic Biol Med. 1994; 16(1): 99–109.
42. Rautiainen S., Larsson S., Virtamo J. ym. Total antioxidant capacity of diet and risk of stroke: a population-based prospective cohort of women. Stroke. 2012; 43(2): 335–40.
43. Del Rio D., Agnoli C., Pellegrini N. ym. Total antioxidant capacity of the diet is associated with lower risk of ischemic stroke in a large Italian cohort. J Nutr. 2011; 141(1): 118–23.
44. Satia J.A., Littman A., Slatore C.G., Galanko J.A. ja White E. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol. 2009; 169(7): 815–28.
45. Hankey G.J. Vitamin supplementation and stroke prevention. Stroke. 2012; 43(10): 2814–8.
46. Carlsen M.H., Halvorsen B.L., Holte K. ym. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010 Jan 22; 9: 3.
47. Yang M., Chung S.J., Chung C.E. ym. Estimation of total antioxidant capacity from diet and supplements in US adults. Br J Nutr. 2011; 106(2): 254–63.
48. Carlsen M.H., Halvorsen B.L., Holte K. ym. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010 Jan 22; 9: 3.
49. Bastin S. ja Henken K. Water Content of Fruits and Vegetables. ENRI-129. University of Kentucky College of Agriculture Cooperative Extension Service. http://www2.ca.uky.edu/enri/pubs/enri129.pdf. 12.1997. Haettu 3.3.2015.
50. Katso viite 48.
51. Sama.
52. Kelly P.J., Morrow J.D., Ning M. ym. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke. 2008; 39(1): 100–4.
53. Lilamand M., Kelaiditi E., Guyonnet S. ym. Flavonoids and arterial stiffness: promising perspectives. Nutr Metab Cardiovasc Dis. 2014; 24(7): 698–704.
54. Santhakumar A.B., Bulmer A.C. ja Singh I. A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk. J Hum Nutr Diet. 2014; 27(1): 1–21.
55. Stoclet J.C., Chataigneau T., Ndiaye M. ym. Vascular protection by dietary polyphenols. Eur J Pharmacol. 2004; 500(1–3): 299–313.
56. Moylan S., Berk M., Dean O.M. ym. Oxidative & nitrosative stress in depression: why so much stress?. Neurosci Biobehav Rev. 2014; 45: 46–62.
57. Watzl B. Anti-inflammatory effects of plant- based foods and of their constituents. Int J Vitam Nutr Res. 2008; 78(6): 293–8.
58. Franzini L., Ardigi D., Valtueña S. ym. Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population. Nutr Metab Cardiovasc Dis. 2012; 22(1): 50–7.
59. Alzheimer’s Associationin tiedote. http://www.alz.org/documents_custom/2013_facts_figures_fact_sheet.pdf. 3.2013. Haettu 3.4.2015.
60. de la Torre J.C. A turning point for Alzheimer’s disease? Biofactors. 2012; 38(2): 78–83.
61. de la Torre J.C. Alzheimer’s disease is incurable but preventable. J Alzheimers Dis. 2010; 20(3): 861–70.
62. Barnes D.E. ja Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011; 10(9): 819–28.
63. Singh-Manoux A., Kivimaki M., Glymour MM. ym. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ. 2012; 344: d7622.
64. Roher A.E., Tyas S.L., Maarouf C.L. ym. Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia. Alzheimers Dement. 2011; 7(4): 436–44.
65. Barnard N.D., Bush A.I., Ceccarelli A. ym. Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease. Neurobiol Aging. 2014; 35 Suppl 2: S74–8.
66. Ramirez-Bermudez J. Alzheimer’s disease: critical notes on the history of a medical concept. Arch Med Res. 2012; 43(8): 595–9.
67. Alzheimer A., Stelzmann R.A., Schnitzlein H.N. ja Murtagh FR. Englanninnos Alzheimerin 1907 tutkimuksesta ”Uber eine eigenartige Erkankung der Hirnrinde.” Clin Anat. 1995; 8(6): 429–31.
68. Kovacic J.C. ja Fuster V. Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease. Mt Sinai J Med. 2012; 79: 664–73.
69. Cardiogenic Dementia. Lancet. 1977; 1(8001): 27–8.
70. Katso viite 64.
71. Sama.
72. Yarchoan M., Xie S.X., Kling M.A. ym. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain. 2012; 135(Pt 12): 3749–56.
73. Honig L.S., Kukull W. ja Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating Center. Neurology. 2005; 64(3): 494–500.
74. de la Torre J.C. Vascular risk factors: a ticking time bomb to Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2013; 28(6): 551–9.
75. Katso viite 64.
76. de la Torre J.C. Vascular basis of Alzheimer’s pathogenesis. Ann N Y Acad Sci. 2002; 977: 196–215.
77. Zhu J., Wang Y., Li J. ym. Intracranial artery stenosis and progression from mild cognitive impairment to Alzheimer disease. Neurology. 2014; 82(10): 842–9.
78. Deschaintre Y., Richard F., Leys D. ja Pasquier F. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009; 73(9): 674–80.
79. Mizuno T., Nakata M., Naiki H. ym. Cholesterol-dependent generation of a seeding amyloid
beta-protein in cell culture. J Biol Chem. 1999; 274(21): 15110–4.
80. Trumbo P.R. ja Shimakawa T. Tolerable upper intake levels for trans fat, saturated fat, and cholesterol. Nutr Rev. 2011; 69(5): 270–8.
81. Benjamin M.M. ja Roberts W.C. Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent). 2013; 26(2): 124–36.
82. Corsinovi L., Biasi F., Poli G. ym. Dietary lipids and their oxidized products in Alzheimer’s disease. Mol Nutr Food Res. 2011; 55 Suppl 2: S161–72.
83. Harris J.R. ja Milton N.G.N. Cholesterol in Alzheimer’s disease and other amyloidogenic disorders. Subcell Biochem. 2010; 51: 47–75.
84. Puglielli L., Tanzi R.E. ja Kovacs D.M. Alzheimer’s disease: the cholesterol connection. Nat Neurosci. 2003; 6(4): 345–51.
85. Katso viite 83.
86. Reed B., Villeneuve S., Mack W. ym. Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol. 2014; 71(2): 195–200.
87. Yhdysvaltojen elintarvike- ja lääkevirasto. Important safety label changes to cholesterol-lowering statin drugs. Silver Spring, MD: Yhdysvaltojen terveys- ja sosiaalipalveluministeriö; 2012. http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm. 7.7.2012. Haettu 2.4.2015.
88. Rojas-Fernandez C.H. ja Cameron J.C. Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations. Ann Pharmacother. 2012; 46(4): 549–57.
89. Grant W.B. Dietary links to Alzheimer’s disease. Alzheimer Dis Rev. 1997; 2: 42–55.
90. Chandra V., Pandav R., Dodge H.H. ym. Incidence of Alzheimer’s disease in a rural community in India: the Indo-US study. Neurology. 2001; 57(6): 985–9.
91. White L., Petrovitch H., Ross G.W. ym. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia aging study. JAMA. 1996; 276(12): 955–60.
92. Katso viite 89.
93. Grant W.B. Trends in diet and Alzheimer’s disease during the nutrition transition in Japan and developing countries. J Alzheimers Dis. 2014; 38(3): 611–20.
94. Chan K.Y., Wang W., Wu J.J. ym. Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990–2010: A systematic review and analysis. Lancet. 2013; 381(9882): 2016–23.
95. Katso viite 93.
96. Chandra V., Ganguli M., Pandav R. ym. Prevalence of Alzheimer’s disease and other dementias in rural India: the Indo-US study. Neurology. 1998; 51(4): 1000–8.
97. Shetty P.S. Nutrition transition in India. Public Health Nutr. 2002; 5(1A): 175–82.
98. Giem P., Beeson W.L. ja Fraser G.E. The incidence of dementia and intake of animal products: preliminary findings from the Adventist Health Study. Neuroepidemiology. 1993; 12(1): 28–36.
99. Roses A.D. ja Saunders A.M. APOE is a major susceptibility gene for Alzheimer’s disease. Curr Opin Biotechnol. 1994; 5(6): 663–7.
100. Puglielli L., Tanzi R.E. ja Kovacs D.M. Alzheimer’s disease: the cholesterol connection. Nat Neurosci. 2003; 6(4): 345–51.
101. Chen X., Hui L., Soliman M.L. ja Geiger J.D. Altered cholesterol intracellular trafficking and the development of pathological hallmarks of sporadic AD. J Parkinsons Dis Alzheimers Dis. 2014; 1(1).
102. Sepehrnia B., Kamboh M.I., Adams-Campbell L.L. ym. Genetic studies of human apolipoproteins.X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. Am J Hum Genet. 1989; 45(4): 586–91.
103. Katso viite 89.
104. Katso viite 102.
105. Hendrie H.C., Murrell J., Gao S., Unverzagt F.W., Ogunniyi A. ja Hall K.S. International studies in dementia with particular emphasis on populations of African origin. Alzheimer Dis Assoc Disord. 2006; 20(3 Suppl 2): S42–6.
106. Kivipelto M., Helkala E.L., Laakso M.P. ym. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002; 137(3): 149–55.
107. Sama.
108. Jost B.C. ja Grossberg G.T. The natural history of Alzheimer’s disease: a brain bank study. J Am Geriatr Soc. 1995; 43(11): 1248–55.
109. Del Tredici K. ja Braak H. Neurofibrillary changes of the Alzheimer type in very elderly individuals: neither inevitable nor benign: Commentary on ‘No disease in the brain of a 115-year-old woman.’ Neurobiol Aging. 2008; 29(8): 1133–6.
110. Barnard N.D., Bush A.I., Ceccarelli A. ym. Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease. Neurobiol Aging. 2014; 35 Suppl 2: S74–8.
111. Lourida I., Soni M., Thompson-Coon J. ym. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology. 2013; 24(4): 479–89.
112. Roberts R.O., Geda Y.E., Cerhan J.R. ym. Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 2010; 29(5): 413–23.
113. Okereke O.I., Rosner B.A., Kim D.H. ym. Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol. 2012; 72(1): 124–34.
114. Parletta N., Milte C.M. ja Meyer B.J. Nutritional modulation of cognitive function and mental health. J Nutr Biochem. 2013; 24(5): 725–43.
115. Essa M.M., Vijayan R.K., Castellano-Gonzalez G., Memon M.A., Braidy N. ja Guillemin G.J. Neuroprotective effect of natural products against Alzheimer’s disease. Neurochem Res. 2012; 37(9): 1829–42.
116. Shukitt-Hale B. Blueberries and neuronal aging. Gerontology. 2012; 58(6): 518–23.
117. Cherniack E.P. A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders. Br J Nutr. 2012; 108(5): 794–800.
118. Johnson E.J. A possible role for lutein and zeaxanthin in cognitive function in the elderly. Am J Clin Nutr. 2012; 96(5): 1161S–5S.
119. Krikorian R., Shidler M.D., Nash T.A. ym. Blueberry supplementation improves memory in older adults. J Agric Food Chem. 2010; 58(7): 3996–4000.
120. Devore E.E., Kang J.H., Breteler M.M.B. ym. Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol. 2012; 72(1): 135–43.
121. Dai Q., Borenstein A.R., Wu Y. ym. Fruit and vegetable juices and Alzheimer’s disease: the Kame Project. Am J Med. 2006; 119(9): 751–9.
122. Krikorian R., Nash T.A., Shidler M.D., Shukitt-Hale B. ja Joseph J.A. Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. Br J Nutr. 2010; 103(5): 730–4.
123. Nurk E., Refsum H., Drevon C.A. ym. Cognitive performance among the elderly in relation to the intake of plant foods. The Hordaland Health Study. Br J Nutr. 2010; 104(8): 1190–201.
124. Mullen W., Marks S.C. ja Crozier A. Evaluation of phenolic compounds in commercial fruit juices and fruit drinks. J Agric Food Chem. 2007; 55(8): 3148–57.
125. Tarozzi A., Morroni F., Merlicco A. ym. Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25–35) oligomer-induced toxicity. Neurosci Lett. 2010; 473(2): 72–6.
126. Hattori M., Sugino E., Minoura K. ym. Different inhibitory response of cyanidin and methylene blue for filament formation of tau microtubule-binding domain. Biochem Biophys Res Commun. 2008; 374(1): 158–63.
127. Mandel S.A., Weinreb O., Amit T. ja Youdim M.B. Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols. Front Biosci (Schol Ed). 2012; 4: 581–98.
128. Ward R.J., Zucca F.A., Duyn J.H., Crichton R.R. ja Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014; 13(10): 1045–60.
129. Hishikawa N., Takahashi Y., Amakusa Y. ym. Effects of turmeric on Alzheimer’s disease with behavioral and psychological symptoms of dementia. Ayu. 2012; 33(4): 499–504.
130. Akhondzadeh S., Sabet M.S., Harirchian M.H. ym. Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial. J Clin Pharm Ther. 2010; 35(5): 581–8.
131. Akhondzadeh S., Shafiee Sabet M., Harirchian M.H. ym. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease. Psychopharmacology (Berl). 2010; 207(4): 637–43.
132. Hyde C., Peters J., Bond M. ym. Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer’s disease: systematic review and economic model. Age Ageing. 2013; 42(1): 14–20.
133. Yhdysvaltojen elintarvike- ja lääkevirasto. ARICEPT® (Donepezil Hydrochloride Tablets) package insert. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/DrugMarketingAdvertisingandCommunications/UCM368444.pdf. Haettu 2.4.2015.
134. Toledo C. ja Saltsman K. Genetics by the Numbers. Inside Life Science, Bethesda, MD: National Institute of General Medical Sciences. http://publications.nigms.nih.gov/insidelifescience/genetics-numbers.html. 11.6.2012. Haettu 3.3.2015.
135. Mostoslavsky R., Esteller M. ja Vaquero A. At the crossroad of lifespan, calorie restriction, chromatin and disease: meeting on sirtuins. Cell Cycle. 2010; 9(10): 1907–12.
136. Julien C., Tremblay C., Emond V. ym. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol. 2009; 68(1): 48–58.
137. Cai W., Uribarri J., Zhu L. ym. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci USA. 2014; 111(13): 4940–5.
138. Sama.
139. Rahmadi A., Steiner N. ja Münch G. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer’s disease. Clin Chem Lab Med. 2011; 49(3): 385–91.
140. Semba R.D., Nicklett E.J. ja Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci. 2010; 65(9): 963–75.
141. Srikanth V., Westcott B., Forbes J. ym. Methylglyoxal, cognitive function and cerebral atrophy in older people. J Gerontol A Biol Sci Med Sci. 2013; 68(1): 68–73.
142. Katso viite 137.
143. Beeri M.S., Moshier E., Schmeidler J. ym. Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev. 2011; 132(11–12): 583–7.
144. Yaffe K., Lindquist K., Schwartz A.V. ym. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology. 2011; 77(14): 1351–6.
145. Angeloni C., Zambonin L. ja Hrelia S. Role of methylglyoxal in Alzheimer’s disease. Biomed Res Int. 2014; 2014: 238485.
146. Vlassara H., Cai W., Goodman S. ym. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab. 2009; 94(11): 4483–91.
147. Cerami C., Founds H., Nicholl I. ym. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA. 1997; 94(25): 13915–20.
148. Uribarri J., Cai W., Sandu O., Peppa M., Goldberg T. ja Vlassara H. Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci. 2005; 1043: 461–6.
149. Sama.
150. Uribarri J., Woodruff S., Goodman S. ym. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010; 110(6): 911–6.e12.
151. Sama.
152. Sama.
153. Katso viite 137.
154. Baker L.D., Frank L.L., Foster-Schubert K. ym. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol. 2010; 67(1): 71–9.
155. Sama.
156. Erickson K.I., Voss M.W., Prakash R.S. ym. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA. 2011; 108(7): 3017–22.
157. ten Brinke L.F., Bolandzadeh N., Nagamatsu L.S. ym. Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomised controlled trial. Br J Sports Med. 2015; 49(4): 248–54.

4. Kuinka elää kuolematta ruoansulatuselinten syöpään
1. Liu P.H., Wang J.D. ja Keating N.L. Expected years of life lost for six potentially preventable cancers in the United States. Prev Med. 2013; 56(5): 309–13.
2. Bertram J.S., Kolonel L.N. ja Meyskens F.L. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res. 1987; 47(11): 3012–31.
3. Hasleton P.S. The internal surface area of the adult human lung. J Anat. 1972; 112(Pt 3): 391–400.
4. Macdonald T.T. ja Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005; 307(5717): 1920–5.
5. What are the key statistics about colorectal cancer? American Cancer Societyn verkkojulkaisu. http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer–key-statistics. Haettu 3.3.2015.
6. What are the key statistics about pancreatic cancer? American Cancer Societyn verkkojulkaisu. http://www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-key-statistics. Haettu 3.3.2015.
7. American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
8. Katso viite 5.
10. Screening for Colorectal Cancer. US Preventive Services Task Forcen verkkojulkaisu. http://www.uspreventiveservicestaskforce.org/Home/GetFile/1/467/colcancsumm/pdf. Haettu 3.3.2015.
11. International Monetary Fund. World Economic Outlook Database. http://bit.ly/1bNdlWu. 4.2015. Haettu 2.5.2015.
12. Maailmanpankki. World Development Indicators. http://data.worldbank.org/country/india. 2011. Haettu 2.5.2015.
13. Bengmark S., Mesa M.D. ja Gill A. Plant-derived health: the effects of turmeric and curcuminoids. Nutr Hosp. 2009; 24(3): 273–81.
14. Hutchins-Wolfbrandt A. ja Mistry A.M. Dietary turmeric potentially reduces the risk of cancer. Asian Pac J Cancer Prev. 2011; 12(12): 3169–73.
15. Sharma R.A., Euden S.A., Platton S.L. ym. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004; 10(20): 6847–54.
16. Carroll R.E., Benya R.V., Turgeon D.K. ym. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila). 2011; 4(3): 354–64.
17. Cruz-Correa M., Shoskes D.A., Sanchez P. ym. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2006; 4(8): 1035–8.
18. Sharma R.A., McLelland H.R., Hill K.A. ym. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001; 7(7): 1894–900.
19. Singh S. From exotic spice to modern drug? Cell. 2007; 130(5): 765–8.
20. International Institute for Population Sciences & Macro International: National Family Health Survey (NFHS-3), 2005–06: India: Vol. I. Mumbai: IIPS; 2007.
21. Cummings J.H., Bingham S.A., Heaton K.W. ja Eastwood M.A. Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology. 1992; 103(6): 1783–9.
22. Gear J.S., Brodribb A.J., Ware A. ja Mann J.I. Fibre and bowel transit times. Br J Nutr. 1981; 45(1): 77–82.
23. Burkitt D.P., Walker A.R. ja Painter N.S. Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease. Lancet. 1972; 2(7792): 1408–12.
24. Sonnenberg A., Koch T.R. Physician visits in the United States for constipation: 1958 to 1986. Dig Dis Sci. 1989; 34(4): 606–11.
25. Burkitt D.P. A deficiency of dietary fiber may be one cause of certain colonic and venous disorders. Am J Dig Dis. 1976; 21(2): 104–8.
26. Fox A., Tietze P.H. ja Ramakrishnan K. Anorectal conditions: anal fissure and anorectal fistula. FP Essent. 2014; 419: 20–7.
27. Katso viite 25.
28. Sanjoaquin M.A., Appleby P.N., Spencer E.A. ja Key T.J. Nutrition and lifestyle in relation to bowel movement frequency: a cross-sectional study of 20630 men and women in EPIC-Oxford. Public Health Nutr. 2004; 7(1): 77–83.
29. What are the key statistics about colorectal cancer? American Cancer Societyn verkkojulkaisu. http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics. Haettu 3.3.2015.
30. Doll R. The geographical distribution of cancer. Br J Cancer. 1969; 23(1): 1–8.
31. Lipski E. Traditional non-Western diets. Nutr Clin Pract. 2010; 25(6): 585–93.
32. Burkitt D.P. Epidemiology of cancer of the colon and rectum.1971. Dis. Colon Rectum. 1993; 36(11): 1071–82.
33. Shaper A.G. ja Jones K.W. Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda: 1959. Int J Epidemiol. 2012; 41(5): 1221–5.
34. Malila N. ja Hakulinen T. Epidemiological trends of colorectal cancer in the Nordic countries. Scand J Surg. 2003; 92(1): 5–9.
35. Englyst H.N., Bingham S.A., Wiggins H.S. ym. Nonstarch polysaccharide consumption in four Scandinavian populations. Nutr Cancer. 1982; 4(1): 50–60.
36. Graf E. ja Eaton J.W. Dietary suppression of colonic cancer. Fiber or phytate? Cancer. 1985; 56(4): 717–8.
37. Fonseca-Nunes A., Jakszyn P. ja Agudo A. Iron and cancer risk— a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014; 23(1): 12–31.
38. Mellanby E. The rickets-producing and anti-calcifying action of phytate. J Physiol. 1949; 109(3–4): 488–533.
39. House W.A., Welch R.M. ja Van Campen D.R. Effect of phytic acid on the absorption, distribution, and endogenous excretion of zinc in rats. J Nutr. 1982; 112(5): 941–53.
40. Urbano G., López-Jurado M., Aranda P., Vidal-Valverde C., Tenorio E. ja Porres J. The role of phytic acid in legumes: antinutrient or beneficial function? J Physiol Biochem. 2000; 56(3): 283–94.
41. López-González A.A., Grases F., Roca P., Mari B., Vicente-Herrero M.T. ja Costa-Bauzá A. Phytate (myo-inositol hexaphosphate) and risk factors for osteoporosis. J Med Food. 2008; 11(4): 747–52.
42. López-González A.A., Grases F., Monroy N. ym. Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women. Eur J Nutr. 2013; 52(2): 717–26.
43. Arriero Mdel M., Ramis J.M., Perelló J. ja Monjo M. Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts. PLoS ONE. 2012; 7(8): e43187.
44. Khosla S., Burr D., Cauley J. ym. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007; 22(10): 1479–91.
45. Singh P.N. ja Fraser G.E. Dietary risk factors for colon cancer in a low-risk population. Am J Epidemiol. 1998; 148(8): 761–74.
46. Manousos O., Day N.E., Trichopoulos D., Gerovassilis F., Tzonou A. ja Polychronopoulou A. Diet and colorectal cancer: A case-control study in Greece. Int J Cancer. 1983; 32(1): 1–5.
47. Lanza E., Hartman T.J., Albert P.S. ym. High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the polyp prevention trial. J Nutr. 2006; 136(7): 1896–1903.
48. Vucenik I. ja Shamsuddin A.M. Protection against cancer by dietary IP6 and inositol. Nutr Cancer. 2006; 55(2): 109–25.
49. Vucenik I. ja Shamsuddin A.M. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J Nutr. 2003; 133(11- Suppl-1): 3778S–84S.
50. Ogawa S., Kobayashi H., Amada S. ym. Sentinel node detection with (99m)Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy. Int J Clin Oncol. 2010; 15(1): 52–8.
51. Vucenik I. ja Shamsuddin A.M. Protection against cancer by dietary IP6 and inositol. Nutr Cancer. 2006; 55(2): 109–25.
52. Vucenik I., Passaniti A., Vitolo M.I., Tantivejkul K., Eggleton P. ja Shamsuddin A.M. Anti-angiogenic activity of inositol hexaphosphate (IP6). Carcinogenesis. 2004; 25(11): 2115–23.
53. Wang H., Khor T.O., Shu L. ym. Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med Chem. 2012; 12(10): 1281–305.
54. Yang G.Y. ja Shamsuddin A.M. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates. Anticancer Res. 1995; 15 (6B): 2479–87.
55. Shamsuddin A.M., Yang G.Y. ja Vucenik I. Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer Res. 1996; 16(6A): 3287–92.
56. Vucenik I., Tantivejkul K., Zhang Z.S., Cole K.E., Saied I. ja Shamsuddin A.M. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Anticancer Res. 1998; 18(6A): 4083–90.
57. Shamsuddin A.M. ja Yang G.Y. Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis. 1995; 16(8): 1975–9.
58. Shamsuddin A.M. Anti-cancer function of phytic acid. Int J Food Sci Tech. 2002; 37(7): 769–82.
59. Sun J., Chu Y.F., Wu X. ja Liu R.H. Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem. 2002; 50(25): 7449–54.
60. Olsson M.E., Andersson C.S., Oredsson S., Berglund R.H. ja Gustavsson K.E. Antioxidant levels and inhibition of cancer cell proliferation in vitro by extracts from organically and conventionally cultivated strawberries. J Agric Food Chem. 2006; 54(4): 1248–55.
61. Graham D.J., Campen D., Hui R. ym. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet. 2005; 365(9458): 475–81.
62. Wang L.S., Burke C.A., Hasson H. ym. A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. Cancer Prev Res (Phila). 2014; 7(7): 666–74.
63. Sama.
64. Pan A., Sun Q., Bernstein A.M. ym. Red meat consumption and mortality: Results from 2 prospective cohort studies. Arch Intern Med. 2012; 172(7): 555–63.
65. Sinha R., Cross A.J., Graubard B.I., Leitzmann M.F. ja Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009; 169(6): 562–71.
66. Popkin B.M. Reducing meat consumption has multiple benefits for the world’s health. Arch Intern Med. 2009; 169(6): 543.
67. Dixon S.J. ja Stockwell B.R. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014; 10(1): 9–17.
68. Hurrell R. ja Egli I. Iron bioavailability and dietary reference values. Am J Clin Nutr. 2010; 91(5): 1461S–7S.
69. Cook J.D. Adaptation in iron metabolism. Am J Clin Nutr. 1990; 51(2): 301–8.
70. Fonseca-Nunes A., Jakszyn P. ja Agudo A. Iron and cancer risk—a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014; 23(1): 12–31.
71. Yang W., Li B., Dong X. ym. Is heme iron intake associated with risk of coronary heart disease? A meta-analysis of prospective studies. Eur J Nutr. 2014; 53(2): 395–400.
72. Bao W., Rong Y., Rong S. ja Liu L. Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis. BMC Med. 2012; 10: 119.
73. Zacharski L.R., Chow B.K., Howes P.S. ym. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst. 2008; 100(14): 996–1002.
74. Edgren G., Nyrén O. ja Melbye M. Cancer as a ferrotoxic disease: are we getting hard stainless evidence? J Natl Cancer Inst. 2008; 100(14): 976–7.
75. Corpet D.E. Red meat and colon cancer: should we become vegetarians, or can we make meat safer? Meat Sci. 2011; 89(3): 310–6.
76. Farmer B., Larson B.T., Fulgoni V.L 3rd., Rainville A.J. ja Liepa G.U. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the national health and nutrition examination survey 1999–2004. J Am Diet Assoc. 2011; 111(6): 819–27.
77. Iron deficiency—United States, 1999–2000. MMWR Morb Mortal Wkly Rep. 2002; 51(40): 897–9.
78. Craig W.J. ja Mangels A.R. Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc. 2009; 109(7): 1266–82.
79. Tiwari A.K., Mahdi A.A., Chandyan S. ym. Oral iron supplementation leads to oxidative imbalance in anemic women: a prospective study. Clin Nutr. 2011; 30(2): 188–93.
80. Saunders A.V., Craig W.J., Baines S.K. ja Posen J.S. Iron and vegetarian diets. Med J Aust. 2013; 199(4 Suppl): S11–6.
81. American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
82. Iodice S., Gandini S., Maisonneuve P. ja Lowenfels A.B. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008; 393(4): 535–45.
83. Kolodecik T., Shugrue C., Ashat M. ja Thrower E.C. Risk factors for pancreatic cancer: underlying mechanisms and potential targets. Front Physiol. 2013; 4: 415.
84. Thiébaut A.C., Jiao L., Silverman D.T. ym. Dietary fatty acids and pancreatic cancer in the NIHAARP diet and health study. J Natl Cancer Inst. 2009; 101(14): 1001–11.
85. Landrigan P.J. Preface. Ann N Y Acad Sci. 1991; 643: xv– xvi.
86. Weiner R., Rees D., Lunga F.J. ja Felix M.A. Third wave of asbestos-related disease from secondary use of asbestos. A case report from industry. S Afr Med J. 1994; 84(3): 158–60.
87. Johnson E.S., Zhou Y., Lillian Yau C. ym. Mortality from malignant diseases-update of the Baltimore union poultry cohort. Cancer Causes Control. 2010; 21(2): 215–21.
88. Felini M., Johnson E., Preacely N., Sarda V., Ndetan H. ja Bangara S. A pilot case-cohort study of liver and pancreatic cancers in poultry workers. Ann Epidemiol. 2011; 21(10): 755–66.
89. Lynch S.M., Vrieling A., Lubin J.H. ym. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 2009; 170(4): 403–13.
90. Rohrmann S., Linseisen J., Nöthlings U. ym. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2013; 132(3): 617–24.
91. Rohrmann S., Linseisen J., Jakobsen M.U. ym. Consumption of meat and dairy and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011; 128(3): 623–34.
92. Lotti M., Bergamo L. ja Murer B. Occupational toxicology of asbestos-related malignancies. Clin Toxicol (Phila). 2010; 48(6): 485–96.
93. Marvisi M., Balzarini L., Mancini C. ja Mouzakiti P. A new type of hypersensitivity pneumonitis: salami brusher’s disease. Monaldi Arch Chest Dis. 2012; 77(1): 35–7.
94. Yang Z.Y., Yuan J.Q., Di M.Y. ym. Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis. PLoS ONE. 2013; 8(3): e57528.
95. Li L., Aggarwal B.B., Shishodia S., Abbruzzese J. ja Kurzrock R. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer. 2004; 101(10): 2351–62.
96. Dhillon N., Aggarwal B.B., Newman R.A. ym. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008; 14(14): 4491–9.
97. Bosetti C., Bravi F., Turati F. ym. Nutrient-based dietary patterns and pancreatic cancer risk. Ann Epidemiol. 2013; 23(3): 124–8.
98. Mills P.K., Beeson W.L., Abbey D.E., Fraser G.E. ja Phillips R.L. Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists. Cancer. 1988; 61(12): 2578–85.
99. American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
100. Bagnardi V., Rota M., Botteri E. ym. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol. 2013; 24(2): 301–8.
101. Rubenstein J.H. ja Chen J.W. Epidemiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014; 43(1): 1–14.
102. Lagergren J., Bergström R., Lindgren A. ja Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999; 340(11): 825–31.
103. Pohl H. ja Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005; 97(2): 142–6.
104. Parasa S. ja Sharma P. Complications of gastro-oesophageal reflux disease. Best Pract Res Clin Gastroenterol. 2013; 27(3): 433–42.
105. El-Serag H.B. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007; 5(1): 17–26.
106. De Ceglie A., Fisher D.A., Filiberti R., Blanchi S. ja Conio M. Barrett’s esophagus, esophageal and esophagogastric junction adenocarcinomas: the role of diet. Clin Res Hepatol Gastroenterol. 2011; 35(1): 7–16.
107. Navarro Silvera S.A., Mayne S.T., Risch H. ym. Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer. 2008; 123(4): 852–60.
108. Nebel O.T. ja Castell D.O. Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology. 1972; 63(5): 778–83.
109. Becker D.J., Sinclair J., Castell D.O. ja Wu W.C. A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol. 1989; 84(7): 782–6.
110. Charlton K.E., Tapsell L.C., Batterham M.J. ym. Pork, beef and chicken have similar effects on acute satiety and hormonal markers of appetite. Appetite. 2011; 56(1): 1–8.
111. Mitsukawa T., Takemura J., Ohgo S. ym. Gallbladder function and plasma cholecystokinin levels in diabetes mellitus. Am J Gastroenterol. 1990; 85(8): 981–5.
112. Matsuki N., Fujita T., Watanabe N. ym. Lifestyle factors associated with gastroesophageal reflux disease in the Japanese population. J Gastroenterol. 2013; 48(3): 340–9.
113. Jung J.G., Kang H.W., Hahn S.J. ym. Vegetarianism as a protective factor for reflux esophagitis: a retrospective, cross-sectional study between Buddhist priests and general population. Dig Dis Sci. 2013; 58(8): 2244–52.
114. Fashner J. ja Gitu A.C. Common gastrointestinal symptoms: risks of long-term proton pump inhibitor therapy. FP Essent. 2013; 413: 29–39.
115. Terry P., Lagergren J., Ye W., Nyrén O. ja Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer. 2000; 87(5): 750–4.
116. Ekström A.M., Serafini M., Nyrén O., Hansson L.E., Ye W. ja Wolk A. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden. Int J Cancer. 2000; 87(1): 133–40.
117. Nilsson M., Johnsen R., Ye W., Hveem K. ja Lagergren J. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut. 2004; 53(12): 1730–5.
118. Coleman H.G., Murray L.J., Hicks B. ym. Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis. Nutr Rev. 2013; 71(7): 474–82.
119. Burkitt D.P. Hiatus hernia: is it preventable? Am J Clin Nutr. 1981; 34(3): 428–31.
120. Burkitt D.P. ja James P.A. Low-residue diets and hiatus hernia. Lancet. 1973; 2(7821): 128–30.
121. Sama.
122. Burkitt D.P. Two blind spots in medical knowledge. Nurs Times. 1976; 72(1): 24–7.
123. Katso viite 119.
124. American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
125. Polednak A.P. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer. 2003; 105(1): 98–100.
126. Chen T., Yan F., Qian J. ym. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res (Phila). 2012; 5(1): 41–50.
127. Sama.
128. Eaton S.B., Konner M. ja Shostak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med. 1988; 84(4): 739–49.
129. King D.E., Mainous A.G. ja Lambourne C.A. Trends in dietary fiber intake in the United States, 1999–2008. J Acad Nutr Diet. 2012; 112(5): 642–8.
130. Zhang N., Huang C. ja Ou S. In vitro binding capacities of three dietary fibers and their mixture for four toxic elements, cholesterol, and bile acid. J Hazard Mater. 2011; 186(1): 236–9.
131. Moshfegh A., Goldman J. ja Cleveland l. What We Eat in America, NHANES 2001–2002: Usual Nutrient Intakes from Food Compared to Dietary Reference Intakes. Washington, D.C.: US Department of Agriculture Agricultural Research Service; 2005.

5. Kuinka elää kuolematta tulehduksiin
1. Civil Practice And Remedies Code. Title 4. Liability in Tort. Chapter 96. False Disparagement of Perishable Food Products. Texas Constitution and Statutes. http://www.statutes.legis.state.tx.us/Docs/CP/htm/CP.96.htm. Haettu 3.3.2015.
2. Sama.
3. Oppel Jr R.A. Taping of farm cruelty is becoming the crime. New York Times. http://www.nytimes.com/2013/04/07/us/taping-of-farm-cruelty-is-becoming-the-crime.html. 6.4.2013. Haettu 3.3.2015.
4. Shrestha S.S., Swerdlow D.L., Borse R.H. ym. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009–April 2010). Clin Infect Dis. 2011; 52 Suppl 1: S75–82.
5. Woolhouse M.E. ja Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerging Infect Dis. 2005; 11(12): 1842–7.
6. Epstein P.R., Chivian E. ja Frith K. Emerging diseases threaten conservation. Environ Health Perspect. 2003; 111(10): A506–7.
7. Espinosa de los Monteros L.E., Galán J.C., Gutiérrez M. ym. Allele-specific PCR method based on pncA and oxyR sequences for distinguishing Mycobacterium bovis from Mycobacterium tuberculosis: intraspecific M. bovis pncA sequence polymorphism. J Clin Microbiol. 1998; 36(1): 239–42.
8. Esmail H., Barry C.E., Young D.B. ja Wilkinson R.J. The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond, B, Biol Sci. 2014; 369(1645): 20130437.
9. Daszak P. ja Cunningham A.A. Emerging infectious diseases: a key role for conservation medicine. Teoksessa Aguirre A.A., Ostfeld R.S., Tabor G.M. ym. Conservation Medicine: Ecological Health in Practice. Oxford: Oxford University Press; 2002: 40–61.
10. McMichael A.J. Human Frontiers, Environments and Disease, Past Patterns, Uncertain Futures. Cambridge: Cambridge University Press; 2001.
11. Torrey E.F. ja Yolken R.H. Beasts of the Earth, Animals, Humans, and Disease. New Brunswick, NJ: Rutgers University Press; 2005.
12. Katso viite 10.
13. Van Heuverswyn F. ja Peeters M. The origins of HIV and implications for the global epidemic. Curr Infect Dis Rep. 2007; 9(4): 338–46.
14. Whon T.W., Kim M.S., Roh S.W., Shin N.R., Lee H.W. ja Bae J.W. Metagenomic characterization of airborne viral DNA diversity in the near-surface atmosphere. J Virol. 2012; 86(15): 8221–31.
15. Yhdysvaltojen maatalousministeriö (USDA). Microbiological testing of AMS purchased meat, poultry and egg commodities. http://www.ams.usda.gov/AMSv1.0/ams.fetchTemplateData.do?template=TemplateA&navID=MicrobialTestingofCommodities&rightNav1=MicrobialTestingofCommodities&topNav=&leftNav=&page=FPPMicroDataReports&resultType=&acct=lsstd. Haettu 3.3.2015.
16. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report. 2016; 64(2).
17. Barker J., Stevens D. ja Bloomfield S.F. Spread and prevention of some common viral infections in community facilities and domestic homes. J Appl Microbiol. 2001; 91(1): 7–21.
18. Boone S.A. ja Gerba C.P. The occurrence of influenza A virus on household and day care center fomites. J Infect. 2005; 51(2): 103–9.
19. Maailman terveysjärjestö WHO. WHO Guidelines on Hand Hygiene in Health Care. Geneva: Maailman terveysjärjestö; 2009. http://www.ncbi.nlm.nih.gov/books/n/whohand/pdf/. Haettu 4.4.2015.
20. How does the immune system work? PubMed Health. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0010386/. Haettu 3.3.2015.
21. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46(RR-08): 1–24.
22. Gibson A., Edgar J., Neville C. ym. Effect of fruit and vegetable consumption on immune function in older people: a randomized controlled trial. Am J Clin Nutr. 2012; 96(6): 1429–36.
23. Yhdysvaltojen maatalousministeriö (USDA).Food availability (per capita) Data System. Fresh kale: per capita availability adjusted for loss. http://www.ers.usda.gov/datafiles/Food_Availabily_Per_Capita_Data_System/LossAdjusted_Food_Availability/veg.xls. Haettu 3.3.2015.
24. Nishi K., Kondo A., Okamoto T. ym. Immunostimulatory in vitro and in vivo effects of a watersoluble extract from kale. Biosci Biotechnol Biochem. 2011; 75(1): 40–6.
25. Sama.
26. Macdonald T.T. ja Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005; 307(5717): 1920–5.
27. Yhdysvaltojen väestönlaskentavirasto. Median and average square feet of floor area in new single-family houses completed by location. https://www.census.gov/const/C25Ann/sftotalmedavgsqft.pdf. Haettu 3.4.2015.
28. Sheridan B.S. ja Lefrançois L. Intraepithelial lymphocytes: To serve and protect. Curr Gastroenterol Rep. 2010; 12(6): 513–21.
29. Hooper L.V. You AhR what you eat: linking diet and immunity. Cell. 2011; 147(3): 489–91.
30. Esser C. Biology and function of the aryl hydrocarbon receptor: report of an international and interdisciplinary conference. Arch Toxicol. 2012; 86(8): 1323–9.
31. Veldhoen M. Direct interactions between intestinal immune cells and the diet. Cell Cycle. 2012 Feb 1; 11(3): 426–7.
32. Katso viite 29.
33. Savouret J.F., Berdeaux A. ja Casper R.F. The aryl hydrocarbon receptor and its xenobiotic ligands: A fundamental trigger for cardiovascular diseases. Nutr Metab Cardiovasc Dis. 2003; 13(2): 104–13.
34. Ashida H., Fukuda I., Yamashita T. ja Kanazawa K. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett. 2000; 476 (3): 213–7.
35. Sama.
36. Alhaider A.A., El Gendy M.A.M., Korashy H.M. ja El-Kadi A.O.S. Camel urine inhibits the cytochrome P450 1a1 gene expression through an AhR-dependent mechanism in Hepa 1c1c7 cell line. J Ethnopharmacol. 2011; 133(1): 184–90.
37. Watts A.R., Lennard M.S., Mason S.L., Tucker G.T. ja Woods H.F. Beeturia and the biological fate of beetroot pigments. Pharmacogenetics. 1993; 3(6): 302–11.
38. Yalindag-Ozturk N., Ozdamar M. ja Cengiz P. Trial of garlic as an adjunct therapy for multidrug resistant Pseudomonas aeruginosa pneumonia in a critically ill infant. J Altern Complement Med. 2011; 17(4): 379–80. Verkkojulkaisu 11.4.2011.
39. Seeram N.P. Recent trends and advances in berry health benefits research. J Agric Food Chem. 2010; 58(7): 3869–70.
40. Seeram N.P. Berry fruits for cancer prevention: Current status and future prospects. J Agric Food Chem. 2008; 56(3): 630–5.
41. Caligiuri M.A. Human natural killer cells. Blood. 2008; 112(3): 461–9.
42. McAnulty L.S., Nieman D.C., Dumke C.L. ym. Effect of blueberry ingestion on natural killer cell counts, oxidative stress, and inflammation prior to and after 2. 5 H of running. Appl Physiol Nutr Metab. 2011; 36(6): 976–84.
43. Majdalawieh A.F. ja Carr R.I. In vitro investigation of the potential immunomodulatory and anticancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum). J Med Food. 2010; 13(2): 371–81.
44. Bager P., Wohlfahrt J. ja Westergaard T. Caesarean delivery and risk of atopy and allergic disease: Meta-analyses. Clin Exp Allergy. 2008; 38(4): 634–42
45. Benn C.S., Thorsen P., Jensen J.S. ym. Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood. J Allergy Clin Immunol. 2002; 110(1): 72–7
46. Sheih Y.H., Chiang B.L., Wang L.H., Liao C.K. ja Gill H.S. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr. 2001; 20(Suppl 2): 149–56.
47. Berggren A., Lazou Ahrhiang B.L., Wang L.H. ja Liao G. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr. 2011; 50(3): 203–10.
48. Hao Q., Lu Z., Dong B.R., Huang C.Q. ja Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 2011; 9: 1–42.
49. Homayoni Rad A., Akbarzadeh F. ja Mehrabany E.V. Which are more important: prebiotics or probiotics? Nutrition. 2012; 28(11–12): 1196–7.
50. Vitali B., Minervini G., Rizzello C.G. ym. Novel probiotic candidates for humans isolated from raw fruits and vegetables. Food Microbiol. 2012; 31(1): 116–25.
51. Nieman D.C. Moderate exercise improves immunity and decreases illness rates. Am J Lifestyle Med. 2011; 5(4): 338–45.
52. Schwindt C.D., Zaldivar F., Wilson L. ym. Do circulating leucocytes and lymphocyte subtypes increase in response to brief exercise in children with and without asthma? Br J Sports Med. 2007; 41(1): 34–40.
53. Nieman D.C., Henson D.A., Gusewitch G. ym. Physical activity and immune function in elderly women. Med Sci Sports Exerc. 1993; 25(7): 823–31.
54. Neville V., Gleeson M. ja Folland J.P. Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes. Med Sci Sports Exerc. 2008; 40(7): 1228–36.
55. Otsuki T., Shimizu K., Iemitsu M. ja Kono I. Salivary secretory immunoglobulin A secretion increases after 4-weeks ingestion of chlorella-derived multicomponent supplement in humans: a randomized cross over study. Nutr J. 2011 Sep 9; 10: 91.
56. Klentrou P., Cieslak T., MacNeil M., Vintinner A. ja Plyley M. Effect of moderate exercise on salivary immunoglobulin A and infection risk in humans. Eur J Appl Physiol. 2002; 87(2): 153–8.
57. Nieman D.C. Moderate exercise improves immunity and decreases illness rates. Am J Lifestyle Med. 2011; 5(4): 338–46.
58. Walsh N.P., Gleeson M., Shephard R.J. ym. Position statement. Part one: immune function and exercise. Exerc Immunol Rev. 2011; 17: 6–63.
59. Akimoto T., Nakahori C., Aizawa K., Kimura F., Fukubayashi T. ja Kono I. Acupuncture and responses of immunologic and endocrine markers during competition. Med Sci Sports Exerc. 2003; 35(8): 1296–302.
60. Neville V., Gleeson M. ja Folland J.P. Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes. Med Sci Sports Exerc. 2008; 40(7): 1228–36.
61. Nieman D.C. Exercise effects on systemic immunity. Immunol Cell Biol. 2000; 78(5): 496–501.
62. Otsuki T., Shimizu K., Iemitsu M. ja Kono I. Salivary secretory immunoglobulin A secretion increases after 4-weeks ingestion of chlorella-derived multicomponent supplement in humans: a randomized cross over study. Nutr J. 2011 Sep 9; 10: 91.
63. Halperin S.A., Smith B., Nolan C., Shay J. ja Kralovec J. Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial. CMAJ. 2003 Jul 22; 169(2): 111–7.
64. Otsuki T., Shimizu K., Iemitsu M. ja Kono I. Chlorella intake attenuates reduced salivary SIgA secretion in kendo training camp participants. Nutr J. 2012 Dec 11; 11: 103.
65. Selvaraj V., Singh H. ja Ramaswamy S. Chlorella-induced psychosis. Psychosomatics. 2013; 54(3): 303–4.
66. Sama.
67. Carpenter K.C., Breslin W.L., Davidson T., Adams A. ja McFarlin B.K. Baker’s yeast β-glucan supplementation increases monocytes and cytokines post-exercise: implications for infection risk? Br J Nutr. 2013; 109(3): 478–86.
68. Sama.
69. Talbott S. ja Talbott J. Effect of BETA 1, 3/1, 6 GLUCAN on upper respiratory tract infection symptoms and mood state in marathon athletes. J Sports Sci Med. 2009 Dec 1; 8(4): 509–15.
70. Merrill R.M., Isakson R.T. ja Beck R.E. The association between allergies and cancer: what is currently known? Ann Allergy Asthma Immunol. 2007; 99(2): 102–16.
71. Wakchaure G.C. Production and marketing of mushrooms: global and national scenario. Teoksessa Singh M. (toim.) Mushrooms: Cultivation, Marketing and Consumption. Indian Council of Agricultural Research Directorate of Mushroom Research; 2011.
72. Jeong S.C., Koyyalamudi S.R. ja Pang G. Dietary intake of Agaricus bisporus white button mushroom accelerates salivary immunoglobulin A secretion in healthy volunteers. Nutrition. 2012; 28(5): 527–31.
73. Sama.
74. Moro C., Palacios I., Lozano M. ym. Anti-inflammatory activity of methanolic extracts from edible mushrooms in LPS activated RAW 264. 7 macrophages. Food Chemistry. 2012; 130: 350–5.
75. Jesenak M., Hrubisko M., Majtan J., Rennerova Z. ja Banovcin P. Anti-allergic effect of Pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections. Phytother Res. 2014; 28(3): 471–4.
76. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Estimates of foodborne illness in the United States. http://www.cdc.gov/foodborneburden/. Haettu 3.3.2015.
77. Batz M.B., Hoffmann S. ja Morris Jr J.G. Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J Food Prot. 2012; 75(7): 1278–91.
78. Park S., Navratil S., Gregory A. ym. Multifactorial effects of ambient temperature, precipitation, farm management, and environmental factors determine the level of generic Escherichia coli contamination on preharvested spinach. Appl Environ Microbiol. 2015; 81 (7): 2635–50.
79. Hoffmann S., Batz M.B. ja Morris Jr J.G. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot. 2012; 75(7): 1292–302.
80. Chai S.J. ja White P.L. Salmonella enterica Serotype Enteritidis: increasing incidence of domestically acquired infections. Clin Infect Dis. 2012; 54(Sup5): 488–97.
81. Salmonella. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. http://www.cdc.gov/salmonella/. Haettu 3.3.2015.
82. Baura G.D. The incredible inedible egg. IEEE Pulse. 2010 Nov–Dec; 1(3): 56, 62.
83. Krouse B. Opposing view on food safety: committed to safety. USA Today. http://usatoday30.usatoday.com/news/opinion/editorials/2010-08-30-editorial30_ST1_N.htm. Haettu 3.3.2015.
84. Davis A.L., Curtis P.A., Conner D.E., McKee S.R. ja Kerth L.K. Validation of cooking methods using shell eggs inoculated with Salmonella serotypes Enteritidis and Heidelberg. Poult Sci. 2008; 87(8): 1637–42.
85. Stadelman W.J., Muriana P.M. ja Schmieder H. The effectiveness of traditional egg- cooking practices for elimination of Salmonella enteritidis. Poult Sci. 1995; 74(s1): 119.
86. Humphrey T.J., Greenwood M., Gilbert R.J., Rowe B. ja Chapman P.A. The survival of salmonellas in shell eggs cooked under simulated domestic conditions. Epidemiol Infect. 1989; 103: 35–45.
87. Yhdysvaltojen elintarvike- ja lääkevirasto.Playing it safe with eggs. http://www.fda.gov/food/resourcesforyou/Consumers/ucm077342.htm. Haettu 3.3.2015.
88. Batz M.B., Hoffmann S. ja Morris Jr J.G. Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J Food Prot. 2012; 75(7): 1278–91.
89. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Multistate outbreak of multidrug-resistant Salmonella Heidelberg infections linked to Foster Farms brand chicken. http://www.cdc.gov/salmonella/heidelberg-10-13/. Haettu 3.3.2015.
90. Yhdysvaltojen maatalousministeriö (USDA). Notice of Intended Enforcement. http://www.marlerblog.com/files/2013/10/foster-farms-est-6137a-p1.pdf. Haettu 3.3.2015.
91. Voetsch A.C., Van Gilder T.J., Angulo F.J. ym. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis. 2004; 38(Supplement-3): S127– S134.
92. Katso viite 90.
93. Pierson D. Mexico blocks Foster Farms chicken imports amid salmonella fears. LA Times. http://articles.latimes.com/2013/oct/24/business/la-fi-foster-farms-mexico-20131025. Haettu 3.3.2015.
94. Supreme Beef Processors, Inc v United States Dept. of Agriculture, 275 F. 3d 432 (5th Cir 2001).
95. Fravalo P., Laisney M.J., Gillard M.O., Salvat G. ja Chemaly M. Campylobacter transfer from naturally contaminated chicken thighs to cutting boards is inversely related to initial load. J Food Prot. 2009; 72(9): 1836–40.
96. Guyard-Nicodème M., Tresse O., Houard E. ym. Characterization of Campylobacter spp. transferred from naturally contaminated chicken legs to cooked chicken slices via a cutting board. Int J Food Microbiol. 2013 Jun 3; 164(1): 7–14.
97. Foster Farms Provides Food Safety Update. Close Up Median verkkojulkaisu. http://closeupmedia.com/food/Foster-Farms-Provides-Food-Safety-Update.html. 2013. Haettu 5.3.2015.
98. Hoffmann S., Batz M.B. ja Morris Jr J.G. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot. 2012; 75(7): 1292–302.
99. Karapetian A. Model EU. Meatingplace. March 2010: 91.
100. The high cost of cheap chicken. Consumer Reports. http://www.consumerreports.org/cro/magazine/2014/02/the-high-cost-of-cheap-chicken/index.htm. 2.2014. Haettu 5.3.2015.
101. Antibiotic Resistance Threats in the United States, 2013. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. Haettu 3.3.2015.
102. Mayo Clinic Staff. Salmonella infection. The Mayo Clinic. http://www.mayoclinic.org/diseases-conditions/salmonella/basics/causes/con-20029017. Haettu 3.3.2015.
103. Yhdysvaltojen elintarvike- ja lääkevirasto. NARMS 2011 retail meat annual report. http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/UCM334834.pdf. Haettu 3.4.2015.
104. Sama.
105. NA. Vital signs: incidence and trends of infection with pathogens transmitted commonly through food—foodborne diseases active surveillance network, 10 U.S. Sites, 1996–2010. MMWR Morb Mortal Wkly Rep. 2011; 60(22): 749–55.
106. Chai S.J., White P.L., Lathrop S.L. ym. Salmonella enterica serotype Enteritidis: increasing incidence of domestically acquired infections. Clin Infect Dis. 2012; 54-Suppl-5(NA): S488–97.
107. Hoffmann S., Batz M.B. ja Morris Jr J.G. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot. 2012; 75(7): 1292–302.
108. 511 F. 2d 331-American Public Health Association v. Butz. http://openjurist.org/511/f2d/331/american-public-health-association-v-butz. Haettu 3.3.2015.
109. Supreme Beef Processors v. U.S. Dept. of Agriculture. United States Court of Appeals, Fifth Circuit. http://www.leagle.com/decision/2001707275F3d432_1672. Haettu 3.3.2015.
110. Stamey T.A., Timothy M., Millar M. ja Mihara G. Recurrent urinary infections in adult women. The role of introital enterobacteria. Calif Med. 1971; 115(1): 1–19.
111. Yamamoto S., Tsukamoto T., Terai A., Kurazono H., Takeda Y. ja Yoshida O. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J Urol. 1997; 157(3): 1127–9.
112. Bergeron C.R., Prussing C., Boerlin P. ym. Chicken as reservoir for extraintestinal pathogenic Escherichia coli in humans, Canada. Emerging Infect Dis. 2012; 18(3): 415–21.
113. Jakobsen L., Garneau P., Bruant G. ym. Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis. 2012; 31(6): 1121–9.
114. Foxman B., Barlow R., D’arcy H., Gillespie B. ja Sobel J.D. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000; 10(8): 509–15.
115. Platell J.L., Johnson J.R., Cobbold R.N. ja Trott D.J. Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol. 2011; 153(1–2): 99–108.
116. Linton A.H., Howe K., Bennett P.M., Richmond M.H. ja Whiteside E.J. The colonization of the human gut by antibiotic resistant Escherichia coli from chickens. J Appl Bacteriol. 1977; 43(3): 465–9.
117. Sama.
118. Rusin P., Orosz-Coughlin P. ja Gerba C. Reduction of faecal coliform, coliform and heterotrophic plate count bacteria in the household kitchen and bathroom by disinfection with hypochlorite cleaners. J Appl Microbiol. 1998; 85(5): 819–28.
119. Cogan T.A., Bloomfield S.F. ja Humphrey T.J. The effectiveness of hygiene procedures for prevention of cross-contamination from chicken carcases in the domestic kitchen. Lett Appl Microbiol. 1999; 29(5): 354–8.
120. Sama.
121. Sama.
122. Linton A.H., Howe K., Bennett P.M., Richmond M.H. ja Whiteside E.J. The colonization of the human gut by antibiotic resistant Escherichia coli from chickens. J Appl Bacteriol. 1977; 43(3): 465–9.
123. Scallan E., Hoekstra R.M., Angulo F.J. ym. Foodborne illness acquired in the United States—major pathogens. Emerging Infect Dis. 2011; 17: 7–15.
124. Batz M.B., Hoffmann S. ja Morris Jr J.G. Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J Food Prot. 2012; 75: 1278–91.
125. Zheng H., Sun Y., Lin S., Mao Z. ja Jiang B. Yersinia enterocolitica infection in diarrheal patients. Eur J Clin Microbiol Infect Dis. 2008; 27: 741–52.
126. Bari M.L., Hossain M.A., Isshiki K. ja Ukuku D. Behavior of Yersinia enterocolitica in foods. J Pathog. 2011; 2011: 420732.
127. Ternhag A., Törner A., Svensson A., Ekdahl K. ja Giesecke J. Short- and long-term effects of bacterial gastrointestinal infections. Emerging Infect Dis. 2008; 14: 143–8.
128. Brix T.H., Hansen P.S., Hegedüs L. ja Wenzel B.E. Too early to dismiss Yersinia enterocolitica infection in the aetiology of Graves’ disease: evidence from a twin case-control study. Clin Endocrinol (Oxf). 2008; 69: 491–6.
129. What’s in that pork? Consumer Reports. http://www.consumerreports.org/cro/magazine/2013/01/what-s-in-that-pork/index.htm. Haettu 3.3.2015.
130. Katso viite 126.
131. Crowding pigs pays—if it’s managed properly. National Hog Farmer. November 15, 1993; 62.
132. Poljak Z., Dewey C.E., Martin S.W. ym. Prevalence of Yersinia enterocolitica shedding and bioserotype distribution in Ontario finisher pig herds in 2001, 2002, and 2004. Prev Vet Med. 2010; 93: 110–20.
133. Hoffmann S., Batz M.B. ja Morris Jr J.G. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot. 2012; 75: 1292–1302.
134. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Antibiotic Resistance Threats in the United States, 2013. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Haettu 3.3.2015.
135. Eyre D.W., Cule M.L., Wilson D.J. ym. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013 Sep 26; 369(13): 1195–205.
136. Songer J.G., Trinh H.T., Killgore G.E., Thompson A.D., McDonald L.C. ja Limbago B.M. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis. 2009; 15(5): 819–21.
137. Rupnik M. ja Songer J.G. Clostridium difficile: its potential as a source of foodborne disease. Adv Food Nutr Res. 2010; 60: 53–66.
138. Rodriguez-Palacios A., Borgmann S., Kline T.R. ja LeJeune J.T. Clostridium difficile in foods and animals: history and measures to reduce exposure. Anim Health Res Rev. 2013; 14(1): 11–29.
139. Hensgrens M.P.M., Keessen E.C., Squire M.M. ym. European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD). Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect. 2012; 18(7): 635–45.
140. Katso viite 137.
141. Sayedy L., Kothari D. ja Richards R.J. Toxic megacolon associated Clostridium difficile colitis. World J Gastrointest Endosc. 2010; 2(8): 293–7.
142. Gweon T.G., Lee K.J., Kang D.H. ym. A case of toxic megacolon caused by Clostridium difficile infection and treated with fecal microbiota transplantation. Gut Liver. 2015; 9(2): 247–50.
143. Weese J.S. Clostridium difficile in food—innocent bystander or serious threat? Clin Microbiol Infect. 2010; 16: 3–10.
144. Jabbar U., Leischner J., Kasper D. ym. Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol. 2010; 31(6): 565–70.
145. Bhargava K., Wang X., Donabedian S., Zervos M., de Rocha L. ja Zhang Y. Methicillin-resistant Staphylococcus aureus in retail meat, Detroit, Michigan, USA. Emerging Infect Dis. 2011; 17(6): 1135–7.
146. Reinberg S. Scientists find MRSA germ in supermarket meats. http://usatoday30.usatoday.com/news/health/medical/health/medical/story/2011/05/Scientists-find-MRSA-germ–in-supermarket-meats/47105974/1. 12.5.2011. Haettu 4.4.2015.
147. Chan M. Antimicrobial resistance in the European Union and the world. Puhe konferenssissa ”Conference on combating antimicrobial resistance: time for action.” 14.3.2012; Kööpenhaminassa, Tanskassa. http://www.who.int/dg/speeches/2012/amr_20120314/en/. Haettu 6.3.2015.
148. Love D.C., Halden R.U., Davis M.F. ja Nachman K.E. Feather meal: a previously unrecognized route for reentry into the food supply of multiple pharmaceuticals and personal care products (PPCPs). Environ Sci Technol. 2012; 46(7): 3795–802.
149. Ji K., Kho Y., Park C. ym. Influence of water and food consumption on inadvertent antibiotics intake among general population. Environ Res. 2010; 110(7): 641–9.
150. Ji K., Lim Kho Y.L., Park Y. ja Choi K. Influence of a five-day vegetarian diet on urinary levels of antibiotics and phthalate metabolites: a pilot study with ”Temple Stay” participants. Environ Res. 2010; 110(4): 375–82.
151. Keep Antibiotics Working. http://www.keepantibioticsworking.com/new/indepth_groups.php. Haettu 3.3.2015.
152. Hayes D.J. ja Jenson H.H. Technology choice and the economic effects of a ban on the use of antimicrobial feed additives in swine rations. Food Control. 2002; 13(2): 97–101.
153. Rival diet doc leaks Atkins death report. http://www.thesmokinggun.com/file/rival-diet-doc-leaks-atkins-death-report?page=3. Haettu 3.3.2015.
154. Corporate Threat. http://www.atkinsexposed.org/Corporate_Threat.htm. Haettu 14.6.2015.

6. Kuinka elää kuolematta diabetekseen
1. Matthews D.R. ja Matthews P.C. Banting Memorial Lecture 2010. Type 2 diabetes as an ‘infectious’ disease: is this the Black Death of the 21st century? Diabet Med. 2011; 28(1): 2–9.
2. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Number (in millions) of civilian, noninstitutionalized persons with diagnosed diabetes, United States, 1980–2011. http://www.cdc.gov/diabetes/statistics/prev/national/figpersons.htm. 28.3.2013. Haettu 3.5.2015.
3. Boyle J.P., Thompson T.J., Gregg E.W., Barker L.E. ja Williamson D.F. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010; 8: 29.
4. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: Yhdysvaltojen terveys- ja sosiaalipalveluministeriö.
5. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016; 64(2).
6. 2014 Statistics Report. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.html. Päivitetty 24.10.2014. Haettu 3.3.2015.
7. Lempainen J., Tauriainen S., Vaarala O. ym. Interaction of enterovirus infection and cow’s milkbased formula nutrition in type 1 diabetes-associated autoimmunity. Diabetes Metab Res Rev. 2012; 28(2): 177–85.
8. Katso viite 6.
9. Rachek L.I. Free fatty acids and skeletal muscle insulin resistance. Prog Mol Biol Transl Sci. 2014; 121: 267–92.
10. Katso viite 6.
11. Sweeney J.S. Dietary factors that influence the dextrose tolerance test. Arch Intern Med. 1927; 40(6): 818–30.
12. Roden M., Price T.B., Perseghin G. ym. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996; 97(12): 2859–65.
13. Roden M., Krssak M., Stingl H. ym. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes. 1999; 48(2): 358–64.
14. Santomauro A.T., Boden G., Silva M.E. ym. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes. 1999; 48(9): 1836–41.
15. Krssak M., Falk Petersen K., Dresner A. ym. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 1999; 42(1): 113–6.
16. Lee S., Boesch C., Kuk J.L. ja Arslanian S. Effects of an overnight intravenous lipid infusion on intramyocellular lipid content and insulin sensitivity in African-American versus Caucasian adolescents. Metab Clin Exp. 2013; 62(3): 417–23.
17. Katso viite 13.
18. Himsworth H.P. Dietetic factors influencing the glucose tolerance and the activity of insulin. J Physiol (Lond). 1934; 81(1): 29–48.
19. Tabák AG1., Herder C., Rathmann W., Brunner E.J. ja Kivimäki M. Prediabetes: a high-risk state for diabetes. Lancet. 2012; 379(9833): 2279–90.
20. Pratley R.E. The early treatment of type 2 diabetes. Am J Med. 2013; 126(9 Suppl 1): S2–9.
21. Reinehr T. Type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2013; 4(6): 270–81.
22. Pihoker C., Scott C.R., Lensing S.Y., Cradock M.M. ja Smith J. Non-insulin dependent diabetes mellitus in African-American youths of Arkansas. Clin Pediatr (Phila). 1998; 37(2): 97–102.
23. Dean H. ja Flett B. Natural history of type 2 diabetes diagnosed in childhood: long term follow-up in young adult years. Diabetes. 2002; 51(s1): A24.
24. Hannon T.S., Rao G. ja Arslanian S.A. Childhood obesity and type 2 diabetes mellitus. Pediatrics. 2005; 116(2): 473–80.
25. Rocchini A.P. Childhood obesity and a diabetes epidemic. N Engl J Med. 2002; 346(11): 854–5.
26. Lifshitz F. Obesity in children. J Clin Res Pediatr Endocrinol. 2008; 1(2): 53–60.
27. Must A., Jacques P.F., Dallal G.E., Bajema C.J. ja Dietz W.H. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992; 327(19): 1350–5.
28. Sabaté J. ja Wien M. Vegetarian diets and childhood obesity prevention. Am J Clin Nutr. 2010; 91(5): 1525S–1529S.
29. Tonstad S., Butler T., Yan R. ja Fraser G.E. Type of vegetarian diet, body weight, and prevalence of type 2 diabetes. Diabetes Care. 2009; 32(5): 791–6.
30. Sabaté J., Lindsted K.D., Harris R.D. ja Sanchez A. Attained height of lacto-ovo vegetarian children and adolescents. Eur J Clin Nutr. 1991; 45(1): 51–8.
31. Katso viite 28.
32. Cali A.M. ja Caprio S. Prediabetes and type 2 diabetes in youth: an emerging epidemic disease? Curr Opin Endocrinol Diabetes Obes. 2008; 15(2): 123–7.
33. Ginter E. ja Simko V. Type 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol. 2012; 771: 42–50.
34. Spalding K.L., Arner E., Westermark P.O. ym. Dynamics of fat cell turnover in humans. Nature. 2008; 453(7196): 783–7.
35. Roden M. How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci. 2004; 19: 92–6.
36. Fraser G.E. Vegetarian diets: what do we know of their effects on common chronic diseases? Am J Clin Nutr. 2009; 89(5): 1607S–1612S.
37. Tonstad S., Stewart K., Oda K., Batech M., Herring R.P. ja Fraser G.E. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr Metab Cardiovasc Dis. 2013; 23(4): 292–9.
38. Nolan C.J. ja Larter C.Z. Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it? J Gastroenterol Hepatol. 2009; 24(5): 703–6.
39. Evans W.J. Oxygen-carrying proteins in meat and risk of diabetes mellitus. JAMA Intern Med. 2013; 173(14): 1335–6.
40. Egnatchik R.A., Leamy A.K., Jacobson D.A., Shiota M. ja Young J.D. ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload. Mol Metab. 2014; 3(5): 544–53.
41. Estadella D., da Penha Oller do Nascimento C.M., Oyama L.M., Ribeiro E.B., Dâmaso A.R. ja de Piano A. Lipotoxicity: effects of dietary saturated and transfatty acids. Mediators Infl amm. 2013; 2013: 137579.
42. Perseghin G., Scifo P., De Cobelli F. ym. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes. 1999; 48(8): 1600–6.
43. Nolan C.J. ja Larter C.Z. Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it? J Gastroenterol Hepatol. 2009; 24(5): 703–6.
44. Goff L.M., Bell J.D., So P.W., Dornhorst A. ja Frost G.S. Veganism and its relationship with insulin resistance and intramyocellular lipid. Eur J Clin Nutr. 2005; 59(2): 291–8.
45. Gojda J., Patková J., Jaček M. ym. Higher insulin sensitivity in vegans is not associated with higher mitochondrial density. Eur J Clin Nutr. 2013; 67(12): 1310–5.
46. Katso viite 44.
47. Papanikolaou Y. ja Fulgoni V.L. Bean consumption is associated with greater nutrient intake, reduced systolic blood pressure, lower body weight, and a smaller waist circumference in adults: results from the National Health and Nutrition Examination Survey 1999–2002. J Am Coll Nutr. 2008; 27(5): 569–76.
48. Mollard R.C., Luhovyy B.L., Panahi S., Nunez M., Hanley A. ja Anderson G.H. Regular consumption of pulses for 8 weeks reduces metabolic syndrome risk factors in overweight and obese adults. Br J Nutr. 2012; 108 Suppl 1: S111–22.
49. Cnop M., Hughes S.J., Igoillo-Esteve M. ym. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia. 2010; 53(2): 321–30.
50. Taylor R. Banting Memorial lecture 2012: reversing the twin cycles of type 2 diabetes. Diabet Med. 2013; 30(3): 267–75.
51. Cunha D.A., Igoillo-Esteve M., Gurzov E.N. ym. Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis. Diabetes. 2012; 61(11): 2763–75.
52. Cnop M., Hannaert J.C., Grupping A.Y. ja Pipeleers D.G. Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. Endocrinology. 2002; 143(9): 3449–53.
53. Maedler K., Oberholzer J., Bucher P., Spinas G.A. ja Donath M.Y. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes. 2003; 52(3): 726–33.
54. Xiao C., Giacca A., Carpentier A. ja Lewis G.F. Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia. 2006; 49(6): 1371–9.
55. Wang L., Folsom A.R., Zheng Z.J., Pankow J.S. ja Eckfeldt J.H. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2003; 78(1): 91–8.
56. Cunha D.A., Igoillo-Esteve M., Gurzov E.N. ym. Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis. Diabetes. 2012; 61(11): 2763–75.
57. Welch R.W. Satiety: have we neglected dietary non-nutrients? Proc Nutr Soc. 2011; 70(2): 145–54.
58. Barnard N.D., Cohen J., Jenkins D.J. ym. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care. 2006; 29(8): 1777–83.
59. Trapp C.B. ja Barnard N.D. Usefulness of vegetarian and vegan diets for treating type 2 diabetes. Curr Diab Rep. 2010; 10(2): 152–8.
60. Pratley R.E. The early treatment of type 2 diabetes. Am J Med. 2013; 126(9 Suppl 1): S2–9.
61. Juutilainen A., Lehto S., Rönnemaa T., Pyörälä K. ja Laakso M. Type 2 diabetes as a ”coronary heart disease equivalent”: an 18-year prospective population-based study in Finnish subjects. Diabetes Care. 2005; 28(12): 2901–7.
62. Kahleova H., Matoulek M., Malinska H. ym. Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with type 2 diabetes. Diabet Med. 2011; 28(5): 549–59.
63. Ornish D. Statins and the soul of medicine. Am J Cardiol. 2002; 89(11): 1286–90.
64. Kahleova H., Hrachovinova T., Hill M. ym. Vegetarian diet in type 2 diabetes—improvement in quality of life, mood and eating behaviour. Diabet Med. 2013; 30(1): 127–9.
65. Chiu T.H.T., Huang H.Y., Chiu Y.F. ym. Taiwanese vegetarians and omnivores: dietary composition, prevalence of diabetes and IFG. PLoS One. 2014; 9(2): e88547.
66. Sama.
67. Magliano D.J., Loh V.H.Y., Harding J.L. ym. Persistent organic pollutants and diabetes: a review of the epidemiological evidence. Diabetes Metab. 2014; 40(1): 1–14.
68. Lee D.H., Lee I.K., Song K. ym. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999–2002. Diabetes Care. 2006; 29(7): 1638–44.
69. Wu H., Bertrand K.A., Choi A.L. ym. Persistent organic pollutants and type 2 diabetes: a prospective analysis in the Nurses’ Health Study and meta-analysis. Environ Health Perspect. 2013; 121(2): 153–61.
70. Schecter A., Colacino J., Haffner D. ym. Perfluorinated compounds, polychlorinated biphenyls, and organochlorine pesticide contamination in composite food samples from Dallas, Texas, USA. Environ Health Perspect. 2010; 118(6): 796–802.
71. Crinnion W.J. The role of persistent organic pollutants in the worldwide epidemic of type 2 diabetes mellitus and the possible connection to farmed Atlantic salmon (Salmo salar). Altern Med Rev. 2011; 16(4): 301–13.
72. Katso viite 68.
73. Crinnion W.J. The role of persistent organic pollutants in the worldwide epidemic of type 2 diabetes mellitus and the possible connection to farmed Atlantic salmon (Salmo salar). Altern Med Rev. 2011; 16(4): 301–13.
74. Farmer B., Larson B.T., Fulgoni V.L. III. ym. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the National Health and Nutrition Examination Survey 1999–2004. J Am Diet Assoc. 2011; 111(6): 819–27.
75. Sama.
76. Toth M.J. ja Poehlman E.T. Sympathetic nervous system activity and resting metabolic rate in vegetarians. Metabolism. 1994; 43(5): 621–5.
77. Karlic H., Schuster D., Varga F. ym. Vegetarian diet affects genes of oxidative metabolism and collagen synthesis. Ann Nutr Metab. 2008; 53(1): 29–32.
78. Vergnaud A.C., Norat T., Romaguera D. ym. Meat consumption and prospective weight change in participants of the EPIC-PANACEA study. Am J Clin Nutr. 2010; 92(2): 398–407.
79. The Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein H.C., Miller M.E. ym. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24): 2545–59.
80. Sama.
81. Luan F.L. ja Nguyen K. Intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359(14): 1519–20.
82. Blagosklonny M.V. Prospective treatment of age-related diseases by slowing down aging. Am J Pathol. 2012; 181(4): 1142–6.
83. Madonna R., Pandolfi A., Massaro M. ym. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004; 47(3): 532–6.
84. Lingvay I., Guth E., Islam A. ym. Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care. 2013; 36(9): 2741–7.
85. Sama.
86. Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013; 36(4): 1047–55.
87. Lim E.L., Hollingsworth K.G., Aribisala B.S., Chen M.J., Mathers J.C. ja Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011; 54(10): 2506–14.
88. Taheri S., Tahrani A. ja Barnett A. Bariatric surgery: a cure for diabetes? Pract Diabetes Int. 2009; 26: 356–8.
89. Vergnaud A.C., Norat T., Romaguera D. ym. Meat consumption and prospective weight change in participants of the EPIC-PANACEA study. Am J Clin Nutr. 2010; 92(2): 398–407.
90. Gilsing A.M., Weijenberg M.P., Hughes L.A. ym. Longitudinal changes in BMI in older adults are associated with meat consumption differentially, by type of meat consumed. J Nutr. 2012; 142(2): 340–9.
91. Wang Y., Lehane C., Ghebremeskel K. ym. Modern organic and broiler chickens sold for human consumption provide more energy from fat than protein. Public Health Nutr. 2010; 13(3): 400–8.
92. National Cattlemen’s Beef Association, Young M.K. ja Redson B.A. New USDA data show 29 beef cuts now meet government guidelines for lean. http://www.beef.org/udocs/29leancuts.pdf. 2005. Haettu 6.3.2015.
93. Steven S., Lim E.L. ja Taylor R. Dietary reversal of type 2 diabetes motivated by research knowledge. Diabet Med. 2010; 27(6): 724–5.
94. Taylor R. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia. 2008; 51(10): 1781–9.
95. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015; 38(suppl 1): S1– S93.
96. Dunaief D.M., Fuhrman J., Dunaief J.L. ym. Glycemic and cardiovascular parameters improved in type 2 diabetes with the high nutrient density (HND) diet. Open Journal of Preventive Medicine. 2012; 2(3): 364–71.
97. Lim E.L., Hollingsworth K.G., Aribisala B.S., Chen M.J., Mathers J.C. ja Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011; 54(10): 2506–14.
98. Steven S., Lim E.L. ja Taylor R. Population response to information on reversibility of Type 2 diabetes. Diabet Med. 2013; 30(4): e135–8.
99. Katso viite 96.
100. Anderson J.W. ja Ward K. High-carbohydrate, high-fiber diets for insulin-treated men with diabetes mellitus. Am J Clin Nutr. 1979; 32(11): 2312–21.
101. Sama.
102. Callaghan B.C., Cheng H., Stables C.L. ym. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012; 11(6): 521–34.
103. Said G. Diabetic neuropathy—a review. Nat Clin Pract Neurol. 2007; 3(6): 331–40.
104. Crane M.G. ja Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994; 4(4): 431–9.
105. Sama.
106. Rabinowitch I.M. Effects of the high carbohydrate-low calorie diet upon carbohydrate tolerance in diabetes mellitus. Can Med Assoc J. 1935; 33(2): 136–44.
107. Newborg B. ja Kempner W. Analysis of 177 cases of hypertensive vascular disease with papilledema; one hundred twenty-six patients treated with rice diet. Am J Med. 1955; 19(1): 33–47.
108. Katso viite 104.
109. Sama.
110. Sama.
111. Crane M.G., Zielinski R. ja Aloia R. Cis and trans fats in omnivores, lacto-ovo vegetarians and vegans. Am J Clin Nutr. 1988; 48: 920.
112. Tesfaye S., Chaturvedi N., Eaton S.E.M. ym. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005; 352(4): 341–50.
113. Newrick P.G., Wilson A.J., Jakubowski J. ym. Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed). 1986; 293(6554): 1053–4.
114. McCarty M.F. Favorable impact of a vegan diet with exercise on hemorheology: implications for control of diabetic neuropathy. Med Hypotheses. 2002; 58(6): 476–86.
115. Kempner W., Peschel R.L. ja Schlayer C. Effect of rice diet on diabetes mellitus associated with vascular disease. Postgrad Med. 1958; 24(4): 359–71.
116. Katso viite 114.
117. Browning L.M., Hsieh S.D. ja Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev. 2010; 23(2): 247–69.
118. Bigaard J., Tjønneland A., Thomsen B.L., Overvad K., Heitmann B.L., S., Sørensen T.I. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res. 2003; 11(7): 895–903.
119. Sama.
120. Leitzmann M.F., Moore S.C., Koster A. ym. Waist circumference as compared with body-mass index in predicting mortality from specific causes. PLoS One. 2011; 6(4): e18582.
121. Katso viite 117.
122. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014. http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.html
. Päivitetty 24.10.2014. Haettu 6.3.2015.
123. Nathan D.M., Davidson M.B., Defronzo R.A. ym. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007; 30(3): 753–9.
124. Karve A. ja Hayward R.A. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care. 2010; 33(11): 2355–9.
125. Cardona-Morrell M., Rychetnik L., Morrell S.L., Espinel P.T. ja Bauman A. Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis. BMC Public Health. 2010; 10: 653.
126. Holman H. Chronic disease—the need for a new clinical education. JAMA. 2004; 292(9): 1057–9.
127. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, D.C.: The National Academies Press, 2001: 213. http://www.iom.edu/Reports/2001/Crossing-the-Quality-Chasm-A-New-Health-System-for-the-21st- Century.aspx.

7. Kuinka elää kuolematta korkeaan verenpaineeseen
1. Lozano R., Naghavi M., Foreman K. ym. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2095–128.
2. Das P. ja Samarasekera U. The story of GBD 2010: a ”super-human” effort. Lancet. 2012; 380 (9859): 2067–70.
3. Lim S.S., Vos T., Flaxman A.D. ym. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224–60.
4. Sama.
5. Sama.
6. Bromfield S. ja Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep. 2013; 15(3): 134–6.
7. Katso viite 3.
8. Yhdysvaltain sydänyhdistys. Understanding Blood Pressure Readings. http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/AboutHighBloodPressure/Understanding-Blood-Pressure-Readings_UCM_301764_Article.jsp. 11.3. 2015. Haettu 11.3.2015.
9. Go A.S., Bauman M.A., Coleman King S.M. ym. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014; 63(12): 1230–8.
10. Nwankwo T., Yoon S.S., Burt V. ja Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013; (133): 1–8.
11. Walker A.R. ja Walker B.F. High high-density-lipoprotein cholesterol in African children and adults in a population free of coronary heart diseae. Br Med J. 1978; 2(6148): 1336–7.
12. Donnison C.P. Blood pressure in the African native. Lancet. 1929; 213(5497): 6–7.
13. Macmahon S., Neal B. ja Rodgers A. Hypertension—time to move on. Lancet. 2005; 365(9464): 1108–9.
14. Law M.R., Morris J.K. ja Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338: b1665.
15. Katso viite 12.
16. Katso viite 3.
17. Sama.
18. Karppanen H. ja Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. 2006; 49(2): 59–75.
19. Delahaye F. Should we eat less salt? Arch Cardiovasc Dis. 2013; 106(5): 324–32.
20. Jenkins D.J. ja Kendall C.W. The garden of Eden: plant-based diets, the genetic drive to store fat and conserve cholesterol, and implications for epidemiology in the 21st century. Epidemiology. 2006; 17(2): 128–30.
21. Roberts W.C. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001; 88(11): 1338–46.
22. Sama.
23. Celermajer D.S. ja Neal B. Excessive sodium intake and cardiovascular disease: a-salting our vessels. J Am Coll Cardiol. 2013; 61(3): 344–5.
24. Whelton P.K., Appel L.J., Sacco R.L. ym. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012; 126(24): 2880–9.
25. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Sodium intake among adults – United States, 2005–2006. MMWR Morb Mortal Wkly Rep. 2010; 59(24): 746–9.
26. Beaglehole R., Bonita R., Horton R. ym. Priority actions for the non-communicable disease crisis. Lancet. 2011; 377(9775): 1438–47.
27. Law M.R., Frost C.D. ja Wald N.J. By how much does dietary salt reduction lower blood pressure? III—Analysis of data from trials of salt reduction. BMJ. 1991; 302(6780): 819–24.
28. Bibbins-Domingo K., Chertow G.M., Coxson P.G. ym. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18; 362(7): 590–9.
29. MacGregor G.A., Markandu N.D., Best F.E. ym. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet. 1982; 1(8268): 351–5.
30. MacGregor G.A., Markandu N.D., Sagnella G.A., Singer D.R. ja Cappuccio F.P. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989; 2(8674): 1244–7.
31. Sama.
32. Rudelt A., French S. ja Harnack L. Fourteen-year trends in sodium content of menu offerings at eight leading fast-food restaurants in the USA. Public Health Nutr. 2014; 17(8): 1682–8.
33. Suckling R.J., He F.J., Markandu N.D. ja MacGregor G.A. Dietary salt influences postprandial plasma sodium concentration and systolic blood pressure. Kidney Int. 2012; 81(4): 407–11.
34. He F.J., Li J. ja MacGregor G.A. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013; 346: f1325.
35. Celermajer D.S. ja Neal B. Excessive sodium intake and cardiovascular disease: a- salting our vessels. J Am Coll Cardiol. 2013; 61(3): 344–5.
36. Oliver W.J., Cohen E.L. ja Neel J.V. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a ”no- salt” culture. Circulation. 1975; 52(1): 146–51.
37. Mancilha-Carvalho J. de J. ja de Souza e Silva N.A. The Yanomami Indians in the INTERSALT Study. Arq Bras Cardiol. 2003; 80(3): 289–300.
38. Celermajer D.S. ja Neal B. Excessive sodium intake and cardiovascular disease: a-salting our vessels. J Am Coll Cardiol. 2013; 61(3): 344–5.
39. Katso viite 37.
40. Mancilha-Carvalho J. de J. ja Crews D.E. Lipid profiles of Yanomamo Indians of Brazil. Prev Med. 1990; 19(1): 66–75.
41. Kempner W. Treatment of heart and kidney disease and of hypertensive and arteriosclerotic vascular disease with the rice diet. Ann Intern Med. 1949; 31(5): 821–56.
42. Klemmer P., Grim C.E. ja Luft F.C. Who and what drove Walter Kempner? The rice diet revisited. Hypertension. 2014; 64(4): 684–8.
43. Katso viite 41.
44. Roberts W.C. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001; 88(11): 1338–46.
45. Dickinson K.M., Clifton P.M. ja Keogh J.B. Endothelial function is impaired after a high-salt meal in healthy subjects. Am J Clin Nutr. 2011; 93(3): 500–5.
46. DuPont J.J., Greaney J.L., Wenner M.M. ym. High dietary sodium intake impairs endotheliumdependent dilation in healthy salt-resistant humans. J Hypertens. 2013; 31(3): 530–6.
47. Katso viite 45.
48. Greaney J.L., DuPont J.J., Lennon-Edwards S.L., Sanders P.W., Edwards D.G. ja Farquhar W.B. Dietary sodium loading impairs microvascular function independent of blood pressure in humans: role of oxidative stress. J Physiol (Lond). 2012; 590(Pt 21): 5519–28.
49. Jablonski K.L., Racine M.L., Geolfos C.J. ym. Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure. J Am Coll Cardiol. 2013; 61(3): 335–43.
50. McCord J.M. Analysis of superoxide dismutase activity. Curr Protoc Toxicol. 1999; Chapter 7: Unit 7.3.
51. Dickinson K.M., Clifton P.M., Burrell L.M., Barrett P.H.R. ja Keogh J.B. Postprandial effects of a high salt meal on serum sodium, arterial stiffness, markers of nitric oxide production and markers of endothelial function. Atherosclerosis. 2014; 232(1): 211–6.
52. Huang Ti Nei Ching Su Wua [The Yellow Emperor’s Classic of Internal Medicine] (Kääntänyt I. Veith) Oakland, CA: University of California Press; 1972: 141.
53. Hanneman RL, Satin M. Salt Institute-yhdistyksen huomautus Ravitsemusohjeiden komitealle (Dietary Guidelines Committee). Comment ID: 000447. 23.4.2009.
54. Vital signs: food categories contributing the most to sodium consumption – United States, 2007–2008. MMWR Morb Mortal Wkly Rep. 2012; 61(5): 92–8.
55. Miller G.D. National Dairy Councilin huomautus Ravitsemusohjeiden komitealle (Dietary Guidelines Committee) 27.7.2009.
56. Roberts W.C. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001; 88(11): 1338–46.
57. MacGregor G. ja de Wardener H.E. Salt, blood pressure and health. Int J Epidemiol. 2002; 31(2): 320–7.
58. Appel L.J. ja Anderson C.A.M. Compelling evidence for public health action to reduce salt intake. N Engl J Med. 2010; 362(7): 650–2.
59. Katso viite 56.
60. Buying this chicken? Consum Rep. June 2008; 7.
61. Drewnowski A. ja Rehm C.D. Sodium intakes of US children and adults from foods and beverages by location of origin and by specific food source. Nutrients. 2013; 5(6): 1840–55.
62. Yhdysvaltojen maatalousministeriö (USDA), Agricultural Research Service. 2014. USDA National Nutrient Database for Standard Reference, Release 27. Pizza Hut 14″ pepperoni pizza, pan crust. http://ndb.nal.usda.gov/ndb/foods/show/6800. Haettu 22.3.2015.
63. Katso viite 61.
64. Blais C.A., Pangborn R.M., Borhani N.O., Ferrell M.F., Prineas R.J. ja Laing B. Effect of dietary sodium restriction on taste responses to sodium chloride: a longitudinal study. Am J Clin Nutr. 1986; 44(2): 232–43.
65. Tucker R.M. ja Mattes R.D. Are free fatty acids effective taste stimuli in humans? Esitetty 12.6.2011 New Orleansissa Institute of Food Technologistsissa pidetyssä vuosittaisessa symposiumissa, jonka aiheena oli ”The Taste for Fat: New Discoveries on the Role of Fat in Sensory Perception, Metabolism, Sensory Pleasure and Beyond”. J Food Sci. 2012; 77(3): S148–51.
66. Grieve F.G. ja Vander Weg M.W. Desire to eat high- and low-fat foods following a low-fat dietary intervention. J Nutr Educ Behav. 2003; 35(2): 98–102.
67. Stewart J.E., Newman L.P. ja Keast R.S. Oral sensitivity to oleic acid is associated with fat intake and body mass index. Clin Nutr. 2011; 30(6): 838–44.
68. Stewart J.E. ja Keast R.S. Recent fat intake modulates fat taste sensitivity in lean and overweight subjects. Int J Obes (Lond). 2012; 36(6): 834–42.
69. Roberts W.C. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001; 88(11): 1338–46.
70. Newson R.S., Elmadfa I., Biro G. ym. Barriers for progress in salt reduction in the general population. An international study. Appetite. 2013; 71: 22–31.
71. Cappuccio F.P., Capewell S., Lincoln P. ja McPherson K. Policy options to reduce population salt intake. BMJ. 2011; 343: d4995.
72. Toldrá F. ja Barat J.M. Strategies for salt reduction in foods. Recent Pat Food Nutr Agric. 2012; 4(1): 19–25.
73. Lin B-H. ja Guthrie J. Nutritional Quality of Food Prepared at Home and Away from Home, 1977–2008. USDA, Economic Research Service, December 2012.
74. Katso viite 70.
75. Roberts W.C. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001; 88(11): 1338–46.
76. Yhdysvaltojen maatalousministeriö (USDA) ja Yhdysvaltojen terveys- ja sosiaalipalveluministeriö. Dietary Guidelines for Americans, 2010. 7th Edition, Washington, D.C.: US Government Printing Office, December 2010.
77. Karppanen H. ja Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. 2006; 49(2): 59–75.
78. Law M.R., Morris J.K. ja Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338: b1665.
79. Tighe P., Duthie G., Vaughan N. ym. Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial. Am J Clin Nutr. 2010; 92(4): 733–40.
80. Diaconu C.C., Balaceanu A. ja Bartos D. Diuretics, first-line antihypertensive agents: are they always safe in the elderly? Rom J Intern Med. 2014; 52(2): 87–90.
81. Li C.I., Daling J.R., Tang M.T., Haugen K.L., Porter P.L. ja Malone K.E. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. JAMA Intern Med. 2013; 173(17): 1629–37.
82. Kaiser E.A., Lotze U. ja Schiser H.H. Increasing complexity: which drug class to choose for treatment of hypertension in the elderly? Clin Interv Aging. 2014; 9: 459–75.
83. Rasmussen E.R., Mey K. ja Bygum A. Angiotensin-converting enzyme inhibitor-induced angioedema—a dangerous new epidemic. Acta Derm Venereol. 2014; 94(3): 260–4.
84. Tinetti M.E., Han L., Lee D.S. ym. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014; 174(4): 588–95.
85. Ye E.Q., Chacko S.A., Chou E.L., Kugizaki M. ja Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012; 142(7): 1304–13.
86. Aune D., Chan D.S., Lau R. ym. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2011; 343: d6617.
87. Katso viite 79.
88. Sun Q., Spiegelman D., van Dam R.M. ym. White rice, brown rice, and risk of type 2 diabetes in US men and women. Arch Intern Med. 2010; 170(11): 961–9.
89. Katso viite 85.
90. Mellen P.B., Liese A.D., Tooze J.A., Vitolins M.Z., Wagenknecht L.E. ja Herrington D.M. Wholegrain intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr. 2007; 85(6): 1495–502.
91. Erkkilä A.T., Herrington D.M., Mozaffarian D. ym. Cereal fiber and whole-grain intake are associated with reduced progession of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease. Am Heart J. 2005; 150(1): 94–101.
92. Go A.S., Bauman M.A., Coleman King S.M. ym. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014; 63(12): 1230–8.
93. Mahmud A. ja Feely J. Low-dose quadruple antihypertensive combination: more efficacious than individual agents—a preliminary report. Hypertension. 2007; 49(2): 272–5.
94. Kronish I.M., Woodward M., Sergie Z., Ogedegbe G., Falzon L. ja Mann D.M. Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation. 2011; 123(15): 1611–21.
95. Messerli FH, Bangalore S. Half a century of hydrochlorothiazide: facts, fads, fiction, and follies. Am J Med. 2011; 124(10): 896–9.
96. Law M.R, Morris J.K. ja Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338: b1665.
97. Donnison C.P. Blood pressure in the African native. Lancet. 1929; 213(5497): 6–7.
98. Morse W.R, McGill M.D. ja Beh Y.T. Blood pressure amongst aboriginal ethnic groups of Szechwan Province, West China. Lancet. 1937; 229(5929): 966–8.
99. Sacks F.M. ja Kass E.H. Low blood pressure in vegetarians: effects of specific foods and nutrients. Am J Clin Nutr. 1988; 48(3 Suppl): 795–800.
100. Katso viite 92.
101. Sharma A.M. ja Schorr U. Dietary patterns and blood pressure. N Engl J Med. 1997; 337(9): 637.
102. Chen Q., Turban S., Miller E.R. ja Appel L.J. The effects of dietary patterns on plasma renin activity: results from the Dietary Approaches to Stop Hypertension trial. J Hum Hypertens. 2012; 26(11): 664–9.
103. Sacks F.M., Rosner B. ja Kass E.H. Blood pressure in vegetarians. Am J Epidemiol. 1974; 100(5): 390–8.
104. Donaldson A.N. The relation of protein foods to hypertension. Cal West Med. 1926; 24(3): 328–31.
105. Appel L.J., Brands M.W., Daniels S.R. ym. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006; 47(2): 296–308.
106. Sacks F.M., Obarzanek E., Windhauser M.M. ym. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol. 1995; 5(2): 108–18.
107. Karanja N.M., Obarzanek E., Lin P.H. ym. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension trial. DASH Collaborative Research Group. J Am Diet Assoc. 1999; 99(8 Suppl): S19–27.
108. Katso viite 99.
109. de Paula T.P., Steemburgo T., de Almeida J.C., Dall’Alba V., Gross J.L. ja de Azevedo M.J. The role of Dietary Approaches to Stop Hypertension (DASH) diet food groups in blood pressure in type 2 diabetes. Br J Nutr. 2012; 108(1): 155–62.
110. Yokoyama Y., Nishimura K., Barnard ND. ym. Vegetarian diets and blood pressure: a meta-analysis. JAMA Intern Med. 2014; 174(4): 577–87.
111. Le L.T. ja Sabaté J. Beyond meatless, the health effects of vegan diets: findings from the Adventist cohorts. Nutrients. 2014; 6(6): 2131–47.
112. Fraser G.E. Vegetarian diets: what do we know of their effects on common chronic diseases? Am J Clin Nutr. 2009; 89(5): 1607S–1612S.
113. Tonstad S., Stewart K., Oda K., Batech M., Herring R.P. ja Fraser G.E. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr Metab Cardiovasc Dis. 2013; 23(4): 292–9.
114. Katso viite 112.
115. Fontana L., Meyer T.E., Klein S. ja Holloszy J.O. Long-term low-calorie low-protein vegan diet and endurance exercise are associated with low cardiometabolic risk. Rejuvenation Res. 2007; 10(2): 225–34.
116. Rodriguez-Leyva D., Weighell W., Edel A.L. ym. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013; 62(6): 1081–9.
117. Cornelissen V.A., Buys R. ja Smart N.A. Endurance exercise beneficially affects ambulatory blood pressure: a systematic review and meta-analysis. J Hypertens. 2013; 31(4): 639–48.
118. Geleijnse J.M. Relation of raw and cooked vegetable consumption to blood pressure: the INTERMAP study. J Hum Hypertens. 2014; 28(6): 343–4.
119. Jayalath V.H., de Souza R.J., Sievenpiper J.L. ym. Effect of dietary pulses on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Am J Hypertens. 2014; 27(1): 56–64.
120. Chiva-Blanch G., Urpi-Sarda M., Ros E. ym. Dealcoholized red wine decreases systolic and diastolic blood pressure and increases plasma nitric oxide: short communication. Circ Res. 2012; 111(8): 1065–8.
121. Figueroa A., Sanchez-Gonzalez M.A., Wong A. ja Arjmandi B.H. Watermelon extract supplementation reduces ankle blood pressure and carotid augmentation index in obese adults with prehypertension or hypertension. Am J Hypertens. 2012; 25(6): 640–3.
122. Gammon C.S., Kruger R., Brown S.J., Conlon C.A., von Hurst P.R. ja Stonehouse W. Daily kiwifruit consumption did not improve blood pressure and markers of cardiovascular function in men with hypercholesterolemia. Nutr Res. 2014; 34(3): 235–40.
123. Anderson J.W., Weiter K.M., Christian A.L., Ritchey M.B. ja Bays H.E. Raisins compared with other snack effects on glycemia and blood pressure: a randomized, controlled trial. Postgrad Med. 2014; 126(1): 37–43.
124. Akhtar S., Ismail T. ja Riaz M. Flaxseed – a miraculous defense against some critical maladies. Pak J Pharm Sci. 2013; 26(1): 199–208.
125. Katso viite 116.
126. Ninomiya T., Perkovic V., Turnbull F. ym. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ. 2013; 347: f5680.
127. Goyal A., Sharma V., Upadhyay N., Gill S. ja Sihag M. Flax and flaxseed oil: an ancient medicine & modern functional food. J Food Sci Technol. 2014; 51(9): 1633–53.
128. Carlsen M.H., Halvorsen B.L., Holte K. ym. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010; 9: 3.
129. Frank T., Netzel G., Kammerer D.R. ym. Consumption of Hibiscus sabdariffa L. aqueous extract and its impact on systemic antioxidant potential in healthy subjects. J Sci Food Agric. 2012; 92(10): 2207–18.
130. Chang H.C., Peng C.H., Yeh D.M., Kao E.S. ja Wang C.J. Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans. Food Funct. 2014; 5(4): 734–9.
131. Mozaffari-Khosravi H., Jalali-Khanabadi B.A., Afkhami-Ardekani M. ja Fatehi F. Effects of sour tea (Hibiscus sabdariffa) on lipid profile and lipoproteins in patients with type II diabetes. J Altern Complement Med. 2009; 15(8): 899–903.
132. Aziz Z., Wong S.Y. ja Chong N.J. Effects of Hibiscus sabdariffa L. on serum lipids: a systematic review and meta-analysis. J Ethnopharmacol. 2013; 150(2): 442–50.
133. Lin T-L., Lin H-H., Chen C-C. ym. Hibiscus sabdariffa extract reduces serum cholesterol in men and women. Nutr Res. 2007; 27: 140–5.
134. Hopkins A.L., Lamm M.G., Funk J.L. ja Ritenbaugh C. Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies. Fitoterapia. 2013; 85: 84–94.
135. McKay D.L., Chen C.Y., Saltzman E. ja Blumberg J.B. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr. 2010; 140(2): 298–303.
136. Chobanian A.V., Bakris G.L., Black H.R. ym. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6): 1206–52.
137. Katso viite 135.
138. Herrera-Arellano A., Flores-Romero S., Chávez-Soto M.A. ja Tortoriello J. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine. 2004; 11(5): 375–82.
139. Yhdysvaltojen elintarvike- ja lääkevirasto. CAPOTEN® (Captopril Tablets, USP) http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018343s084lbl.pdf. Haettu 19.3.2015.
140. Hendricks J.L., Marshall T.A., Harless J.D., Hogan M.M., Qian F. ja Wefel J.S. Erosive potentials of brewed teas. Am J Dent. 2013; 26(5): 278–82.
141. Malik J., Frankova A., Drabek O., Szakova J., Ash C. ja Kokoska L. Aluminium and other elements in selected herbal tea plant species and their infusions. Food Chem. 2013; 139(1–4): 728–34.
142. Förstermann U. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol Chem. 2006; 387(12): 1521–33.
143. Franzini L., Ardigò D., Valtueña S. ym. Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population. Nutr Metab Cardiovasc Dis. 2012; 22(1): 50–7.
144. Webb A.J., Patel N., Loukogeorgakis S. ym. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension. 2008; 51(3): 784–90.
145. Smith R.E. ja Ashiya M. Antihypertensive therapies. Nat Rev Drug Discov. 2007; 6(8): 597–8.
146. Kapil V., Khambata R.S., Robertson A., Caulfield M.J. ja Ahluwalia A. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, doubleblind, placebo-controlled study. Hypertension. 2015; 65(2): 320–7.
147. Wylie L.J., Kelly J., Bailey S.J. ym. Beetroot juice and exercise: pharmacodynamic and doseresponse relationships. J Appl Physiol. 2013; 115(3): 325–36.
148.Euroopan elintarviketurvallisuusviranomainen. Nitrate in vegetables: scientific opinion of the panel on contaminants in the food chain. EFSA J. 2008; 689: 1–79.
149. Murphy M., Eliot K., Heuertz R.M. ja Weiss E. Whole beetroot consumption acutely improves running performance. J Acad Nutr Diet. 2012; 112(4): 548–52.
150. Clements W.T., Lee S.R. ja Bloomer R.J. Nitrate ingestion: a review of the health and physical performance effects. Nutrients. 2014; 6(11): 5224–64.
151. Hord N.G., Tang Y. ja Bryan N.S. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr. 2009; 90(1): 1–10.
152. Bhupathiraju S.N., Wedick N.M., Pan A. ym. Quantity and variety in fruit and vegetable intake and risk of coronary heart disease. Am J Clin Nutr. 2013; 98(6): 1514–23.
153. Tamakoshi A., Tamakoshi K., Lin Y., Yagyu K. ja Kikuchi S. Healthy lifestyle and preventable death: findings from the Japan Collaborative Cohort (JACC) Study. Prev Med. 2009; 48(5): 486–92.
154. Wang F., Dai S., Wang M. ja Morrison H. Erectile dysfunction and fruit/vegetable consumption among diabetic Canadian men. Urology. 2013; 82(6): 1330–5.
155. Presley T.D., Morgan A.R., Bechtold E. ym. Acute effect of a high nitrate diet on brain perfusion in older adults. Nitric Oxide. 2011; 24(1): 34–42.
156. Engan H.K., Jones A.M., Ehrenberg F. ja Schagatay E. Acute dietary nitrate supplementation improves dry static apnea performance. Respir Physiol Neurobiol. 2012; 182(2–3): 53–9.
157. Bailey S.J., Winyard P., Vanhatalo A. ym. Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol. 2009; 107(4): 1144–55.
158. Murphy M., Eliot K., Heuertz R.M. ja Weiss E. Whole beetroot consumption acutely improves running performance. J Acad Nutr Diet. 2012; 112(4): 548–52.
159. Lidder S. ja Webb A.J. Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway. Br J Clin Pharmacol. 2013; 75(3): 677–96.
160. Wylie L.J., Kelly J., Bailey S.J. ym. Beetroot juice and exercise: pharmacodynamic and doseresponse relationships. J Appl Physiol. 2013; 115(3): 325–36.

8. Kuinka elää kuolematta maksasairauksiin
1. Chiras D.D. Human Biology. Burlington, MA: Jones & Bartlett Learning; 2015.
2. . Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016; 64(2).
3. National Cancer Institute Surveillance, Epidemiology, and End Results Program. SEER stat fact sheets: liver and intrahepatic bile duct cancer. http://seer.cancer.gov/statfacts/html/livibd.html. Haettu 3.5.2015.
4. Holubek W.J., Kalman S. ja Hoffman R.S. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2006; 43(4): 880.
5. Mokdad A.H., Marks J.S., Stroup D.F. ja Gerberding J.L. Actual causes of death in the United States, 2000. JAMA. 2004; 291(10): 1238–45.
6. CDC Morbidity and Mortality Weekly Report. Alcohol-attributable deaths and years of potential life l—United States, 2001. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5337a2 .htm. 24.9.2004. Haettu 2.3.2015.
7. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Fact sheets – alcohol use and your health. http://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm. 7.11.2014. Haettu 2.3.2015.
8. Schwartz JM, Reinus JF. Prevalence and natural history of alcoholic liver disease. Clin Liver Dis. 2012; 16(4): 659–66.
9. Lane B.P. ja Lieber C.S. Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets. Am J Pathol. 1966; 49(4): 593–603.
10. Mendenhall C.L. Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis. Am J Dig Dis. 1968; 13(9): 783–91.
11. O’Shea R.S., Dasarathy S. ja McCullough A.J. Alcoholic liver disease. Hepatology. 2010; 51(1): 307–28.
12. Mandayam S., Jamal M.M. ja Morgan T.R. Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004; 24(3): 217–32.
13. Galambos J.T. Natural history of alcoholic hepatitis. 3. Histological changes. Gastroenterology. 1972; 63(6): 1026–35.
14. Woerle S., Roeber J. ja Landen M.G. Prevalence of alcohol dependence among excessive drinkers in New Mexico. Alcohol Clin Exp Res. 2007; 31(2): 293–8.
15. Kaskutas L.A. Alcoholics anonymous effectiveness: faith meets science. J Addict Dis. 2009; 28(2): 145–57.
16. Grønbæk M. The positive and negative health effects of alcohol and the public health implications. J Intern Med. 2009; 265(4): 407–20.
17. Britton A., Marmot M.G. ja Shipley M. Who benefits most from the cardioprotective properties of alcohol consumption—health freaks or couch potatoes? J Epidemiol Community Health. 2008; 62(10): 905–8.
18. Agarwal D.P. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol. 2002; 37(5): 409–15.
19. Katso viite 17.
20. Sama.
21. Kechagias S., Ernersson Å., Dahlqvist O. ym. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut. 2008; 57(5): 649–54.
22. McCarthy E.M. ja Rinella M.E. The role of diet and nutrient composition in nonalcoholic fatty liver disease. J Acad Nutr Diet. 2012; 112(3): 401–9.
23. Silverman J.F., Pories W.J. ja Caro J.F. Liver pathology in diabetes mellitus and morbid obesity: clinical, pathological and biochemical considerations. Pathol Annu. 1989; 24: 275–302.
24. Singh S., Allen A.M., Wang Z., Prokop L.J., Murad M.H. ja Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2014; S1542–3565(14): 00602–8.
25. Zelber-Sagi S., Nitzan-Kaluski D., Goldsmith R. ym. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007; 47(5): 711–7.
26. Sama.
27. Longato L. Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar? Fibrogenesis Tissue Repair. 2013; 6(1): 14.
28. Musso G., Gambino R., De Michieli F. ym. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003; 37(4): 909–16.
29. Kontogianni M.D., Tileli N., Margariti A. ym. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr. 2014; 33(4): 678–83.
30. Kim E.J., Kim B.H., Seo H.S. ym. Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation. PLoS ONE. 2014; 9(6): e97841.
31. Yasutake K., Nakamuta M., Shima Y. ym. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol. 2009; 44(4): 471–7.
32. Duewell P., Kono H., Rayner K.J. ym. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease. Nature. 2010; 464(7293): 1357–61.
33. Ioannou G.N., Haigh W.G., Thorning D. ja Savard C. Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J Lipid Res. 2013; 54(5): 1326–34.
34. Yhdysvaltojen maatalousministeriö (USDA) Agricultural Research Service. National Nutrient Database for Standard Reference Release 27. Basic Report: 21359, McDonald’s, sausage McMuffin with egg. http://ndb.nal.usda.gov/ndb/foods/show/6845. Haettu 2.3.2015.
35. Ioannou G.N., Morrow O.B., Connole M.L. ja Lee S.P. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology. 2009; 50(1): 175–84.
36. National Institute of Diabetes and Digestive and Kidney Diseases. Liver transplantation. http://www.niddk.nih.gov/health-information/health-topics/liver-disease/liver-transplant /Pages/facts.aspx. 6.2010. Haettu 2.3.2015.
37. Kwak J.H., Baek S.H., Woo Y. ym. Beneficial immunostimulatory effect of short-term Chlorella supplementation: enhancement of natural killer cell activity and early inflammatory response (randomized, double-blinded, placebo-controlled trial). Nutr J. 2012; 11: 53.
38. Azocar J. ja Diaz A. Efficacy and safety of Chlorella supplementation in adults with chronic hepatitis C virus infection. World J Gastroenterol. 2013 Feb 21; 19(7): 1085–90.
39. Goozner M. Why Sovaldi shouldn’t cost $84,000. Mod Healthc. 2014; 44(18): 26.
40. Lock G., Dirscherl M., Obermeier F. ym. Hepatitis C – contamination of toothbrushes: myth or reality? J Viral Hepat. 2006; 13(9): 571–3.
41. Bocket L., Chevaliez S., Talbodec N., Sobaszek A., Pawlotsky J.M. ja Yazdanpanah Y. Occupational transmission of hepatitis C virus resulting from use of the same supermarket meat slicer. Clin Microbiol Infect. 2011; 17(2): 238–41.
42. Teo C.G. Much meat, much malady: changing perceptions of the epidemiology of hepatitis E. Clin Microbiol Infect. 2010; 16(1): 24–32.
43. Yazaki Y., Mizuo H., Takahashi M. ym. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol. 2003; 84(Pt 9): 2351–7.
44. Feagins A.R., Opriessnig T., Guenette D.K., Halbur P.G. ja Meng X.J. Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol. 2007; 88(Pt 3): 912–7.
45. Sama.
46. Dalton H.R., Bendall R.P., Pritchard C., Henley W. ja Melzer D. National mortality rates from chronic liver disease and consumption of alcohol and pig meat. Epidemiol Infect. 2010; 138(2): 174–82.
47. Emerson S.U., Arankalle V.A. ja Purcell R.H. Thermal stability of hepatitis E virus. J Infect Dis. 2005 Sep 1; 192(5): 930–3.
48. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. What can you do to protect yourself and your family from food poisoning? http://www.cdc.gov/foodsafety/prevention.html. 6.9.2013. Haettu 11.3.2015.
49. Shinde N.R., Patil T.B., Deshpande A.S., Gulhane R.V., Patil M.B. ja Bansod Y.V. Clinical profile, maternal and fetal outcomes of acute hepatitis E in pregnancy. Ann Med Health Sci Res. 2014; 4(Suppl 2): S133–9.
50. Navarro V.J., Barnhart H., Bonkovsky H.L. ym. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014; 60(4): 1399–408.
51. Yu E.L., Sivagnanam M., Ellis L. ja Huang J.S. Acute hepatotoxicity after ingestion of Morinda citrifolia (Noni Berry) juice in a 14-year-old boy. J Pediatr Gastroenterol Nutr. 2011; 52(2): 222–4.
52. Licata A. ja Craxt A. Considerations regarding the alleged association between Herbalife products and cases of hepatotoxicity: a rebuttal. Intern Emerg Med. 2014; 9(5): 601–2.
53. Lobb A.L. Science in liquid dietary supplement promotion: the misleading case of mangosteen juice. Hawaii J Med Public Health. 2012; 71(2): 46–8.
54. Sama.
55. Boozer C.N., Nasser J.A., Heymsfield S.B., Wang V., Chen G. ja Solomon J.L. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord. 2001; 25(3): 316–24.
56. US Government Accountability Office. Dietary Supplements Containing Ephedra: Health Risks and FDA’s Oversight. http://www.gao.gov/assets/120/110228.pdf. 23.7.2003. Haettu 2.3.2015.
57. Preuss H.G., Bagchi D., Bagchi M., Rao C.V., Dey D.K. ja Satyanarayana S. Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabetes Obes Metab. 2004; 6(3): 171–80.
58. Fong T.L., Klontz K.C., Canas-Coto A. ym. Hepatotoxicity due to hydroxycut: a case series. Am J Gastroenterol. 2010; 105(7): 1561–6.
59. Ye E.Q., Chacko S.A., Chou E.L., Kugizaki M. ja Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012; 142(7): 1304–13.
60. Karl J.P. ja Saltzman E. The role of whole grains in body weight regulation. Adv Nutr. 2012; 3(5): 697–707.
61. Katso viite 59.
62. Chang H-C., Huang C-N., Yeh D-M., Wang S-J., Peng C-H. ja Wang C-J. Oat prevents obesity and abdominal fat distribution, and improves liver function in humans. Plant Foods Hum Nutr. 2013; 68(1): 18–23.
63. Sama.
64. Georgoulis M., Kontogianni M.D., Tileli N. ym. The impact of cereal grain consumption on the development and severity of non-alcoholic fatty liver disease. Eur J Nutr. 2014; 53(8): 1727–35.
65. Valenti L., Riso P., Mazzocchi A., Porrini M., Fargion S. ja, Agostoni C. Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2013; 2013: 145421.
66. Suda I., Ishikawa F., Hatakeyama M. ym. Intake of purple sweet potato beverage affects on serum hepatic biomarker levels of healthy adult men with borderline hepatitis. Eur J Clin Nutr. 2008; 62(1): 60–7.
67. Sun J., Chu Y.F., Wu X. ja Liu R.H. Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem. 2002; 50(25): 7449–54.
68. Ferguson P.J., Kurowska E.M., Freeman D.J., Chambers A.F. ja Koropatnick J. In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract. Nutr Cancer. 2006; 56(1): 86–94.
69. Sun J. ja Hai Liu R. Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett. 2006; 241(1): 124–34.
70. Katso viite 68.
71. Kresty L.A., Howell A.B. ja Baird M. Cranberry proanthocyanidins mediate growth arrest of lung cancer cells through modulation of gene expression and rapid induction of apoptosis. Molecules. 2011; 16(3): 2375–90.
72. Seeram N.P., Adams L.S., Zhang Y. ym. Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J Agric Food Chem. 2006; 54(25): 9329–39.
73. Kim K.K., Singh A.P., Singh R.K. ym. Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells. Int J Oncol. 2012; 40(1): 227–35.
74. Déziel B., MacPhee J., Patel K. ym. American cranberry (Vaccinium macrocarpon) extract affects human prostate cancer cell growth via cell cycle arrest by modulating expression of cell cycle regulators. Food Funct. 2012; 3(5): 556–64.
75. Liu M., Lin L.Q., Song B.B. ym. Cranberry phytochemical extract inhibits SGC-7901 cell growth and human tumor xenografts in Balb/c nu/nu mice. J Agric Food Chem. 2009; 57(2): 762–8.
76. Seeram N.P., Adams L.S., Hardy M.L. ja Heber D. Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem. 2004; 52(9): 2512–7.
77. Grace M.H., Massey A.R., Mbeunkui F., Yousef G.G. ja Lila M.A. Comparison of health-relevant flavonoids in commonly consumed cranberry products. J Food Sci. 2012; 77(8): H176–83.
78. Sama.
79. Vinson J.A., Bose P., Proch J., Al Kharrat H. ja Samman N. Cranberries and cranberry products: powerful in vitro, ex vivo, and in vivo sources of antioxidants. J Agric Food Chem. 2008; 56(14): 5884–91.
80. White B.L., Howard L.R. ja Prior R.L. Impact of different stages of juice processing on the anthocyanin, flavonol, and procyanidin contents of cranberries. J Agric Food Chem. 2011; 59(9): 4692–8.
81. Arnesen E., Huseby N-E., Brenn T. ja Try K. The Tromse heart study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scand J Clin Lab Invest. 1986; 46(1): 63–70.
82. Ruhl C.E. ja Everhart J.E. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology. 2005; 129(6): 1928–36.
83. Salgia R. ja Singal A.G. Hepatocellular carcinoma and other liver lesions. Med Clin North Am. 2014; 98(1): 103–18.
84. Sang L.X., Chang B., Li X-H. ja Jiang M. Consumption of coffee associated with reduced risk of liver cancer: a meta- analysis. BMC Gastroenterol. 2013; 13: 34.
85. Lai G.Y., Weinstein S.J., Albanes D. ym. The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. Br J Cancer. 2013; 109(5): 1344–51.
86. Fujita Y., Shibata A., Ogimoto I. ym. The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer. 2006; 94(5): 737–9.
87. Danielsson J., Kangastupa P., Laatikainen T., Aalto M. ja Niemelä O. Dose- and gender-dependent interactions between coffee consumption and serum GGT activity in alcohol consumers. Alcohol Alcohol. 2013; 48(3): 303–7.
88. Bravi F., Bosetti C., Tavani A., Gallus S. ja La Vecchia C. Coffee reduces risk for hepatocellular carcinoma: an meta-analysis. Clin Gastroenterol Hepatol. 2013; 11(11): 1413–21.e1.
89. Browning J.D., Szczepaniak L.S., Dobbins R. ym. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004; 40(6): 1387–95.
90. Cardin R., Piciocchi M., Martines D., Scribano L., Petracco M. ja Farinati F. Effects of coffee consumption in chronic hepatitis C: a randomized controlled trial. Dig Liver Dis. 2013; 45(6): 499–504.
91. Torres D.M. ja Harrison S.A. Is it time to write a prescription for coffee? Coffee and liver disease. Gastroenterology. 2013; 144(4): 670–2.
92. Ng V. ja Saab S. Can daily coffee consumption reduce liver disease- related mortality? Clin Gastroenterol Hepatol. 2013; 11(11): 1422–3.
93. Katso viite 91.
94. Juliano L.M. ja Griffiths R.R. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl). 2004; 176(1): 1–29.
95. O’Keefe J.H., Bhatti S.K., Patil H.R., DiNicolantonio J.J., Lucan S.C. ja Lavie C.J. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 2013; 62(12): 1043–51.

9. Kuinka elää kuolematta verisyöpiin
1. Hunger S.P., Lu X., Devidas M. ym. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol. 2012; 30(14): 1663–9.
2. National Cancer Institute Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Leukemia. http://seer.cancer.gov/statfacts/html/leuks.html.Haettu 15.6.2015.
3. American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
4. Sama.
5. Sama.
6. Key T.J., Appleby P.N., Spencer E.A. ym. Cancer incidence in British vegetarians. Br J Cancer. 2009; 101(1): 192–7.
7. Vegetarians less likely to develop cancer than meat eaters [news release]. London, UK: British Journal of Cancer; 1.7.2009. http://www.nature.com/bjc/press_releases/p_r_jul09_6605098 .html. Haettu 11.3.2015.
8. Suppipat K., Park C.S., Shen Y., Zhu X. ja Lacorazza H.D. Sulforaphane induces cell cycle arrest and apoptosis in acute lymphoblastic leukemia cells. PLoS One. 2012; 7(12): e51251.
9. Han X., Zheng T., Foss F. ym. Vegetable and fruit intake and non-Hodgkin lymphoma survival in Connecticut women. Leuk Lymphoma. 2010; 51(6): 1047–54.
10. Thompson C.A. ja Cerhan J.R. Fruit and vegetable intake and survival from non-Hodgkin lymphoma: does an apple a day keep the doctor away? Leuk Lymphoma. 2010; 51(6): 963–4.
11. Thompson C.A., Habermann T.M., Wang A.H. ym. Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin’s lymphoma: the Iowa Women’s Health Study. Int J Cancer. 2010; 126(4): 992–1003.
12. Holtan S.G., O’Connor H.M., Fredericksen Z.S. ym. Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphoma. Int J Cancer. 2012; 131(5): 1158–68.
13. Sama.
14. Katso viite 11.
15. Bjelakovic G., Nikolova D., Simonetti R.G. ja Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet. 2004; 364(9441): 1219–28.
16. Jacobs D.R. ja Tapsell L.C. Food synergy: the key to a healthy diet. Proc Nutr Soc. 2013; 72(2): 200–6.
17. Elsayed R.K., Glisson J.K. ja Minor D.S. Rhabdomyolysis associated with the use of a mislabeled ”acai berry” dietary supplement. Am J Med Sci. 2011; 342(6): 535–8.
18. Zhang Y., Wang D., Lee R.P., Henning S.M. ja Heber D. Absence of pomegranate ellagitannins in the majority of commercial pomegranate extracts: implications for standardization and quality control. J Agric Food Chem. 2009; 57(16): 7395–400.
19. Zhang Y., Krueger D., Durst R. ym. International multidimensional authenticity specification (IMAS) algorithm for detection of commercial pomegranate juice adulteration. J Agric Food Chem. 2009; 57(6): 2550–7.
20. Del Pozo-Insfran D., Percival S.S. ja Talcott S.T. Açai (Euterpe oleracea Mart.) polyphenolics in their glycoside and aglycone forms induce apoptosis of HL-60 leukemia cells. J Agric Food Chem. 2006; 54(4): 1222–9.
21. Schauss A.G., Wu X., Prior R.L. ym. Antioxidant capacity and other bioactivities of the freezedried Amazonian palm berry, Euterpe oleraceae mart. (aSch). J Agric Food Chem. 2006; 54(22): 8604–10.
22. Jensen G.S., Ager D.M., Redman K.A., Mitzner M.A., Benson K.F. ja Schauss A.G. Pain reduction and improvement in range of motion after daily consumption of an açai (Euterpe oleracea Mart.) pulp-fortified polyphenolic-rich fruit and berry juice blend. J Med Food. 2011; 14(7–8): 702–11.
23. Udani J.K., Singh B.B., Singh V.J. ja Barrett M.L. Effects of açai (Euterpe oleracea Mart.) berry preparation on metabolic parameters in a healthy overweight population: a pilot study. Nutr J. 2011; 10: 45.
24. Haytowitz D.B. ja Bhagwat S.A. USDA database for the oxygen radical capacity (ORAC) of selected foods, release 2. Washington, D.C.: United States Department of Agriculture; 2010.
25. American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
26. Landgren O., Kyle R.A., Pfeiffer R.M. ym. Monoclonal gammopathy of undetermined signifi-cance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009; 113(22): 5412–7.
27. Sama.
28. Greenberg A.J., Vachon C.M. ja Rajkumar S.V. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites. Leukemia. 2012; 26(4): 609–14.
29. Kyle R.A., Therneau T.M., Rajkumar S.V. ym. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002; 346(8): 564–9.
30. Bharti A.C., Donato N., Singh S. ja Aggarwal B.B. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood. 2003; 101(3): 1053–62.
31. Golombick T., Diamond T.H., Badmaev V., Manoharan A. ja Ramakrishna R. The potential role of curcumin in patients with monoclonal gammopathy of undefined significance—its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker. Clin Cancer Res. 2009; 15(18): 5917–22.
32. Golombick T., Diamond T.H., Manoharan A. ja Ramakrishna R. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, doubleblind placebo-controlled cross-over 4g study and an open-label 8g extension study. Am J Hematol. 2012; 87(5): 455–60.
33. Key T.J., Appleby P.N., Spencer E.A. ym. Cancer incidence in British vegetarians. Br J Cancer. 2009; 101(1): 192–7.
34. Rohrmann S., Linseisen J., Jakobsen M.U. ym. Consumption of meat and dairy and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011; 128(3): 623–34.
35. Yhdysvaltojen maatalousministeriö (USDA) Agricultural Research Service. National Nutrient Database for Standard Reference Release 27. Basic Report: 05358, Chicken, broiler, rotisserie, BBQ, breast meat and skin. http://ndb.nal.usda.gov/ndb/foods/show/1058. Haettu 2.3.2015.
36. Katso viite 34.
37. Chiu B.C., Cerhan J.R., Folsom A.R. ym. Diet and risk of non-Hodgkin lymphoma in older women. JAMA. 1996; 275(17): 1315–21.
38. Daniel C.R., Sinha R., Park Y. ym. Meat intake is not associated with risk of non-Hodgkin lymphoma in a large prospective cohort of U.S. men and women. J Nutr. 2012; 142(6): 1074–80.
39. Puangsombat K., Gadgil P., Houser T.A., Hunt M.C. ja Smith J.S. Occurrence of heterocyclic amines in cooked meat products. Meat Sci. 2012; 90(3): 739–46.
40. ’t Mannetje A., Eng A. ja Pearce N. Farming, growing up on a farm, and haematological cancer mortality. Occup Environ Med. 2012; 69(2): 126–32.
41. Johnson E.S., Zhou Y., Yau L.C. ym. Mortality from malignant diseases-update of the Baltimore union poultry cohort. Cancer Causes Control. 2010; 21(2): 215–21.
42. Neasham D., Sifi A., Nielsen K.R. ym. Occupation and risk of lymphoma: a multicentre prospective cohort study (EPIC). Occup Environ Med. 2011; 68(1): 77–81.
43. Kalland K.H., Ke X.S. ja Øyan A.M. Tumour virology—history, status and future challenges. APMIS. 2009; 117(5–6): 382–99.
44. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Human Orf virus infection from household exposures—United States, 2009–2011. MMWR Morb Mortal Wkly Rep. 2012; 61(14): 245–8.
45. Benton E.C. Warts in butchers—a cause for concern? Lancet. 1994; 343(8906): 1114.
46. Gubéran E., Usel M., Raymond L. ja Fioretta G. Mortality and incidence of cancer among a cohort of self employed butchers from Geneva and their wives. Br J Ind Med. 1993; 50(11): 1008–16.
47. Johnson E.S., Zhou Y., Yau L.C. ym. Mortality from malignant diseases-update of the Baltimore union poultry cohort. Cancer Causes Control. 2010; 21(2): 215–21.
48. Johnson E.S., Ndetan H. ja Lo K.M. Cancer mortality in poultry slaughtering/processing plant workers belonging to a union pension fund. Environ Res. 2010; 110(6): 588–94.
49. Choi K.M. ja Johnson E.S. Occupational exposure assessment using antibody levels: exposure to avian leukosis/sarcoma viruses in the poultry industry. Int J Environ Health Res. 2011; 21(4): 306–16.
50. Choi K.M. ja Johnson E.S. Industrial hygiene assessment of reticuloendotheliosis viruses exposure in the poultry industry. Int Arch Occup Environ Health. 2011; 84(4): 375–82.
51. Sama.
52. Katso viite 48.
53. ’t Mannetje A., Eng A. ja Pearce N. Farming, growing up on a farm, and haematological cancer mortality. Occup Environ Med. 2012; 69(2): 126–32.
54. Tranah G.J., Bracci P.M. ja Holly E.A. Domestic and farm-animal exposures and risk of non-Hodgkin’s lymphoma in a population-based study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev. 2008; 17(9): 2382–7.
55. Buehring G.C., Philpott S.M. ja Choi K.Y. Humans have antibodies reactive with Bovine leukemia virus. AIDS Res Hum Retroviruses. 2003; 19(12): 1105–13.
56. Yhdysvaltojen maatalousministeriö (USDA), Animal and Plant Health Inspection Service. Bovine Leukosis Virus (BLV) on U.S. Dairy Operations, 2007. http://www.aphis.usda.gov/animal_health/nahms/dairy/downloads/dairy07/Dairy07_is_BLV.pdf. 10.2008. Haettu 2.3.2015.
57. Buehring G.C., Shen H.M., Jensen H.M., Choi K.Y., Sun D. ja Nuovo G. Bovine leukemia virus DNA in human breast tissue. Emerging Infect Dis. 2014; 20(5): 772–82.
58. Katso viite 54.
59. Schernhammer E.S., Bertrand K.A., Birmann B.M., Sampson L., Willett W.C. ja Feskanich D. Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am J Clin Nutr. 2012; 96(6): 1419–28.
60. Lim U., Subar A.F., Mouw T. ym. Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol Biomarkers Prev. 2006; 15(9): 1654–9.
61. McCullough M.L., Teras L.R., Shah R., Diver W.R., Gaudet M.M. ja Gapstur S.M. Artificially and sugar-sweetened carbonated beverage consumption is not associated with risk of lymphoid neoplasms in older men and women. J Nutr. 2014; 144(12): 2041–9.

10. Kuinka elää kuolematta munuaissirauksiin
1. Stokes J.B. Consequences of frequent hemodialysis: comparison to conventional hemodialysis and transplantation. Trans Am Clin Climatol Assoc. 2011; 122: 124–36.
2. Coresh J., Selvin E., Stevens L.A. ym. Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17): 2038–47.
3. Stevens L.A., Li S., Wang C. ym. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2010; 55(3 Suppl 2): S23–33.
4. Ryan T.P., Sloand J.A., Winters P.C., Corsetti J.P. ja Fisher S.G. Chronic kidney disease prevalence and rate of diagnosis. Am J Med. 2007; 120(11): 981–6.
5. Hoerger T.J., Simpson S.A., Yarnoff B.O. ym. The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative. Am J Kidney Dis. 2015; 65(3): 403–11.
6. Dalrymple L.S., Katz R., Kestenbaum B. ym. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. 2011; 26(4): 379–85.
7. Kumar S., Bogle R. ja Banerjee D. Why do young people with chronic kidney disease die early? World J Nephrol. 2014; 3(4): 143–55.
8. Lin J., Hu F.B. ja Curhan G.C. Associations of diet with albuminuria and kidney function decline. Clin J Am Soc Nephrol. 2010; 5(5): 836–43.
9. Sama.
10. Virchow R. Cellular Pathology as Based upon Physiological and Pathological Histology. Twenty Lectures Delivered in the Pathological Institute of Berlin During the Months of February, March and April, 1858. Philadelpia, PA: J. B. Lippincott and Co.; 1863.
11. Moorhead J.F., Chan M.K., El-Nahas M. ja Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982; 2(8311): 1309–11.
12. Hartroft W.S. Fat emboli in glomerular capillaries of choline-deficient rats and of patients with diabetic glomerulosclerosis. Am J Pathol. 1955; 31(3): 381–97.
13. Gyebi L., Soltani Z. ja Reisin E. Lipid nephrotoxicity: new concept for an old disease. Curr Hypertens Rep. 2012; 14(2): 177–81.
14. US Burden of Disease Collaborators. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013 Aug 14; 310(6): 591–608.
15. Odermatt A. The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am J Physiol Renal Physiol. 2011; 301(5): F919–31.
16. van den Berg E., Hospers F.A., Navis G. ym. Dietary acid load and rapid progression to endstage renal disease of diabetic nephropathy in Westernized South Asian people. J Nephrol. 2011; 24(1): 11–7.
17. Piccoli G.B., Vigotti F.N., Leone F. ym. Low-protein diets in CKD: how can we achieve them? A narrative, pragmatic review. Clin Kidney J. 2015; 8(1): 61–70.
18. Brenner B.M., Meyer T.W. ja Hostetter T.H. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982 Sep 9; 307(11): 652–9.
19. Wiseman M.J., Hunt R., Goodwin A., Gross J.L., Keen H. ja Viberti G.C. Dietary composition and renal function in healthy subjects. Nephron. 1987; 46(1): 37–42.
20. Nakamura H., Takasawa M., Kashara S. ym. Effects of acute protein loads of different sources on renal function of patients with diabetic nephropathy. Tohoku J Exp Med. 1989; 159(2): 153–62.
21. Simon A.H., Lima P.R., Almerinda M., Alves V.F., Bottini P.V. ja de Faria J.B. Renal haemodynamic responses to a chicken or beef meal in normal individuals. Nephrol Dial Transplant. 1998; 13(9): 2261–4.
22. Kontessis P., Jones S., Dodds R. ym. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int. 1990; 38(1): 136–44.
23. Katso viite 20.
24. Azadbakht L., Shakerhosseini R., Atabak S., Jamshidian M., Mehrabi Y. ja Esmaill-Zadeh A. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr. 2003; 57(10): 1292–4.
25. Kontessis P.A., Bossinakou I., Sarika L. ym. Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients. Diabetes Care. 1995; 18(9): 1233–40.
26. Teixeira S.R., Tappenden K.A., Carson L. ym. Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr. 2004; 134(8): 1874–80.
27. Stephenson T.J., Setchell K.D., Kendall C.W., Jenkins D.J., Anderson J.W. ja Fanti P. Effect of soy protein-rich diet on renal function in young adults with insulin-dependent diabetes mellitus. Clin Nephrol. 2005; 64(1): 1–11.
28. Jibani M.M., Bloodworth L.L., Foden E., Griffiths K.D. ja Galpin O.P. Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status. Diabet Med. 1991; 8(10): 949–53.
29. Bosch J.P., Saccaggi A., Lauer A., Ronco C., Belledonne M. ja Glabman S. Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate. Am J Med. 1983; 75(6): 943–50.
30. Liu Z.M., Ho S.C., Chen Y.M., Tang N. ja Woo J. Effect of whole soy and purified isoflavone daidzein on renal function— a 6-month randomized controlled trial in equol-producing postmenopausal women with prehypertension. Clin Biochem. 2014; 47(13–14): 1250–6.
31. Fioretto P., Trevisan R., Valerio A. ym. Impaired renal response to a meat meal in insulin dependent diabetes: role of glucagon and prostaglandins. Am J Physiol. 1990; 258(3 Pt 2): F675–83.
32. Frassetto L., Morris R.C., Sellmeyer D.E., Todd K. ja Sebastian A. Diet, evolution and aging—the pathophysiologic effects of the post-agricultural inversion of the potassium-to-sodium and base-to-chloride ratios in the human diet. Eur J Nutr. 2001; 40(5): 200–13.
33. Banerjee T., Crews D.C., Wesson D.E. ym. Dietary acid load and chronic kidney disease among adults in the United States. BMC Nephrol. 2014 Aug 24; 15: 137.
34. Sebastian A., Frassetto L.A., Sellmeyer D.E., Merriam R.L. ja Morris R.C. Estimation of the net acid load of the diet of ancestral preagricultural Homo sapiens and their hominid ancestors. Am J Clin Nutr. 2002; 76(6): 1308–16.
35. van den Berg E., Hospers F.A., Navis G. ym. Dietary acid load and rapid progression to end stage renal disease of diabetic nephropathy in Westernized South Asian people. J Nephrol. 2011; 24(1): 11–7.
36. Uribarri J. ja Oh M.S. The key to halting progression of CKD might be in the produce market, not in the pharmacy. Kidney Int. 2012; 81(1): 7–9.
37. Cohen E., Nardi Y., Krause I. ym. A longitudinal assessment of the natural rate of decline in renal function with age. J Nephrol. 2014; 27(6): 635–41.
38. Brenner B.M., Meyer T.W. ja Hostetter T.H. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982 Sep 9; 307(11): 652–9.
39. Frassetto L.A., Todd K.M., Morris R.C. ja Sebastian A. Estimation of net endogenous noncarbonic acid production in humans from diet potassium and protein contents. Am J Clin Nutr. 1998; 68(3): 576–83.
40. Wiseman M.J., Hunt R., Goodwin A., Gross J.L., Keen H. ja Viberti G.C. Dietary composition and renal function in healthy subjects. Nephron. 1987; 46(1): 37–42.
41. Kempner W. Treatment of heart and kidney disease and of hypertensive and arteriosclerotic vascular disease with the rice diet. Ann Intern Med. 1949; 31(5): 821–56.
42. Barsotti G., Morelli E., Cupisti A., Meola M., Dani L. ja Giovannetti S. A low-nitrogen low-phosphorus vegan diet for patients with chronic renal failure. Nephron. 1996; 74(2): 390–4.
43. Deriemaeker P., Aerenhouts D., Hebbelinck M. ja Clarys P. Nutrient based estimation of acid-base balance in vegetarians and non-vegetarians. Plant Foods Hum Nutr. 2010; 65(1): 77–82.
44. Goraya N., Simoni J., Jo C. ja Wesson D.E. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int. 2012; 81(1): 86–93.
45. Yaqoob M.M. Treatment of acidosis in CKD. Clin J Am Soc Nephrol. 2013; 8(3): 342–3.
46. Katso viite 44.
47. Wright J.A. ja Cavanaugh K.L. Dietary sodium in chronic kidney disease: a comprehensive approach. Semin Dial. 2010; 23(4): 415–21.
48. Uribarri J. ja Oh M.S. The key to halting progression of CKD might be in the produce market, not in the pharmacy. Kidney Int. 2012; 81(1): 7–9.
49. Goldfarb S. Dietary factors in the pathogenesis and prophylaxis of calcium nephrolithiasis. Kidney Int. 1988; 34(4): 544–55.
50. Scales C.D. Jr, Smith A.C., Hanley J.M. ja Saigal C.S. Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012; 62(1): 160–5.
51. Robertson W.G., Peacock M. ja Hodgkinson A. Dietary changes and the incidence of urinary calculi in the U.K. between 1958 and 1976. J Chronic Dis. 1979; 32(6): 469–76.
52. Robertson W.G., Heyburn P.J., Peacock M., Hanes F.A. ja Swaminathan R. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci (Lond).
1979; 57(3): 285–8.
53. Sama.
54. Robertson W.G., Peacock M., Heyburn P.J. ym. Should recurrent calcium oxalate stone formers become vegetarians? Br J Urol. 1979; 51(6): 427–31.
55. Turney B.W., Appleby P.N., Reynard J.M., Noble J.G., Key T.J. ja Allen N.E. Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol. 2014; 29(5): 363–9.
56. Tracy C.R., Best S., Bagrodia A. ym. Animal protein and the risk of kidney stones: A comparative metabolic study of animal protein sources. J Urol. 2014 Feb 8; 192: 137–41.
57. Bushinsky D.A. Recurrent hypercalciuric nephrolithiasis—does diet help? N Engl J Med. 2002 Jan 10; 346(2): 124–5.
58. Borghi L., Schianchi T., Meschi T. ym. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002 Jan 10; 346(2): 77–84.
59. Sorensen M.D., Hsi R.S., Chi T. ym. Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women’s Health Initiative report. J Urol. 2014; 192(6): 1694–9.
60. Mehta T.H. ja Goldfarb D.S. Uric acid stones and hyperuricosuria. Adv Chronic Kidney Dis. 2012; 19(6): 413–8.
61. de Vries A., Frank M., Liberman U.A. ja Sperling O. Allopurinol in the prophylaxis of uric acid stones. Ann Rheum Dis. 1966; 25(6 Suppl): 691–3.
62. Siener R. ja Hesse A. The effect of a vegetarian and different omnivorous diets on urinary risk factors for uric acid stone formation. Eur J Nutr. 2003; 42(6): 332–7.
63. Sama.
64. Trinchieri A. Development of a rapid food screener to assess the potential renal acid load of diet in renal stone formers (LAKE score). Arch Ital Urol Androl. 2012; 84(1): 36–8.
65. Chae J.Y., Kim J.W., Kim J.W. ym. Increased fluid intake and adequate dietary modification may be enough for the successful treatment of uric acid stone. Urolithiasis. 2013; 41(2): 179–82.
66. Deriemaeker P., Aerenhouts D., Hebbelinck M. ja Clarys P. Nutrient based estimation of acid-base balance in vegetarians and non-vegetarians. Plant Foods Hum Nutr. 2010; 65(1): 77–82.
67. Adeva M.M. ja Souto G. Diet-induced metabolic acidosis. Clin Nutr. 2011; 30(4): 416–21.
68. Dawson-Hughes B., Harris S.S. ja Ceglia L. Alkaline diets favor lean tissue mass in older adults. Am J Clin Nutr. 2008; 87(3): 662–5.
69. Ritz E., Hahn K., Ketteler M., Kuhlmann M.K. ja Mann J. Phosphate additives in food—a health risk. Dtsch Arztebl Int. 2012; 109(4): 49–55.
70. Sama.
71. Calvo M.S. ja Uribarri J. Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population. Am J Clin Nutr. 2013; 98(1): 6–15.
72. Moe S.M., Zidehsarai M.P., Chambers M.A. ym. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011; 6(2): 257–64.
73. Fukagawa M., Komaba H. ja Miyamoto K. Source matters: from phosphorus load to bioavailability. Clin J Am Soc Nephrol. 2011; 6(2): 239–40.
74. Murphy-Gutekunst L. ja Uribarri J. Hidden phosphorus-enhanced meats: Part 3. J Ren Nutr. 2005 15(4): E1– E4.
75. Katso viite 69.
76. Karp H., Ekholm P., Kemi V. ym. Differences among total and in vitro digestible phosphorus content of plant foods and beverages. J Ren Nutr. 2012; 22(4): 416–22.
77. Karp H., Ekholm P., Kemi V., Hirvonen T. ja Lamberg-Allardt C. Differences among total and in vitro digestible phosphorus content of meat and milk products. J Ren Nutr. 2012; 22(3): 344–9.
78. Katso viite 76.
79. Murphy-Gutekunst L. ja Uribarri J. Hidden phosphorus-enhanced meats: Part 3. J Ren Nutr. 2005,15(4): E1– E4.
80. Sherman R.A. ja Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009; 4(8): 1370–3.
81. Benini O., D’Alessandro C., Gianfaldoni D. ja Cupisti A. Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients. J Ren Nutr. 2011; 21(4): 303–8.
82. Katso viite 80.
83. Katso viite 81.
84. Shroff R. Phosphate is a vascular toxin. Pediatr Nephrol. 2013; 28(4): 583–93.
85. Shuto E., Taketani Y., Tanaka R. ym. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol. 2009; 20(7): 1504–12.
86. Gunther N.W., He Y. ja Fratamico P. Effects of polyphosphate additives on the pH of processed chicken exudates and the survival of Campylobacter. J Food Prot. 2011; 74(10): 1735–40.
87. Sherman R.A. ja Mehta O. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis. 2009; 54(1): 18–23.
88. Sama.
89. Sullivan C.M., Leon J.B. ja Sehgal A.R. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr. 2007; 17(5): 350–4.
90. Yhdysvaltojen elintarvike- ja lääkevirasto, Yhdysvaltojen terveys- ja sosiaalipalveluministeriö. Final Determination Regarding Partially Hydrogenated Oils. Docket No. FDA-2013-N-1317. https://s3.amazonaws.com/public-inspection.federalregister.gov/2015-14883.pdf. 16.6. 2015. Haettu 16.6.2015.
91. Yhdysvaltojen elintarvike- ja lääkevirasto, Yhdysvaltojen terveys- ja sosiaalipalveluministeriö. Tentative determination regarding partially hydrogenated oils; request for comments and for scientific data and information. Federal Register Docket No. D78 FR 67169-75. https://www.federalregister.gov/articles/2013/11/08/2013-26854/tentative-determination-regarding-partially–hydrogenated-oils-request-for-comments-and-for. 8.11.2013. Haettu 2.3.2015.
92. Sama.
93. Neltner T.G., Kulkami N.R., Alger H.M. ym. Navigating the U.S. food additive regulatory program. Compr Rev Food Sci Food Saf. 2011; 10(6): 342–68.
94. Neltner T.G., Alger H.M., O’Reilly J.T., Krimsky S., Bero L.A. ja Maffini M.V. Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance. JAMA Intern Med. 2013; 173(22): 2032–6.
95. Stuckler D., Basu S. ja McKee M. Commentary: UN high level meeting on non-communicable diseases: an opportunity for whom? BMJ. 2011; 343: d5336.
96. Moodie R., Stuckler D., Monteiro C. ym. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet. 2013; 381(9867): 670–9.
97. American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
98. Kirkali Z. ja Cal C. Renal Cell Carcinoma: Overview. In Nargund VH, Raghavan D, Sandler HM, eds. Urological Oncology. London, UK: Springer; 2008: 263–80.
99. Sama.
100. Ramírez N., Özel M.Z., Lewis A.C., Marcé R.M., Borrull F. ja Hamilton J.F. Exposure to nitrosamines in thirdhand tobacco smoke increases cancer risk in non-smokers. Environ Int. 2014; 71: 139–47.
101. Schick S.F., Farraro K.F., Perrino C. ym. Thirdhand cigarette smoke in an experimental chamber: evidence of surface deposition of nicotine, nitrosamines and polycyclic aromatic hydrocarbons and de novo formation of NNK. Tob Control. 2014; 23(2): 152–9.
102. Hecht S.S. It is time to regulate carcinogenic tobacco-specific nitrosamines in cigarette tobacco. Cancer Prev Res (Phila). 2014; 7(7): 639–47.
103. Rodgman A. ja Perfetti T.A. The Chemical Components of Tobacco and Tobacco Smoke. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2009.
104. Haorah J., Zhou L., Wang X., Xu G. ja Mirvish SS. Determination of total N-nitroso compounds and their precursors in frankfurters, fresh meat, dried salted fish, sauces, tobacco, and tobacco smoke particulates. J Agric Food Chem. 2001; 49(12): 6068–78.
105. Rohrmann S., Overvad K, Bueno-de-Mesquita H.B. ym. Meat consumption and mortality—results from the European Prospective Investigation into Cancer and Nutrition. BMC Med. 2013; 11: 63.
106. Sinha R., Cross A.J., Graubard B.I., Leitzmann M.F. ja Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009; 169(6): 562–71.
107. Yhdysvaltain syöpätutkimusinstituutti. Recommendations for Cancer Prevention. http://www.aicr.org/reduce-your-cancer-risk/recommendations-for-cancer-prevention/recommendations_05_red_meat.html. 17.4.2011. Haettu 2.3.2015.
108. USDA. Additives in meat and poultry products. http://www.fsis.usda.gov/wps/portal/fsis/topics/food-safety-education/get-answers/food-safety-fact-sheets/food-labeling/additives-in-meat-and-poultry-products/additives-in-meat-and-poultry-products. 24.3.2015. Haettu 3.5.2015.
109. Sebranek J.G., Jackson-Davis A.L., Myers K.L. ja Lavieri N.A. Beyond celery and starter culture: advances in natural/organic curing processes in the United States. Meat Sci. 2012; 92(3): 267–73.
110. Dellavalle C.T., Daniel C.R., Aschebrook-Kilfoy B. ym. Dietary intake of nitrate and nitrite and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. Br J Cancer. 2013; 108(1): 205–12.
111. Bartsch H., Ohshima H. ja Pignatelli B. Inhibitors of endogenous nitrosation. Mechanisms and implications in human cancer prevention. Mutat Res. 1988; 202(2): 307–24.
112. Katso viite 110.
113. Liu B., Mao Q., Wang X. ym. Cruciferous vegetables consumption and risk of renal cell carcinoma: a meta-analysis. Nutr Cancer. 2013; 65(5): 668–76.

11. Kuinka elää kuolematta rintasyöpään
1. American Cancer Society. Breast Cancer Facts & Figures 2013–2014. http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042725.pdf. 2013. Haettu 10.32015.
2. Sanders M.E., Schuyler P.A., Dupont W.D. ja Page D.L. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of longterm follow-up. Cancer. 2005; 103(12): 2481–4.
3. Nielsen M., Thomsen J.L., Primdahl S., Dyreborg U. ja Andersen J.A. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer. 1987; 56(6): 814–9.
4. Soto A.M., Brisken C., Schaeberle C. ja Sonnenschein C. Does cancer start in the womb? Altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors. J Mammary Gland Biol Neoplasia. 2013; 18(2): 199–208.
5. Del Monte U. Does the cell number 10(9) still really fit one gram of tumor tissue? Cell Cycle.2009; 8(3): 505–6.
6. Black W.C. ja Welch H.G. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993; 328(17): 1237–43.
7. Friberg S. ja Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol. 1997; 65(4): 284–97.
8. Philippe E. ja Le Gal Y. Growth of seventy-eight recurrent mammary cancers. Quantitative study. Cancer. 1968; 21(3): 461–7.
9. Kuroishi T., Tominaga S., Morimoto T. ym. Tumor growth rate and prognosis of breast cancer mainly detected by mass screening. Jpn J Cancer Res. 1990; 81(5): 454–62.
10. American Association for Cancer Research. Studies weigh cost, effectiveness of mammography. Cancer Discov. 2014; 4(5): OF5.
11. Katso viite 3.
12. American Institute for Cancer Research. Recommendations for Cancer Prevention. http://www.aicr.org/reduce-your-cancer-risk/recommendations-for-cancer-prevention/.12.9.2014. Haettu 10.3.2015.
13. American Institute for Cancer Research. AICR, the China Study, and Forks Over Knives. http://www.aicr.org/about/advocacy/the-china-study.html. 9.1.2015. Haettu 10.3.2015.
14. Hastert T.A., Beresford S.A.A., Patterson R.E., Kristal A.R. ja White E. Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2013; 22(9): 1498–508.
15. Barnard R.J., Gonzalez J.H., Liva M.E. ja Ngo T.H. Effects of a low-fat, high-fiber diet and exercise program on breast cancer risk factors in vivo and tumor cell growth and apoptosis in vitro. Nutr Cancer. 2006; 55(1): 28–34.
16. Ngo T.H., Barnard R.J., Tymchuk C.N., Cohen P. ja Aronson W.J. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control. 2002; 13(10): 929–35.
17. Allen N.E., Appleby P.N., Davey G.K., Kaaks R., Rinaldi S. ja Key T.J. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev. 2002; 11(11): 1441–8.
18. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 96, Alcohol Consumption and Ethyl Carbamate. Lyon, France: International Agency for Research on Cancer; 2010.
19. Stewart B.W. ja Wild C.P. (toim.). World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer; 2014.
20. Bagnardi V., Rota M., Botteri E. ym. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol. 2013; 24(2): 301–8.
21. Linderborg K., Salaspuro M. ja Väkeväinen S. A single sip of a strong alcoholic beverage causes exposure to carcinogenic concentrations of acetaldehyde in the oral cavity. Food Chem Toxicol. 2011; 49(9): 2103–6.
22. Lachenmeier D.W., Gumbel-Mako S., Sohnius E.M., Keck-Wilhelm A., Kratz E. ja Mildau G. Salivary acetaldehyde increase due to alcohol-containing mouthwash use: a risk factor for oral cancer. Int J Cancer. 2009; 125(3): 730–5.
23. Chen W.Y., Rosner B., Hankinson S.E., Colditz G.A. ja Willett W.C. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA. 2011; 306(17): 1884–90.
24. Shufelt C., Merz C.N., Yang Y. ym. Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot study. J Womens Health (Larchmt). 2012; 21(3): 281–4.
25. Eng E.T., Williams D., Mandava U., Kirma N., Tekmal R.R. ja Chen S. Anti-aromatase chemicals in red wine. Ann N Y Acad Sci. 2002; 963: 239–46.
26. Katso viite 24.
27. Chen S., Sun X.Z., Kao Y.C., Kwon A., Zhou D. ja Eng E. Suppression of breast cancer cell growth with grape juice. Pharmaceutical Biology. 1998; 36(Suppl 1): 53–61.
28. Sama.
29. Adams L.S., Zhang Y., Seeram N.P., Heber D. ja Chen S. Pomegranate ellagitannin-derived compounds exhibit anti-proliferative and anti-aromatase activity in breast cancer cells in vitro. Cancer Prev Res (Phila). 2010; 3(1): 108–13.
30. Chen S., Oh S.R., Phung S. ym. Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus). Cancer Res. 2006; 66(24): 12026–34.
31. Mishal A.A. Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Osteoporos Int. 2001; 12(11): 931–5.
32. Cardinali D.P. ja Pévet P. Basic aspects of melatonin action. Sleep Med Rev. 1998; 2(3): 175–90.
33. Blask D.E., Dauchy R.T. ja Sauer L.A. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine. 2005; 27(2): 179–88.
34. Flynn-Evans E.E., Stevens R.G., Tabandeh H., Schernhammer E.S. ja Lockley S.W. Total visual blindness is protective against breast cancer. Cancer Causes Control. 2009; 20(9): 1753–6.
35. He C., Anand S.T., Ebell M.H., Vena J.E. ja Robb S.W. Circadian disrupting exposures and breast cancer risk: a meta-analysis. Int Arch Occup Environ Health. 2015 Jul; 88(5): 533–47.
36. Hurley S., Goldberg D., Nelson D. ym. Light at night and breast cancer risk among California teachers. Epidemiology. 2014; 25(5): 697–706.
37. Bauer S.E., Wagner S.E., Burch J., Bayakly R. ja Vena J.E. A case-referent study: light at night and breast cancer risk in Georgia. Int J Health Geogr. 2013; 12: 23.
38. Kloog I., Haim A., Stevens R.G., Barchana M. ja Portnov B.A. Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol Int. 2008; 25(1): 65–81.
39. Li Q., Zheng T., Holford T.R., Boyle P., Zhang Y. ja Dai M. Light at night and breast cancer risk: results from a population-based case-control study in Connecticut, USA. Cancer Causes Control. 2010; 21(12): 2281–5.
40. Basler M., Jetter A., Fink D., Seifert B., Kullak-Ublick G.A. ja Trojan A. Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast Care (Basel). 2014; 9(3): 182–7.
41. Nagata C., Nagao Y., Shibuya C., Kashiki Y. ja Shimizu H. Association of vegetable intake with urinary 6-sulfatoxymelatonin level. Cancer Epidemiol Biomarkers Prev. 2005; 14(5): 1333–5.
42. Schernhammer E.S., Feskanich D., Niu C., Dopfel R., Holmes M.D. ja Hankinson S.E. Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses’ Health Study cohorts. Am J Clin Nutr. 2009; 90(4): 975–85.
43. Gonçalves A.K., Dantas Florencio G.L., Maisonnette de Atayde Silva M.J., Cobucci R.N., Giraldo P.C. ja Cote N.M. Effects of physical activity on breast cancer prevention: a systematic review. J Phys Act Health. 2014; 11(2): 445–54.
44. Friedenreich C.M., Woolcott C.G., McTiernan A. ym. Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol. 2010; 28(9): 1458–66.
45. Kossman D.A., Williams N.I., Domchek S.M., Kurzer M.S., Stopfer J.E. ja Schmitz K.H. Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer. J Appl Physiol. 2011; 111(6): 1687–93.
46. Thune I. ja Furberg A.S. Physical activity and cancer risk: dose-response and cancer, all sites and site-specific. Med Sci Sports Exerc. 2001; 33(6 Suppl): S530–50.
47. Carpenter C.L., Ross R.K., Paganini-Hill A. ja Bernstein L. Lifetime exercise activity and breast cancer risk among post-menopausal women. Br J Cancer. 1999; 80(11): 1852–8.
48. Peters T.M., Moore S.C., Gierach G.L. ym. Intensity and timing of physical activity in relation to postmenopausal breast cancer risk: the prospective NIH-AARP diet and health study. BMC Cancer. 2009; 9: 349.
49. Friedenreich C.M. ja Cust A.E. Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med. 2008; 42(8): 636–47.
50. Hildebrand J.S., Gapstur S.M., Campbell P.T., Gaudet M.M. ja Patel A.V. Recreational physical activity and leisure-time sitting in relation to postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2013; 22(10): 1906–12.
51. Widmark E.M.P. Presence of cancer-producing substances in roasted food. Nature. 1939; 143: 984.
52. National Cancer Institute. Chemicals in Meat Cooked at High Temperatures and Cancer Risk. http://www.cancer.gov/cancertopics/factsheet/Risk/cooked-meats. Tarkistettu 15.10.2010. Haettu 10.3.
53. Shaughnessy D.T., Gangarosa L.M., Schliebe B. ym. Inhibition of fried meat-induced colorectal DNA damage and altered systemic genotoxicity in humans by crucifera, chlorophyllin, and yogurt. PLoS ONE. 2011; 6(4): e18707.
54. Zaidi R., Kumar S. ja Rawat P.R. Rapid detection and quantification of dietary mutagens in food using mass spectrometry and ultra performance liquid chromatography. Food Chem. 2012; 135(4): 2897–903.
55. Thiébaud H.P., Knize M.G., Kuzmicky P.A., Hsieh D.P. ja Felton J.S. Airborne mutagens produced by frying beef, pork and a soy-based food. Food Chem Toxicol. 1995; 33(10): 821–8.
56. Zheng W. ja Lee S.A. Well-done meat intake, heterocyclic amine exposure, and cancer risk. Nutr Cancer. 2009; 61(4): 437–46.
57. Goldfinger S.E. By the way, doctor. In your May issue you say that eating medium or well-done beef increases one’s risk for stomach cancer. But what about the dangers of eating rare beef?. Harv Health Lett. 1999; 24(5): 7.
58. Frandsen H., Frederiksen H. ja Alexander J. 2-Amino-1-methyl-6-(5-hydroxy-)phenylimidazo [4,5-b]pyridine (5-OH-PhIP), a biomarker for the genotoxic dose of the heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Food Chem Toxicol. 2002; 40(8): 1125–30.
59. Frandsen H. Biomonitoring of urinary metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) following human consumption of cooked chicken. Food Chem Toxicol. 2008; 46(9): 3200–5.
60. Steck S.E., Gaudet M.M., Eng S.M. ym. Cooked meat and risk of breast cancer—lifetime versus recent dietary intake. Epidemiology. 2007; 18(3): 373–82.
61. Zheng W., Gustafson D.R., Sinha R. ym. Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst. 1998; 90(22): 1724–9.
62. Rohrmann S., Lukas Jung S.U., Linseisen J. ja Pfau W. Dietary intake of meat and meat-derived heterocyclic aromatic amines and their correlation with DNA adducts in female breast tissue. Mutagenesis. 2009; 24(2): 127–32.
63. Santella R.M., Gammon M., Terry M. ym. DNA adducts, DNA repair genotype/phenotype and cancer risk. Mutat Res. 2005; 592(1–2): 29–35.
64. Lauber S.N., Ali S. ja Gooderham N.J. The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity. Carcinogenesis. 2004; 25(12): 2509–17.
65. Debruin L.S., Martos P.A. ja Josephy P.D. Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in the milk of healthy women. Chem Res Toxicol. 2001; 14(11): 1523–8.
66. Katso viite 64.
67. Katso viite 65.
68. Bessette E.E., Yasa I., Dunbar D., Wilkens L.R., Le Marchand L. ja Turesky R.J. Biomonitoring of carcinogenic heterocyclic aromatic amines in hair: a validation study. Chem Res Toxicol. 2009; 22(8): 1454–63.
69. Grose K.R., Grant J.L., Bjeldanes L.F. ym. Isolation of the carcinogen IQ from fried egg patties. J Agric Food Chem. 1986; 34(2): 201–2.
70. Holland R.D., Gehring T., Taylor J., Lake B.G., Gooderham N.J. ja Turesky R.J. Formation of a mutagenic heterocyclic aromatic amine from creatinine in urine of meat eaters and vegetarians. Chem Res Toxicol. 2005; 18(3): 579–90.
71. Magagnotti C., Orsi F., Bagnati R. ym. Effect of diet on serum albumin and hemoglobin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans. Int J Cancer. 2000; 88(1): 1–6.
72. Lauber S.N. ja Gooderham N.J. The cooked meat-derived mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine promotes invasive behaviour of breast cancer cells. Toxicology. 2011; 279(1–3): 139–45.
73. Sama.
74. Vergnaud A.C., Romaguera D., Peeters P.H. ym. Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study. Am J Clin Nutr. 2013; 97(5): 1107–20.
75. Danilo C. ja Frank P.G. Cholesterol and breast cancer development. Current Opinion in Pharmacology. 2012; 12(6): 677.
76. Firestone R.A. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjug Chem. 1994 5(2): 105–13.
77. Rudling M.J., Ståhle L., Peterson C.O. ja Skoog L. Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients. Br Med J (Clin Res Ed). 1986; 292(6520): 580–2.
78. Danilo C. ja Frank P.G. Cholesterol and breast cancer development. Current Opinion in Pharmacology. 2012; 12(6): 677–82.
79. Antalis C.J., Arnold T., Rasool T., Lee B., Buhman K.K. ja Siddiqui R.A. High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation. Breast Cancer Res Treat. 2010; 122(3): 661–70.
80. Firestone R.A. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjug Chem. 1994; 5(2): 105–13.
81. Kitahara C.M, Berrington de González A, Freedman ND, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol. 2011; 29(12): 1592–8.
82. Undela K., Srikanth V. ja Bansal D. Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast Cancer Res Treat. 2012; 135(1): 261–9.
83. McDougall J.A., Malone K.E., Daling J.R., Cushing-Haugen K.L., Porter P.L. ja Li C.I. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev. 2013; 22(9): 1529–37.
84. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Data table for Figure 17. Statin drug use in the past 30 days among adults 45 years of age and over, by sex and age: United States, 1988–1994, 1999–2002, and 2005–2008. National Health and Nutrition Examination Survey. Chartbook: Centers for Disease Control; 2010. http://www.cdc.gov/nchs/data/hus/2010/fig17.pdf. Haettu 25.3.2015.
85. Maunsell E., Drolet M., Brisson J., Robert J. ja Deschell L. Dietary change after breast cancer: extent, predictors, and relation with psychological distress. J Clin Oncol. 2002; 20(4): 1017–25.
86. Pierce J.P., Stefanick M.L., Flatt S.W. ym. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol. 2007; 25(17): 2345–51.
87. Li Q., Holford T.R., Zhang Y. ym. Dietary fiber intake and risk of breast cancer by menopausal and estrogen receptor status. Eur J Nutr. 2013; 52(1): 217–23.
88. Sama.
89. Howe G.R., Hirohata T., Hislop T.G. ym. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990; 82(7): 561–9.
90. Dong J-Y., He K., Wang P. ja Qin L.Q. Dietary fiber intake and risk of breast cancer: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2011; 94(3): 900–5.
91. Aune D., Chan D.S., Greenwood D.C. ym. Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies. Ann Oncol. 2012; 23(6): 1394–402.
92. Clemens R., Kranz S., Mobley A.R. ym. Filling America’s fiber intake gap: summary of a roundtable to probe realistic solutions with a focus on grain-based foods. J Nutr. 2012; 142(7): 1390S–401S.
93. Farmer B., Larson B.T., Fulgoni V.L., Rainville A.J. ja Liepa G.U. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the National Health and Nutrition Examination Survey 1999–2004. J Am Diet Assoc. 2011; 111(6): 819–27.
94. Rizzo N.S., Jaceldo-Siegl K., Sabate J. ja Fraser G.E. Nutrient profiles of vegetarian and nonvegetarian dietary patterns. J Acad Nutr Diet. 2013; 113(12): 1610–9.
95. Dewell A., Weidner G., Sumner M.D., Chi C.S. ja Ornish D. A very-low-fat vegan diet increases intake of protective dietary factors and decreases intake of pathogenic dietary factors. J Am Diet Assoc. 2008; 108(2): 347–56.
96. Gallus S., Talamini R., Giacosa A. ym. Does an apple a day keep the oncologist away? Ann Oncol. 2005; 16(11): 1841–4.
97. Wolfe K., Wu X. ja Liu R.H. Antioxidant activity of apple peels. J Agric Food Chem. 2003; 51(3): 609–14.
98. Sun J. ja Liu R.H. Apple phytochemical extracts inhibit proliferation of estrogen-dependent and estrogen-independent human breast cancer cells through cell cycle modulation. J Agric Food Chem. 2008; 56(24): 11661–7.
99. Katso viite 97.
100. Reagan-Shaw S., Eggert D., Mukhtar H. ja Ahmad N. Antiproliferative effects of apple peel extract against cancer cells. Nutr Cancer. 2010; 62(4): 517–24.
101. Steck S.E., Gaudet M.M., Eng S.M. ym. Cooked meat and risk of breast cancer—lifetime versus recent dietary intake. Epidemiology. 2007; 18(3): 373–82.
102. Murray S., Lake B.G., Gray S. ym. Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man. Carcinogenesis. 2001; 22(9): 1413–20.
103. Sama.
104. Sama.
105. Thiébaud H.P., Knize M.G., Kuzmicky P.A., Hsieh D.P. ja Felton J.S. Airborne mutagens produced by frying beef, pork and a soy-based food. Food Chem Toxicol. 1995; 33(10): 821–8.
106. Boggs D.A., Palmer J.R., Wise L.A. ym. Fruit and vegetable intake in relation to risk of breast cancer in the Black Women’s Health Study. Am J Epidemiol. 2010; 172(11): 1268–79.
107. Sama.
108. Tiede B. ja Kang Y. From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer. Cell Res. 2011; 21(2): 245–57.
109. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med. 2011; 17(3): 313–9.
110. Karrison T.G., Ferguson D.J. ja Meier P. Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst. 1999; 91(1): 80–5.
111. Aguirre-Ghiso J.A. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007; 7(11): 834–46.
112. Katso viite 109.
113. Li Y., Zhang T., Korkaya H. ym. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res. 2010; 16(9): 2580–90.
114. Cornblatt B.S., Ye L., Dinkova-Kostova A.T. ym. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis. 2007; 28(7): 1485–90.
115. Fahey J.W., Zhang Y. ja Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA. 1997; 94(19): 10367–72.
116. Goyal A., Sharma V., Upadhyay N., Gill S. ja Sihag M. Flax and flaxseed oil: an ancient medicine & modern functional food. J Food Sci Technol. 2014; 51(9): 1633–53.
117. Smeds A.I., Eklund P.C., Sjöholm R.E. ym. Quantification of a broad spectrum of lignans in cereals, oilseeds, and nuts. J Agric Food Chem. 2007; 55(4): 1337–46.
118. Rosolowich V., Saettler E., Szuck B. ym. Mastalgia. J Obstet Gynaecol Can. 2006; 170: 49–57.
119. Phipps W.R., Martini M.C., Lampe J.W., Slavin J.L. ja Kurzer M.S. Effect of flax seed ingestion on the menstrual cycle. J Clin Endocrinol Metab. 1993; 77(5): 1215–9.
120. Kelsey J.L., Gammon M.D. ja John E.M. Reproductive factors and breast cancer. Epidemiol Rev. 1993; 15(1): 36–47.
121. Knekt P., Adlercreutz H., Rissanen H., Aromaa A., Teppo L. ja Heliövaara M. Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer? Br J Cancer. 2000; 82(5): 1107–10.
122. Buck K., Zaineddin A.K., Vrieling A., Linseisen J. ja Chang-Claude J. Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr. 2010; 92(1): 141–53.
123. Abarzua S., Serikawa T., Szewczyk M., Richter D.U., Piechulla B. ja Briese V. Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20. Arch Gynecol Obstet. 2012; 285(4): 1145–51.
124. Fabian C.J., Kimler B.F., Zalles C.M. ym. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside. Cancer Prev Res (Phila). 2010; 3(10): 1342–50.
125. Buck K., Vrieling A., Zaineddin AK. ym. Serum enterolactone and prognosis of postmenopausal breast cancer. J Clin Oncol. 2011; 29(28): 3730–8.
126. Guglielmini P., Rubagotti A. ja Boccardo F. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. Breast Cancer Res Treat. 2012; 132(2): 661–8.
127. McCann S.E., Thompson L.U., Nie J. ym. Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat. 2010; 122(1): 229–35.
128. Åberg U.W., Saarinen N., Abrahamsson A., Nurmi T., Engblom S. ja Dabrosin C. Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo. PLoS ONE. 2011; 6(9): e25720.
129. Thompson L.U., Chen J.M., Li T., Strasser-Weippl K. ja Goss P.E. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005; 11(10): 3828–35.
130. Mueller S.O., Simon S., Chae K., Metzler M. ja Korach K.S. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci. 2004; 80(1): 14–25.
131. Oseni T., Patel R., Pyle J. ja Jordan V.C. Selective estrogen receptor modulators and phytoestrogens. Planta Med. 2008; 74(13): 1656–65.
132. Sama.
133. Nagata C., Mizoue T., Tanaka K. ym. Soy intake and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2014; 44(3): 282–95.
134. Chen M.N., Lin C.C. ja Liu C.F. Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. Climacteric. 2015; 18(2): 260–9.
135. Chi F., Wu R., Zeng Y.C., Xing R., Liu Y. ja Xu Z.G. Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev. 2013; 14(4): 2407–12.
136. Bhagwat S., Haytowitz D.B. ja Holden J.M. USDA Database for the Isoflavone Content of Selected Foods, Release 2.0. http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/isoflav/Isoflav_R2.pdf. 9.2008. Haettu 26.3.2015.
137. Nechuta S.J., Caan B.J., Chen W.Y. ym. Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr. 2012; 96(1): 123–32.
138. Katso viite 135.
139. Kang H.B., Zhang Y.F., Yang J.D. ja Lu K.L. Study on soy isoflavone consumption and risk of breast cancer and survival. Asian Pac J Cancer Prev. 2012; 13(3): 995–8.
140. Bosviel R., Dumollard E., Déchelotte P., Bignon Y.J. ja Bernard-Gallon D. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? OMICS. 2012; 16(5): 235–44.
141. National Breast Cancer Coalition. National Breast Cancer Coalition survey reveals that heightened breast cancer awareness has insufficient impact on knowledge. http://www.prnewswire.com/news-releases/national-breast-cancer-coalition-survey-reveals-that-heightened-breast-cancer-awareness-has-insufficient-impact-on-knowledge-58248962.html. 1.10.2007. Haettu 23.3.2015.
142. Colditz G.A., Willett W.C., Hunter D.J. ym. Family history, age, and risk of breast cancer. Prospective data from the Nurses’ Health Study. JAMA. 1993; 270(3): 338–43.
143. Bal A., Verma S., Joshi K. ym. BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression. Virchows Arch. 2012; 461(3): 305–12.
144. Bosviel R., Dumollard E., Déchelotte P., Bignon Y.J. ja Bernard-Gallon D. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? OMICS. 2012; 16(5): 235–44.
145. Magee P.J. ja Rowland I. Soy products in the management of breast cancer. Curr Opin Clin Nutr Metab Care. 2012; 15(6): 586–91.
146. Parkin D.M. ja Fernández L.M. Use of statistics to assess the global burden of breast cancer. Breast J. 2006; 12 Suppl 1: S70–80.
147. Wu A.H. ja Butler L.M. Green tea and breast cancer. Mol Nutr Food Res. 2011; 55(6): 921–30.
148. Korde L.A., Wu A.H., Fears T. ym. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev. 2009; 18(4): 1050–9.
149. Wakchaure G.C. Chapter 3: Production and marketing of mushrooms: Global and national scenario. Teoksessa Singh N., Cijay B., Kamal S. ja Wakchaure GC. (toim.) Mushrooms. Cultivation, Marketing and Consumption. Himachal Pradesh-173213, India: Directorate of Mushroom Research; 2014: 15–22.
150. Zhang M., Huang J., Xie X. ja Holman C.D. Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int J Cancer. 2009; 124(6): 1404–8.
151. Ganz P.A. A teachable moment for oncologists: cancer survivors, 10 million strong and growing! J Clin Oncol. 2005; 23(24): 5458–60.
152. Sama.

12. Kuinka elää kuolematta itsetuhoisaan masennukseen
1. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. National Center for Health Statistics. Deaths: Final Data for 2013, table 18. http://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_02.pdf. Haettu 20.3.2015.
2. Sartorius N. The economic and social burden of depression. J Clin Psychiatry. 2001; 62 Suppl 15: 8–11.
3. Johdanto Maailman terveysjärjestön WHO: n perustusasiakirjaan, joka hyväksyttiin New Yorkissa 19–22.6.1946 pidetyssä International Health Conferencessa, ja sen allekirjoittivat 61 valtion edustajat (Official Records of the World Health Organization, no. 2, p. 100) 22.7.1946 ja se tuli voimaan 7.4.1948.
4. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R. ja Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6): 617–27.
5. Chida Y. ja Steptoe A. Positive psychological well-being and mortality: a quantitative review of prospective observational studies. Psychosom Med. 2008; 70(7): 741–56.
6. Sama.
7. Grant N., Wardle J. ja Steptoe A. The relationship between life satisfaction and health behavior: a cross-cultural analysis of young adults. Int J Behav Med. 2009; 16(3): 259–68.
8. Cohen S., Doyle W.J., Turner R.B., Alper C.M. ja Skoner D.P. Emotional style and susceptibility to the common cold. Psychosom Med. 2003; 65(4): 652–7.
9. Cohen S., Alper C.M., Doyle W.J., Treanor J.J. ja Turner R.B. Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza A virus. Psychosom Med. 2006; 68(6): 809–15.
10. Beezhold B.L., Johnston C.S. ja Daigle D.R. Vegetarian diets are associated with healthy mood states: a cross-sectional study in Seventh Day Adventist adults. Nutr J. 2010; 9: 26.
11. Sama.
12. Knutsen S.F. Lifestyle and the use of health services. Am J Clin Nutr. 1994; 59(5 Suppl): 1171S–1175S.
13. Katso viite 10.
14. Fisher M., Levine P.H., Weiner B. ym. The effect of vegetarian diets on plasma lipid and platelet levels. Arch Intern Med. 1986; 146(6): 1193–7.
15. Institute of Medicine. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. Washington, D.C.: National Academies Press; 2006.
16. Vaz J.S., Kac G., Nardi A.E. ja Hibbeln J.R. Omega-6 fatty acids and greater likelihood of suicide risk and major depression in early pregnancy. J Affect Disord. 2014; 152–154: 76–82.
17. National Cancer Institute. Table 4: Food Sources of Arachidonic Acid. http://appliedresearch.cancer.gov/diet/foodsources/fatty_acids/table4 . html Päivitetty 18.10.2013. Haettu 11.3.2015.
18. Hirota S., Adachi N., Gomyo T., Kawashima H., Kiso Y. ja Kawabata T. Low-dose arachidonic acid intake increases erythrocytes and plasma arachidonic acid in young women. Prostaglandins Leukot Essent Fatty Acids. 2010; 83(2): 83–8.
19. Beezhold B.L., Johnston C.S. ja Daigle D.R. Vegetarian diets are associated with healthy mood states: a cross-sectional study in Seventh Day Adventist adults. Nutr J. 2010; 9: 26.
20. Beezhold B.L. ja Johnston C.S. Restriction of meat, fish, and poultry in omnivores improves mood: a pilot randomized controlled trial. Nutr J. 2012; 11: 9.
21. Beezhold B.L., Johnston C.S. ja Daigle DR. Restriction of flesh foods in omnivores improves mood: a pilot randomized controlled trial. Esitetty Philadelphiassa 7–11.11.2009 pidetyssä American Public Health Associationin vuosittaisessa konferenssissa.
22. Katcher H.I., Ferdowsian H.R., Hoover V.J., Cohen J.L. ja Barnard N.D. A worksite vegan nutrition program is well-accepted and improves health-related quality of life and work productivity. Ann Nutr Metab. 2010; 56(4): 245–52.
23. Sama.
24. Mishra S., Xu J., Agarwal U., Gonzales J., Levin S. ja Barnard N.D. A multicenter randomized controlled trial of a plant-based nutrition program to reduce body weight and cardiovascular risk in the corporate setting: the GEICO study. Eur J Clin Nutr. 2013; 67(7): 718–24.
25. Agarwal U., Mishra S., Xu J., Levin S., Gonzales J. ja Barnard N.D. A multicenter randomized controlled trial of a nutrition intervention program in a multiethnic adult population in the corporate setting reduces depression and anxiety and improves quality of life: The GEICO Study. Am J Health Promot. 2015; 29(4): 245–54.
26. Tsai A.C., Chang T-L. ja Chi S-H. Frequent consumption of vegetables predicts lower risk of depression in older Taiwanese—results of a prospective population-based study. Public Health Nutr. 2012; 15(6): 1087–92.
27. Gomez-Pinilla F. ja Nguyen T.T.J. Natural mood foods: the actions of polyphenols against psychiatric and cognitive disorders. Nutr Neurosci. 2012; 15(3): 127–33.
28. Meyer J.H., Ginovart N., Boovariwala A. ym. Elevated monoamine oxidase A levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry. 2006; 63(11): 1209–16.
29. de Villiers J.C. Intracranial haemorrhage in patients treated with monoamineoxidase inhibitors. Br J Psychiatry. 1966; 112(483): 109–18.
30. Dixon Clarke S.E. ja Ramsay R.R. Dietary inhibitors of monoamine oxidase A. J Neural Transm. 2011; 118(7): 1031–41.
31. Lai J.S., Hiles S., Bisquera A., Hure A.J., McEvoy M. ja Attia J. A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults. Am J Clin Nutr. 2014; 99(1): 181–97.
32. White B.A., Horwath C.C. ja Conner T.S. Many apples a day keep the blues away—daily experiences of negative and positive affect and food consumption in young adults. Br J Health Psychol. 2013; 18(4): 782–98.
33. Odjakova M. ja Hadjiivanova C. Animal neurotransmitter substances in plants. Bulg J Plant Physiol. 1997; 23: 94–102.
34. Ghirri A., Cannella C. ja Bignetti E. The psychoactive effects of aromatic amino acids. Curr Nutr Food Science. 2011; 7(1): 21–32.
35. Allen J.A., Peterson A., Sufit R. ym. Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthritis Rheum. 2011; 63(11): 3633–9.
36. Fernstrom J.D. ja Faller D.V. Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem. 1978; 30(6): 1531–8.
37. Wurtman R.J., Wurtman J.J., Regan M.M., McDermott J.M., Tsay R.H. ja Breu J.J. Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios. Am J Clin Nutr. 2003; 77(1): 128–32.
38. Wurtman J.J., Brzezinski A., Wurtman R.J. ja Laferrere B. Effect of nutrient intake on premenstrual depression. Am J Obstet Gynecol. 1989; 161(5): 1228–34.
39. Brinkworth G.D., Buckley J.D., Noakes M., Clifton P.M. ja Wilson C.J. Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function. Arch Intern Med. 2009; 169(20): 1873–80.
40. Fernstrom J.D. ja Wurtman R.J. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science. 1972; 178(4059): 414–6.
41. Hudson C., Hudson S. ja MacKenzie J. Protein-source tryptophan as an efficacious treatment for social anxiety disorder: a pilot study. Can J Physiol Pharmacol. 2007; 85(9): 928–32.
42. Schweiger U., Laessle R., Kittl S., Dickhaut B., Schweiger M. ja Pirke K.M. Macronutrient intake, plasma large neutral amino acids and mood during weight-reducing diets. J Neural Transm. 1986; 67(1–2): 77–86.
43. Ferrence S.C. ja Bendersky G. Therapy with saffron and the goddess at Thera. Perspect Biol Med. 2004; 47(2): 199–226.
44. Noorbala A.A., Akhondzadeh S., Tahmacebi-Pour N. ja Jamshidi A.H. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a doubleblind, randomized pilot trial. J Ethnopharmacol. 2005; 97(2): 281–4.
45. Gohari A.R., Saeidnia S. ja Mahmoodabadi M.K. An overview on saffron, phytochemicals, and medicinal properties. Pharmacogn Rev. 2013; 7(13): 61–6.
46. Fukui H., Toyoshima K. ja Komaki R. Psychological and neuroendocrinological effects of odor of saffron (Crocus sativus). Phytomedicine. 2011; 18(8–9): 726–30.
47. Lucas M., O’Reilly E.J., Pan A. ym. Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults. World J Biol Psychiatry. 2014; 15(5): 377–86.
48. Klatsky A.L. ja Armstrong M.A, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol. 1993; 3(4): 375–81.
49. Tanskanen A., Tuomilehto J., Viinamäki H., Vartiainen E., Lehtonen J. ja Puska P. Heavy coffee drinking and the risk of suicide. Eur J Epidemiol. 2000; 16(9): 789–91.
50. Guo X., Park Y., Freedman N.D. ym. Sweetened beverages, coffee, and tea and depression risk among older US adults. PLoS One. 2014; 9(4): e94715.
51. Maher T.J. ja Wurtman R.J. Possible neurologic effects of aspartame, a widely used food additive. Environ Health Perspect. 1987; 75: 53–7.
52. Walton R.G., Hudak R. ja Green-Waite R.J. Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population. Biol Psychiatry. 1993; 34(1–2): 13–7.
53. Lindseth G.N., Coolahan S.E., Petros T.V. ja Lindseth P.D. Neurobehavioral effects of aspartame consumption. Res Nurs Health. 2014; 37(3): 185–93.
54. Yhdysvaltojen elintarvike- ja lääkevirasto. Aspartame: Commissioner’s final decision. Fed Reg. 1981; 46: 38285–308.
55. Lindseth G.N., Coolahan S.E., Petros T.V. ja Lindseth P.D. Neurobehavioral effects of aspartame consumption. Res Nurs Health. 2014; 37(3): 185–93.
56. Whitehouse C.R., Boullata J. ja McCauley L.A. The potential toxicity of artificial sweeteners. AAOHN J. 2008; 56(6): 251–9.
57. Aspartame Information Center: Consumer Products. Aspartame-yhdistyksen verkkojulkaisu. http://www.aspartame.org/about/consumer-products/#.VF_cyr74tSU. Päivitetty 2015. Haettu 11.3.2015.
58. Whitehouse C.R., Boullata J. ja McCauley L.A. The potential toxicity of artificial sweeteners. AAOHN J. 2008; 56(6): 251–9.
59. Yeung R.R. The acute effects of exercise on mood state. J Psychosom Res. 1996; 40(2): 123–41.
60. Goodwin R.D. Association between physical activity and mental disorders among adults in the United States. Prev Med. 2003; 36(6): 698–703.
61. Blumenthal J.A., Babyak M.A., Moore K.A. ym. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999; 159(19): 2349–56.
62. Blumenthal J.A., Babyak M.A., Doraiswamy P.M. ym. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007; 69(7): 587–96.
63. Pandya C.D., Howell K.R. ja Pillai A. Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 46: 214–23.
64. Michel T.M., Pülschen D. ja Thome J. The role of oxidative stress in depressive disorders. Curr Pharm Des. 2012; 18(36): 5890–9.
65. McMartin S.E., Jacka F.N. ja Colman I. The association between fruit and vegetable consumption and mental health disorders: evidence from five waves of a national survey of Canadians. Prev Med. 2013; 56(3–4): 225–30.
66. Beydoun M.A., Beydoun H.A., Boueiz A., Shroff M.R. ja Zonderman A.B. Antioxidant status and its association with elevated depressive symptoms among US adults: National Health and Nutrition Examination Surveys 2005–6. Br J Nutr. 2013; 109(9): 1714–29.
67. Niu K., Guo H., Kakizaki M. ym. A tomato-rich diet is related to depressive symptoms among an elderly population aged 70 years and over: a population-based, cross- sectional analysis. J Affect Disord. 2013; 144(1–2): 165–70.
68. Payne M.E., Steck S.E., George R.R. ja Steffens D.C. Fruit, vegetable, and antioxidant intakes are lower in older adults with depression. J Acad Nutr Diet. 2012; 112(12): 2022–7.
69. Gilbody S., Lightfoot T. ja Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health. 2007; 61(7): 631–7.
70. Tolmunen T., Hintikka J., Ruusunen A. ym. Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother Psychosom. 2004; 73(6): 334–9.
71. Sharpley A.L., Hockney R., McPeake L., Geddes J.R. ja Cowen P.J. Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trial. J Affect Disord. 2014; 167: 306–11.
72. Penn E. ja Tracy D.K. The drugs don’t work? Antidepressants and the current and future pharmacological management of depression. Ther Adv Psychopharmacol. 2012; 2(5): 179–88.
73. Turner E.H., Matthews A.M., Linardatos E., Tell R.A. ja Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008; 358(3): 252–60.
74. Kirsch I. Antidepressants and the placebo effect. Z Psychol. 2014; 222(3): 128–34.
75. Kirsch I. Antidepressants and the placebo response. Epidemiol Psichiatr Soc. 2009; 18(4): 318–22.
76. Spence D. Are antidepressants overprescribed? Yes. BMJ. 2013; 346: f191.
77. Sugarman M.A., Loree A.M., Baltes B.B., Grekin E.R. ja Kirsch I. The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales. PLoS ONE. 2014; 9(8): e106337.
78. Katso viite 74.
79. Blease C. Deception as treatment: the case of depression. J Med Ethics. 2011; 37(1): 13–6.
80. Katso viite 74.
81. Sama.

13. Kuinka elää kuolematta eturauhassyöpään
1. Jahn J.L., Giovannucci E.L. ja Stampfer M.J. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era. Int J Cancer. 2014; Dec 29.
2. Draisma G., Etzioni R., Tsodikov A. ym. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst. 2009; 101(6): 374–83.
3. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Eturauhassyöpätilastot. http://www.cdc.gov/cancer/prostate/statistics/index.htm. Päivitetty 2.9.2014. Haettu 11.3.2015.
4. Maruyama K., Oshima T. ja Ohyama K. Exposure to exogenous estrogen through intake of commercial milk produced from pregnant cows. Pediatr Int. 2010; 52(1): 33–8.
5. Danby F.W. Acne and milk, the diet myth, and beyond. J Am Acad Dermatol. 2005; 52(2): 360–2.
6. Afeiche M., Williams P.L., Mendiola J. ym. Dairy food intake in relation to semen quality and reproductive hormone levels among physically active young men. Hum Reprod. 2013; 28(8): 2265–75.
7. Katso viite 4.
8. Steinman G. Mechanisms of twinning: VII. Effect of diet and heredity on the human twinning rate. J Reprod Med. 2006; 51(5): 405–10.
9. Melnik B.C., John S.M. ja Schmitz G. Milk is not just food but most likely a genetic transfection system activating mTORC1 signaling for postnatal growth. Nutr J. 2013; 12: 103.
10. Ludwig D.S. ja Willett W.C. Three daily servings of reduced-fat milk: an evidence-based recommendation? JAMA Pediatr. 2013; 167(9): 788–9.
11. Sama.
12. Tate P.L., Bibb R. ja Larcom L.L. Milk stimulates growth of prostate cancer cells in culture. Nutr Cancer. 2011; 63(8): 1361–6.
13. Ganmaa D., Li X.M., Qin L.Q., Wang P.Y., Takeda M. ja Sato A. The experience of Japan as a clue to the etiology of testicular and prostatic cancers. Med Hypotheses. 2003; 60(5): 724–30.
14. Ganmaa D., Li X.M., Wang J., Qin L.Q., Wang P.Y. ja Sato A. Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices. Int J Cancer. 2002; 98(2): 262–7.
15. Epstein S.S. Unlabeled milk from cows treated with biosynthetic growth hormones: a case of regulatory abdication. Int J Health Serv. 1996; 26(1): 173–85.
16. Katso viite 12.
17. Qin L.Q., Xu J.Y., Wang P.Y., Kaneko T., Hoshi K. ja Sato A. Milk consumption is a risk factor for prostate cancer: meta-analysis of case-control studies. Nutr Cancer. 2004; 48(1): 22–7.
18. Qin L.Q., Xu J.Y., Wang P.Y., Tong J. ja Hoshi K. Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. Asia Pac J Clin Nutr. 2007; 16(3): 467–76.
19. Aune D., Navarro Rosenblatt D.A., Chan D.S. ym. Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies. Am J Clin Nutr. 2015; 101(1): 87–117.
20. Bischoff-Ferrari H.A., Dawson-Hughes B., Baron J.A. ym. Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies. J Bone Miner Res. 2011; 26(4): 833–9.
21. Feskanich D., Bischoff-Ferrari H.A., Frazier A.L. ja Willett W.C. Milk consumption during teenage years and risk of hip fractures in older adults. JAMA Pediatr. 2014; 168(1): 54–60.
22. Michaëlsson K., Wolk A., Langenskiöld S. ym. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014; 349: g6015.
23. Batey L.A., Welt C.K., Rohr F. ym. Skeletal health in adult patients with classic galactosemia. Osteoporos Int. 2013; 24(2): 501–9.
24. Katso viite 22.
25. Cui X., Wang L., Zuo P. ym. D-galactose-caused life shortening in Drosophila melanogaster and Musca domestica is associated with oxidative stress. Biogerontology. 2004; 5(5): 317–25.
26. Cui X., Zuo P., Zhang Q. ym. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res. 2006; 84(3): 647–54.
27. Katso viite 22.
28. Sama.
29. Sama.
30. Sama.
31. Schooling C.M. Milk and mortality. BMJ. 2014; 349: g6205.
32. Richman E.L., Stampfer M.J., Paciorek A., Broering J.M., Carroll P.R. ja Chan J.M. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010; 91(3): 712–21.
33. Sama.
34. Sama.
35. Sama.
36. Johansson M., Van Guelpen B., Vollset S.E. ym. One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites. Cancer Epidemiol Biomarkers Prev. 2009; 18(5): 1538–43.
37. Katso viite 32.
38. Richman E.L., Kenfield S.A., Stampfer M.J. ym. Choline intake and risk of lethal prostate cancer: incidence and survival. Am J Clin Nutr. 2012; 96(4): 855–63.
39. Richman E.L., Kenfield S.A., Stampfer M.J., Giovannucci E.L. ja Chan J.M. Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival. Cancer Prev Res (Phila). 2011; 4(12): 2110–21.
40. Tang W.H., Wang Z. ja Levison B.S. ym. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013; 368(17): 1575–84.
41. Koeth R.A., Wang Z., Levison B.S. ym. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013; 19: 576–85.
42. Katso viite 40.
43. Choline: there’s something fishy about this vitamin. Harv Health Lett. 2004; 30(1): 3.
44. Mitch Kanter (Ph.D.), sähköpostiviestintä, 6.1.2010.
45. Hubbard J.D., Inkeles S. ja Barnard R.J. Nathan Pritikin’s heart. N Engl J Med. 1985; 313(1): 52.
46. Ornish D., Weidner G., Fair W.R. ym. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005; 174(3): 1065–9.
47. Sama.
48. Barnard R.J., Gonzalez J.H., Liva M.E. ja Ngo T.H. Effects of a low-fat, high-fiber diet and exercise program on breast cancer risk factors in vivo and tumor cell growth and apoptosis in vitro. Nutr Cancer. 2006; 55(1): 28–34.
49. Barnard R.J., Ngo T.H., Leung P.S., Aronson W.J. ja Golding L.A. A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate. 2003; 56(3): 201–6.
50. Sama.
51. Sama.
52. Katso viite 46.
53. Sama.
54. Ornish D., Magbanua M.J., Weidner G. ym. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA. 2008; 105(24): 8369–74.
55. Frattaroli J., Weidner G., Dnistrian A.M. ym. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology. 2008; 72(6): 1319–23.
56. Frey A.U., Sønksen J. ja Fode M. Neglected side effects after radical prostatectomy: a systematic review. J Sex Med. 2014; 11(2): 374–85.
57. Carmody J.F., Olendzki B.C., Merriam P.A., Liu Q., Qiao Y. ja Ma Y. A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training. J Acad Nutr Diet. 2012; 112(11): 1822–7.
58. Blanchard C.M., Courneya K.S. ja Stein K. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol. 2008; 26(13): 2198–204.
59. Carmody J.F., Olendzki B.C., Merriam P.A., Liu Q., Qiao Y. ja Ma Y. A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training. J Acad Nutr Diet. 2012; 112(11): 1822–7.
60. Sama.
61. Sama.
62. Richman E.L., Stampfer M.J., Paciorek A., Broering J.M., Carroll P.R. ja Chan J.M. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010; 91(3): 712–21.
63. Richman E.L., Carroll P.R. ja Chan J.M. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer. 2012; 131(1): 201–10.
64. Allen N.E., Appleby P.N., Key T.J. ym. Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition. Int J Cancer. 2013; 132(3): 635–44.
65. Morton M.S., Chan P.S., Cheng C. ym. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate. 1997; 32(2): 122–8.
66. van Die M.D., Bone K.M., Williams S.G. ja Pirotta M.V. Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials. BJU Int. 2014; 113(5b): E119–30.
67. Katso viite 65.
68. Lin X., Switzer B.R. ja Demark-Wahnefried W. Effect of mammalian lignans on the growth of prostate cancer cell lines. Anticancer Res. 2001; 21(6A): 3995–9.
69. Demark-Wahnefried W., Price D.T., Polascik T.J. ym. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology. 2001; 58(1): 47–52.
70. Leite K.R., Camara-Lopes L.H., Cury J., Dall’oglio M.F., Sañudo A. ja Srougi M. Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy. Clinics (Sao Paulo). 2008; 63(3): 339–42.
71. Demark-Wahnefried W., Robertson C.N., Walther P.J., Polascik T.J., Paulson D.F. ja Vollmer R.T. Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology. 2004; 63(5): 900–4.
72. Demark-Wahnefried W., Polascik T.J., George S.L. ym. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev. 2008; 17(12): 3577–87.
73. Wei J.T., Calhoun E. ja Jacobsen S.J. Urologic Diseases in America Project: benign prostatic hyperplasia. J Urol. 2008; 179(5 Suppl): S75–80.
74. Burnett A.L. ja Wein A.J. Benign prostatic hyperplasia in primary care: what you need to know. J Urol. 2006; 175(3 Pt 2): S19–24.
75. Taub D.A. ja Wei J.T. The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States. Curr Urol Rep. 2006; 7(4): 272–81.
76. Metcalfe C. ja Poon K.S. Long-term results of surgical techniques and procedures in men with benign prostatic hyperplasia. Curr Urol Rep. 2011; 12(4): 265–73.
77. Katso viite 74.
78. Sama.
79. Gu F. Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China. Chin Med J. 2000; 113(4): 299–302.
80. Barnard R.J., Kobayashi N. ja Aronson W.J. Effect of diet and exercise intervention on the growth of prostate epithelial cells. Prostate Cancer Prostatic Dis. 2008; 11(4): 362–6.
81. Zhang W., Wang X., Liu Y. ym. Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia. J Med Food. 2008; 11(2): 207–14.
82. Galeone C., Pelucchi C., Talamini R. ym. Onion and garlic intake and the odds of benign prostatic hyperplasia. Urology. 2007; 70(4): 672–6.
83. Bravi F., Bosetti C., Dal Maso L. ym. Food groups and risk of benign prostatic hyperplasia. Urology. 2006; 67(1): 73–9.
84. Zhou Z., Wang Z., Chen C. ym. Transurethral prostate vaporization using an oval electrode in 82 cases of benign prostatic hyperplasia. Chin Med J. 1998; 111(1): 52–5.
85. Piantanelli L. Cancer and aging: from the kinetics of biological parameters to the kinetics of cancer incidence and mortality. Ann N Y Acad Sci. 1988; 521: 99–109.
86. Salvioli S., Capri M., Bucci L. ym. Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. Cancer Immunol Immunother. 2009; 58(12): 1909–17.
87. Reed J.C. Dysregulation of apoptosis in cancer. J Clin Oncol. 1999; 17(9): 2941–53.
88. Rowlands M.A., Gunnell D., Harris R., Vatten L.J., Holly J.M. ja Martin R.M. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer. 2009; 124(10): 2416–29.
89. Guevara-Aguirre J., Balasubramanian P., Guevara-Aguirre M. ym. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011; 3(70): 70ra13.
90. Allen N.E., Appleby P.N., Davey G.K., Kaaks R., Rinaldi S. ja Key T.J. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev. 2002; 11(11): 1441–8.
91. Soliman S., Aronson W.J. ja Barnard R.J. Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention. Evid Based Complement Alternat Med. 2011; 2011: 529053.
92. Ngo T.H., Barnard R.J., Tymchuk C.N., Cohen P. ja Aronson W.J. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control. 2002; 13(10): 929–35.
93. Allen N.E., Appleby P.N., Davey G.K. ja Key T.J. Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer. 2000; 83(1): 95–7.
94. Katso viite 90.

14. Kuinka elää kuolematta Parkinsonin tautiin
1. Jafari S., Etminan M., Aminzadeh F. ja Samii A. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord. 2013; 28(9): 1222–9.
2. National Cancer Institute. President’s Cancer Panel. Reducing environmental cancer risk: what we can do now. http://deainfo.nci.nih.gov/advisory/pcp/annualReports/pcp08-09rpt/PCP_Report_08-09_508.pdf. 4.2010. Haettu 12.3.2015.
3. Zeliger H.I. Exposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseases. Interdiscip Toxicol. 2013; 6(3): 103–10.
4. Woodruff T.J., Zota A.R. ja Schwartz J.M. Environmental chemicals in pregnant women in the
United States: NHANES 2003–2004. Environ Health Perspect. 2011; 119(6): 878–85.
5. Sama.
6. Mariscal-Arcas M., Lopez-Martinez C., Granada A., Olea N., Lorenzo-Tovar M.L. ja Olea-Serrano F. Organochlorine pesticides in umbilical cord blood serum of women from Southern Spain and adherence to the Mediterranean diet. Food Chem Toxicol. 2010; 48(5): 1311–5.
7. Bjermo H., Darnerud P.O., Lignell S. ym. Fish intake and breastfeeding time are associated with serum concentrations of organochlorines in a Swedish population. Environ Int. 2013; 51: 88–96.
8. Glynn A., Larsdotter M., Aune M., Darnerud P.O., Bjerselius R., ja Bergman A. Changes in serum concentrations of polychlorinated biphenyls (PCBs), hydroxylated PCB metabolites and pentachlorophenol during pregnancy. Chemosphere. 2011; 83(2): 144–51.
9. Soechitram S.D., Athanasiadou M., Hovander L., Bergman A. ja Sauer P.J. Fetal exposure to PCBs and their hydroxylated metabolites in a Dutch cohort. Environ Health Perspect. 2004; 112(11): 1208–12.
10. Ulaszewska M.M., Zuccato E. ja Davoli E. PCDD/Fs and dioxin-like PCBs in human milk and estimation of infants’ daily intake: a review. Chemosphere. 2011; 83(6): 774–82.
11. Gallo M.V., Schell L.M., Decaprio A.P. ja Jacobs A. Levels of persistent organic pollutant and their predictors among young adults. Chemosphere. 2011; 83(10): 1374–82.
12. Katso viite 10.
13. Aliyu M.H., Alio A.P. ja Salihu H.M. To breastfeed or not to breastfeed: a review of the impact of lactational exposure to polychlorinated biphenyls (PCBs) on infants. J Environ Health. 2010; 73(3): 8–14.
14. Vogt R., Bennett D., Cassady D., Frost J., Ritz B. ja Hertz-Picciotto I. Cancer and non-cancer health effects from food contaminant exposures for children and adults in California: a risk assessment. Environ Health. 2012; 11: 83.
15. Vogt R., Bennett D., Cassady D., Frost J., Ritz B. ja Hertz-Picciotto I. Cancer and non-cancer health effects from food contaminant exposures for children and adults in California: a risk assessment. Environ Health. 2012; 11: Table S3. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551655/bin/1476-069X-11-83-S3.doc. Haettu 28.3.2015.
16. Katso viite 14.
17. Dórea J.G., Bezerra V.L., Fajon V. ja Horvat M. Speciation of methyl- and ethyl-mercury in hair of breastfed infants acutely exposed to thimerosal-containing vaccines. Clin Chim Acta. 2011; 412(17–18): 1563–6.
18. Zeilmaker M.J., Hoekstra J., van Eijkeren J.C. ym. Fish consumption during child bearing age: a quantitative risk-benefit analysis on neurodevelopment. Food Chem Toxicol. 2013; 54: 30–4.
19. Fromberg A., Granby K., Højgård A., Fagt S. ja Larsen J.C. Estimation of dietary intake of PCB and organochlorine pesticides for children and adults. Food Chem. 2011; 125: 1179–87.
20. European Food Safety Authority. Results of the monitoring of non dioxin-like PCBs in food and feed. EFSA Journal. 2010; 8(7): 1701.
21. Katso viite 19.
22. Zhang T., Sun H.W., Wu Q., Zhang X.Z., Yun S.H. ja Kannan K. Perfluorochemicals in meat, eggs and indoor dust in China: assessment of sources and pathways of human exposure to perfluorochemicals. Environ Sci Technol. 2010; 44(9): 3572–9.
23. Schecter A., Cramer P., Boggess K. ym. Intake of dioxins and related compounds from food in the U.S. population. J Toxicol Environ Health Part A. 2001; 63(1): 1–18.
24. Aune D., De Stefani E., Ronco A.L. ym. Egg consumption and the risk of cancer: a multisite case-control study in Uruguay. Asian Pac J Cancer Prev. 2009; 10(5): 869–76.
25. Yaginuma-Sakurai K., Murata K., Iwai-Shimada M. ym. Hair-to-blood ratio and biological halflife of mercury: experimental study of methylmercury exposure through fish consumption in humans. J Toxicol Sci. 2012; 37(1): 123–30.
26. Wimmerová S., Lancz K., Tihányi J. ym. Half-lives of serum PCB congener concentrations in environmentally exposed early adolescents. Chemosphere. 2011; 82(5): 687–91.
27. Hageman K.J., Hafner W.D., Campbell D.H., Jaffe D.A., Landers D.H. ja Simonich S.L. Variability in pesticide deposition and source contributions to snowpack in Western U.S. national parks. Environ Sci Technol. 2010; 44(12): 4452–8.
28. Schecter A., Startin J., Wright C. ym. Congener-specific levels of dioxins and dibenzofurans in U.S. food and estimated daily dioxin toxic equivalent intake. Environ Health Perspect. 1994; 102(11): 962–6.
29. Fiedler H., Cooper K.R., Bergek S., Hjelt M. ja Rappe C. Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans (PCDD/PCDF) in food samples collected in southern Mississippi, USA. Chemosphere. 1997; 34(5–7): 1411–9.
30. Rappe C., Bergek S., Fiedler H. ja Cooper K.R. PCDD and PCDF contamination in catfish feed from Arkansas, USA. Chemosphere. 1998; 36(13): 2705–20.
31. Ferrario J.B., Byrne C.J. ja Cleverly D.H. 2,3,7,8-Dibenzo-p-dioxins in mined clay products from the United States: evidence for possible natural origin. Environ Sci Technol. 2000; 34(21): 4524–32.
32. US Department of Commerce. Broiler, turkey, and egg production: 1980 to 1999, No. 1143,p. 684. In Statistical Abstract of the United States, 2000. Washington, D.C.: Government Printing Office, 2000.
33. Hayward D.G., Nortrup D., Gardner A. ja Clower M. Elevated TCDD in chicken eggs and farmraised catfish fed a diet with ball clay from a Southern United States mine. Environ Res. 1999; 81(3): 248–56.
34. Sama.
35. Yhdysvaltojen elintarvike- ja lääkevirasto. Linda Tollefsonin kirje savea sisältävän eläinrehun tuottajille tai käyttäjille. https://web.archive.org/web/20081107120600/http://www.fda.gov/cvm/Documents/ballclay.pdf. 7.10.1997. Haettu 12.3.2015.
36. Hanson T. ja Sites D. 2012 US catfish database. Fisheries and Allied Aquacultures Department Series No. 6. http://aurora.auburn.edu/repo/bitstream/handle/11200/44174/2012%20Catfish%20Database.pdf ?sequence= 1. 3. 2013. Haettu 26.3.2015.
37. Huwe J.K. ja Archer J.C. Dioxin congener patterns in commercial catfish from the United States and the indication of mineral clays as the potential source. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2013; 30(2): 331–8.
38. Rappe C., Bergek S., Fiedler H. ja Cooper K.R. PCDD and PCDF contamination in catfish feed from Arkansas, USA. Chemosphere. 1998; 36(13): 2705–20.
39. Yaktine A.L., Harrison G.G. ja Lawrence R.S. Reducing exposure to dioxins and related compounds through foods in the next generation. Nutr Rev. 2006; 64(9): 403–9.
40. Schecter A., Startin J., Wright C. ym. Congener-specific levels of dioxins and dibenzofurans in U.S. food and estimated daily dioxin toxic equivalent intake. Environ Health Perspect. 1994; 102(11): 962–6.
41. Yhdysvaltojen terveys- ja sosiaalipalveluministeriö. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
42. Lee P.N. 1979 Surgeon General’s Report. http://legacy.library.ucsf.edu/tid/zkl36b00/pdf?search=%221979%20surgeon%20general%20s%20report%20lee%22. 2.9.1979. Haettu 12.3.2015.
43. Sama.
44. Tupakointikieltoa Yhdysvaltojen hallintorakennuksissa koskevat käsittelyt. http://legacy.library.ucsf.edu/tid/fzt08h00/pdf?search=%22to%20prohibit%20smoking%20in%20federal%20buildings%20hearings%20jd%20047710%22. 11.3.1993; 22.4.1993. Haettu 12.3.2015.
45. Noyce A.J., Bestwick J.P., Silveira-Moriyama L. ym. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012; 72(6): 893–901.
46. Morens D.M., Grandinetti A., Davis J.W., Ross G.W., White L.R. ja Reed D. Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease. Am J Epidemiol. 1996; 144(4): 400–4.
47. Katso viite 45.
48. Allam M.F., Campbell M.J., Del Castillo A.S. ja Fernández-Crehuet Navajas R. Parkinson’s disease protects against smoking? Behav Neurol. 2004; 15(3–4): 65–71.
49. Tanner C.M., Goldman S.M., Aston D.A. ym. Smoking and Parkinson’s disease in twins. Neurology. 2002; 58(4): 581–8.
50. O’Reilly E.J., Chen H., Gardener H., Gao X., Schwarzschild M.A. ja Ascherio A. Smoking and Parkinson’s disease: using parental smoking as a proxy to explore causality. Am J Epidemiol. 2009; 169(6): 678–82.
51. Yhdysvaltojen terveys- ja sosiaalipalveluministeriö. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
52. Wolf P.A., D’Agostino R.B., Kannel W.B., Bonita R. ja Belanger A.J. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA. 1988; 259(7): 1025–9.
53. Quik M., Perez X.A. ja Bordia T. Nicotine as a potential neuroprotective agent for Parkinson’s disease. Mov Disord. 2012; 27(8): 947–57.
54. Siegmund B., Leitner E. ja Pfannhauser W. Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. J Agric Food Chem. 1999; 47(8): 3113–20.
55. Brody A.L., Mandelkern M.A., London E.D. ym. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry. 2006; 63(8): 907–15.
56. Searles Nielsen S., Gallagher L.G., Lundin J.I. ym. Environmental tobacco smoke and Parkinson’s disease. Mov Disord. 2012; 27(2): 293–6.
57. Katso viite 54.
58. Nielsen S.S., Franklin G.M., Longstreth W.T., Swanson P.D. ja Checkoway H. Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol. 2013; 74(3): 472–7.
59. Sama.
60. Richardson J.R., Shalat S.L., Buckley B. ym. Elevated serum pesticide levels and risk of Parkinson disease. Arch Neurol. 2009; 66(7): 870–5.
61. Corrigan F.M., Wienburg C.L., Shore R.F., Daniel S.E. ja Mann D. Organochlorine insecticides in substantia nigra in Parkinson’s disease. J Toxicol Environ Health Part A. 2000; 59(4): 229–34.
62. Hatcher-Martin J.M., Gearing M., Steenland K., Levey A.I., Miller G.W. ja Pennell K.D. Association between polychlorinated biphenyls and Parkinson’s disease neuropathology. Neurotoxicology. 2012; 33(5): 1298–304.
63. Kanthasamy A.G., Kitazawa M., Kanthasamy A. ja Anantharam V. Dieldrin-induced neurotoxicity: relevance to Parkinson’s disease pathogenesis. Neurotoxicology. 2005; 26(4): 701–19.
64. Arguin H., Sánchez M., Bray G.A. ym. Impact of adopting a vegan diet or an olestra supplementation on plasma organochlorine concentrations: results from two pilot studies. Br J Nutr. 2010; 103(10): 1433–41.
65. Jiang W., Ju C., Jiang H. ja Zhang D. Dairy foods intake and risk of Parkinson’s disease: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2014; 29(9): 613–9.
66. Park M., Ross G.W., Petrovitch H. ym. Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology. 2005; 64(6): 1047–51.
67. Kotake Y., Yoshida M., Ogawa M., Tasaki Y., Hirobe M. ja Ohta S. Chronic administration of 1-benzyl-1,2,3,4- tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate. Neurosci Lett. 1996; 217(1): 69–71.
68. Niwa T., Yoshizumi H., Takeda N., Tatematsu A., Matsuura S. ja Nagatsu T. Detection of tetrahy-droisoquinoline, a parkinsonism-related compound, in parkinsonian brains and foods by gas chromatography-mass spectrometry. Advances in Behavioral Biology. 1990; 38A: 313–6.
69. Niwa T., Yoshizumi H., Tatematsu A., Matsuura S. ja Nagatsu T. Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods. J Chromatogr. 1989; 493(2): 347–52.
70. Niwa T., Takeda N., Kaneda N., Hashizume Y. ja Nagatsu T. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains. Biochem Biophys Res Commun. 1987; 144(2): 1084–9.
71. Ułamek-Kozioł M., Bogucka-Kocka A., Kocki J. ja Pluta R. Good and bad sides of diet in Parkinson’s disease. Nutrition. 2013; 29(2): 474–5.
72. Sama.
73. Kistner A. ja Krack P. Parkinson’s disease: no milk today? Front Neurol. 2014; 5: 172.
74. Chen H., Zhang S.M., Hernn M.A., Willett W.C. ja Ascherio A. Diet and Parkinson’s disease: a potential role of dairy products in men. Ann Neurol. 2002; 52(6): 793–801.
75. Jiang W., Ju C., Jiang H. ja Zhang D. Dairy foods intake and risk of Parkinson’s disease: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2014; 29(9): 613–9.
76. Michaëlsson K., Wolk A., Langenskiöld S. ym. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014; 349: g6015.
77. Ridel K.R., Leslie N.D. ja Gilbert D.L. An updated review of the long-term neurological effects of galactosemia. Pediatr Neurol. 2005; 33(3): 153–61.
78. Marder K., Gu Y., Eberly S. ym. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol. 2013; 70(11): 1382–8.
79. Ames B.N., Cathcart R., Schwiers E. ja Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA. 1981; 78(11): 6858–62.
80. Duan W., Ladenheim B., Cutler R.G., Kruman I.I., Cadet J.L. ja Mattson M.P. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson’s disease. J Neurochem. 2002; 80(1): 101–10.
81. Auinger P., Kieburtz K. ja McDermott MP. The relationship between uric acid levels and Huntington’s disease progression. Mov Disord. 2010; 25(2): 224–8.
82. Schwarzschild M.A., Schwid S.R., Marek K. ym. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol. 2008; 65(6): 716–23.
83. Shen C., Guo Y., Luo W., Lin C. ja Ding M. Serum urate and the risk of Parkinson’s disease: results from a meta-analysis. Can J Neurol Sci. 2013; 40(1): 73–9.
84. Fang P., Li X., Luo J.J., Wang H. ja Yang X. A double-edged sword: uric acid and neurological disorders. Brain Disord Ther. 2013; 2(2): 109.
85. Kutzing M.K. ja Firestein B.L. Altered uric acid levels and disease states. J Pharmacol Exp Ther. 2008; 324(1): 1–7.
86. Schmidt J.A., Crowe F.L., Appleby P.N., Key T.J. ja Travis R.C. Serum uric acid concentrations in meat eaters, fish eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort. PLoS ONE. 2013; 8(2): e56339.
87. Kuo C.F., See L.C., Yu K.H., Chou I.J., Chiou M.J. ja Luo S.F. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford). 2013; 52(1): 127–34.
88. Arguin H., Sánchez M., Bray G.A. ym. Impact of adopting a vegan diet or an olestra supplementation on plasma organochlorine concentrations: results from two pilot studies. Br J Nutr. 2010; 103(10): 1433–41.
89. Siddiqui M.K., Saxena M.C. ja Krishna Murti C.R. Storage of DDT and BHC in adipose tissue of Indian males. Int J Environ Anal Chem. 1981; 10(3–4): 197–204.
90. Norén K. Levels of organochlorine contaminants in human milk in relation to the dietary habits of the mothers. Acta Paediatr Scand. 1983; 72(6): 811–6.
91. Schecter A. ja Papke O. Comparison of blood dioxin, dibenzofuran and coplanar PCB levels in strict vegetarians (vegans) and the general United States population. Org Comps. 1998; 38: 179–82.
92. Schecter A., Harris T.R., Päpke O. ja Tunga K.C, Musumba A. Polybrominated diphenyl ether (PBDE) levels in the blood of pure vegetarians (vegans). Tox Env Chem. 2006; 88(1): 107–12.
93. Eskenazi B., Chevrier J., Rauch S.A. ym. In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study. Environ Health Perspect.
2013; 121(2): 257–62.
94. Schecter A., Päpke O., Harris T.R. ym. Polybrominated diphenyl ether (PBDE) levels in an expanded market basket survey of U.S. food and estimated PBDE dietary intake by age and sex. Environ Health Perspect. 2006; 114(10): 1515–20.
95. Fraser A.J., Webster T.F. ja McClean M.D. Diet contributes significantly to the body burden of PBDEs in the general U.S. population. Environ Health Perspect. 2009; 117(10): 1520–5.
96. Katso viite 92.
97. Huwe J.K. ja West M. Polybrominated diphenyl ethers in U.S. meat and poultry from two statistically designed surveys showing trends and levels from 2002 to 2008. J Agric Food Chem. 2011; 59(10): 5428–34.
98. Dickman M.D., Leung C.K. ja Leong M.K. Hong Kong male subfertility links to mercury in human hair and fish. Sci Total Environ. 1998; 214: 165–74.
99. Srikumar T.S., Johansson G.K., Ockerman P.A., Gustafsson J.A. ja Akesson B. Trace element status in healthy subjects switching from a mixed to a lactovegetarian diet for 12 mo. Am J Clin Nutr. 1992; 55(4): 885–90.
100. Wimmerová S., Lancz K., Tihányi J. ym. Half-lives of serum PCB congener concentrations in environmentally exposed early adolescents. Chemosphere. 2011; 82(5): 687–91.
101. Parkinson J. An Essay on the Shaking Palsy. London: Whittingham and Rowland for Sherwood, Neely and Jones, 1817: 7.
102. Abbott R.D., Petrovitch H., White L.R. ym. Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology. 2001; 57(3): 456–62.
103. Ueki A. ja Otsuka M. Life style risks of Parkinson’s disease: association between decreased water intake and constipation. J Neurol. 2004; 251 Suppl 7: vII18–23.
104. Gao X., Chen H., Schwarzschild M.A. ja Ascherio A. A prospective study of bowel movement frequency and risk of Parkinson’s disease. Am J Epidemiol. 2011; 174(5): 546–51.
105. Kamel F. Epidemiology. Paths from pesticides to Parkinson’s. Science. 2013; 341(6147): 722–3.
106. Barnhill L.M. ja Bronstein J.M. Pesticides and Parkinson’s disease: is it in your genes? Neurodegener Dis Manag. 2014; 4(3): 197–200.
107. Wang A., Cockburn M., Ly T.T., Bronstein J.M. ja Ritz B. The association between ambient exposure to organophosphates and Parkinson’s disease risk. Occup Environ Med. 2014; 71(4): 275–81.
108. Narayan S., Liew Z., Paul K. ym. Household organophosphorus pesticide use and Parkinson’s disease. Int J Epidemiol. 2013; 42(5): 1476–85.
109. Liu X., Ma T., Qu B., Ji Y. ja Liu Z. Pesticide-induced gene mutations and Parkinson disease risk: a meta-analysis. Genet Test Mol Biomarkers. 2013; 17(11): 826–32.
110. Lee S.J., Lim H.S., Masliah E. ja Lee H.J. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives. Neurosci Res. 2011; 70(4): 339–48.
111. Chorfa A., Lazizzera C., Bétemps D. ym. A variety of pesticides trigger in vitro α-synuclein accumulation, a key event in Parkinson’s disease. Arch Toxicol. 2014.
112. Dunnett S.B. ja Björklund S.B.A.. Prospects for new restorative and neuroprotective treatments in Parkinson’s disease. Nature. 1999; 399(6738 Suppl): A32–9.
113. Campdelacreu J. Parkinson disease and Alzheimer disease: environmental risk factors. Neurologia. 2014; 29(9): 541–9.
114. Meng X., Munishkina L.A., Fink A.L. ja Uversky V.N. Effects of various flavonoids on the α-synuclein fibrillation process. Parkinson’s Dis. 2010; 2010: 650794.
115. Strathearn K.E., Yousef G.G., Grace M.H., Roy S.A. ym. Neuroprotective effects of anthocyaninand proanthocyanidin-rich extracts in cellular models of Parkinson’s disease. Brain Res. 2014; 1555: 60–77.
116. Golbe L.I., Farrell T.M. ja Davis P.H. Case-control study of early life dietary factors in Parkinson’s disease. Arch Neurol. 1988; 45(12): 1350–3.
117. Gao X., Cassidy A., Schwarzschild M.A., Rimm E.B. ja Ascherio A. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurol. 2012; 78(15): 1138–45.
118. Kukull W.A. An apple a day to prevent Parkinson disease: reduction of risk by flavonoids. Neurol. 2012; 78(15): 1112–3.
119. Katso viite 117.
120. Serafini M., Testa M.F., Villain D. ym. Antioxidant activity of blueberry fruit is impaired by association with milk. Free Radic Biol Med. 2009; 46(6): 769–74.
121. Jekanowski M. Survey says: a snapshot of rendering. Render Magazine. 2011; April: 58–61.
122. Schepens P.J., Covaci A., Jorens P.G., Hens L., Scharpé S. ja van Larebeke N. Surprising findings following a Belgian food contamination with polychlorobiphenyls and dioxins. Environ Health Perspect. 2001; 109(2): 101–3.
123. Dórea J.G. Vegetarian diets and exposure to organochlorine pollutants, lead, and mercury. Am J Clin Nutr. 2004; 80(1): 237–8.
124. Dórea JG. Fish meal in animal feed and human exposure to persistent bioaccumulative and toxic substances. J Food Prot. 2006; 69(11): 2777–85.
125. Moser G.A. ja McLachlan M.S. The influence of dietary concentration on the absorption and excretion of persistent lipophilic organic pollutants in the human intestinal tract. Chemosphere. 2001; 45(2): 201–11.
126. Katso viite 123.
127. Noyce A.J., Bestwick J.P., Silveira-Moriyama L. ym. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012; 72(6): 893–901.
128. Barranco Quintana J.L., Allam M.F., Del Castillo A.S. ja Navajas R.F. Parkinson’s disease and tea: a quantitative review. J Am Coll Nutr. 2009; 28(1): 1–6.
129. Palacios N., Gao X., McCullough M.L. ym. Caffeine and risk of Parkinson’s disease in a large cohort of men and women. Mov Disord. 2012; 27(10): 1276–82.
130. Nakaso K., Ito S. ja Nakashima K. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson’s disease model of SH-SY5Y cells. Neurosci Lett. 2008; 432(2): 146–50.
131. Postuma R.B., Lang A.E., Munhoz R.P. ym. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology. 2012; 79(7): 651–8.
132. Sama.
133. Grazina R. ja Massano J. Physical exercise and Parkinson’s disease: influence on symptoms, disease course and prevention. Rev Neurosci. 2013; 24(2): 139–52.
134. Chen J., Guan Z., Wang L., Song G., Ma B. ja Wang Y. Meta-analysis: overweight, obesity, and Parkinson’s disease. Int J Endocrinol. 2014; 2014: 203930.

15. Kuinka elää kuolematta iatrogeenisiin syihin

1. Pereira T.V., Horwitz R.I. ja Ioannidis J.P.A. Empirical evaluation of very large treatment effects of medical interventions. JAMA. 2012; 308(16): 1676–84.
2. Lazarou J., Pomeranz B.H. ja Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279(15): 1200–5.
3. Starfield B. Is US health really the best in the world? JAMA. 2000; 284(4): 483–5.
4. Klevens R.M., Edwards J.R., Richards C.L. ym. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007; 122(2): 160–6.
5. Gilbert K., Stafford C., Crosby K., Fleming E. ja Gaynes R. Does hand hygiene compliance among health care workers change when patients are in contact precaution rooms in ICUs? Am J Infect Control. 2010; 38(7): 515–7.
6. Sama.
7. Leape L.L. ja Berwick D.M. Five years after To Err Is Human: what have we learned? JAMA. 2005; 293(19): 2384–90.
8. Starfield B. Is US health really the best in the world? JAMA. 2000; 284(4): 483–5.
9. Institute of Medicine. To Err Is Human: building a safer health system. http://www.iom.edu/~/media/Files/Report%20Files/1999/To-Err-is-Human/To%20Err%20is%20Human%201999%20%20report%20brief.pdf. 11.1999. Haettu 12.3.2015.
10. Weingart S.N., Wilson R.M., Gibberd R.W. ja Harrison B. Epidemiology of medical error. BMJ. 2000; 320(7237): 774–7.
11. Millenson M.L. The silence. Health Aff (Millwood). 2003; 22(2): 103–12.
12. Mills D.H. Medical insurance feasibility study. A technical summary. West J Med. 1978; 128(4): 360–5.
13. Leape L.L. Error in medicine. JAMA. 1994 Dec 21; 272(23): 1851–7.
14. Katso viite 11.
15. Institute of Medicine. To Err Is Human: building a safer health system. http://www.iom.edu/~/media/Files/Report%20Files/1999/To-Err-is-Human/To%20Err%20is%20Human%201999%20%20report%20brief.pdf. 11.1999. Haettu 12.3.2015.
16. Katso viite 11.
17. Lockley S.W., Barger L.K., Ayas N.T., Rothschild J.M., Czeisler C.A. ja Landrigan C.P. Effects of health care provider work hours and sleep deprivation on safety and performance. Jt Comm J Qual Patient Saf. 2007; 33(11 Suppl): 7–18.
18. Barger L.K., Ayas N.T., Cade B.E. ym. Impact of extended-duration shifts on medical errors, adverse events, and attentional failures. PLoS Med. 2006; 3(12): e487.
19. Katso viite 11.
20. Egger G.J., Binns A.F. ja Rossner S.R. The emergence of ”lifestyle medicine” as a structured approach for management of chronic disease. Med J Aust. 2009; 190(3): 143–5.
21. Malone J., Guleria R., Craven C. ym. Justification of diagnostic medical exposures: some practical issues. Report of an International Atomic Energy Agency Consultation. Br J Radiol. 2012; 85(1013): 523–38.
22. Pierce D.A., Shimizu Y., Preston D.L., Vaeth M. ja Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950–1990. 1996. Radiat Res. 2012; 178(2): AV61–87.
23. Brenner D., Elliston C., Hall E. ja Berdon W.E. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001; 176(2): 289–96.
24. Rogers L.F. Taking care of children: check out the parameters used for helical CT. AJR Am J Roentgenol. 2001; 176(2): 287.
25. Berrington de Gonzingt A., Mahesh M., Kim K.P. ym. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009; 169(22): 2071–7.
26. Institute of Medicine. Breast cancer and the environment: a life course approach. Washington, D.C.: The National Academies Press; 2012.
27. Picano E. Informed consent and communication of risk from radiological and nuclear medicine examinations: how to escape from a communication inferno. BMJ. 2004; 329(7470): 849–51.
28. Schmidt C.W. CT scans: balancing health risks and medical benefits. Environ Health Perspect. 2012; 120(3): A118–21.
29. Pearce M.S., Salotti J.A., Little M.P. ym. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012; 380(9840): 499–505.
30. Limaye M.R. ja Severance H. Pandora’s boxes: questions unleashed in airport scanner debate. J Am Osteopath Assoc. 2011; 111(2): 87–8, 119.
31. Friedberg W., Copeland K., Duke F.E., O’Brien K. ja Darden E.B. Radiation exposure during air travel: guidance provided by the Federal Aviation Administration for air carrier crews. Health Phys. 2000; 79(5): 591–5.
32. Yong L.C., Petersen M.R., Sigurdson A.J., Sampson L.A. ja Ward E.M. High dietary antioxidant intakes are associated with decreased chromosome translocation frequency in airline pilots. Am J Clin Nutr. 2009; 90(5): 1402–10.
33. Podmore I.D., Griffiths H.R., Herbert K.E., Mistry N., Mistry P. ja Lunec J. Vitamin C exhibits pro-oxidant properties. Nature. 1998; 392(6676): 559.
34. Katso viite 32.
35. Sama.
36. Sauvaget C., Kasagi F. ja Waldren C.A. Dietary factors and cancer mortality among atomic-bomb survivors. Mutat Res. 2004; 551(1–2): 145–52.
37. Kordysh E.A., Emerit I., Goldsmith J.R. ym. Dietary and clastogenic factors in children who immigrated to Israel from regions contaminated by the Chernobyl accident. Arch Environ Health. 2001; 56(4): 320–6.
38. Langham W.H., Bassett H., Harris P.S. ja Carter R.E. Distribution and excretion of plutonium administered intravenously to man. Los Alamos: Los Alamos Scientifi c Laboratory, LAB1151. Health Physics. 1980; 38: 1,031B1,060.
39. Loscialpo M.J. Nontherapeutic human research experiments on institutionalized mentally retarded children: civil rights and remedies. 23 New Eng J on Crim & Civ Confinement. 1997; 139: 143–5.
40. Assistant to the Secretary of Defense for Nuclear and Chemical and Biological Defense Programs, Department of Defense. Report on search for human radiation experiment records 1944–1994. http://www.defense.gov/pubs/dodhre/. 6.1997. Haettu 12.3.2015.
41. Kouvaris J.R., Kouloulias V.E. ja Vlahos L.J. Amifostine: the first selective-target and broadspectrum radioprotector. Oncologist. 2007; 12(6): 738–47.
42. Rao B.N., Archana P.R., Aithal B.K. ja Rao B.S.S. Protective effect of zingerone, a dietary compound against radiation induced genetic damage and apoptosis in human lymphocytes. Eur J Pharmacol. 2011; 657(1–3): 59–66.
43. Arora R., Gupta D., Chawla R. ym. Radioprotection by plant products: present status and future prospects. Phytother Res. 2005; 19(1): 1–22.
44. Malekirad A.A., Ranjbar A., Rahzani K. ym. Oxidative stress in radiology staff . Environ Toxicol Pharmacol. 2005; 20(1): 215–8.
45. Zeraatpishe A., Oryan S., Bagheri M.H. ym. Effects of Melissa officinalis L. on oxidative status and DNA damage in subjects exposed to long-term low-dose ionizing radiation. Toxicol Ind Health. 2011; 27(3): 205–12.
46. Zhong W., Maradit-Kremers H., St Sauver J.L. ym. Age and sex patterns of drug prescribing in a defined American population. Mayo Clin Proc. 2013; 88(7): 697–707.
47. Lindsley C.W. The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics. ACS Chem Neurosci. 2012; 3(8): 630–1.
48. Centers for Disease Control National Center for Health Statistics. National Ambulatory Medical Care Survey: 2010 Summary Tables. http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf. 2010. Haettu 12.3.2015.
49. Hudson B., Zarifeh A., Young L. ja Wells J.E. Patients’ expectations of screening and preventive treatments. Ann Fam Med. 2012; 10(6): 495–502.
50. Lytsy P. ja Westerling R. Patient expectations on lipid-lowering drugs. Patient Educ Couns. 2007; 67(1–2): 143–50.
51. Trewby P.N., Reddy A.V., Trewby C.S., Ashton V.J., Brennan G. ja Inglis J. Are preventive drugs preventive enough? A study of patients’ expectation of benefit from preventive drugs. Clin Med. 2002; 2(6): 527–33.
52. Sama.
53. Sama.
54. Sama.
55. Esselstyn C.B. Jr, Gendy G., Doyle J., Golubic M. ja Roizen M.F. A way to reverse CAD? J Fam Pract. 2014; 63(7): 356–364b.
56. Sama.
57. Duthie G.G. ja Wood A.D. Natural salicylates: foods, functions and disease prevention. Food Funct. 2011; 2(9): 515–20.
58. Fuster V. ja Sweeny J.M. Aspirin: a historical and contemporary therapeutic overview. Circulation. 2011; 123(7): 768–78.
59. Pasche B., Wang M., Pennison M. ja Jimenez H. Prevention and treatment of cancer with aspirin: where do we stand? Semin Oncol. 2014; 41(3): 397–401.
60. Karnezis T., Shayan R., Fox S., Achen M.G. ja Stacker SA. The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway. Oncotarget. 2012; 3(8): 893–906.
61. Macdonald S. Aspirin use to be banned in under 16 year olds. BMJ. 2002; 325(7371): 988.
62. Siller-Matula J.M. Hemorrhagic complications associated with aspirin: an underestimated hazard in clinical practice? JAMA. 2012; 307(21): 2318–20.
63. Sutcliffe P., Connock M., Gurung T. ym. Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials. PLoS ONE. 2013; 8(12): e81970.
64. Thun M.J., Jacobs E.J. ja Patrono C. The role of aspirin in cancer prevention. Nat Rev Clin Oncol. 2012; 9(5): 259–67.
65. McCarty M.F. Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention. Med Hypotheses. 2012; 78(1): 45–57.
66. Katso viite 57.
67. Paterson J.R., Blacklock C., Campbell G., Wiles D. ja Lawrence J.R. The identification of salicylates as normal constituents of serum: a link between diet and health? J Clin Pathol. 1998; 51(7): 502–5.
68. Rinelli S., Spadafranca A., Fiorillo G., Cocucci M., Bertoli S. ja Battezzati A. Circulating salicylic acid and metabolic and inflammatory responses after fruit ingestion. Plant Foods Hum Nutr. 2012; 67(1): 100–4.
69. Blacklock C.J., Lawrence J.R., Wiles D. ym. Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin. J Clin Pathol. 2001; 54(7): 553–5.
70. Knutsen S.F. Lifestyle and the use of health services. Am J Clin Nutr. 1994; 59(5 Suppl): 1171S–1175S.
71. McCarty M.F. Dietary nitrate and reductive polyphenols may potentiate the vascular benefit and alleviate the ulcerative risk of low-dose aspirin. Med Hypotheses. 2013; 80(2): 186–90.
72. Willcox B.J., Willcox D.C., Todoriki H. ym. Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world’s longest-lived people and its potential impact on morbidity and life span. Ann N Y Acad Sci. 2007; 1114: 434–55.
73. Katso viite 65.
74. Paterson J.R., Srivastava R., Baxter G.J., Graham A.B. ja Lawrence J.R. Salicylic acid content of spices and its implications. J Agric Food Chem. 2006; 54(8): 2891–6.
75. Sama.
76. Pasche B., Wang M., Pennison M. ja Jimenez H. Prevention and treatment of cancer with aspirin: where do we stand? Semin Oncol. 2014; 41(3): 397–401.
77. Katso viite 74.
78. Baxter G.J., Graham A.B., Lawrence J.R., Wiles D. ja Paterson J.R. Salicylic acid in soups prepared from organically and non-organically grown vegetables. Eur J Nutr. 2001; 40(6): 289–92.
79. Scheier L. Salicylic acid: one more reason to eat your fruits and vegetables. J Am Diet Assoc. 2001; 101(12): 1406–8.
80. Duthie G.G. ja Wood A.D. Natural salicylates: foods, functions and disease prevention. Food Funct. 2011; 2(9): 515–20.
81. Seeff L.C., Richards T.B., Shapiro J.A. ym. How many endoscopies are performed for colorectal cancer screening? Results from CDC’s survey of endoscopic capacity. Gastroenterology. 2004; 127(6): 1670–7.
82. McLachlan S.A., Clements A. ja Austoker J. Patients’ experiences and reported barriers to colonoscopy in the screening context—a systematic review of the literature. Patient Educ Couns. 2012; 86(2): 137–46.
83. Lobel E.Z. ja Korelitz B.I. Postendoscopy syndrome: ”the doctor never talked to me.” J Clin Gastroenterol. 2001; 33(5): 353–4.
84. Katso viite 82.
85. Whitlock E.P., Lin J.S., Liles E., Beil T.L. ja Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008; 149(9): 638–58.
86. Manner H., Plum N., Pech O., Ell C. ja Enderle M.D. Colon explosion during argon plasma coagulation. Gastrointest Endosc. 2008; 67(7): 1123–7.
87. Ko C.W. ja Dominitz J.A. Complications of colonoscopy: magnitude and management. Gastrointest Endosc Clin N Am. 2010; 20(4): 659–71.
88. Katso viite 85.
89. van Hees F., Habbema J.D., Meester R.G., Lansdorp-Vogelaar I., van Ballegooijen M. ja Zauber A.G. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med. 2014; 160(11): 750–9.
90. Katso viite 85.
91. Brenner H., Stock C. ja Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014; 348: g2467.
92. Swan H., Siddiqui A.A. ja Myers R.E. International colorectal cancer screening programs: population contact strategies, testing methods and screening rates. Pract Gastroenter. 2012; 36(8): 20–9.
93. Ling B.S., Trauth J.M., Fine M.J. ym. Informed decision-making and colorectal cancer screening: is it occurring in primary care? Med Care. 2008; 46(9 Suppl 1): S23–9.
94. Sama.
95. Brett A.S. Flexible sigmoidoscopy for colorectal cancer screening: more evidence, persistent ironies. JAMA. 2014; 312(6): 601–2.
96. Yabroff K.R., Klabunde C.N., Yuan G. ym. Are physicians’ recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med. 2011; 26(2): 177–84.
97. Katso viite 92.
98. Sama.
99. Butterfield S. Changes coming for colon cancer screening. ACP Internist. 2014; 34(7): 10–11.
100. Rosenthal E. The $2.7 trillion medical bill: colonoscopies explain why U.S. leads the world in health expenditures. New York Times. http://www.nytimes.com/2013/06/02/health/colonoscopies-explain-why-us-leads-the-world-in-health-expenditures.html. 1.6.2013. Haettu 12.3.2015.
101. Whoriskey P. ja Keating D. How a secretive panel uses data that distorts doctors’ pay. Washington Post. http://www.washingtonpost.com/business/economy/how-a-secretive-panel-uses-data-that-distorts-doctors-pay/2013/07/20/ee134e3a-eda8-11e2-9008-61e94a7ea20d_story.html. 20.7.2013. Haettu 12.3.2015.
102. US Government Accountability Office. Medicare: action needed to address higher use of anatomic pathology services by providers who self-refer. GAO-13-445. http://www.gao.gov/products/GAO-13-445. 24.6.2013. Haettu 12.3.2015.
103. Spirling L.I. ja Daniels I.R. Botanical perspectives on health peppermint: more than just an afterdinner mint. J R Soc Promot Health. 2001; 121(1): 62–3.
104. Amato A., Liotta R. ja Mulè F. Effects of menthol on circular smooth muscle of human colon: analysis of the mechanism of action. Eur J Pharmacol. 2014; 740: 295–301.
105. Leicester R.J. ja Hunt R.H. Peppermint oil to reduce colonic spasm during endoscopy. Lancet. 1982; 2(8305): 989.
106. Asao T., Mochiki E., Suzuki H. ym. An easy method for the intraluminal administration of peppermint oil before colonoscopy and its effectiveness in reducing colonic spasm. Gastrointest Endosc. 2001; 53(2): 172–7.
107. Shavakhi A., Ardestani S.K., Taki M., Goli M. ja Keshteli A.H. Premedication with peppermint oil capsules in colonoscopy: a double blind placebo-controlled randomized trial study. Acta Gastroenterol Belg. 2012; 75(3): 349–53.
108. Stange K.C. Barbara Starfield: passage of the pathfinder of primary care. Ann Fam Med. 2011; 9(4): 292–6.
109. Starfield B. Is US health really the best in the world? JAMA. 2000; 284(4): 483–5.
110. Rappoport J. Dr. Barbara Starfieldin ekskulsiivinen haastattelu: medically caused death in America. Jon Rappoportin blogi: https://jonrappoport.wordpress.com/2009/12/09/an-exclusive-interview-with-dr-barbara-starfield-medically-caused-death-in-america/. 9.12.2009. Haettu 12.3.2015.
111. Millenson M.L. The silence. Health Aff (Millwood). 2003; 22(2): 103–12.
112. Holtzman N.A. Chronicle of an unforetold death. Arch Intern Med. 2012; 172(15): 1174–7.
113. Anand S.S., Islam S., Rosengren A. ym. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008; 29(7): 932–40.

OSA 2

Johdanto
1. Mozaffarian D., Willet W.C. ja Hu F.B. The authors reply. N Engl J Med. 2011; 365(11): 1059.
2. Bernstein A.M., Bloom D.E., Rosner B.A., Franz M. ja Willett W.C. Relation of food cost to healthfulness of diet among US women. Am J Clin Nutr. 2010; 92(5): 1197–203.
3. Atwater W.O. Foods: nutritive value and cost. U.S. Department of Agriculture Farmers’ Bulletin. 1894; 23: 1–30.
4. Connell C.L., Zoellner J.M., Yadrick M.K., Chekuri S.C., Crook L.B. ja Bogle M.L. Energy density, nutrient adequacy, and cost per serving can provide insight into food choices in the lower Mississippi Delta. J Nutr Educ Behav. 2012; 44(2): 148–53.
5. Lo Y.T., Chang Y.H., Wahlqvist M.L., Huang H.B. ja Lee M.S. Spending on vegetable and fruit consumption could reduce all-cause mortality among older adults. Nutr J. 2012; 11: 113.
6. Yhdysvaltojen maatalousministeriö (USDA) ja Yhdysvaltojen terveys- ja sosiaalipalveluministeriö. Dietary guidelines for Americans, 2010. Washington, D.C., U.S. Government Printing Office; 2010.
7. Dietary Guidelines Advisory Committee. The Report of the Dietary Guidelines Advisory Committee on Dietary Guidelines for Americans, 2010. Washington, D.C., U.S. Government Printing Office; 2010.
8. Yhdysvaltojen maatalousministeriö (USDA) ja Yhdysvaltojen terveys- ja sosiaalipalveluministeriö. Dietary guidelines for Americans, 2005. Washington, D.C., U.S. Government Printing Office; 2005.
9. Yhdysvaltojen maatalousministeriö (USDA) ja Yhdysvaltojen terveys- ja sosiaalipalveluministeriö. Dietary guidelines for Americans, 2010. Washington, D.C., U.S. Government Printing Office; 2010.
10.Sama.
11. World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, D.C., AICR, 2007.
12. Pork Information Gateway. Quick facts—the pork industry at a glance. http://www.porkgateway.org/FileLibrary/PIGLibrary/References/NPB%20Quick%20%20Facts%20book.pdf. Haettu 7.4.2015.
13. Green D. McDonald’s Corporation v. Steel & Morris [1997] EWHC QB 366.
14. Yhdysvaltojen maatalousministeriö (USDA). Mission statement. http://www.usda.gov/wps/portal/usda/usdahome?navid=MISSION_STATEMENT. Haettu 6.4.2015.
15. Katso viite 9.
16. Katso viite 14.
17. Yhdysvaltojen maatalousministeriö (USDA). Greening Headquarters Update. http://www.moran.senate.gov/public/index.cfm/files/serve?File_id=668d6da1-314c-4647-9f17-25edb67bb2f2. 23.7.2012. Haettu 20.5.2015.
18. Yhdysvaltojen maatalousministeriö (USDA) on perunut suosituksen lihattomasta maanantaista. http://www.meatlessmonday.com/articles/usda-misses-mark-on-meatless-monday/. 26.7.2012. Haettu 6.4.2015.
19. Herman J. (2010). Saving U.S. dietary advice from conflicts of interest. Food and Drug Law Journal. 65(20): 285–316.
20. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty, Acids, Cholesterol, Protein, and Amino Acids. Washington, D.C., National Academies Press,2003.
21. Sama.
22. Yhdysvaltojen maatalousministeriö (USDA). Fat and fatty acid content of selected foods containing trans-fatty acids. ARS Nutrient Data Laboratory. http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/Classics/trans_fa.pdf. Haettu 6.4.2015.
23. Katso viite 20.
24. Fox M. Report recommends limiting trans-fats in diet. Reuters, 10.7.2002.
25. Krebs-Smith S.M., Guenther P.M., Subar A.F., Kirkpatrick S.I. ja Dodd K.W. Americans do not meet federal dietary recommendations. J Nutr. 2010; 140(10): 1832–8.
26. Sama.
27. Sama.
28. Stuckler D., McKee M., Ebrahim S. ja Basu S. Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med. 2012; 9(6): e1001235.
29. Brownell K.D. Thinking forward: the quicksand of appeasing the food industry. PLoS Med. 2012; 9(7): e1001254.
30. Freedhoff Y. ja Hébert P.C. Partnerships between health organizations and the food industry risk derailing public health nutrition. CMAJ. 2011; 183(3): 291–2.
31. Neuman W. Save the Children breaks with soda tax effort. New York Times. 14.12.2010. http://www.nytimes.com/2010/12/15/business/15soda.html. Haettu 8.4.2015.
32. Murray C.J., Atkinson C., Bhalla K. ym. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013; 310(6): 591–608.
33. Neal B. Fat chance for physical activity. Popul Health Metr. 2013; 11(1): 9.
34. Gilroy D.J., Kauffman K.W., Hall R.A., Huang X. ja Chu F.S. Assessing potential health risks from microcystin toxins in blue-green algae dietary supplements. Environ Health Perspect. 2000; 108(5): 435–9.
35. Parker-Pope T. Michael Pollan offers 64 ways to eat food. New York Times, 8.1.2010.
36. Arnold D. British India and the ”beriberi problem”, 1798–1942. Med Hist. 2010; 54(3): 295–314.
37. Freeman B.B. ja Reimers K. Tomato consumption and health: emerging benefits. Am J Lifestyle Med. 2010; 5(2): 182–91.
38. Denke M.A. Effects of cocoa butter on serum lipids in humans: historical highlights. Am J Clin Nutr. 1994; 60(6 Suppl): 1014S–1016S.
39. Feingold Association of the United States. Regulations re 36 Colorants Covering 80 Countries. http://www.feingold.org/Research/PDFstudies/List-of-Colorants.pdf. Haettu 30.6.2015.
40. Galloway D. DIY bacon fat candle. http://lifehacker.com/5929854/diy-bacon-fat-candle. 28.7.2012. Haettu 10.4.2015.
41. Orlich M.J., Singh P.N., Sabaté J. ym. Vegetarian dietary patterns and mortality in Adventist Health Study 2. JAMA Intern Med. 2013; 173(13): 1230–8.
42. Willcox B.J., Willcox D.C., Todoriki H. ym. Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world’s longest-lived people and its potential impact on morbidity and life span. Ann NY Acad Sci. 2007; 1114: 434–55.
43. Kaiser Permanente. The plant-based diet: a healthier way to eat. http://mydoctor.kaiserpermanente.org/ncal/Images/New%20Plant%20Based%20Booklet%201214_tcm28-781815.pdf. 2013. Haettu 10.4.2015.
44. Campbell T.C., Parpia B. ja Chen J. Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China study. Am J Cardiol. 1998; 82(10B): 18T–21T.
45. Schane R.E., Glantz S.A. ja Ling P.M. Social smoking implications for public health, clinical practice, and intervention research. Am J Prev Med. 2009; 37(2): 124–31.
46. Willard Bishop. Supermarket facts. The future of food retailing, 2014. http://www.fmi.org/research-resources/supermarket-facts. Haettu 7.4.2015.
47. Vohs K.D. ja Heatherton T.F. Self-regulatory failure: a resource-depletion approach. Psychol Sci. 2000; 11(3): 249–54.
48. Katso viite 43.
49. Barnard N., Scialli A.R., Bertron P., Hurlick D. ja Edmondset K. Acceptability of a therapeutic low-fat, vegan diet in premenopausal women. J Nutr Educ. 2000; 32(6): 314–9.
50. Miller K.B, Hurst W.J, Payne M.J. ym. Impact of alkalization on the antioxidant and flavanol content of commercial cocoa powders. J Agric Food Chem. 2008; 56(18): 8527–33.

Tri Gregerin päivittäinen tusina
1. Kon S.K. ja Klein A. The value of whole potato in human nutrition. Biochem J. 1928; 22(1): 258–60.
2. Cheah I.K. ja Halliwell B. Ergothioneine; antioxidant potential, physiological function and role in disease. Biochim Biophys Acta. 2012; 1822(5): 784–93.
3. Yhdysvaltojen korkein oikeus. Nix v. Hedden, 149 U.S. 304 (1893).
4. Arkansas Code, Volume 1, luku 4, jakso 1-4-115. http://archive.org/stream/govlawarcode012008/govlawarcode012008_djvu.txt. Haettu 8.4.2015.

Pavut
1. World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, D.C.: AICR, 2007.
2. Yhdysvaltojen maatalousministeriö (USDA). National Nutrient Database for Standard Reference Release 27. Basic Report: 16426, Tofu, raw, firm, prepared with calcium sulfate. http://ndb.nal.usda.gov/ndb/foods/show/4995. Haettu 4.4.2015.
3. Fields of gold. Nature. 2013; 497(7447): 5–6.
4. Bøhn T., Cuhra M., Traavik T., Sanden M., Fagan J. ja Primicerio R. Compositional differences in soybeans on the market: glyphosate accumulates in Roundup Ready GM soybeans. Food Chem. 2014; 153: 207–15.
5. Aris A. ja Leblanc S. Maternal and fetal exposure to pesticides associated to genetically modified foods in Eastern Townships of Quebec, Canada. Reprod Toxicol. 2011; 31(4): 528–33.
6. Katso viite 4.
7. Marc J., Mulner-Lorillon O., Boulben S., Hureau D.,Durand G. ja Bellé R. Pesticide Roundup provokes cell division dysfunction at the level of CDK1/cyclin B activation. Chem Res Toxicol. 2002; 15(3): 326–31.
8. Walsh L.P., McCormick C., Martin C. ja Stocco D.M. Roundup inhibits steroidogenesis by disrupting steroidogenic acute regulatory (StAR) protein expression. Environ Health Perspect. 2000; 108(8): 769–76.
9. Vaughan E. Men! Save your testicles (and humanity): avoid Roundup® and GMO/GE Roundup Ready® foods. http://www.drvaughan.com/2013/07/men-save-your-testicles-and-humanity.html.
29.7.2013. Haettu 9.4.2015.
10. Romano R.M., Romano M.A., Bernardi M.M., Furtado P.V. ja Oliveira C.A. Prepubertal exposure to commercial formulation of the herbicide glyphosate alters testosterone levels and testicular morphology. Arch Toxicol. 2010; 84(4): 309–17.
11. Richard S., Moslemi S., Sipahutar H., Benachour N. ja Seralini G.E. Differential effects of glyphosate and Roundup on human placental cells and aromatase. Environ Health Perspect. 2005; 113(6): 716–20.
12. De Roos A.J., Blair A., Rusiecki J.A. ym. Cancer incidence among glyphosate-exposed pesticide applicators in the Agricultural Health Study. Environ Health Perspect. 2005; 113(1): 49–54.
13. De Roos A.J., Zahm S.H., Cantor K.P. ym. Integrative assessment of multiple pesticides as risk factors for non-Hodgkin’s lymphoma among men. Occup Environ Med. 2003; 60(9): E11.
14. Garry V.F., Harkins M.E., Erickson L.L., Long-Simpson L.K., Holland S.E. ja Burroughs B.L. Birth defects, season of conception, and sex of children born to pesticide applicators living in the Red River Valley of Minnesota, USA. Environ Health Perspect. 2002; 110 Suppl 3: 441–9.
15. Thongprakaisang S., Thiantanawat A., Rangkadilok N., Suriyo T. ja Satayavivad J. Glyphosate induces human breast cancer cells growth via estrogen receptors. Food Chem Toxicol. 2013; 59: 129–36.
16. Butler D. ja Reichhardt T. Long-term effect of GM crops serves up food for thought. Nature.1999; 398(6729): 651–6.
17. Smyth S. International considerations of food biotechnology regulatory frameworks. http://regulation.upf.edu/exeter-12-papers/Paper%20260%20-%20Smyth%202012%20-%20International%20Considerations%20of%20Food%20Biotechnology%20Regulatory%20Frameworks.pdf. 29.6.2012. Haettu 9.4.2015.
18. Kramkowska M., Grzelak T. ja Czyżewska K. Benefits and risks associated with genetically modified food products. Ann Agric Environ Med. 2013; 20(3): 413–9.
19. Murooka Y. ja Yamshita M. Traditional healthful fermented products of Japan. J Ind Microbiol Biotechnol. 2008; 35(8): 791–8.
20. World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, D.C.: AICR, 2007.
21. Parkin D.M. 7. Cancers attributable to dietary factors in the UK in 2010. IV. Salt. Br J Cancer.2011; 105 Suppl 2: S31–3.
22. Lee Y.Y. ja Derakhshan M.H. Environmental and lifestyle risk factors of gastric cancer. Arch Iran Med. 2013; 16(6): 358–65.
23. González C.A., Jakszyn P., Pera G. ym. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006; 98(5): 345–54.
24. Key T.J., Appleby P.N., Crowe F.L., Bradbury K.E., Schmidt J.A. ja Travis R.C. Cancer in British vegetarians: updated analyses of 4998 incident cancers in a cohort of 32,491 meat eaters, 8612 fish eaters, 18,298 vegetarians, and 2246 vegans. Am J Clin Nutr. 2014; 100 Suppl 1: 378S–85S.
25. D’Elia L., Rossi G., Ippolito R., Cappuccio F.P. ja Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr. 2012; 31(4): 489–98.
26. Joossens J.V., Hill M.J., Elliott P. ym. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol. 1996; 25(3): 494–504.
27. Katso viite 25.
28. Ko K.P., Park S.K., Yang J.J. ym. Intake of soy products and other foods and gastric cancer risk: a prospective study. J Epidemiol. 2013; 23(5): 337–43.
29. Katso viite 25.
30. Turati F., Pelucchi C., Guercio V., La Vecchia C. ja Galeone C. Allium vegetable intake and gastric cancer: a case-control study and meta-analysis. Mol Nutr Food Res. 2015; 59(1): 171–9.
31. J. He, D. Gu, X. Wu ym. Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann Intern Med. 2005; 143(1): 1–9.
32. Rivas M., Garay R.P., Escanero J.F., Cia P., Cia P. ja Alda J.O. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr. 2002; 132(7): 1900–2.
33. Kanda A., Hoshiyama Y. ja Kawaguchi T. Association of lifestyle parameters with the prevention of hypertension in elderly Japanese men and women: a four-year follow-up of normotensive subjects. Asia Pac J Public Health. 1999; 11(2): 77–81.
34. Jenkins D.J., Wolever T.M., Taylor R.H. ym. Slow release dietary carbohydrate improves second meal tolerance. Am J Clin Nutr. 1982; 35(6): 1339–46.
35. Ropert A., Cherbut C., Rozé C. ym. Colonic fermentation and proximal gastric tone in humans. Gastroenterology. 1996; 111(2): 289–96.
36. Mollard R.C., Wong C.L., Luhovyy B.L. ja Anderson G.H. First and second meal effects of pulses on blood glucose, appetite, and food intake at a later meal. Appl Physiol Nutr Metab. 2011; 36(5): 634–42.
37. Yashin Y.I., Nemzer B.V., Ryzhnev V.Y., Yashin A.Y., Chernousova N.I. ja Fedina P.A. Creation of a databank for content of antioxidants in food products by an amperometric method. Molecules. 2010; 15(10): 7450–66.
38. Zanovec M., O’Neil C.E. ja Nicklas T.A. Comparison of nutrient density and nutrient-to-cost between cooked and canned beans. Food Nutr Sci. 2011; 2(2): 66–73.
39. Sama.
40. Kid Tested Firefighter Approved -reseptisivusto. Buffalo ranch -maustetut paahdetut kikherneet: http://kidtestedfirefighterapproved.com/2012/08/05/buffalo-ranch-roasted-chickpeas/. 5.8.2012. Haettu 9.4.2015.
41. Bazzano L.A., Thompson A.M., Tees M.T., Nguyen C.H. ja Winham D.M. Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2011; 21(2): 94–103.
42. Anderson J.W. ja Bush H.M. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr. 2011; 30(2): 79–91.
43. Winham D.M., Hutchins A.M. ja Johnston C.S. Pinto bean consumption reduces biomarkers for heart disease risk. J Am Coll Nutr. 2007; 26(3): 243–9.
44. Fuhrman J. Fudgy black bean brownies. The Dr. Oz Show. http://www.doctoroz.com/recipe/fudgy-black-bean-brownies. 12.11.2014. Haettu 9.4.2015.
45. Yhdysvaltojen maatalousministeriö (USDA). Oxygen Radical Absorbance Capacity (ORAC) of Selected Foods—2007. http://www.orac-info-portal.de/download/ORAC_R2.pdf. 11.2007. Haettu 10.4.2015.
46. Darmadi-Blackberry I., Wahlqvist M.L., Kouris-Blazos A. ym. Legumes: the most important dietary predictor of survival in older people of different ethnicities. Asia Pac J Clin Nutr. 2004; 13(2): 217–20.
47. Sama.
48. Desrochers N. ja Brauer P.M. Legume promotion in counselling: an e-mail survey of dietitians. Can J Diet Pract Res. 2001; 62(4): 193–8.
49. Winham D.M. ja Hutchins A.M. Perceptions of flatulence from bean consumption among adults in 3 feeding studies. Nutr J. 2011; 10: 128.
50. Levitt M.D., Lasser R.B., Schwartz J.S. ja Bond J.H. Studies of a flatulent patient. N Engl J Med. 1976; 295(5): 260–2.
51. Levitt M.D., Furne J. ja Olsson S. The relation of passage of gas and abdominal bloating to colonic gas production. Ann Intern Med. 1996; 124(4): 422–4.
52. Price K.R., Lewis J., Wyatt G.M. ja Fenwick G.R. Flatulence—causes, relation to diet and remedies. Nahrung. 1988; 32(6): 609–26.
53. Matthews S.B., Waud J.P.,Roberts A.G. ja Campbell A.K. Systemic lactose intolerance: a new perspective on an old problem. Postgrad Med J. 2005; 81(953): 167–73.
54. Katso viite 50.
55. McEligot A.J., Gilpin E.A., Rock C.L. ym. High dietary fiber consumption is not associated with gastrointestinal discomfort in a diet intervention trial. J Am Diet Assoc. 2002; 102(4): 549–51.
56. Price K.R., Lewis J., Wyatt G.M. ja Fenwick G.R. Flatulence—causes, relation to diet and remedies. Nahrung. 1988; 32(6): 609–26.
57. Jood S., Mehta U., Singh R. ja Bhat C.M. Effect of processing on flatus producing factors in legumes. J Agric Food Chem. 1985; 3: 268–71.
58. Savitri A., Bhavanishankar T.N. ja Desikachar H.S.R. Effect of spices on in vitro gas production by Clostridium perfringens. Food Microbiol. 1986; 3: 195–9.
59. Di Stefano M., Miceli E., Gotti S., Missanelli A., Mazzocchi S. ja Corazza G.R. The effect of oral alphagalactosidase on intestinal gas production and gas-related symptoms. Dig Dis Sci. 2007; 52(1): 78–83.
60. How you can limit your gas production. 12 tips for dealing with flatulence. Harv Health Lett. 2007; 32(12): 3.
61. Magee E.A., Richardson C.J., Hughes R. ja Cummings J.H. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr. 2000; 72(6): 1488–94.
62. Gorbach S.L. Bismuth therapy in gastrointestinal diseases. Gastroenterology. 1990; 99(3): 863–75.
63. Suarez F.L., Springfield J. ja Levitt M.D. Identification of gases responsible for the odour of human flatus and evaluation of a device purported to reduce this odour. Gut. 1998; 43(1): 100–4.
64. Bouchier I.A. Flatulence. Practitioner. 1980; 224(1342): 373–7.
65. Fardy J. ja Sullivan S. Gastrointestinal gas. CMAJ. 1988; 139(12): 1137–42.

Marjat
1. McCullough M.L., Peterson J.J., Patel R., Jacques P.F., Shah R. ja Dwyer J.T. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr. 2012; 95(2): 454–64.
2. Hernandez-Marin E., Galano A. ja Martínez A. Cis carotenoids: colorful molecules and free radical quenchers. J Phys Chem B. 2013; 117(15): 4050–61.
3. Yhdysvaltojen maatalousministeriö (USDA). Oxygen Radical Absorbance Capacity (ORAC) of Selected Foods—2007. http://www.orac-info-portal.de/download/ORAC_R2.pdf. 11.2007. Haettu 10.4.2015.
4. Carlsen M.H., Halvorsen B.L., Holte K. ym. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010; 9: 3.
5. Sama.
6. Sama.
7. Dinstel R.R., Cascio J. ja Koukel S. The antioxidant level of Alaska’s wild berries: high, higher and highest. Int J Circumpolar Health. 2013; 72.
8. Katso viite 4.
9. Petta S., Marchesini G., Caracausi L. ym. Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Hepatol. 2013; 59(6): 1169–76.
10. Madero M., Arriaga J.C., Jalal D. ym. The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial. Metab Clin Exp. 2011; 60(11): 1551–9.
11. Yhdysvaltojen maatalousministeriö (USDA), Economic Research Service. U.S. sugar production. http://www.ers.usda.gov/topics/crops/sugar-sweeteners/background.aspx. 14.11.2014. Haettu 11.4.2015.
12.Katso viite 9.
13. Törrönen R., Kolehmainen M., Sarkkinen E., Mykkänen H. ja Niskanen L. Postprandial glucose, insulin, and free fatty acid responses to sucrose consumed with blackcurrants and lingonberries in healthy women. Am J Clin Nutr. 2012; 96(3): 527–33.
14. Sama.
15. Törrönen R., Kolehmainen M., Sarkkinen E., Poutanen K., Mykkänen H. ja Niskanen L. Berries reduce postprandial insulin responses to wheat and rye breads in healthy women. J Nutr. 2013; 143(4): 430–6.
16. Katso viite 13.
17. Manzano S. ja Williamson G. Polyphenols and phenolic acids from strawberry and apple decrease glucose uptake and transport by human intestinal Caco-2 cells. Mol Nutr Food Res. 2010; 54(12): 1773–80.
18. Sievenpiper J.L., Chiavaroli L., de Souza R.J. ym. ‘‘Catalytic’’ doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomized controlled feeding trials. Br J Nutr. 2012; 108(3): 418–23.
19. Christensen A.S., Viggers L., Hasselström K. ja Gregersen S. Effect of fruit restriction on glycemic control in patients with type 2 diabetes—a randomized trial. Nutr J. 2013; 12: 29.
20. Meyer B.J., van der Merwe M., du Plessis D.G., de Bruin E.J. ja Meyer A.C. Some physiological effects of a mainly fruit diet in man. S Afr Med J. 1971; 45(8): 191–5.
21. Meyer B.J., de Bruin E.J., du Plessis D.G., van der Merwe M. ja Meyer A.C. Some biochemical effects of a mainly fruit diet in man. S Afr Med J. 1971; 45(10): 253–61.
22. Jenkins D.J., Kendall C.W., Popovich D.G. ym. Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function. Metab Clin Exp. 2001; 50(4): 494–503.
23. Sama.
24. Ou B., Bosak K.N., Brickner P.R., Iezzoni D.G. ja Seymour E.M. Processed tart cherry products—comparative phytochemical content, in vitro antioxidant capacity and in vitro anti-inflammatory activity. J Food Sci. 2012; 77(5): H105–12.
25. Mullen W., Stewart A.J., Lean M.E., Gardner P., Duthie G.G. ja Crozier A. Effect of freezing and storage on the phenolics, ellagitannins, flavonoids, and antioxidant capacity of red raspberries. J Agric Food Chem. 2002; 50(18): 5197–201.
26. Marques K.K., Renfroe M.H., Brevard P.B., Lee R.E. ja Gloeckner J.W. Differences in antioxidant levels of fresh, frozen and freeze-dried strawberries and strawberry jam. Int J Food Sci Nutr. 2010; 61(8): 759–69.
27. Blau L.W. Cherry diet control for gout and arthritis. Tex Rep Biol Med. 1950; 8(3): 309–11.
28. Overman T. Pegloticase: a new treatment for gout. Cleveland Clinic Pharmacotherapy Update. 2011; 14(2): 1–3.
29. Finkelstein Y., Aks S.E., Hutson J.R. ym. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila). 2010; 48(5): 407–14.
30. Fritsch P.O. ja Sidoroff A. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol. 2000; 1(6): 349–60.
31. Zhang Y., Chen C., Choi H. ym. Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis. 2012; 71(9): 1448–53.
32. Kelley D.S., Rasooly R., Jacob R.A., Kader A.A. ja Mackey B.E. Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr. 2006; 136(4): 981–6.
33. Zielinsky P. ja Busato S. Prenatal effects of maternal consumption of polyphenol-rich foods in late pregnancy upon fetal ductus arteriosus. Birth Defects Res C. 2013; 99(4): 256–74.
34. Howatson G., Bell P.G., Tallent J., Middleton B., McHugh M.P. ja Ellis J. Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality. Eur J Nutr. 2012; 51(8): 909–16.
35. Huang X. ja Mazza G. Application of LC and LC-MS to the analysis of melatonin and serotonin in edible plants. Crit Rev Food Sci Nutr. 2011; 51(4): 269–84.
36. Carlsen M.H., Halvorsen B.L., Holte K. ym. The total antioxidant content of more than 3100
foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010; 9: 3.
37. Beatty S., Murray I.J., Henson D.B., Carden D., Koh H. ja Boulton M.E. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci. 2001; 42(2): 439–46.
38. Cheng C.Y., Chung W.Y., Szeto Y.T. ja Benzie I.F. Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze, suomeksi goji-marja) in a food-based human supplementation trial. Br J Nutr. 2005; 93(1): 123–30.
39. Bucheli P., Vidal K., Shen L. ym. Goji berry effects on macular characteristics and plasma antioxidant levels. Optom Vis Sci. 2011; 88(2): 257–62.
40. Nakaishi H., Matsumoto H., Tominaga S., Hirayama M. Effects of black currant anthocyanoside intake on dark adaptation and VDT work-induced transient refractive alteration in healthy humans. Altern Med Rev. 2000; 5(6): 553–62.
41. Wu X., Beecher G.R., Holden J.M., Haytowitz D.B., Gebhardt S.E. ja Prior R.L. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem. 2006; 54(11): 4069–75.
42. Muth E.R., Laurent J.M. ja Jasper P. The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity. Altern Med Rev. 2000; 5(2): 164–73.
43. Rababah T.M., Al-Mahasneh M.A., Kilani I. ym. Effect of jam processing and storage on total phenolics,antioxidant activity, and anthocyanins of different fruits. J Sci Food Agric. 2011; 91(6): 1096–102.
44. Marques K.K., Renfroe M.H., Brevard P.B., Lee R.E. ja Gloeckner J.W. Differences in antioxidant levels of fresh, frozen and freeze-dried strawberries and strawberry jam. Int J Food Sci Nutr. 2010; 61(8): 759–69.
45. Vivian J. Foraging for edible wild plants: a field guide to wild berries. Mother Earth News, October/November 1999. http://www.motherearthnews.com/organic-gardening/edible-wild-plants.aspx. Haettu 11.4.2015.

Muut hedelmät
1. Horton R. GBD 2010: understanding disease, injury, and risk. Lancet. 2012; 380(9859): 2053–4.
2. Murray C.J., Atkinson C., Bhalla K. ym. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013; 310(6): 591–608.
3. Lim S.S., Vos T., Flaxman A.D. ym. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224–60.
4. Arranz S., Silván J.M., Saura-Calixto F. Nonextractable polyphenols, usually ignored, are the major part of dietary polyphenols: a study on the Spanish diet. Mol Nutr Food Res. 2010; 54(11): 1646–58.
5. Mullen W., Marks S.C. ja Crozier A. Evaluation of phenolic compounds in commercial fruit juices and fruit drinks. J Agric Food Chem. 2007; 55(8): 3148–57.
6. Muraki I., Imamura F., Manson J.E. ym. Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies. BMJ. 2013; 347: f5001.
7. Li N., Shi J. ja Wang K. Profile and antioxidant activity of phenolic extracts from 10 crabapples (Malus wild species). J Agric Food Chem. 2014; 62(3): 574–81.
8. Vogel R.A. Brachial artery ultrasound: a noninvasive tool in the assessment of triglyceride-rich lipoproteins. Clin Cardiol. 1999; 22(6 Suppl): II34–9.
9. Rueda-Clausen C.F., Silva F.A., Lindarte M.A. ym. Olive, soybean and palm oils intake have a similar acute detrimental effect over the endothelial function in healthy young subjects. Nutr Metab Cardiovasc Dis. 2007; 17(1): 50–7.
10. Casas-Agustench P., Lopez-Uriarte P., Ros E., Bullo M. ja Salas-Salvado J. Nuts, hypertension and endothelial function. Nutr Metab Cardiovasc Dis. 2011; 21 Suppl 1: S21–33.
11. Vogel R.A., Corretti M.C. ja Plotnick G.D. The postprandial effect of components of the Mediterranean diet on endothelial function. J Am Coll Cardiol. 2000; 36(5): 1455–60.
12. Carlsen M.H., Halvorsen B.L., Holte K. ym. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010; 9: 3.
13. Cormio L., De Siati M., Lorusso F. ym. Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology. 2011; 77(1): 119–22.
14. Rimando A.M. ja Perkins-Veazie P.M. Determination of citrulline in watermelon rind. J Chromatogr A. 2005; 1078(1–2): 196–200.
15. Pfizerin vuoden 2014 yhtiökokouksen tilinpäätöstiedot (Annual Meeting of Shareholders 2014 Financial Report). http://www.pfizer.com/system/files/presentation/2014_Pfizer_Financial_Report.pdf. Haettu 16.5. 2015.
16. Johnson G. Watermelon board approves officers, budget, marketing plan. The Packer. http://www.thepacker.com/news/watermelon-board-approves-officers-budget-marketing-plan. 24.2.2015. Haettu 16.5.2015.
17. Chai S.C., Hooshmand S., Saadat R.L., Payton M.E., Brummel-Smith K. ja Arjmandi B.H. Daily apple versus dried plum: impact on cardiovascular disease risk factors in postmenopausal women. J Acad Nutr Diet. 2012; 112(8): 1158–68.
18. Magee E. A nutritional component to inflammatory bowel disease: the contribution of meat to fecal sulfide excretion. Nutrition. 1999; 15(3): 244–6.
19. Ananthakrishnan A.N., Khalili H., Konijeti G.G. ym. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology. 2013; 145(5): 970–7.
20. Lin H.H., Tsai P.S., Fang S.C. ja Liu J.F. Effect of kiwifruit consumption on sleep quality in adults with sleep problems. Asia Pac J Clin Nutr. 2011; 20(2): 169–74.
21. Yhdysvaltojen elintarvike- ja lääkevirasto. FDA announces discontinued marketing of GI drug, Zelnorm, for safety reasons. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108879.htm. 30.3.2007. Haettu 11.4.2015.
22. Skinner M.A. Gold kiwifruit for immune support and reducing symptoms of cold and influenza. J Food Drug Anal. 2012; 20: 261–4.
23. Hunter D.C., Skinner M.A., Wolber F.M. ym. Consumption of gold kiwifruit reduces severity and duration of selected upper respiratory tract infection symptoms and increases plasma vitamin C concentration in healthy older adults. Br J Nutr. 2012; 108(7): 1235–45.
24. Orhan F., Karakas T., Cakir M., Aksoy A., Baki A. ja Gedik Y. Prevalence of immunoglobulin E–mediated food allergy in 6–9-year-old urban schoolchildren in the eastern Black Sea region of Turkey. Clin Exp Allergy. 2009; 39(7): 1027–35.
25. Rancé F., Grandmottet X. ja Grandjean H. Prevalence and main characteristics of schoolchildren diagnosed with food allergies in France. Clin Exp Allergy. 2005; 35(2): 167–72.
26. Szeto Y.T., To T.L., Pak S.C. ja Kalle W. A study of DNA protective effect of orange juice supplementation. Appl Physiol Nutr Metab. 2013; 38(5): 533–6.
27. Slyskova J., Lorenzo Y., Karlsen A. ym. Both genetic and dietary factors underlie individual differences in DNA damage levels and DNA repair capacity. DNA Repair (Amst). 2014; 16: 66–73.
28. Szeto Y.T., Chu W.K. ja Benzie I.F. Antioxidants in fruits and vegetables: a study of cellular availability and direct effects on human DNA. Biosci Biotechnol Biochem. 2006; 70(10): 2551–5.
29. Katso viite 26.
30. Song J.K. ja Bae J.M. Citrus fruit intake and breast cancer risk: a quantitative systematic review. J Breast Cancer. 2013; 16(1): 72–6.
31. Miller J.A., Lang J.E., Ley M. ym. Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer. Cancer Prev Res (Phila). 2013; 6(6): 577–84.
32. Lorenzo Y., Azqueta A., Luna L., Bonilla F., Domínguez G. ja Collins A.R. The carotenoid beta-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidantin human cells. Carcinogenesis. 2009; 30(2): 308–14.
33. Hakim I.A., Harris R.B. ja Ritenbaugh C. Citrus peel use is associated with reduced risk of squamous cell carcinoma of the skin. Nutr Cancer. 2000; 37(2): 161–8.
34. Astley S.B., Elliott R.M., Archer D.B. ja Southon S. Evidence that dietary supplementation with carotenoids and carotenoid-rich foods modulates the DNA damage: repair balance in human lymphocytes. Br J Nutr. 2004; 91(1): 63–72.
35. Feskanich D., Willett W.C., Hunter D.J. ja Colditz G.A. Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women. Br J Cancer. 2003; 88(9): 1381–7.
36. Owira P.M. ja Ojewole J.A. The grapefruit: an old wine in a new glass? Metabolic and cardiovascular perspectives. Cardiovasc J Afr. 2010; 21(5): 280–5.
37. Fuhr U., Klittich K. ja Staib A.H. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol. 1993; 35(4): 431–6.
38. Ratain M.J. ja Cohen E.E. The value meal: how to save $1,700 per month or more on lapatinib. J Clin Oncol. 2007; 25(23): 3397–8.
39. Aziz S., Asokumaran T. ja Intan G. Penetrating ocular injury by durian fruit. Med J Malaysia. 2009; 64(3): 244–5.
40. Winokur J. The Traveling Curmudgeon. Seattle: Sasquatch Books, 2003.

Ristikukkaiset kasvikset
1. Lenzi M., Fimognari C. ja Hrelia P. Sulforaphane as a promising molecule for fighting cancer. Cancer Treat Res. 2014; 159: 207–23.
2. Tarozzi A., Angeloni C., Malaguti M., Morroni F., Hrelia S. ja Hrelia P. Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxid Med Cell Longev. 2013; 2013: 415078.
3. Liu H., Smith A.J., Lott M.C. ym. Sulforaphane can protect lens cells against oxidative stress: implications for cataract prevention. Invest Ophthalmol Vis Sci. 2013; 54(8): 5236–48.
4. Heber D., Li Z., Garcia-Lloret M. ym. Sulforaphane-rich broccoli sprout extract attenuates nasal allergic response to diesel exhaust particles. Food Funct. 2014; 5(1): 35–41.
5. Bahadoran Z., Mirmiran P. ja Azizi F. Potential efficacy of broccoli sprouts as a unique supplement for management of type 2 diabetes and its complications. J Med Food. 2013; 16(5): 375–82.
6. Matusheski N.V., Juvik J.A. ja Jeffery E.H. Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli. Phytochemistry. 2004; 65(9): 1273–81.
7. Singh K., Connors S.L., Macklin E.A. ym. Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci USA. 2014; 111(43): 15550–5.
8. Vermeulen M., Klöpping-Ketelaars I.W., van den Berg R. ja Vaes W.H. Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli. J Agric Food Chem. 2008; 56(22): 10505–9.
9. Ferrarini L., Pellegrini N., Mazzeo T. ym. Anti-proliferative activity and chemoprotective effects towards DNA oxidative damage of fresh and cooked Brassicaceae. Br J Nutr. 2012; 107(9): 1324–32.
10. Collins P.J., Horowitz M. ja Chatterton B.E. Proximal, distal and total stomach emptying of a digestible solid meal in normal subjects. Br J Radiol. 1988; 61(721): 12–8.
11. Dosz E.B. ja Jeffery E.H. Modifying the processing and handling of frozen broccoli for increased sulforaphane formation. J Food Sci. 2013; 78(9): H1459–63.
12. Olsen H., Grimmer S., Aaby K., Saha S. ja Borge G.I. Antiproliferative effects of fresh and thermal processed green and red cultivars of curly kale (Brassica oleracea L. convar. acephala var. sabellica). J Agric Food Chem. 2012; 60(30): 7375–83.
13. Dosz E.B. ja Jeffery E.H. Commercially produced frozen broccoli lacks the ability to form sulforaphane. Journal of Functional Foods. 2013; (5)2: 987–90.
14. Ghawi S.K., Methven L. ja Niranjan K. The potential to intensify sulforaphane formation in cooked broccoli (Brassica oleracea var. italica) using mustard seeds (Sinapis alba). Food Chem. 2013; 138(2–3): 1734–41.
15. Katso viite 11.
16. Nolan C. Kale is a noun. http://engine2diet.com/the-daily-beet/kale-is-a-noun/. Haettu 12.4.2015.
17. Yhdysvaltojen maatalousministeriö (USDA), Economic Research Service. Cabbage—average retail price per pound and per cup equivalent, 2013. http://www.ers.usda.gov/datafiles/Fruit_and_Vegetable_Prices/Vegetables/cabbage.xlsx. Haettu 21.5.2015.
18. Yhdysvaltojen maatalousministeriö (USDA). Oxygen Radical Absorbance Capacity (ORAC) of Selected Foods—2007. http://www.orac-info-portal.de/download/ORAC_R2.pdf. 11.2007. Haettu 10.4.2015.
19. Katso viite 17.
20. Gu Y., Guo Q., Zhang L., Chen Z., Han Y. ja Gu Z. Physiological and biochemical metabolism of germinating broccoli seeds and sprouts. J Agric Food Chem. 2012; 60(1): 209–13.
21. Clarke J.D., Hsu A., Riedl K. ym. Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacol Res. 2011; 64(5): 456–63.
22. Shapiro T.A., Fahey J.W., Dinkova-Kostova A.T. ym. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr Cancer. 2006; 55(1): 53–62.
23. Sestili P., Paolillo M., Lenzi M. ym. Sulforaphane induces DNA single strand breaks in cultured human cells. Mutat Res. 2010; 689(1–2): 65–73.

Lehtivihannekset
1. Kwak C.S., Moon S.C. ja Lee M.S. Antioxidant, antimutagenic, and antitumor effects of pine needles (Pinus densiflora). Nutr Cancer. 2006; 56(2): 162–71.
2. Grivetti L.E., Corlett J.L., Gordon B.M. ja Lockett G.T. Food in American history: Part 10. Greens: Part 1. Vegetable greens in a historical context. Nutr Today. 2008; 42(2): 88–94.
3. Krebs-Smith S.M., Guenther P.M., Subar A.F., Kirkpatrick S.I. ja Dodd K.W. Americans do not meet federal dietary recommendations. J Nutr. 2010; 140(10): 1832–8.
4. Walker F.B. Myocardial infarction after diet-induced warfarin resistance. Arch Intern Med. 1984; 144(10): 2089–90.
5. Tamakoshi A., Tamakoshi K., Lin Y., Yagyu K. ja Kikuchi S. Healthy lifestyle and preventable death: findings from the Japan Collaborative Cohort (JACC) Study. Prev Med. 2009; 48(5): 486–92.
6. Hung H.C., Joshipura K.J., Jiang R. ym. Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst. 2004; 96(21): 1577–84.
7. Joshipura K.J., Hu F.B., Manson J.E. ym. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001; 134(12): 1106–14.
8. Joshipura K.J., Ascherio A., Manson J.E. ym. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA. 1999; 282(13): 1233–9.
9. Patent publication number EP 1069819 B1. Method for selective increase of the anticarcinogenic glucosinolates in brassica species. http://www.google.com/patents/EP1069819B1?cl=en. 24.7.2002. Haettu 13.4.2015.
10. Archetti M., Döring T.F., Hagen S.B. ym. Unravelling the evolution of autumn colours: an interdisciplinary approach. Trends Ecol Evol (Amst). 2009; 24(3): 166–73.
11. Benaron D.A., Cheong W.F. ja Stevenson D.K. Tissue optics. Science. 1997; 276(5321): 2002–3.
12. Pietrzak M., Halicka H.D., Wieczorek Z., Wieczorek J. ja Darzynkiewicz Z. Attenuation of acridine mutagen ICR-191—DNA interactions and DNA damage by the mutagen interceptor chlorophyllin. Biophys Chem. 2008; 135(1–3): 69–75.
13. Jubert C., Mata J., Bench G. ym. Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B(1) pharmacokinetics in human volunteers. Cancer Prev Res (Phila). 2009; 2(12): 1015–22.
14. Bachem A. jaReed C.I. The penetration of light through human skin. Am J Physiol. 1931; 97: 86–91.
15. Katso viite 11.
16. Xu C., Zhang J., Mihai D.M. ja Washington I. Light-harvesting chlorophyll pigments enable mammalian mitochondria to capture photonic energy and produce ATP. J Cell Sci. 2014; 127(Pt 2): 388–99.
17. Qu J., Ma L., Zhang J., Jockusch S. ja Washington I. Dietary chlorophyll metabolites catalyze the photoreduction of plasma ubiquinone. Photochem Photobiol. 2013; 89(2): 310–3.
18. Olsen H., Grimmer S., Aaby K., Saha S. ja Borge G.I. Antiproliferative effects of fresh and thermal processed green and red cultivars of curly kale (Brassica oleracea L. convar. acephala var. sabellica). J Agric Food Chem. 2012; 60(30): 7375–83.
19. De Nicola G.R., Bagatta M., Pagnotta E. ym. Comparison of bioactive phytochemical content and release of isothiocyanates in selected brassica sprouts. Food Chem. 2013; 141(1): 297–303.
20. Capaldi E.D. ja Privitera G.J. Decreasing dislike for sour and bitter in children and adults. Appetite. 2008; 50(1): 139–45.
21. Sama.
22. Sharafi M., Hayes J.E. ja Duffy V.B. Masking vegetable bitterness to improve palatability depends on vegetable type and taste phenotype. Chemosens Percept. 2013; 6(1): 8–19.
23. Brown M.J., Ferruzzi M.G., Nguyen M.L. ym. Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. Am J Clin Nutr. 2004; 80(2): 396–403.
24. Unlu N.Z., Bohn T., Clinton S.K. ja Schwartz S.J. Carotenoid absorption from salad and salsa by humans is enhanced by the addition of avocado or avocado oil. J Nutr. 2005; 135(3): 431–6.
25. Roodenburg A.J., Leenen R., van het Hof K.H., Weststrate J.A. ja Tijburg L.B. Amount of fat in the diet affects bioavailability of lutein esters but not of alpha-carotene, beta-carotene, and vitamin E in humans. Am J Clin Nutr. 2000; 71(5): 1187–93.
26. Bongoni R., Verkerk R., Steenbekkers B., Dekker M. ja Stieger M. Evaluation of different cooking conditions on broccoli (Brassica oleracea var. italica) to improve the nutritional value and consumer acceptance. Plant Foods Hum Nutr. 2014; 69(3): 228–34.
27. Johnston C.S., Steplewska I., Long C.A., Harris L.N. ja Ryals R.H. Examination of the antiglycemic properties of vinegar in healthy adults. Ann Nutr Metab. 2010; 56(1): 74–9.
28. Johnston C.S. ja Gaas C.A. Vinegar: medicinal uses and antiglycemic effect. MedGenMed. 2006; 8(2): 61.
29. White A.M. ja Johnston C.S. Vinegar ingestion at bedtime moderates waking glucose concentrations in adults with well-controlled type 2 diabetes. Diabetes Care. 2007; 30(11): 2814–5.
30. Johnston C.S., White A.M. ja Kent S.M. Preliminary evidence that regular vinegar ingestion favorably influences hemoglobin A1c values in individuals with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2009; 84(2): e15–7.
31. Chung C.H. Corrosive oesophageal injury following vinegar ingestion. Hong Kong Med J. 2002; 8(5): 365–6.
32. Lhotta K., Höfle G., Gasser R. ja Finkenstedt G. Hypokalemia, hyperreninemia and osteoporosis in a patient ingesting large amounts of cider vinegar. Nephron. 1998; 80(2): 242–3.
33. Wu D., Kimura F., Takashima A. ym. Intake of vinegar beverage is associated with restoration of ovulatory function in women with polycystic ovary syndrome. Tohoku J Exp Med. 2013; 230(1): 17–23.
34. Sakakibara S., Murakami R., Takahashi M. ym. Vinegar intake enhances flow-mediated vasodilatation via upregulation of endothelial nitric oxide synthase activity. Biosci Biotechnol Biochem. 2010; 74(5): 1055–61.
35. Kajimoto O., Ohshima Y., Tayama K., Hirata H., Nishimura A. ja Tsukamoto Y. Hypotensive effects of drinks containing vinegar on high normal blood pressure and mild hypertensive subjects. J Nutr Food. 2003; 6: 51–68.
36. Takano-Lee M., Edman J.D., Mullens B.A. ja Clark J.M. Home remedies to control head lice: assessment of home remedies to control the human head louse, Pediculus humanus capitis (Anoplura: Pediculidae). J Pediatr Nurs. 2004; 19(6): 393–8.
37. Kondo T., Kishi M., Fushimi T., Ugajin S. ja Kaga T. Vinegar intake reduces body weight, body fat mass, and serum triglyceride levels in obese Japanese subjects. Biosci Biotechnol Biochem. 2009; 73(8): 1837–43.
38. Bergquist S.A., Gertsson U.E., Knuthsen P. ja Olsson M.E. Flavonoids in baby spinach (Spinacia oleracea L.): changes during plant growth and storage. J Agric Food Chem. 2005; 53(24): 9459–64.
39. Xiao Z., Lester G.E., Luo Y. ja Wang Q. Assessment of vitamin and carotenoid concentrations of emerging food products: edible microgreens. J Agric Food Chem. 2012; 60(31): 7644–51.
40. Dechet A.M., Herman K.M., Chen Parker C. ym. Outbreaks caused by sprouts, United States, 1998–2010: lessons learned and solutions needed. Foodborne Pathog Dis. 2014; 11(8): 635–44.
41. Yhdysvaltojen elintarvike- ja lääkevirasto. Playing it safe with eggs. http://www.fda.gov/Food/ResourcesForYou/Consumers/ucm077342.htm. Päivitetty 30.3.2015. Haettu 14.4.2015.

Muut kasvikset
1. Murray C.J., Atkinson C., Bhalla K. ym. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013; 310(6): 591–608.
2. Lim S.S., Vos T., Flaxman A.D. ym. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224–60.
3. O’Hara J.K. The $11 trillion reward: how simple dietary changes can save lives and money, and how we get there. http://www.ucsusa.org/assets/documents/food_and_agriculture/11-trillion-reward.pdf. 8.2013. Haettu 15.4.2015.
4. Murakami A. ja Ohnishi K. Target molecules of food phytochemicals: food science bound for the next dimension. Food Funct. 2012; 3(5): 462–76.
5. Watzl B., Bub A., Brandstetter B.R. ja Rechkemmer G. Modulation of human T-lymphocyte functions by the consumption of carotenoid-rich vegetables. Br J Nutr. 1999; 82(5): 383–9.
6. Willcox J.K., Catignani G.L. ja Lazarus S. Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr. 2003; 43(1): 1–18.
7. Dutta-Roy A.K., Crosbie L. ja Gordon M.J. Effects of tomato extract on human platelet aggregation in vitro. Platelets. 2001; 12(4): 218–27.
8. O’Kennedy N., Crosbie L., Whelan S. ym. Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. Am J Clin Nutr. 2006; 84(3): 561–9.
9. O’Kennedy N., Crosbie L., van Lieshout M., Broom J.I., Webb D.J. ja Duttaroy A.K. Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans. Am J Clin Nutr. 2006; 84(3): 570–9.
10. Fuentes E., Forero-Doria O., Carrasco G. ym. Effect of tomato industrial processing on phenolic profile and antiplatelet activity. Molecules. 2013; 18(9): 11526–36.
11. Nurk E., Refsum H., Drevon C.A. ym. Cognitive performance among the elderly in relation to the intake of plant foods. The Hordaland Health Study. Br J Nutr. 2010; 104(8): 1190–201.
12. Putnam J., Allshouse J. ja Kantor L.S. U.S. per capita food supply trends: more calories, refined carbohydrates, and fats. FoodReview. 2002; 25: 2–15.
13. Bhupathiraju S.N. ja Tucker K.L. Greater variety in fruit and vegetable intake is associated with lower inflammation in Puerto Rican adults. Am J Clin Nutr. 2011; 93(1): 37–46.
14. Cooper A.J., Sharp S.J., Lentjes M.A. ym. A prospective study of the association between quantity and variety of fruit and vegetable intake and incident type 2 diabetes. Diabetes Care. 2012; 35(6): 1293–300.
15. Lichtenstein A.H., Appel L.J., Brands M. ym. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006; 114(1): 82–96.
16. Büchner F.L., Bueno-de-Mesquita H.B., Ros M.M. ym. Variety in fruit and vegetable consumption and the risk of lung cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2010; 19(9): 2278–86.
17. Dias J.S. Nutritional quality and health benefits of vegetables: a review. Food and Nutrition Sciences. 2012; 3(10): 1354–74.
18. Sillanpää S., Salminen J-P. ja Eeva T. Breeding success and lutein availability in great tit (Parus major). Acta Oecologica. 2009; 35(6): 805–10.
19. Whitehead R.D., Coetzee V., Ozakinci G. ja Perrett D.I. Cross-cultural effects of fruit and vegetable consumption on skin color. Am J Public Health. 2012; 102(2): 212–3.
20. Stephen I.D., Law Smith M.J., Stirrat M.R. ja Perrett D.I. Facial skin coloration affects perceived health of human faces. Int J Primatol. 2009; 30(6): 845–57.
21. Whitehead R.D., Re D., Xiao D., Ozakinci G. ja Perrett D.I. You are what you eat: within-subject increases in fruit and vegetable consumption confer beneficial skin-color changes. PLoS ONE. 2012; 7(3): e32988.
22. Whitehead R.D., Ozakinci G., Stephen I.D. ja Perrett D.I. Appealing to vanity: could potential appearance improvement motivate fruit and vegetable consumption? Am J Public Health. 2012; 102(2): 207–11.
23. Nagata C., Nakamura K., Wada K. ym. Association of dietary fat, vegetables and antioxidant micronutrients with skin ageing in Japanese women. Br J Nutr. 2010; 103(10): 1493–8.
24. Greens to be gorgeous: Why eating your five fruit and veg a day makes you sexy. Daily Mail. http://www.dailymail.co.uk/health/article-1228348/Eating-fruit-veg-makes-attractiveopposite-sex.html. 17.11.2009. Haettu 14.4.2015.
25. Paul B.D. ja Snyder S.H. The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death Differ. 2010; 17(7): 1134–40.
26. Sama.
27. Berk L. ja Castle W.B. Observations on the etiologic relationship of achylia gastrica to pernicious anemia; activity of vitamin B12 as food, extrinsic factor. N Engl J Med. 1948; 239(24): 911–3.
28. Ey J., Schömig E. ja Taubert D. Dietary sources and antioxidant effects of ergothioneine. J Agric Food Chem. 2007; 55(16): 6466–74.
29. Nguyen T.H., Nagasaka R. ja Ohshima T. Effects of extraction solvents, cooking procedures and storage conditions on the contents of ergothioneine and phenolic compounds and antioxidative capacity of the cultivated mushroom Flammulina velutipes. Int J Food Sci Tech. 2012; 47(6): 1193–205.
30. Schulzová V., Hajslová J., Peroutka R., Gry J. ja Andersson H.C. Influence of storage and household processing on the agaritine content of the cultivated Agaricus mushroom. Food Addit Contam. 2002; 19(9): 853–62.
31. Gry J. Mushrooms traded as food. Vol II sec 2. http://norden.diva-portal.org/smash/get/diva2: 733528/FULLTEXT01.pdf. 18.7.2012. Haettu 15.4.2015.
32. Mitchell S.C. Food idiosyncrasies: beetroot and asparagus. Drug Metab Dispos. 2001; 29(4 Pt 2): 539–43.
33. Donado-Pestana C.M., Mastrodi Salgado J., de Oliveira Rios A., dos Santos P.R. ja Jablonski A. Stability of carotenoids, total phenolics and in vitro antioxidant capacity in the thermal processing of orange-fleshed sweet potato (Ipomoea batatas Lam) cultivars grown in Brazil. Plant Foods Hum Nutr. 2012; 67(3): 262–70.
34. Padda M.S. ja Picha D.H. Phenolic composition and antioxidant capacity of different heatprocessed forms of sweetpotato cv. “Beauregard.” Int J Food Sci Tech. 2008; 43(8): 1404–9.
35. Bovell-Benjamin A.C. Sweet potato: a review of its past, present, and future role in human nutrition. Adv Food Nutr Res. 2007; 52: 1–59.
36. Center for Science in the Public Interest. 10 best foods. http://www.nutritionaction.com/freedownloads/what-to-eat-10-best-foods/. Haettu 15.4.2015.
37. Wilson C.D., Pace R.D., Bromfield E., Jones G. ja Lu J.Y. Consumer acceptance of vegetarian sweet potato products intended for space missions. Life Support Biosph Sci. 1998; 5(3): 339–46.
38. Drewnowski A. New metrics of affordable nutrition: which vegetables provide most nutrients for least cost? J Acad Nutr Diet. 2013; 113(9): 1182–7.
39. Ameny M.A. ja Wilson P.W. Relationship between hunter color values and b-carotene contents in white-fleshed African sweet potatoes (Ipomoea batatas Lam). J Sci Food Agric. 1997; 73: 301–6.
40. Kaspar K.L., Park J.S., Brown C.R., Mathison B.D., Navarre D.A. ja Chew B.P. Pigmented potato consumption alters oxidative stress and inflammatory damage in men. J Nutr. 2011; 141(1): 108–11.
41. Vinson J.A., Demkosky C.A., Navarre D.A. ja Smyda M.A. High-antioxidant potatoes: acute in vivo antioxidant source and hypotensive agent in humans after supplementation to hypertensive subjects. J Agric Food Chem. 2012; 60(27): 6749–54.
42. Carlsen M.H., Halvorsen B.L., Holte K. ym. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010; 9: 3.
43. Katso viite 41.
44. Lim S., Xu J., Kim J. ym. Role of anthocyanin-enriched purple-fleshed sweet potato p40 in colorectal cancer prevention. Mol Nutr Food Res. 2013; 57(11): 1908–17.
45. Olsen A., Ritz C., Kramer L. ja Møller P. Serving styles of raw snack vegetables. What do children want? Appetite. 2012; 59(2): 556–62.
46. Sesame Workshop. ”If Elmo eats broccoli, will kids eat it too?” Atkins Foundation grant to fund further research. https://web.archive.org/web/20130125205947/http://archive.sesameworkshop.org/aboutus/inside_press.php?contentId=15092302. 20.9.2005. Haettu 30.6.2015.
47. Kros W., Paulis W.D. ja van der Wouden J.C. Increasing vegetable intake in Mexican-American youth: design and analysis issues. J Am Diet Assoc. 2011; 111(11): 1657.
48. Fisher J.O., Mennella J.A., Hughes S.O., Liu Y., Mendoza P.M. ja Patrick H. Offering ”dip” promotes intake of a moderately-liked raw vegetable among preschoolers with genetic sensitivity to bitterness. J Acad Nutr Diet. 2012; 112(2): 235–45.
49. Isoldi K.K., Dalton S., Rodriguez D.P. ja Nestle M. Classroom ”cupcake” celebrations: observations of foods offered and consumed. J Nutr Educ Behav. 2012; 44(1): 71–5.
50. Wansink B., Just D.R., Payne C.R. ja Klinger M.Z. Attractive names sustain increased vegetable intake in schools. Prev Med. 2012; 55(4): 330–2.
51. Wansink B., van Ittersum K. ja Painter J.E. How descriptive food names bias sensory perceptions in restaurants. Food Qual Prefer. 2005; 16(5): 393–400.
52. Katso viite 50.
53. Sama.
54. Spill M.K., Birch L.L., Roe L.S. ja Rolls B.J. Hiding vegetables to reduce energy density: an effective strategy to increase children’s vegetable intake and reduce energy intake. Am J Clin Nutr. 2011; 94(3): 735–41.
55. Blatt A.D., Roe L.S. ja Rolls B.J. Hidden vegetables: an effective strategy to reduce energy intake and increase vegetable intake in adults. Am J Clin Nutr. 2011; 93(4): 756–63.
56. Vereecken C., Rovner A. ja Maes L. Associations of parenting styles, parental feeding practices and child characteristics with young children’s fruit and vegetable consumption. Appetite. 2010; 55(3): 589–96.
57. World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, D.C.: AICR, 2007.
58. Annema N., Heyworth J.S., McNaughton S.A., Iacopetta B. ja Fritschi L. Fruit and vegetable consumption and the risk of proximal colon, distal colon, and rectal cancers in a case-control study in Western Australia. J Am Diet Assoc. 2011; 111(10): 1479–90.
59. Boivin D., Lamy S., Lord-Dufour S. ym. Antiproliferative and antioxidant activities of common vegetables: a comparative study. Food Chem. 2009; 112: 374–80.
60. Sama.
61. Sama.
62. Sama.
63. Sama.
64. Abdull Razis A.F. ja Noor N.M. Cruciferous vegetables: dietary phytochemicals for cancer prevention. Asian Pac J Cancer Prev. 2013; 14(3): 1565–70.
65. Nicastro H.L., Ross S.A. ja Milner J.A. Garlic and onions: their cancer prevention properties. Cancer Prev Res (Phila). 2015; 8(3): 181–9.
66. Oude Griep L.M., Geleijnse J.M., Kromhout D., Ocké M.C. ja Verschuren W.M. Raw and processed fruit and vegetable consumption and 10-year coronary heart disease incidence in a populationbased cohort study in the Netherlands. PLoS ONE. 2010; 5(10): e13609.
67. Gliszczyńska-Swigło A., Ciska E., Pawlak-Lemańska K., Chmielewski J., Borkowski T. ja Tyrakowska B. Changes in the content of health-promoting compounds and antioxidant activity of broccoli after domestic processing. Food Addit Contam. 2006; 23(11): 1088–98.
68. Ghavami A., Coward W.A. ja Bluck L.J. The effect of food preparation on the bioavailability of carotenoids from carrots using intrinsic labelling. Br J Nutr. 2012; 107(9): 1350–66.
69. Garcia A.L., Koebnick C., Dagnelie P.C. ym. Long-term strict raw food diet is associated with favourable plasma beta-carotene and low plasma lycopene concentrations in Germans. Br J Nutr. 2008; 99(6): 1293–300.
70. Bohm V. ja Bitsch R. Intestinal absorption of lycopene from different matrices and interactions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma. Eur J Nutr. 1999; 38: 118–25.
71. Kahlon T.S., Chiu M.M. ja Chapman M.H. Steam cooking significantly improves in vitro bile acid binding of collard greens, kale, mustard greens, broccoli, green bell pepper and cabbage. Nutr Res. 2008; 28: 351–7.
72. Javitt N.B., Budai K., Miller D.G., Cahan A.C., Raju U. ja Levitz M. Breast-gut connection: origin of chenodeoxycholic acid in breast cyst fluid. Lancet. 1994; 343(8898): 633–5.
73. Stott-Miller M., Neuhouser M.L. ja Stanford J.L. Consumption of deep-fried foods and risk of prostate cancer. Prostate. 2013; 73(9): 960–9.
74. Chen M.J., Hsu H.T., Lin C.L. ja Ju W.Y. A statistical regression model for the estimation of acrylamide concentrations in French fries for excess lifetime cancer risk assessment. Food Chem Toxicol. 2012; 50(10): 3867–76.
75. Lineback D.R., Coughlin J.R. ja Stadler R.H. Acrylamide in foods: a review of the science and future considerations. Annu Rev Food Sci Technol. 2012; 3: 15–35.
76. Jiménez-Monreal A.M., Garcia-Diz L., Martinez-Tomé M., Mariscal M. ja Murcia M.A. Influence of cooking methods on antioxidant activity of vegetables. J Food Sci. 2009; 74(3): H97– H103.
77. Sama.
78. Sama.
79. Barański M., Srednicka-Tober D., Volakakis N. ym. Higher antioxidant and lower cadmium concentrations and lower incidence of pesticide residues in organically grown crops: a systematic literature review and meta-analyses. Br J Nutr. 2014; 112(5): 794–811.
80. Krol W.J. Removal of trace pesticide residues from produce. Connecticut Agricultural Experiment Station. http://www.ct.gov/caes/cwp/view.asp?a=2815&q=376676. 28.6.2012. Haettu 16.4.2015.
81. Krieger R.I., Brutsche-Keiper P., Crosby H.R. ja Krieger A.D. Reduction of pesticide residues of fruit using water only or Plus Fit Fruit and Vegetable Wash. Bull Environ Contam Toxicol. 2003; 70(2): 213–8.
82. Krol W.J., Arsenault T.L., Pylypiw H.M. ja Incorvia Mattina M.J. Reduction of pesticide residues on produce by rinsing. J Agric Food Chem. 2000; 48(10): 4666–70.
83. Wang Z., Huang J., Chen J. ja Li F. Effectiveness of dishwashing liquids in removing chlorothalonil and chlorpyrifos residues from cherry tomatoes. Chemosphere. 2013; 92(8): 1022–8.
84. Zohair A. Behaviour of some organophosphorus and organochlorine pesticides in potatoes during soaking in different solutions. Food Chem Toxicol. 2001; 39(7): 751–5.
85. Zhang Z.Y., Liu X.J. ja Hong X.Y. Effects of home preparation on pesticide residues in cabbage. Food Control. 2007; 18(12): 1484–7.
86. Katso viite 84.
87. Yhdysvaltojen maatalousministeriö (USDA). Organic Agriculture. http://www.usda.gov/wps/portal/usda/usdahome?contentidonly=true&contentid=organic-agriculture.html. Päivitetty 9.1.2015. Haettu 30.3.2015.
88. Monette M. The science of pesticide-free potato chips. CMAJ. 2012; 184(14): E741–2.
89. Smith-Spangler C., Brandeau M.L., Hunter G.E. ym. Are organic foods safer or healthier than conventional alternatives?: a systematic review. Ann Intern Med. 2012; 157(5): 348–66.
90. Katso viite 79.
91. Forman J. ja Silverstein J. Organic foods: health and environmental advantages and disadvantages. Pediatrics. 2012; 130(5): e1406–15.
92. Katso viite 79.
93. Lindén A., Andersson K. ja Oskarsson A. Cadmium in organic and conventional pig production. Arch Environ Contam Toxicol. 2001; 40(3): 425–31.
94. Lee W.C.J., Shimizu M., Kniffin K.M. ja Wansink B. You taste what you see: do organic labels bias taste perceptions? Food Qual Prefer. 2013; 29(1): 33–9.
95. Williams P.R. ja Hammitt J.K. Perceived risks of conventional and organic produce: pesticides, pathogens, and natural toxins. Risk Anal. 2001; 21(2): 319–30.
96. Hammitt J.K. Risk perceptions and food choice: an exploratory analysis of organic-versus conventional-produce buyers. Risk Anal. 1990; 10(3): 367–74.
97. Reiss R., Johnston J., Tucker K., Desesso J.M. ja Keen C.L. Estimation of cancer risks and benefits associated with a potential increased consumption of fruits and vegetables. Food Chem Toxicol. 2012; 50(12): 4421–7.
98. Winter C.K. Pesticide residues in imported, organic, and ”suspect” fruits and vegetables. J Agric Food Chem. 2012; 60(18): 4425–9.

Pellavansiemenet
1. Singh K.K., Mridula D., Rehal J. ja Barnwal P. Flaxseed: a potential source of food, feed and fiber. Crit Rev Food Sci Nutr. 2011; 51(3): 210–22.
2. Hyvärinen H.K., Pihlava J.M., Hiidenhovi J.A., Hietaniemi V., Korhonen H.J. ja Ryhänen E.L. Effect of processing and storage on the stability of flaxseed lignan added to bakery products. J Agric Food Chem. 2006; 54(1): 48–53.
3. Cunnane S.C., Hamadeh M.J., Liede A.C., Thompson L.U., Wolever T.M. ja Jenkins D.J. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr. 1995; 61(1): 62–8.
4. Davidi A., Reynolds J., Njike V.Y., Ma Y., Doughty K. ja Katz D.L. The effect of the addition of daily fruit and nut bars to diet on weight, and cardiac risk profile, in overweight adults. J Hum Nutr Diet. 2011; 24(6): 543–51.
5. Chai S.C., Hooshmand S., Saadat R.L., Payton M.E., Brummel-Smith K. ja Arjmandi B.H. Daily apple versus dried plum: impact on cardiovascular disease risk factors in postmenopausal women. J Acad Nutr Diet. 2012; 112(8): 1158–68.
6. Peterson J.M., Montgomery S., Haddad E., Kearney L. ja Tonstad S. Effect of consumption of dried California mission figs on lipid concentrations. Ann Nutr Metab. 2011; 58(3): 232–8.
7. Katso viite 5.
8. Puglisi M.J., Vaishnav U., Shrestha S. ym. Raisins and additional walking have distinct effects on plasma lipids and inflammatory cytokines. Lipids Health Dis. 2008; 7: 14.
9. Chai S.C., Hooshmand S., Saadat R.L. ja Arjmandi B.H. Daily apple consumption promotes cardiovascular health in postmenopausal women. The FASEB Journal. 2011; 25: 971.10.
10. Keast D.R., O’Neil C.E. ja Jones J.M. Dried fruit consumption is associated with improved diet quality and reduced obesity in US adults: National Health and Nutrition Examination Survey, 1999–2004. Nutr Res. 2011; 31(6): 460–7.
11. Edel A.L., Rodriguez-Leyva D., Maddaford T.G. ym. Dietary flaxseed in dependently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease. J Nutr. 2015; 145(4): 749–57.

Pähkinät ja siemenet
1. Fraser G.E. ja Shavlik D.J. Ten years of life: is it a matter of choice? Arch Intern Med. 2001; 161(13): 1645–52.
2. Lim S.S., Vos T., Flaxman A.D. ym. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224–60.
3. Yhdysvaltojen maatalousministeriö (USDA). Oxygen Radical Absorbance Capacity (ORAC) of Selected Foods—2007. http://www.orac-info-portal.de/download/ORAC_R2.pdf. 11.2007. Haettu 10.4.2015.
4. Ros E. ja Mataix J. Fatty acid composition of nuts—implications for cardiovascular health. Br J Nutr. 2006; 96 Suppl 2: S29–35.
5. Yang J., Liu R.H. ja Halim L. Antioxidant and antiproliferative activities of common edible nut seeds. Food Sci Tech. 2009; 42(1): 1–8.
6. Bao Y., Han J., Hu F.B. ym. Association of nut consumption with total and cause-specific mortality. N Engl J Med. 2013; 369(21): 2001–11.
7. Luu H.N., Blot W.J., Xiang Y.B. ym. Prospective evaluation of the association of nut/peanut consumption with total and cause-specific mortality. JAMA Intern Med. 2015; 175(5): 755–66.
8. Fernández-Montero A., Bes-Rastrollo M., Barrio-López M.T. ym. Nut consumption and 5-yall-cause mortality in a Mediterranean cohort: the SUN project. Nutrition. 2014; 30(9): 1022–7.
9. Estruch R., Ros E., Salas-Salvadó J. ym. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013; 368(14): 1279–90.
10. Täydennysosa tekstiin Estruch R., Ros E., Salas-Salvadó J. ym. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368: 1279–90. DOI: 10.1056/NEJMoa1200303
11. Katso viite 9.
12. Guasch-Ferré M., Bulló M., Martínez-González M.A. ym. Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial. BMC Med. 2013; 11: 164.
13. Guasch-Ferré M., Hu F.B., Martínez-González M.A. ym. Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study. BMC Med. 2014; 12: 78.
14. Keys A. Olive oil and coronary heart disease. Lancet. 1987; 1(8539): 983–4.
15. Katso viite 12.
16. Toner C.D. Communicating clinical research to reduce cancer risk through diet: walnuts as a case example. Nutr Res Pract. 2014; 8(4): 347–51.
17. Li T.Y., Brennan A.M., Wedick N.M., Mantzoros C., Rifai N. ja Hu F.B. Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr. 2009; 139(7): 1333–8.
18. Su X., Tamimi R.M., Collins L.C. ym. Intake of fiber and nuts during adolescence and incidence of proliferative benign breast disease. Cancer Causes Control. 2010; 21(7): 1033–46.
19. Natoli S. ja McCoy P. A review of the evidence: nuts and body weight. Asia Pac J Clin Nutr. 2007; 16(4): 588–97.
20. Martínez-González M.A. ja Bes-Rastrollo M. Nut consumption, weight gain and obesity: Epidemiological evidence. Nutr Metab Cardiovasc Dis. 2011; 21 Suppl 1: S40–5.
21. Wang X., Li Z., Liu Y., Lv X. ja Yang W. Effects of pistachios on body weight in Chinese subjects with metabolic syndrome. Nutr J. 2012; 11: 20.
22. Painter J. The pistachio principle: calorie reduction without calorie restriction. Weight Management Matters. 2008; 6: 8.
23. Murakami K., Sasaki S., Takahashi Y. ym. Hardness (difficulty of chewing) of the habitual diet in relation to body mass index and waist circumference in free-living Japanese women aged 18–22 y. Am J Clin Nutr. 2007; 86(1): 206–13.
24. McKiernan F., Lokko P., Kuevi A. ym. Effects of peanut processing on body weight and fasting plasma lipids. Br J Nutr. 2010; 104(3): 418–26.
25. Brennan A.M., Sweeney L.L., Liu X. ja Mantzoros C.S. Walnut consumption increases satiation but has no effect on insulin resistance or the metabolic profile over a 4-day period. Obesity (Silver Spring). 2010; 18(6): 1176–82.
26. Mattes R.D., Kris-Etherton P.M. ja Foster G.D. Impact of peanuts and tree nuts on body weight and healthy weight loss in adults. J Nutr. 2008; 138(9): 1741S–5S.
27. Tapsell L., Batterham M., Tan S.Y. ja Warensjö E. The effect of a calorie controlled diet containing walnuts on substrate oxidation during 8-hours in a room calorimeter. J Am Coll Nutr. 2009; 28(5): 611–7.
28. Chiurlia E., D’Amico R., Ratti C., Granata A.R., Romagnoli R. ja Modena M.G. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Coll Cardiol. 2005; 46(8): 1503–6.
29. Montorsi P., Ravagnani P.M., Galli S. ym. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol. 2005; 96(12B): 19M–23M.
30. Montorsi P., Montorsi F. ja Schulman C.C. Is erectile dysfunction the ”tip of the iceberg” of a systemic vascular disorder? Eur Urol. 2003; 44(3): 352–4.
31. Montorsi F., Briganti A., Salonia A. ym. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol. 2003; 44(3): 360–4.
32. Katso viite 29.
33. Meldrum D.R., Gambone J.C., Morris M.A., Meldrum D.A., Esposito K. ja Ignarro L.J. The link between erectile and cardiovascular health: the canary in the coal mine. Am J Cardiol. 2011; 108(4): 599–606.
34. Corona G., Fagioli G., Mannucci E. ym. Penile doppler ultrasound in patients with erectile dysfunction (ED): role of peak systolic velocity mea sured in the flaccid state in predicting arteriogenic ED and silent coronary artery disease. J Sex Med. 2008; 5(11): 2623–34.
35. Schwartz B.G. ja Kloner R.A. How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors. Int J Impot Res. 2009; 21(6): 327–35.
36. Inman B.A., Sauver J.L., Jacobson D.J. ym. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009; 84(2): 108–13.
37. Jackson G. Erectile dysfunction and coronary disease: evaluating the link. Maturitas. 2012; 72(3): 263–4.
38. Fung M.M., Bettencourt R. ja Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol. 2004; 43(8): 1405–11.
39. Gupta B.P., Murad M.H., Clifton M.M., Prokop L., Nehra A. ja Kopecky S.L. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011; 171(20): 1797–803.
40. Jackson G. Problem solved: erectile dysfunction (ED) = early death (ED). Int J Clin Pract.2010; 64(7): 831–2.
41. Aldemir M., Okulu E., Neşelioğlu S., Erel O. ja Kayıgil O. Pistachio diet improves erectile function parameters and serum lipid profiles in patients with erectile dysfunction. Int J Impot Res. 2011; 23(1): 32–8.
42. Esposito K., Ciotola M., Maiorino M.I. ym. Hyperlipidemia and sexual function in premenopausal women. J Sex Med. 2009; 6(6): 1696–703.
43. Baer H.J., Glynn R.J., Hu F.B. ym. Risk factors for mortality in the Nurses’ Health Study: a competing risks analysis. Am J Epidemiol. 2011; 173(3): 319–29.
44. Ros E. ja Hu F.B. Consumption of plant seeds and cardiovascular health: epidemiological and clinical trial evidence. Circulation. 2013; 128(5): 553–65.
45. Strate L.L., Liu Y.L., Syngal S., Aldoori W.H. ja Giovannucci E.L. Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA. 2008; 300(8): 907–14.

Yrtit ja mausteet
1. Srinivasan K. Antioxidant potential of spices and their active constituents. Crit Rev Food Sci Nutr.2014; 54(3): 352–72.
2. Carlsen M.H., Halvorsen B.L., Holte K. ym. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010; 9: 3.
3. Tapsell L.C., Hemphill I., Cobiac L. ym. Health benefits of herbs and spices: the past, the present, the future. Med J Aust. 2006; 185(4 Suppl): S4–24.
4. Shishodia S., Sethi G. ja Aggarwal B.B. Curcumin: getting back to the roots. Ann NY Acad Sci. 2005; 1056: 206–17.
5. Gupta S.C., Patchva S. ja Aggarwal B.B. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013; 15(1): 195–218.
6. Agarwal K.A., Tripathi C.D., Agarwal B.B. ja Saluja S. Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebocontrolled study. Surg Endosc. 2011; 25(12): 3805–10.
7. Chandran B. ja Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012; 26(11): 1719–25.
8. Kuptniratsaikul V., Dajpratham P., Taechaarpornkul W. ym. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 2014; 9: 451–8.
9. Khajehdehi P., Zanjaninejad B., Aflaki E. ym. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study. J Ren Nutr. 2012; 22(1): 50–7.
10. Vecchi Brumatti L., Marcuzzi A., Tricarico P.M., Zanin V., Girardelli M. ja Bianco A.M. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. Molecules. 2014; 19(12): 21127–53.
11. Lang A., Salomon N., Wu J.C. ym. Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol Hepatol. 2015; 13(8): 1444–49.e1.
12. Percival S.S., Vanden Heuvel J.P., Nieves C.J., Montero C., Migliaccio A.J. ja Meadors J. Bioavailability of herbs and spices in humans as determined by ex vivo inflammatory suppression and DNA strand breaks. J Am Coll Nutr. 2012; 31(4): 288–94.
13. Gupta S.C., Sung B., Kim J.H., Prasad S., Li S. ja Aggarwal B.B. Multitargeting by turmeric, the golden spice: from kitchen to clinic. Mol Nutr Food Res. 2013; 57(9): 1510–28.
14. Siruguri V. ja Bhat R.V. Assessing intake of spices by pattern of spice use, frequency of consumption and portion size of spices consumed from routinely prepared dishes in southern India. Nutr J. 2015; 14: 7.
15. Gilani A.H. ja Rahman A.U. Trends in ethnopharmacology. J Ethnopharmacol. 2005; 100 (1–2): 43–9.
16. Newman D.J. ja Cragg G.M. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007; 70(3): 461–77.
17. Atal C.K., Dubey R.K. ja Singh J. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther. 1985; 232(1): 258–62.
18. Shoba G., Joy D., Joseph T., Majeed M., Rajendran R. ja Srinivas P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998; 64(4): 353–6.
19. Anand P., Kunnumakkara A.B., Newman R.A. ja Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007; 4(6): 807–18.
20. Sama.
21. Jacobson M.S. Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations. Lancet. 1987; 2(8560): 656–8.
22. Percival S.S., Vanden Heuvel J.P., Nieves C.J., Montero C., Migliaccio A.J. ja Meadors J. Bioavailability of herbs and spices in humans as determined by ex vivo inflammatory suppression and DNA strand breaks. J Am Coll Nutr. 2012; 31(4): 288–94.
23. Arjmandi B.H., Khalil D.A., Lucas E.A. ym. Soy protein may alleviate osteoarthritis symptoms. Phytomedicine. 2004; 11(7–8): 567–75.
24. Agarwal K.A., Tripathi C.D., Agarwal B.B. ja Saluja S. Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebocontrolled study. Surg Endosc. 2011; 25(12): 3805–10.
25. Aggarwal B.B., Yuan W., Li S. ja Gupta S.C. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: identification of novel components of turmeric. Mol Nutr Food Res. 2013; 57(9): 1529–42.
26. Kim J.H., Gupta S.C., Park B., Yadav V.R. ja Aggarwal B.B. Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Mol Nutr Food Res. 2012; 56(3): 454–65.
27. Katso viite 25.
28. Bengmark S., Mesa M.D. ja Gil A. Plant-derived health: the effects of turmeric and curcuminoids. Nutr Hosp. 2009; 24(3): 273–81.
29. Cao J., Jia L., Zhou H.M., Liu Y. ja Zhong L.F. Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol Sci. 2006; 91(2): 476–83.
30. Kurkuma ja kurkumiini ravintolisinä ja mausteina. https://www.consumerlab.com/reviews/turmeric-curcumin-supplements-spice-review/turmeric/. 3.3. 2015. Haettu 17.4.2015.
31. Rasyid A. ja Lelo A. The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Aliment Pharmacol Ther. 1999; 13(2): 245–9.
32. Rasyid A., Rahman A.R., Jaalam K. ja Lelo A. Effect of different curcumin dosages on human gall bladder. Asia Pac J Clin Nutr. 2002; 11(4): 314–8.
33. Asher G.N. ja Spelman K. Clinical utility of curcumin extract. Altern Ther Health Med. 2013; 19(2): 20–2.
34. Goel A., Kunnumakkara A.B. ja Aggarwal B.B. Curcumin as ”curecumin”: from kitchen to clinic. Biochem Pharmacol. 2008; 75(4): 787–809.
35. Ghosh Das S. ja Savage G.P. Total and soluble oxalate content of some Indian spices. Plant Foods Hum Nutr. 2012; 67(2): 186–90.
36. Katso viite 33.
37. Poole C., Bushey B., Foster C. ym. The effects of a commercially available botanical supplement on strength, body composition, power output, and hormonal profiles in resistance-trained males. J Int Soc Sports Nutr. 2010; 7: 34.
38. Shabbeer S., Sobolewski M., Anchoori R.K. ym. Fenugreek: a naturally occurring edible spice as an anticancer agent. Cancer Biol Ther. 2009; 8(3): 272–8.
39. Mebazaa R., Rega B. ja Camel V. Analysis of human male armpit sweat after fenugreek ingestion: characterisation of odour active compounds by gas chromatography coupled to mass spectrometry and olfactometry. Food Chem. 2011; 128(1): 227–35.
40. Korman S.H., Cohen E. ja Preminger A. Pseudo- maple syrup urine disease due to maternal prenatal ingestion of fenugreek. J Paediatr Child Health. 2001; 37(4): 403–4.
41. Marsh T.L. ja Arriola P.E. The science of salsa: antimicrobial properties of salsa components to learn scientifi c methodology. J Microbiol Biol Educ. 2009; 10(1): 3–8.
42. Mauer L. ja El- Sohemy A. Prevalence of cilantro (Coriandrum sativum) disliking among different ethnocultural groups. Flavour. 2012; 1: 8.
43. Eriksson N., Wu S., Do C.B. ym. A genetic variant near olfactory receptor genes influences cilantro preference. Flavour. 2012; 1: 22.
44. Knaapila A., Hwang L.D., Lysenko A. ym. Genetic analysis of chemosensory traits in human twins. Chem Senses. 2012; 37(9): 869–81.
45. Katso viite 43.
46. Sahib N.G., Anwar F., Gilani A.H., Hamid A.A., Saari N. ja Alkharfy K.M. Coriander (Coriandrum sativum L.): a potential source of high- value components for functional foods and nutraceuticals—a review. Phytother Res. 2013; 27(10): 1439–56.
47. Rajeshwari C.U., Siri S. ja Andallu B. Antioxidant and antiarthritic potential of coriander (Coriandrum sativum L.) leaves. e- SPEN J. 2012; 7(6): e223–8.
48. Geppetti P., Fusco B.M., Marabini S., Maggi C.A., Fanciullacci M. ja Sicuteri F. Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man. Br J Pharmacol. 1988; 93(3): 509–14.
49. Nesbitt A.D. ja Goadsby P.J. Cluster headache. BMJ. 2012; 344: e2407.
50. Fusco B.M., Marabini S., Maggi C.A., Fiore G. ja Geppetti P. Preventative effect of repeated nasal applications of capsaicin in cluster headache. Pain. 1994; 59(3): 321–5.
51. Nozu T. ja Kudaira M. Altered rectal sensory response induced by balloon distention in patients with functional abdominal pain syndrome. Biopsychosoc Med. 2009; 3: 13.
52. Bortolotti M. ja Porta S. Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study. Dig Dis Sci. 2011; 56(11): 3288–95.
53. Bortolotti M., Coccia G. ja Grossi G. Red pepper and functional dyspepsia. N Engl J Med. 2002; 346(12): 947–8.
54. Hennessy S., Leonard C.E., Newcomb C., Kimmel S.E. ja Bilker W.B. Cisapride and ventricular arrhythmia. Br J Clin Pharmacol. 2008; 66(3): 375–85.
55. Mustafa T. ja Srivastava K.C. Ginger (Zingiber officinale) in migraine headache. J Ethnopharmacol. 1990; 29(3): 267–73.
56. Gottlieb M.S. Discovering AIDS. Epidemiology. 1998; 9(4): 365–7.
57. Ghofrani H.A., Osterloh I.H. ja Grimminger F. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov. 2006; 5(8): 689–702.
58. Vandenbroucke J.P. In defense of case reports and case series. Ann Intern Med. 2001; 134(4): 330–4.
59. Maghbooli M., Golipour F., Moghimi Esfandabadi A. ja Yousefi M. Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine. Phytother Res. 2014; 28(3): 412–5.
60. Desai H.G., Kalro R.H. ja Choksi A.P. Effect of ginger & garlic on DNA content of gastric aspirate. Indian J Med Res. 1990; 92: 139–41.
61. Wasson S. ja Jayam V.K. Coronary vasospasm and myocardial infarction induced by oral sumatriptan. Clin Neuropharmacol. 2004; 27(4): 198–200.
62. Laine K., Raasakka T., Mäntynen J. ja Saukko P. Fatal cardiac arrhythmia after oral sumatriptan. Headache. 1999; 39(7): 511–2.
63. Katso viite 59.
64. Coco A.S. Primary dysmenorrhea. Am Fam Physician. 1999; 60(2): 489–96.
65. Kashefi F., Khajehei M., Tabatabaeichehr M., Alavinia M. ja Asili J. Comparison of the effect of ginger and zinc sulfate on primary dysmenorrhea: a placebo-controlled randomized trial. Pain Manag Nurs. 2014; 15(4): 826–33.
66. Rahnama P., Montazeri A., Huseini H.F., Kianbakht S. ja Naseri M. Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial. BMC Complement Altern Med. 2012; 12: 92.
67. Ozgoli G., Goli M. ja Moattar F. Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. J Altern Complement Med. 2009; 15(2): 129–32.
68. Kashefi F., Khajehei M., Alavinia M., Golmakani E. ja Asili J. Effect of ginger (Zingiber officinale) on heavy menstrual bleeding: a placebo-controlled, randomized clinical trial. Phytother Res. 2015; 29(1): 114–9.
69. Khayat S., Kheirkhah M., Behboodi Moghadam Z., Fanaei H., Kasaeian A. ja Javadimehr M. Effect of treatment with ginger on the severity of premenstrual syndrome symptoms. ISRN Obstet Gynecol. 2014; 2014: 792708.
70. Mowrey D.B. ja Clayson D.E. Motion sickness, ginger, and psychophysics. Lancet. 1982; 1(8273): 655–7.
71. Palatty P.L., Haniadka R., Valder B., Arora R. ja Baliga M.S. Ginger in the prevention of nausea and vomiting: a review. Crit Rev Food Sci Nutr. 2013; 53(7): 659–69.
72. Ding M., Leach M. ja Bradley H. The effectiveness and safety of ginger for pregnancy-induced nausea and vomiting: a systematic review. Women Birth. 2013; 26(1): e26–30.
73. Carlsen M.H., Halvorsen B.L., Holte K. ym. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010; 9: 3.
74. American Thyroid Association Taskforce on Radioiodine Safety, Sisson J.C., Freitas J. ym. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid. 2011; 21(4): 335–46.
75. Metso S., Auvinen A., Huhtala H., Salmi J., Oksala H. ja Jaatinen P. Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer. 2007; 109(10): 1972–9.
76. Arami S., Ahmadi A. ja Haeri S.A. The radioprotective effects of Origanum vulgare extract against genotoxicity induced by (131)I in human blood lymphocyte. Cancer Biother Radiopharm. 2013; 28(3): 201–6.
77. Berrington D. ja Lall N. Anticancer activity of certain herbs and spices on the cervical epithelial carcinoma (HeLa) cell line. Evid Based Complement Alternat Med. 2012; 2012: 564927.
78. Gunawardena D., Shanmugam K., Low M. ym. Determination of anti-inflammatory activities of standardised preparations of plant- and mushroom-based foods. Eur J Nutr. 2014; 53(1): 335–43.
79. Al Dhaheri Y., Attoub S., Arafat K. ym. Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: inhibition of NFκB signaling and reduction of nitric oxide production. PLoS ONE. 2013; 8(7): e68808.
80. Haj-Husein I., Tukan S., ja Alkazaleh F. The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study. J Hum Nutr Diet. 2015; doi: 10.1111/jhn.12290.
81. Katso viite 73.
82. Sama.
83. Baliga M.S. ja Dsouza J.J. Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer. Eur J Cancer Prev. 2011; 20(3): 225–39.
84. Katso viite 73.
85. Darvin M.E., Patzelt A., Knorr F., Blume-Peytavi U., Sterry W. ja Lademann J. One-year study on the variation of carotenoid antioxidant substances in living human skin: influence of dietary supplementation and stress factors. J Biomed Opt. 2008; 13(4): 044028.
86. Mohanty P., Hamouda W., Garg R., Aljada A., Ghanim H. ja Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab. 2000; 85(8): 2970–3.
87. Ghanim H., Mohanty P., Pathak R., Chaudhuri A., Sia C.L. ja Dandona P. Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care. 2007; 30(6): 1406–11.
88. Prior R.L., Gu L., Wu X. ym. Plasma antioxidant capacity changes following a meal as a measure of the ability of a food to alter in vivo antioxidant status. J Am Coll Nutr. 2007; 26(2): 170–81.
89. Katso viite 73.
90. Saper R.B., Kales S.N., Paquin J. ym. Heavy metal content of Ayurvedic herbal medicine products. JAMA. 2004; 292(23): 2868–73.
91. Martena M.J., van der Wielen J.C., Rietjens I.M., Klerx W.N., de Groot H.N. ja Konings E.J. Monitoring of mercury, arsenic, and lead in traditional Asian herbal preparations on the Dutch market and estimation of associated risks. Food Addit Contam Part A. 2010; 27(2): 190–205.
92. Skulas-Ray A.C., Kris-Etherton P.M., Teeter D.L., Chen C.Y.O., Vanden Heuvel J.P. ja West S.G. A high antioxidant spice blend attenuates postprandial insulin and triglyceride responses and increases some plasma measures of antioxidant activity in healthy, overweight men. J Nutr. 2011; 141(8): 1451–7.
93. Tomita L.Y., Roteli-Martins C.M., Villa L.L., Franco E.L., Cardoso M.A. ja BRINCA Study Team. Associations of dietary dark-green and deep-yellow vegetables and fruits with cervical intraepithelial neoplasia: modification by smoking. Br J Nutr. 2011; 105(6): 928–37.
94. Gomaa E.A., Gray J.I., Rabie S., Lopez-Bote C. ja Booren A.M. Polycyclic aromatic hydrocarbons in smoked food products and commercial liquid smoke fl avourings. Food Addit Contam. 1993; 10(5): 503–21.
95. Fritschi G. ja Prescott W.R Jr. Morphine levels in urine subsequent to poppy seed consumption. Forensic Sci Int. 1985; 27(2): 111–7.
96. Hahn A., Michalak H., Begemann K. ym. Severe health impairment of a 6-week-old infant related to the ingestion of boiled poppy seeds. Clin Toxicol. 2008; 46: 607.
97. Sproll C., Perz R.C. ja Lachenmeier D.W. Optimized LC/MS/MS analysis of morphine and codeine in poppy seed and evaluation of their fate during food processing as a basis for risk analysis. J Agric Food Chem. 2006; 54(15): 5292–8.
98. Euroopan elintarviketurvallisuusviranomainen. Scientific opinion on the risks for public health related to the presence of opium alkaloids in poppy seeds. EFSA J. 2011; 9(11): 2405.
99. Lachenmeier D.W., Sproll C. ja Musshoff F. Poppy seed foods and opiate drug testing—where are we today? Ther Drug Monit. 2010; 32(1): 11–8.
100. Katso viite 97.
101. Katso viite 99.
102. Idle J.R. Christmas gingerbread (Lebkuchen) and Christmas cheer—review of the potential role of mood elevating amphetamine-like compounds formed in vivo and in furno. Prague Med Rep. 2005; 106(1): 27–38.
103. Payne R.B. Nutmeg intoxication. N Engl J Med. 1963; 269: 36–8.
104. Cushny A.R. Nutmeg poisoning. Proc R Soc Med. 1908; 1(Ther Pharmacol Sect): 39–44.
105. Williams E.Y. ja West F. The use of nutmeg as a psychotropic drug. Report of two cases. J Natl Med Assoc. 1968; 60(4): 289–90.
106. Sama.
107. Scholefield J.H. Nutmeg—an unusual overdose. Arch Emerg Med. 1986; 3(2): 154–5.
108. Davis P.A. ja Yokoyama W. Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food. 2011; 14(9): 884–9.
109. Solomon T.P.J. ja Blannin A.K. Effects of short-term cinnamon ingestion on in vivo glucose tolerance. Diabetes Obes Metab. 2007; 9(6): 895–901.
110. Solomon T.P.J. ja Blannin A.K. Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans. Eur J Appl Physiol. 2009; 105(6): 969–76.
111. Fotland T.O., Paulsen J.E., Sanner T., Alexander J. ja Husoy T. Risk assessment of coumarin using the bench mark dose (BMD) approach: children in Norway which regularly eat oatmeal porridge with cinnamon may exceed the TDI for coumarin with several folds. Food Chem Toxicol. 2012; 50(3–4): 903–12.
112. Wickenberg J., Lindstedt S., Berntorp K., Nilsson J. ja Hlebowicz J. Ceylon cinnamon does not affect postprandial plasma glucose or insulin in subjects with impaired glucose tolerance. Br J Nutr. 2012; 107(12): 1845–9.
113. Davis P.A. ja Yokoyama W. Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food. 2011; 14(9): 884–9.

Kokojyväviljat
1. World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, D.C.: AICR,2007.
2. Eat 3 or more whole-grain foods every day. http://www.heart.org/HEARTORG/GettingHealthy/NutritionCenter/HealthyEating/Eat-3-or-More-Whole-Grain-Foods-Every-Day_UCM_320264_Article.jsp. Haettu 18.4.2015.
3. Wu H., Flint A.J., Qi Q. ym. Association between dietary whole grain intake and risk of mortality: two large prospective studies in US men and women. JAMA Intern Med. 2015; 175(3): 373–84.
4. Tang G., Wang D., Long J., Yang F. ja Si L. Meta-analysis of the association between whole grain intake and coronary heart disease risk. Am J Cardiol. 2015; 115(5): 625–9.
5. Aune D., Norat T., Romundstad P. ja Vatten L.J. Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Eur J Epidemiol. 2013; 28(11): 845–58.
6. Cho S.S., Qi L., Fahey G.C. ja Klurfeld D.M. Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. Am J Clin Nutr. 2013; 98(2): 594–619.
7. Lim S.S., Vos T., Flaxman A.D. ym. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224–60.
8. Lefevre M. ja Jonnalagadda S. Effect of whole grains on markers of subclinical inflammation. Nutr Rev. 2012; 70(7): 387–96.
9. Montonen J., Boeing H., Fritsche A. ym. Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress. Eur J Nutr. 2013; 52(1): 337–45.
10. Goletzke J., Buyken A.E., Joslowski G. ym. Increased intake of carbohydrates from sources with a higher glycemic index and lower consumption of whole grains during puberty are prospectively associated with higher IL-6 concentrations in younger adulthood among healthy individuals. J Nutr. 2014; 144(10): 1586–93.
11. Sofi F., Ghiselli L., Cesari F. ym. Effects of short-term consumption of bread obtained by an old Italian grain variety on lipid, inflammatory, and hemorheological variables: an intervention study. J Med Food. 2010; 13(3): 615–20.
12. Vitaglione P., Mennella I., Ferracane R. ym. Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber. Am J Clin Nutr. 2015; 101(2): 251–61.
13. Esposito K., Nappo F., Giugliano F. ym. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2003; 78(6): 1135–40.
14. Masters R.C., Liese A.D., Haffner S.M., Wagenknecht L.E. ja Hanley A.J. Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma. J Nutr. 2010; 140(3): 587–94.
15. Vitaglione P., Mennella I., Ferracane R. ym. Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber. Am J Clin Nutr. 2015; 101(2): 251–61.
16. Qi L., van Dam R.M., Liu S., Franz M., Mantzoros C. ja Hu F.B. Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care. 2006; 29(2): 207–11.
17. Katso viite 11.
18. Esposito K. ja Giugliano D. Whole-grain intake cools down inflammation. Am J Clin Nutr. 2006; 83(6): 1440–1.
19. Jacobs D.R. Jr, Andersen L.F. ja Blomhoff R. Whole-grain consumption is associated with a reduced risk of noncardiovascular, noncancer death attributed to inflammatory diseases in the Iowa Women’s Health Study. Am J Clin Nutr. 2007; 85(6): 1606–14.
20. Rubio-Tapia A., Ludvigsson J.F., Brantner T.L., Murray J.A. ja Everhart J.E. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012; 107(10): 1538–44.
21. Cooper B.T., Holmes G.K., Ferguson R., Thompson R.A., Allan R.N. ja Cooke W.T. Gluten-sensitive diarrhea without evidence of celiac disease. Gastroenterology. 1980; 79(5 Pt 1): 801–6.
22. Falchuk Z.M. Gluten-sensitive diarrhea without enteropathy: fact or fancy? Gastroenterology. 1980; 79(5 Pt 1): 953–5.
23. Aziz I., Hadjivassiliou M. ja Sanders D.S. Does gluten sensitivity in the absence of coeliac disease exist? BMJ. 2012; 345: e7907.
24. Mansueto P., Seidita A., D’Alcamo A. ja Carroccio A. Non-celiac gluten sensitivity: literature review. J Am Coll Nutr. 2014; 33(1): 39–54.
25. Genuis S.J. Sensitivity-related illness: the escalating pandemic of allergy, food intolerance and chemical sensitivity. Sci Total Environ. 2010; 408(24): 6047–61.
26. Di Sabatino A. ja Corazza G.R. Nonceliac gluten sensitivity: sense or sensibility? Ann Intern Med. 2012; 156(4): 309–11.
27. McCarter D.F. Non-celiac gluten sensitivity: important diagnosis or dietary fad? Am Fam Physician. 2014; 89(2): 82–3.
28. Ferch C.C. ja Chey W.D. Irritable bowel syndrome and gluten sensitivity without celiac disease: separating the wheat from the chaff . Gastroenterology. 2012; 142(3): 664–6.
29. Carroccio A., Mansueto P., Iacono G. ym. Non-celiac wheat sensitivity diagnosed by doubleblind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol. 2012; 107(12): 1898–906.
30. Sama.
31. Biesiekierski J.R., Peters S.L., Newnham E.D., Rosella O., Muir J.G. ja Gibson P.R. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013; 145(2): 320–8.e1–3.
32. Peters S.L., Biesiekierski J.R., Yelland G.W., Muir J.G. ja Gibson P.R. Randomised clinical trial: gluten may cause depression in subjects with non-coeliac gluten sensitivity—an exploratory clinical study. Aliment Pharmacol Ther. 2014; 39(10): 1104–12.
33. Aziz I., Hadjivassiliou M. ja Sanders D.S. Editorial: noncoeliac gluten sensitivity—a disease of the mind or gut? Aliment Pharmacol Ther. 2014; 40(1): 113–4.
34. Picarelli A., Borghini R., Isonne C. ja Di Tola M. Reactivity to dietary gluten: new insights into differential diagnosis among gluten-related gastrointestinal disorders. Pol Arch Med Wewn. 2013; 123(12): 708–12.
35. Rubio-Tapia A., Ludvigsson J.F., Brantner T.L., Murray J.A. ja Everhart J.E. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012; 107(10): 1538–44.
36. Riddle M.S., Murray J.A. ja Porter C.K. The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol. 2012; 107(8): 1248–55.
37. Volta U., Bardella M.T., Calabrò A., Troncone R. ja Corazza G.R. An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med. 2014; 12: 85.
38. Holmes G. Non coeliac gluten sensitivity. Gastroenterol Hepatol Bed Bench. 2013; 6(3): 115–9.
39. Gaesser G.A. ja Angadi S.S. Gluten-free diet: imprudent dietary advice for the general population? J Acad Nutr Diet. 2012; 112(9): 1330–3.
40. De Palma G., Nadal I., Collado M.C. ja Sanz Y. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br J Nutr. 2009; 102(8): 1154–60.
41. Katso viite 39.
42. Horiguchi N., Horiguchi H. ja Suzuki Y. Effect of wheat gluten hydrolysate on the immune system in healthy human subjects. Biosci Biotechnol Biochem. 2005; 69(12): 2445–9.
43. Di Sabatino A. ja Corazza G.R. Nonceliac gluten sensitivity: sense or sensibility? Ann Intern Med. 2012; 156(4): 309–11.
44. Koerner T.B., Cleroux C., Poirier C. ym. Gluten contamination of naturally gluten-free flours and starches used by Canadians with celiac disease. Food Addit Contam Part A. 2013; 30(12): 2017–21.
45. McCarter D.F. Non-celiac gluten sensitivity: important diagnosis or dietary fad? Am Fam Physician. 2014; 89(2): 82–3.
46. Tavakkoli A., Lewis S.K., Tennyson C.A., Lebwohl B. ja Green P.H. Characteristics of patients who avoid wheat and/or gluten in the absence of celiac disease. Dig Dis Sci. 2014; 59(6): 1255–61.
47. Pietzak M. Celiac disease, wheat allergy, and gluten sensitivity: when gluten free is not a fad. JPEN J Parenter Enteral Nutr. 2012; 36(1 Suppl): 68S–75S.
48. Goufo P. ja Trindade H. Rice antioxidants: phenolic acids, flavonoids, anthocyanins, proanthocyanidins, tocopherols, tocotrienols, γ- oryzanol, and phytic acid. Food Sci Nutr. 2014; 2(2): 75–104.
49. Choi S.P., Kang M.Y., Koh H.J., Nam S.H. ja Friedman M. Antiallergic activities of pigmented rice bran extracts in cell assays. J Food Sci. 2007; 72(9): S719–26.
50. Pintha K., Yodkeeree S. ja Limtrakul P. Proanthocyanidin in red rice inhibits MDA-MB-231 breast cancer cell invasion via the expression control of invasive proteins. Biol Pharm Bull. 2015; 38(4): 571–81.
51. Suttiarporn P., Chumpolsri W., Mahatheeranont S., Luangkamin S., Teepsawang S. ja Leardkamolkarn V. Structures of phytosterols and triterpenoids with potential anti-cancer activity in bran of black non-glutinous rice. Nutrients. 2015; 7(3): 1672–87.
52. Egilman D., Mailloux C. ja Valentin C. Popcorn-worker lung caused by corporate and regulatory negligence: an avoidable tragedy. Int J Occup Environ Health. 2007; 13(1): 85–98.
53. Egilman D.S. ja Schilling J.H. Bronchiolitis obliterans and consumer exposure to butter-flavored micro wave popcorn: a case series. Int J Occup Environ Health. 2012; 18(1): 29–42.
54. Nelson K., Stojanovska L., Vasiljevic T. ja Mathai M. Germinated grains: a superior whole grain functional food? Can J Physiol Pharmacol. 2013; 91(6): 429–41.
55. Hovey A.L., Jones G.P., Devereux H.M. ja Walker K.Z. Whole cereal and legume seeds increase faecal short chain fatty acids compared to ground seeds. Asia Pac J Clin Nutr. 2003; 12(4): 477–82.
56. Stephen A.M. ja Cummings J.H. The microbial contribution to human faecal mass. J Med Microbiol. 1980; 13(1): 45–56.
57. Fechner A., Fenske K. ja Jahreis G. Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: a randomised, double-blind, crossover human intervention trial. Nutr J. 2013; 12: 101.
58. Katso viite 55.
59. Tan J., McKenzie C., Potamitis M., Thorburn A.N., Mackay C.R. ja Macia L. The role of short- chain fatty acids in health and disease. Adv Immunol. 2014; 121: 91–119.
60. Molteberg E.L., Solheim R., Dimberg L.H. ja Frølich W. Variation in oat groats due to variety, storage and heat treatment. II: sensory quality. J Cereal Sci. 1996; 24(3): 273–82.
61. Cerio R., Dohil M., Downie J. ym. Mechanism of action and clinical benefits of colloidal oatmeal for dermatologic practice. J Drugs Dermatol. 2010; 9(9): 1116–20.
62. Boisnic S., Branchet-Gumila M.C. ja Coutanceau C. Inhibitory effect of oatmeal extract oligomer on vasoactive intestinal peptide-induced inflammation in surviving human skin. Int J Tissue React. 2003; 25(2): 41–6.
63. Alexandrescu D.T., Vaillant J.G. ja Dasanu C.A. Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosinekinase inhibitors. Clin Exp Dermatol. 2007; 32(1): 71–4.
64. Wild R., Fager K., Flefleh C. ym. Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels. Mol Cancer Ther. 2006; 5(1): 104–13.
65. Guo W., Nie L., Wu D. ym. Avenanthramides inhibit proliferation of human colon cancer cell lines in vitro. Nutr Cancer. 2010; 62(8): 1007–16.
66. Clemens R. ja van Klinken B.J.W. Oats, more than just a whole grain: an introduction. Br J Nutr. 2014; 112 Suppl 2: S1–3.
67. Eidson M. ja Saenz B. Average portion sizes of pasta from Italian casual dining restaurants in Tarrant County. http://www.srs.tcu.edu/previous_posters/Nutritional_Sciences/2010/148-Eidson-Gorman.pdf. 2010. Haettu 21.5.2015.

Juomat
1. Popkin B.M., Armstrong L.E., Bray G.M., Caballero B., Frei B. ja Willett W.C. A new proposed guidance system for beverage consumption in the United States. Am J Clin Nutr. 2006; 83(3): 529–42.
2. Rush E.C. Water: neglected, unappreciated and under researched. Eur J Clin Nutr. 2013; 67(5): 492–5.
3. Sama.
4. Jéquier E. ja Constant F. Water as an essential nutrient: the physiological basis of hydration. Eur J Clin Nutr. 2010; 64(2): 115–23.
5. Vivanti A.P. Origins for the estimations of water requirements in adults. Eur J Clin Nutr. 2012; 66(12): 1282–9.
6. Adolph E.F. The regulation of the water content of the human organism. J Physiol (Lond). 1921; 55(1–2): 114–32.
7. Walsh N.P., Fortes M.B., Purslow C. ja Esmaeelpour M. Author response: is whole body hydration an important consideration in dry eye? Invest Ophthalmol Vis Sci. 2013; 54(3): 1713–4.
8. Goodman A.B., Blanck H.M., Sherry B., Park S., Nebeling L. ja Yaroch A.L. Behaviors and attitudes associated with low drinking water intake among US adults, Food Attitudes and Behaviors Survey, 2007. Prev Chronic Dis. 2013; 10: E51.
9. Negoianu D. ja Goldfarb S. Just add water. J Am Soc Nephrol. 2008; 19(6): 1041–3.
10. Michaud D.S., Spiegelman D., Clinton S.K. ym. Fluid intake and the risk of bladder cancer in men. N Engl J Med. 1999; 340(18): 1390–7.
11. Chan J., Knutsen S.F., Blix G.G., Lee J.W. ja Fraser G.E. Water, other fluids, and fatal coronary heart disease: the Adventist Health Study. Am J Epidemiol. 2002; 155(9): 827–33.
12. Guest S., Essick G.K., Mehrabyan A., Dessirier J.M. ja McGlone F. Effect of hydration on the tactile and thermal sensitivity of the lip. Physiol Behav. 2014; 123: 127–35.
13. Benelam B. ja Wyness L. Hydration and health: a review. Nutr Bull. 2010; 35: 3–25.
14. Katso viite 5.
15. Benelam B. ja Wyness L. Hydration and health: a review. Nutr Bull. 2010; 35: 3–25.
16. Killer S.C., Blannin A.K. ja Jeukendrup A.E. No evidence of dehydration with moderate daily coffee intake: a counterbalanced cross-over study in a free-living population. PLoS ONE. 2014; 9(1): e84154.
17. Ruxton C.H. ja Hart V.A. Black tea is not significantly different from water in the maintenance of normal hydration in human subjects: results from a randomised controlled trial. Br J Nutr. 2011; 106(4): 588–95.
18. Katso viite 15.
19. Saleh M.A., Abdel-Rahman F.H., Woodard B.B. ym. Chemical, microbial and physical evaluation of commercial bottled waters in greater Houston area of Texas. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2008; 43(4): 335–47.
20. Valtin H. ”Drink at least eight glasses of water a day.” Really? Is there scientific evidence for ”8 x 8”? Am J Physiol Regul Integr Comp Physiol. 2002; 283(5): R993–1004.
21. Kempton M.J., Ettinger U., Foster R. ym. Dehydration affects brain structure and function in healthy adolescents. Hum Brain Mapp. 2011; 32(1): 71–9.
22. Stookey J.D., Brass B., Holliday A. ja Arieff A. What is the cell hydration status of healthy children in the USA? Preliminary data on urine osmolality and water intake. Public Health Nutr. 2012; 15(11): 2148–56.
23. Edmonds C.J. ja Burford D. Should children drink more water?: the effects of drinking water on cognition in children. Appetite. 2009; 52(3): 776–9.
24. Pross N., Demazières A., Girard N. ym. Influence of progressive fluid restriction on mood and physiological markers of dehydration in women. Br J Nutr. 2013; 109(2): 313–21.
25. Péronnet F., Mignault D., du Souich P. ym. Pharmacokinetic analysis of absorption, distribution and disappearance of ingested water labeled with D2O in humans. Eur J Appl Physiol. 2012; 112(6): 2213–22.
26. Bateman D.N. Effects of meal temperature and volume on the emptying of liquid from the human stomach. J Physiol (Lond). 1982; 331: 461–7.
27. Armstrong L.E., Ganio M.S., Klau J.F., Johnson E.C., Casa D.J. ja Maresh C.M. Novel hydration assessment techniques employing thirst and a water intake challenge in healthy men. Appl Physiol Nutr Metab. 2014; 39(2): 138–44.
28. Cuomo R., Grasso R., Sarnelli G. ym. Effects of carbonated water on functional dyspepsia and constipation. Eur J Gastroenterol Hepatol. 2002; 14(9): 991–9.
29. Freedman N.D., Park Y., Abnet C.C., Hollenbeck A.R. ja Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012; 366(20): 1891–904.
30. Liu J., Sui X., Lavie C.J. ym. Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc. 2013; 88(10): 1066–74.
31. O’Keefe J.H., Bhatti S.K., Patil H.R., DiNicolantonio J.J., Lucan S.C. ja Lavie C.J. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 2013; 62(12): 1043–51.
32. Malerba S., Turati F., Galeone C. ym. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol. 2013; 28(7): 527–39.
33. Shimamoto T., Yamamichi N., Kodashima S. ym. No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan. PLoS ONE. 2013; 8(6): e65996.
34. Wendl B., Pfeiffer A., Pehl C., Schmidt T. ja Kaess H. Effect of decaffeination of coffee or tea on gastro-oesophageal reflux. Aliment Pharmacol Ther. 1994; 8(3): 283–7.
35. Lee D.R., Lee J., Rota M. ym. Coffee consumption and risk of fractures: a systematic review and dose-response meta-analysis. Bone. 2014; 63: 20–8.
36. Sheng J., Qu X., Zhang X. ym. Coffee, tea, and the risk of hip fracture: a meta-analysis. Osteoporos Int. 2014; 25(1): 141–50.
37. Chen B., Shi H.F. ja Wu S.C. Tea consumption didn’t modify the risk of fracture: a dose-response meta-analysis of observational studies. Diagn Pathol. 2014; 9: 44.
38. Nazrun A.S., Tzar M.N., Mokhtar S.A. ja Mohamed I.N. A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag. 2014; 10: 937–48.
39. Li M., Wang M., Guo W., Wang J. ja Sun X. The effect of caffeine on intraocular pressure: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2011; 249(3): 435–42.
40. Kang J.H., Willett W.C., Rosner B.A., Hankinson S.E. ja Pasquale L.R. Caffeine consumption and the risk of primary open-angle glaucoma: a prospective cohort study. Invest Ophthalmol Vis Sci. 2008; 49(5): 1924–31.
41. Gleason J.L., Richter H.E., Redden D.T., Goode P.S., Burgio K.L. ja Markland A.D. Caffeine and urinary incontinence in US women. Int Urogynecol J. 2013; 24(2): 295–302.
42. Davis N.J., Vaughan C.P., Johnson T.M. ym. Caffeine intake and its association with urinary incontinence in United States men: results from National Health and Nutrition Examination Surveys 2005–2006 and 2007–2008. J Urol. 2013; 189(6): 2170–4.
43. Bonilha L. ja Li L.M. Heavy coffee drinking and epilepsy. Seizure. 2004; 13(4): 284–5.
44. Lloret-Linares C., Lafuente-Lafuente C., Chassany O. ym. Does a single cup of coffee at dinner alter the sleep? A controlled cross-over randomised trial in real-life conditions. Nutrition & Dietetics. 2012; 69(4): 250–5.
45. Urgert R. ja Katan M.B. The cholesterol-raising factor from coffee beans. Annu Rev Nutr. 1997; 17: 305–24.
46. Corrêa T.A.F., Rogero M.M., Mioto B.M. ym. Paper-filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: a clinical trial. Nutrition. 2013; 29(7–8): 977–81.
47. Bhave P.D. ja Hoffmayer K. Caffeine and atrial fibrillation: friends or foes? Heart. 2013; 99(19): 1377–8.
48. Patanè S., Marte F., La Rosa F.C. ja La Rocca R. Atrial fibrillation associated with chocolate intake abuse and chronic salbutamol inhalation abuse. Int J Cardiol. 2010; 145(2): e74–6.
49. Caldeira D., Martins C., Alves L.B., Pereira H., Ferreira J.J. ja Costa J. Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart. 2013; 99(19): 1383–9.
50. Cheng M., Hu Z., Lu X., Huang J. ja Gu D. Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies. Can J Cardiol. 2014; 30(4): 448–54.
51. Glade M.J. Caffeine—not just a stimulant. Nutrition. 2010; 26(10): 932–8.
52. Bhave P.D. ja Hoffmayer K. Caffeine and atrial fibrillation: friends or foes? Heart. 2013; 99(19): 1377–8.
53. Sepkowitz K.A. Energy drinks and caffeine-related adverse effects. JAMA. 2013; 309(3): 243–4.
54. O’Keefe J.H., Bhatti S.K., Patil H.R., DiNicolantonio J.J., Lucan S.C. ja Lavie C.J. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 2013; 62(12): 1043–51.
55. Yu X., Bao Z., Zou J. ja Dong J. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer. 2011; 11: 96.
56. Tzellos T.G., Sardeli C., Lallas A., Papazisis G., Chourdakis M. ja Kouvelas D. Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2011; 25(3): 345–53.
57. Dunne E.F., Friedman A., Datta S.D., Markowitz L.E. ja Workowski K.A. Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis. 2011; 53 Suppl 3: S143–52.
58. Tjeerdsma F., Jonkman M.F. ja Spoo J.R. Temporary arrest of basal cell carcinoma formation in a patient with basal cell naevus syndrome (BCNS) since treatment with a gel containing various plant extracts. J Eur Acad Dermatol Venereol. 2011; 25(2): 244–5.
59. Trudel D., Labbé D.P., Bairati I., Fradet V., Bazinet L. ja Tetu B. Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies. Gynecol Oncol. 2012; 126(3): 491–8.
60. Butler L.M. ja Wu A.H. Green and black tea in relation to gynecologic cancers. Mol Nutr Food Res. 2011; 55(6): 931–40.
61. Onakpoya I., Spencer E., Heneghan C. ja Thompson M. The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 2014; 24(8): 823–36.
62. Liu G., Mi X.N., Zheng X.X., Xu Y.L., Lu J. ja Huang X.H. Effects of tea intake on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr. 2014; 112(7): 1043–54.
63. Maruyama K., Iso H., Sasaki S. ja Fukino Y. The association between concentrations of green tea and blood glucose levels. J Clin Biochem Nutr. 2009; 44(1): 41–5.
64. Maki K.C., Reeves M.S., Farmer M. ym. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr. 2009; 139(2): 264–70.
65. Arab L., Khan F. ja Lam H. Epidemiologic evidence of a relationship between tea, coffee, or caffeine consumption and cognitive decline. Adv Nutr. 2013; 4(1): 115–22.
66. Arab L., Liu W. ja Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke. 2009; 40(5): 1786–92.
67. Yang W.S., Wang W.Y., Fan W.Y., Deng Q. ja Wang X. Tea consumption and risk of type 2 diabetes: a dose-response meta-analysis of cohort studies. Br J Nutr. 2014; 111(8): 1329–39.
68. Koyama Y., Kuriyama S., Aida J. ym. Association between green tea consumption and tooth loss: cross-sectional results from the Ohsaki Cohort 2006 Study. Prev Med. 2010; 50(4): 173–9.
69. Watanabe I., Kuriyama S., Kakizaki M. ym. Green tea and death from pneumonia in Japan: the Ohsaki cohort study. Am J Clin Nutr. 2009; 90(3): 672–9.
70. Maeda-Yamamoto M., Ema K., Monobe M. ym. The efficacy of early treatment of seasonal allergic rhinitis with benifuuki green tea containing O-methylated catechin before pollen exposure: an open randomized study. Allergol Int. 2009; 58(3): 437–44.
71. Masuda S., Maeda-Yamamoto M., Usui S. ja Fujisawa T. ‘Benifuuki’ green tea containing Omethylated catechin reduces symptoms of Japanese cedar pollinosis: a randomized, doubleblind, placebo-controlled trial. Allergol Int. 2014; 63(2): 211–7.
72. Millet D. The origins of EEG. ”International Society for the History of the Neurosciences” (ISHN) -yhdistyksen seitsemäs vuosikokous 3.6.2002. http://www.bri.ucla.edu/nha/ishn/ab24-2002.htm. Haettu 21.4.2015.
73. Nobre A.C., Rao A. ja Owen G.N. L-theanine, a natural constituent in tea, and its effect on mental state. Asia Pac J Clin Nutr. 2008; 17 Suppl 1: 167–8.
74. Wang Z.M., Zhou B., Wang Y.S. ym. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr. 2011; 93(3): 506–15.
75. Rusak G., Komes D., Likić S., Horžić D. ja Kovač M. Phenolic content and antioxidative capacity of green and white tea extracts depending on extraction conditions and the solvent used. Food Chem. 2008; 110(4): 852–8.
76. Green R.J., Murphy A.S., Schulz B., Watkins B.A. ja Ferruzzi M.G. Common tea formulations modulate in vitro digestive recovery of green tea catechins. Mol Nutr Food Res. 2007; 51(9): 1152–62.
77. Santana-Rios G., Orner G.A., Amantana A., Provost C., Wu S.Y. ja Dashwood R.H. Potent antimutagenic activity of white tea in comparison with green tea in the Salmonella assay. Mutat Res. 2001; 495(1–2): 61–74.
78. Yang D.J., Hwang L.S. ja Lin J.T. Effects of different steeping methods and storage on caffeine, catechins and gallic acid in bag tea infusions. J Chromatogr A. 2007; 1156(1–2): 312–20.
79. Venditti E., Bacchetti T., Tiano L., Carloni P., Greci L. ja Damiani E. Hot vs. cold water steeping of different teas: do they affect antioxidant activity? Food Chem. 2010; 119(4): 1597–1604.
80. Patel S.S., Beer S., Kearney D.L., Phillips G. ja Carter B.A. Green tea extract: a potential cause of acute liver failure. World J Gastroenterol. 2013; 19(31): 5174–7.
81. Kole A.S., Jones H.D., Christensen R. ja Gladstein J. A case of kombucha tea toxicity. J Intensive Care Med. 2009; 24(3): 205–7.
82. Goenka P., Sarawgi A., Karun V., Nigam A.G., Dutta S. ja Marwah N. Camellia sinensis (tea): implications and role in preventing dental decay. Pharmacogn Rev. 2013; 7(14): 152–6.
83. Kakumanu N. ja Rao S.D. Images in clinical medicine. Skeletal fluorosis due to excessive tea drinking. N Engl J Med. 2013; 368(12): 1140.
84. Malinowska E., Inkielewicz I., Czarnowski W. ja Szefer P. Assessment of fluoride concentration and daily intake by human from tea and herbal infusions. Food Chem Toxicol. 2008; 46(3): 1055–61.
85. Sama.
86. Quock R.L., Gao J.X. ja Chan J.T. Tea fluoride concentration and the pediatric patient. Food Chem. 2012; 130: 615–7.
87. Phillips K.M., Carlsen M.H. ja Blomhoff R. Total antioxidant content of alternatives to refined sugar. J Am Diet Assoc. 2009; 109(1): 64–71.
88. Matsui M., Matsui K., Kawasaki Y. ym. Evaluation of the genotoxicity of stevioside and steviol using six in vitro and one in vivo mutagenicity assays. Mutagenesis. 1996; 11(6): 573–9.
89. Koyama E., Kitazawa K., Ohori Y. ym. In vitro metabolism of the glycosidic sweeteners, stevia mixture and enzymatically modified stevia in human intestinal microflora. Food Chem Toxicol. 2003; 41(3): 359–74.
90. Joint FAO/WHO Expert Committee on Food Additives. Evaluation of certain food additives. World Health Organ Tech Rep Ser. 2009; (952): 1–208.
91. Gold J. Erythritol may reduce dental caries in high-risk school children. J Evid Based Dent Pract. 2014; 14(4): 185–7.
92. Ciappuccini R., Ansemant T., Maillefert J.F., Tavernier C. ja Ornetti P. Aspartame-induced fibromyalgia, an unusual but curable cause of chronic pain. Clin Exp Rheumatol. 2010; 28(6 Suppl 63): S131–3.
93. Halldorsson T.I., Strøm M., Petersen S.B. ja Olsen S.F. Intake of artificially sweetened soft drinks and risk of preterm delivery: a prospective cohort study in 59,334 Danish pregnant women. Am J Clin Nutr. 2010; 92(3): 626–33.
94. Jacob S.E. ja Stechschulte S. Formaldehyde, aspartame, and migraines: a possible connection. Dermatitis. 2008; 19(3): E10–1.
95. Roberts H.J. Overlooked aspartame-induced hypertension. South Med J. 2008; 101(9): 969.
96. Roberts H.J. Perspective on aspartame-induced pseudotumor cerebri. South Med J. 2009; 102(8): 873.
97. Roberts H.J. Aspartame-induced thrombocytopenia. South Med J. 2007; 100(5): 543.
98. Den Hartog G.J.M., Boots A.W., Adam-Perrot A. ym. Erythritol is a sweet antioxidant. Nutrition. 2010; 26(4): 449–58.
99. Carlsen M.H., Halvorsen B.L., Holte K. ym. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010; 9: 3.
100. Chu C.H., Pang K.K.L. ja Lo E.C.M. Dietary behavior and knowledge of dental erosion among Chinese adults. BMC Oral Health. 2010; 10: 13.
101. Attin T., Siegel S., Buchalla W., Lennon A.M., Hannig C. ja Becker K. Brushing abrasion of softened and remineralised dentin: an in situ study. Caries Res. 2004; 38(1): 62–6.
102. Bassiouny M.A. ja Yang J. Influence of drinking patterns of carbonated beverages on dental erosion. Gen Dent. 2005; 53(3): 205–10.
103. Yang Q. Gain weight by ”going diet?” Artificial sweeteners and the neurobiology of sugar cravings: Neuroscience 2010. Yale J Biol Med. 2010; 83(2): 101–8.
104. Porikos K.P., Booth G. ja Van Itallie T.B. Effect of covert nutritive dilution on the spontaneous food intake of obese individuals: a pilot study. Am J Clin Nutr. 1977; 30(10): 1638–44.
105. Mattes R. Effects of aspartame and sucrose on hunger and energy intake in humans. Physiol Behav. 1990; 47(6): 1037–44.
106. Katso viite 103.
107. Sama.

Liikunta
1. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus. Obesity and overweight. http://www.cdc.gov/nchs/fastats/obesity-overweight.htm. 29.4.2015. Haettu 17.5.2015.
2. Laskowski E.R. The role of exercise in the treatment of obesity. PMR. 2012; 4(11): 840–4.
3. Olshansky S.J., Passaro D.J., Hershow R.C. ym. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005; 352(11): 1138–45.
4. Freedhoff Y. ja Hebert P.C. Partnerships between health organizations and the food industry risk derailing public health nutrition. CMAJ. 2011; 183(3): 291–2.
5. Westerterp K.R. ja Speakman J.R. Physical activity energy expenditure has not declined since the 1980s and matches energy expenditures of wild mammals. Int J Obes (Lond). 2008; 32(8): 1256–63.
6. Dwyer-Lindgren L., Freedman G., Engell R.E. ym. Prevalence of physical activity and obesity in US counties, 2001–2011: a road map for action. Popul Health Metr. 2013; 11: 7.
7. Katso viite 2.
8. Swinburn B., Sacks G. ja Ravussin E. Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am J Clin Nutr. 2009; 90(6): 1453–6.
9. Matthews J., International Food Information Council Foundation. Food & Health Survey: Consumer Attitudes Toward Food Safety, Nutrition & Health. http://www.foodinsight.org/2011_Food_Health_Survey_Consumer_Attitudes_Toward_Food_Safety_Nutrition_Health. 31.8.2011. Haettu 31.3.2015.
10. Yhdysvaltojen maatalousministeriö (USDA), Agricultural Research Service. 2014. USDA National Nutrient Database for Standard Reference, Release 27. Chicken, broilers or fryers, leg, meat only, cooked, stewed. http://www.ndb.nal.usda.gov/ndb/foods/show/882. Haettu 23.4.2015.
11. Archer E., Hand G.A. ja Blair S.N. Correction: Validity of U.S. Nutritional Surveillance: National Health and Nutrition Examination Survey Caloric Energy Intake Data, 1971–2010. http://journals.plos.org/plosone/article?id=10.1371/annotation/c313df3a-52bd-4cbe-af14- 6676480d1a43. 11.10.2013. Haettu 23.4.2015.
12. Blair S.N. Physical inactivity: the biggest public health problem of the 21st century. Br J Sports Med. 2009; 43(1): 1–2.
13. Murray C.J., Atkinson C., Bhalla K. ym. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013; 310(6): 591–608.
14. Lim S.S., Vos T., Flaxman A.D. ym. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224–60.
15. Katso viite 13.
16. Wang Y.C., McPherson K., Marsh T., Gortmaker S.L. ja Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011; 378(9793): 815–25.
17. Dunstan D.W., Barr E.L.M., Healy G.N. ym. Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Circulation. 2010; 121(3): 384–91.
18. Stamatakis E., Hamer M. ja Dunstan D.W. Screen-based entertainment time, all-cause mortality, and cardiovascular events: population-based study with ongoing mortality and hospital events follow-up. J Am Coll Cardiol. 2011; 57(3): 292–9.
19. Chaput J.P., Klingenberg L. ja Sjödin A. Do all sedentary activities lead to weight gain: sleep does not. Curr Opin Clin Nutr Metab Care. 2010; 13(6): 601–7.
20. Patel A.V., Bernstein L., Deka A. ym. Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol. 2010; 172(4): 419–29.
21. Van Uffelen J.G., Wong J., Chau J.Y.ym. Occupational sitting and health risks: a systematic review. Am J Prev Med. 2010; 39(4): 379–88.
22. Katso viite 20.
23. Mosley M. Calorie burner: how much better is standing up than sitting? BBC News Magazine. 16.10.2013. http://www.bbc.com/news/magazine-24532996. Haettu 31.3.2015.
24. Thosar S.S., Johnson B.D., Johnston J.D. ja Wallace J.P. Sitting and endothelial dysfunction: the role of shear stress. Med Sci Monit. 2012; 18(12): RA173–80.
25. Koepp G.A., Manohar C.U., McCrady-Spitzer S.K. ym. Treadmill desks: a 1-year prospective trial. Obesity (Silver Spring). 2013; 21(4): 705–11.
26. Healy G.N., Dunstan D.W., Salmon J. ym. Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care. 2008; 31(4): 661–6.
27. Peddie M.C., Bone J.L., Rehrer N.J., Skeaff C.M., Gray A.R. ja Perry T.L. Breaking prolonged sitting reduces postprandial glycemia in healthy, normal-weight adults: a randomized crossover trial. Am J Clin Nutr. 2013; 98(2): 358–66.
28. Esen A.M., Barutcu I., Acar M. ym. Effect of smoking on endothelial function and wall thickness of brachial artery. Circ J. 2004; 68(12): 1123–6.
29. Alexopoulos N., Vlachopoulos C., Aznaouridis K. ym. The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiovasc Prev Rehabil. 2008; 15(3): 300–5.
30. Akazawa N., Choi Y., Miyaki A. ym. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women. Nutr Res. 2012; 32(10): 795–9.
31. Sugawara J., Akazawa N., Miyaki A. ym. Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study. Am J Hypertens. 2012; 25(6): 651–6.
32. McHugh M. The health benefi ts of cherries and potential applications in sports. Scand J Med Sci Sports. 2011; 21(5): 615–6.
33. Aptekmann N.P. ja Cesar T.B. Orange juice improved lipid profile and blood lactate of overweight middle-aged women subjected to aerobic training. Maturitas. 2010; 67(4): 343–7.
34. McAnulty L.S., Nieman D.C., Dumke C.L. ym. Effect of blueberry ingestion on natural killer cell counts, oxidative stress, and inflammation prior to and after 2.5 h of running. Appl Physiol Nutr Metab. 2011; 36(6): 976–84.
35. Connolly D.A., McHugh M.P., Padilla-Zakour O.I., Carlson L. ja Sayers S.P. Efficacy of a tart cherry juice blend in preventing the symptoms of muscle damage. Br J Sports Med. 2006; 40(8): 679–83.
36. Kuehl K.S., Perrier E.T., Elliot D.L. ja Chesnutt J.C. Efficacy of tart cherry juice in reducing muscle pain during running: a randomized controlled trial. J Int Soc Sports Nutr. 2010; 7: 17.
37. Howatson G., McHugh M.P., Hill J.A. ym. Influence of tart cherry juice on indices of recovery following marathon running. Scand J Med Sci Sports. 2010; 20(6): 843–52.
38. Tarazona-Díaz M.P., Alacid F., Carrasco M., Martínez I. ja Aguayo E. Watermelon juice: potential functional drink for sore muscle relief in athletes. J Agric Food Chem. 2013; 61(31): 7522–8.
39. Mastaloudis A., Yu T.W., O’Donnell R.P., Frei B., Dashwood R.H. ja Traber M.G. Endurance exercise results in DNA damage as detected by the comet assay. Free Radic Biol Med. 2004; 36(8): 966–75.
40. Tsai K., Hsu T.G., Hsu K.M. ym. Oxidative DNA damage in human peripheral leukocytes induced by massive aerobic exercise. Free Radic Biol Med. 2001; 31(11): 1465–72.
41. Fogarty M.C., Hughes C.M., Burke G. ym. Exercise-induced lipid peroxidation: Implications for deoxyribonucleic acid damage and systemic free radical generation. Environ Mol Mutagen. 2011; 52(1): 35–42.
42. Childs A., Jacobs C., Kaminski T., Halliwell B. ja Leeuwenburgh C. Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radic Biol Med. 2001; 31(6): 745–53.
43. Fogarty M.C., Hughes C.M., Burke G., Brown J.C. ja Davison G.W. Acute and chronic watercress supplementation attenuates exercise-induced peripheral mononuclear cell DNA damage and lipid peroxidation. Br J Nutr. 2013; 109(2): 293–301.
44. Trapp D., Knez W. ja Sinclair W. Could a vegetarian diet reduce exercise-induced oxidative stress? A review of the literature. J Sports Sci. 2010; 28(12): 1261–8.
45. U.S. Office of Disease Prevention and Health Promotion. 2008 Physical Activity Guidelines for Americans. http://www.health.gov/paguidelines/pdf/paguide.pdf. Haettu 22.4.2015.
46. U.S. Surgeon General. Physical activity and health—a report of the Surgeon General. http://www.cdc.gov/nccdphp/sgr/pdf/sgrfull.pdf. 17.11.1999. Haettu 22.4.2015.
47. Pate R.R., Pratt M., Blair S.N. ym. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995; 273(5): 402–7.
48. Katso viite 45.
49. Samitz G., Egger M. ja Zwahlen M. Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol. 2011; 40(5): 1382–400.
50. Woodcock J., Franco O.H., Orsini N. ja Roberts I. Non-vigorous physical activity and all-cause mortality: systematic review and meta-analysis of cohort studies. Int J Epidemiol. 2011; 40(1): 121–38.
51. Samitz G., Egger M. ja Zwahlen M. Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol. 2011; 40(5): 1382–400.
52. Sama.
53. Yhdysvaltain tartuntatautien valvonta- ja ehkäisykeskus (CDC). Adult participation in aerobic and musclestrengthening physical activities—United States, 2011. MMWR Morb Mortal Wkly Rep. 2013; 62(17): 326–30.

Loppupäätelmä
1. Shimizu N., Iwamoto M., Nakano Y. ym. Long-term electrocardiographic follow-up from childhood of an adult patient with Brugada syndrome associated with sick sinus syndrome. Circ J. 2009; 73(3): 575–9.
2. Lacunza J., San Román I., Moreno S., García-Molina E., Gimeno J. ja Valdés M. Heat stroke, an unusual trigger of Brugada electrocardiogram. Am J Emerg Med. 2009; 27(5): 634.e1–3.
3. Smith J., Hannah A. ja Birnie D.H. Effect of temperature on the Brugada ECG. Heart. 2003; 89(3): 272.
4. Dillehay T.D., Rossen J., Ugent D. ym. Early Holocene coca chewing in northern Peru. Antiquity. 2010; 84(326): 939–53.
5. Iozzo P., Guiducci L., Guzzardi M.A. ja Pagotto U. Brain PET imaging in obesity and food addiction: current evidence and hypothesis. Obes Facts. 2012; 5(2): 155–64.
6. Volkow N.D., Wang G.J., Fowler J.S., Tomasi D. ja Baler R. Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci. 2012; 11: 1–24.
7. Volkow N.D., Wang G.J., Tomasi D. ja Baler R.D. Obesity and addiction: neurobiological overlaps. Obes Rev. 2013; 14(1): 2–18.
8. Frank S., Linder K., Kullmann S. ym. Fat intake modulates cerebral blood flow in homeostatic and gustatory brain areas in humans. Am J Clin Nutr. 2012; 95(6): 1342–9.
9. Smeets P.A., de Graaf C., Stafleu A., van Osch M.J. ja van der Grond J. Functional MRI of human hypothalamic responses following glucose ingestion. Neuroimage. 2005; 24(2): 363–8.
10. Burger K.S. ja Stice E. Frequent ice cream consumption is associated with reduced striatal response to receipt of an ice cream–based milkshake. Am J Clin Nutr. 2012; 95(4): 810–7.
11. Sama.
12. Albayrak Ö., Wölfle S.M. ja Hebebrand J. Does food addiction exist? A phenomenological discussion based on the psychiatric classification of substance-related disorders and addiction. Obes Facts. 2012; 5(2): 165–79.
13. Lisle D.J. ja Goldhamer A. The Pleasure Trap: Mastering the Hidden Force That Undermines Health & Happiness. Summertown, TN: Book Publishing Company; 2007.
14. Grosshans M., Loeber S. ja Kiefer F. Implications from addiction research toward the understanding and treatment of obesity. Addict Biol. 2011; 16(2): 189–98.
15. Drewnowski A., Krahn D.D., Demitrack M.A., Nairn K. ja Gosnell B.A. Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Physiol Behav. 1992; 51(2): 371–9.
16. Wang G.J., Volkow N.D., Thanos P.K. ja Fowler J.S. Imaging of brain dopamine pathways: implications for understanding obesity. J Addict Med. 2009; 3(1): 8–18.
17. Garavan H., Pankiewicz J., Bloom A. ym. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry. 2000; 157(11): 1789–98.
18. Martin-Sölch C., Magyar S., Künig G., Missimer J., Schultz W. ja Leenders K.L. Changes in brain activation associated with reward processing in smokers and nonsmokers. A positron emission tomography study. Exp Brain Res. 2001; 139(3): 278–86.
19. Kelly J. Heal thyself. University of Chicago Magazine. Tammi-helmikuun numero 2015. http://mag.uchicago.edu/science-medicine/heal-thyself. Haettu 31.3.2015.

Täydennysosa: Ravintolisät
1. Farmer B., Larson B.T., Fulgoni V.L. III, Rainville A.J. ja Liepa G.U. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the National Health and Nutrition Examination Survey 1999–2004. J Am Diet Assoc. 2011; 111(6): 819–27.
2. Clarys P., Deliens T., Huybrechts I. ym. Comparison of nutritional quality of the vegan, vegetarian, semi-vegetarian, pesco-vegetarian and omnivorous diet. Nutrients. 2014; 6(3): 1318–32.
3. Pawlak R., Parrott S.J., Raj S., Cullum-Dugan D. ja Lucus D. How prevalent is vitamin B(12) deficiency among vegetarians? Nutr Rev. 2013; 71(2): 110–7.
4. Mądry E., Lisowska A., Grebowiec P. ja Walkowiak J. The impact of vegan diet on B-12 status in healthy omnivores: five-year prospective study. Acta Sci Pol Technol Aliment. 2012; 11(2): 209–13.
5. Brocadello F., Levedianos G., Piccione F., Manara R. ja Pesenti F.F. Irreversible subacute sclerotic combined degeneration of the spinal cord in a vegan subject. Nutrition. 2007; 23(7–8): 622–4.
6. Kuo S.C., Yeh C.B., Yeh Y.W.Y. ja Tzeng N.S. Schizophrenia-like psychotic episode precipitated by cobalamin deficiency. Gen Hosp Psychiatry. 2009; 31(6): 586–8.
7. Milea D., Cassoux N. ja LeHoang P. Blindness in a strict vegan. N Engl J Med. 2000; 342(12): 897–8.
8. Haler D. Death after vegan diet. Lancet. 1968; 2(7560): 170.
9. Roschitz B., Plecko B., Huemer M., Biebl A., Foerster H. ja Sperl W. Nutritional infantile vitamin B12 deficiency: pathobiochemical considerations in seven patients. Arch Dis Child Fetal Neonatal Ed. 2005; 90(3): F281–2.
10. NutraBulk vitamin B-12 sublingual 2500mcg tablets. https://nutrabulk.com/nutrabulk-vitamin-b-12-2500mcg-sublingual-tablets-1000-count.html. Haettu 3.9.2015.
11. Katso viite 3.
12. Donaldson M.S. Metabolic vitamin B12 status on a mostly raw vegan diet with follow-up using tablets, nutritional yeast, or probiotic supplements. Ann Nutr Metab. 2000; 44(5–6): 229–34.
13. Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, D.C.: National Academy Press, 1998.
14. Eussen S.J., de Groot L.C., Clarke R. ym. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. Arch Intern Med. 2005; 165(10): 1167–72.
15. Hill M.H., Flatley J.E., Barker M.E. ym. A vitamin B-12 supplement of 500 μg/d for eight weeks does not normalize urinary methylmalonic acid or other biomarkers of vitamin B-12 status in elderly people with moderately poor vitamin B-12 status. J Nutr. 2013 Feb; 143(2): 142–7.
16. Bor M.V., von Castel-Roberts K.M., Kauwell G.P.A. ym. Daily intake of 4 to 7 μg dietary vitamin B-12 is associated with steady concentrations of vitamin B-12-related biomarkers in a healthy young population. Am J Clin Nutr. 2010; 91(3): 571–7.
17. Heyssel R.M., Bozian R.C., Darby W.J. ja Bell M.C. Vitamin B12 turnover in man. The assimilation of vitamin B12 from natural foodstuff by man and estimates of minimal daily dietary requirements. Am J Clin Nutr. 1966; 18(3): 176–84.
18. Bischoff-Ferrari H.A. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol. 2014; 810: 500–25.
19. Mulligan G.B. ja Licata A. Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D. J Bone Miner Res. 2010; 25(4): 928–30.
20. Harris S.S. Vitamin D and African Americans. J Nutr. 2006; 136(4): 1126–9.
21. Holick M.F., Matsuoka L.Y. ja Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet. 1989; 2(8671): 1104–5.
22. Wacker M. ja Holick M.F. Sunlight and vitamin D: a global perspective for health. Dermatoendocrinol. 2013; 5(1): 51–108.
23. Sama.
24. Langdahl J.H., Schierbeck L.L., Bang U.C. ja Jensen J.E.B. Changes in serum 25-hydroxyvitamin D and cholecalciferol after one whole-body exposure in a commercial tanning bed: a randomized study. Endocrine. 2012; 42(2): 430–5.
25. O’Sullivan N.A. ja Tait C.P. Tanning bed and nail lamp use and the risk of cutaneous malignancy: a review of the literature. Australas J Dermatol. 2014; 55(2): 99–106.
26. Levine J.A., Sorace M., Spencer J. ja Siegel D.M. The indoor UV tanning industry: a review of skin cancer risk, health benefit claims, and regulation. J Am Acad Dermatol. 2005; 53(6): 1038–44.
27. Moan J., Grigalavicius M., Dahlback A., Baturaite Z. ja Juzeniene A. Ultraviolet-radiation and health: optimal time for sun exposure. Adv Exp Med Biol. 2014; 810: 423–8.
28. Dasgupta P.K., Liu Y. ja Dyke J.V. Iodine nutrition: iodine content of iodized salt in the United States. Environ Sci Technol. 2008; 42(4): 1315–23.
29. Lim S.S., Vos T., Flaxman A.D. ym. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224–60.
30. Leung A.M., Braverman L.E. ja Pearce E.N. History of U.S. iodine fortification and supplementation. Nutrients. 2012; 4(11): 1740–6.
31. Teas J., Pino S., Critchley A. ja Braverman L.E. Variability of iodine content in common commercially available edible seaweeds. Thyroid. 2004; 14(10): 836–41.
32. Rose M., Lewis J., Langford N. ym. Arsenic in seaweed forms, concentration and dietary exposure. Food Chem Toxicol. 2007; 45(7): 1263–7.
33. Katso viite 31.
34. Di Matola T., Zeppa P., Gasperi M. ja Vitale M. Thyroid dysfunction following a kelp-containing marketed diet. BMJ Case Rep. 2014; bcr2014206330.
35. Greger M. Do Eden beans have too much iodine? http://nutritionfacts.org/2012/07/05/do-eden-beans-have-too-much-iodine/. 5.7.2012. Haettu 20.4.2015.
36. Tonstad S., Nathan E., Oda K. ja Fraser G. Vegan diets and hypothyroidism. Nutrients. 2013; 5(11): 4642–52.
37. Leung A.M., LaMar A., He X., Braverman L.E. ja Pearce E.N. Iodine status and thyroid function of Boston-area vegetarians and vegans. J Clin Endocrinol Metab. 2011; 96(8): E1303–7.
38. Shaikh M.G., Anderson J.M., Hall S.K. ja Jackson M.A. Transient neonatal hypothyroidism due to a maternal vegan diet. J Pediatr Endocrinol Metab. 2003; 16(1): 111–3.
39. Becker D.V., Braverman L.E., Delange F. ym. Iodine supplementation for pregnancy and lactation—United States and Canada: recommendations of the American Thyroid Association. Thyroid. 2006; 16(10): 949–51.
40. Vannice G. ja Rasmussen H. Position of the Academy of Nutrition and Dietetics: dietary fatty acids for healthy adults. J Acad Nutr Diet. 2014; 114(1): 136–53.
41. Harris W.S. Achieving optimal n-3 fatty acid status: the vegetarian’s challenge . . . or not. Am J Clin Nutr. 2014; 100 Suppl 1: 449S–52S.
42. Sarter B., Kelsey K.S., Schwartz T.A. ja Harris W.S. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement. Clin Nutr. 2015; 34(2): 212–8.
43. Bourdon J.A., Bazinet T.M., Arnason T.T., Kimpe L.E., Blais J.M. ja White P.A. Polychlorinated biphenyls (PCBs) contamination and aryl hydrocarbon receptor (AhR) agonist activity of omega-3 polyunsaturated fatty acid supplements: implications for daily intake of dioxins and PCBs. Food Chem Toxicol. 2010; 48(11): 3093–7.
44. Yokoo E.M., Valente J.G., Grattan L., Schmidt S.L., Platt I. ja Silbergeld E.K. Low level methylmercury exposure affects neuropsychological function in adults. Environ Health. 2003; 2(1): 8.
45. Chang J.W., Pai M.C., Chen H.L., Guo H.R., Su H.J. ja Lee C.C. Cognitive function and blood methylmercury in adults living near a deserted chloralkali factory. Environ Res. 2008; 108(3): 334–9.
46. Masley S.C., Masley L.V. ja Gualtierei T. Effect of mercury levels and seafood intake on cognitive function in middle- aged adults. Integr Med. 2012; 11(3)32–40.
47. Arterburn L.M., Oken H.A., Hoffman J.P. ym. Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food. Lipids. 2007; 42(11): 1011–24.
48. Greene J., Ashburn S.M., Razzouk L. ja Smith D.A. Fish oils, coronary heart disease, and the environment. Am J Public Health. 2013; 103(9): 1568–76.
49. Lane K., Derbyshire E., Li W. ja Brennan C. Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature. Crit Rev Food Sci Nutr. 2014; 54(5): 572–9.
50. Witte A.V., Kerti L., Hermannstädter H.M. ym. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex. 2014; 24(11): 3059–68.
51. Farmer B., Larson B.T., Fulgoni V.L., Rainville A.J. ja Liepa G.U. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the National Health and Nutrition Examination Survey 1999–2004. J Am Diet Assoc. 2011; 111(6): 819–27.
52. Moshfegh A., Goldman J. ja Cleveland L. What we eat in America, NHANES 2001–2002: usual nutrient intakes from food compared to dietary reference intakes. U.S. Department of Agriculture, Agricultural Research Service 2005.
53. Cogswell M.E., Zhang Z., Carriquiry A.L. ym. Sodium and potassium intakes among US adults: NHANES 2003–2008. Am J Clin Nutr. 2012; 96(3): 647–57.
54. Davis B. ja Melina V. Becoming Vegan: The Complete Guide to Adopting a Plant-Based Diet (Comprehensive Edition). Summertown, TN: Book Publishing Company; 2014.
55. Craig W.J. ja Mangels A.R. Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc. 2009; 109(7): 1266–82.
56. Spock B. Good nutrition for kids. Good Medicine. 1998; 7(2).